##fileformat=VCFv4.2
##fileDate=20230429
##source=freeBayes v1.3.6
##reference=/tmp/local_ngs_data_GRCh38//GRCh38.fa
##contig=<ID=chr1,length=248956422>
##contig=<ID=chr2,length=242193529>
##contig=<ID=chr3,length=198295559>
##contig=<ID=chr4,length=190214555>
##contig=<ID=chr5,length=181538259>
##contig=<ID=chr6,length=170805979>
##contig=<ID=chr7,length=159345973>
##contig=<ID=chr8,length=145138636>
##contig=<ID=chr9,length=138394717>
##contig=<ID=chr10,length=133797422>
##contig=<ID=chr11,length=135086622>
##contig=<ID=chr12,length=133275309>
##contig=<ID=chr13,length=114364328>
##contig=<ID=chr14,length=107043718>
##contig=<ID=chr15,length=101991189>
##contig=<ID=chr16,length=90338345>
##contig=<ID=chr17,length=83257441>
##contig=<ID=chr18,length=80373285>
##contig=<ID=chr19,length=58617616>
##contig=<ID=chr20,length=64444167>
##contig=<ID=chr22,length=50818468>
##phasing=none
##commandline="/mnt/storage2/megSAP/tools/freebayes-1.3.6/freebayes -t /tmp/594981.1.default_srv013/megSAP_user_bioinf/vc_freebayes_pid3230559_V2GnHh/chr1.bed --min-alternate-fraction 0.1 --min-mapping-quality 1 --min-base-quality 15 --min-alternate-count 3 --min-alternate-qsum 0 --genotype-qualities -f /tmp/local_ngs_data_GRCh38//GRCh38.fa -b /tmp/594981.1.default_srv013/megSAP_user_bioinf/local_bamSiBzeB/NA12878_03.bam -v /tmp/594981.1.default_srv013/megSAP_user_bioinf/vc_freebayes_pid3230559_V2GnHh/chr1.vcf"
##filter="QUAL > 5"
##ANALYSISTYPE=GERMLINE_SINGLESAMPLE
##PIPELINE=megSAP 2023_04-5-g9863e769
##SAMPLE=<ID=NA12878_03,Gender=female,ExternalSampleName=Coriell-DNA,IsTumor=no,IsFFPE=no,DiseaseGroup=Neoplasms,DiseaseStatus=affected>
##INFO=<ID=NS,Number=.,Type=Integer,Description="Number of samples with data">
##INFO=<ID=DP,Number=.,Type=Integer,Description="Total read depth at the locus">
##INFO=<ID=DPB,Number=.,Type=Float,Description="Total read depth per bp at the locus; bases in reads overlapping / bases in haplotype">
##INFO=<ID=AC,Number=A,Type=Integer,Description="Total number of alternate alleles in called genotypes">
##INFO=<ID=AN,Number=.,Type=Integer,Description="Total number of alleles in called genotypes">
##INFO=<ID=AF,Number=A,Type=Float,Description="Estimated allele frequency in the range (0,1]">
##INFO=<ID=RO,Number=.,Type=Integer,Description="Count of full observations of the reference haplotype.">
##INFO=<ID=AO,Number=A,Type=Integer,Description="Count of full observations of this alternate haplotype.">
##INFO=<ID=PRO,Number=.,Type=Float,Description="Reference allele observation count, with partial observations recorded fractionally">
##INFO=<ID=PAO,Number=A,Type=Float,Description="Alternate allele observations, with partial observations recorded fractionally">
##INFO=<ID=QR,Number=.,Type=Integer,Description="Reference allele quality sum in phred">
##INFO=<ID=QA,Number=A,Type=Integer,Description="Alternate allele quality sum in phred">
##INFO=<ID=PQR,Number=.,Type=Float,Description="Reference allele quality sum in phred for partial observations">
##INFO=<ID=PQA,Number=A,Type=Float,Description="Alternate allele quality sum in phred for partial observations">
##INFO=<ID=SRF,Number=.,Type=Integer,Description="Number of reference observations on the forward strand">
##INFO=<ID=SRR,Number=.,Type=Integer,Description="Number of reference observations on the reverse strand">
##INFO=<ID=SAF,Number=A,Type=Integer,Description="Number of alternate observations on the forward strand">
##INFO=<ID=SAR,Number=A,Type=Integer,Description="Number of alternate observations on the reverse strand">
##INFO=<ID=SRP,Number=.,Type=Float,Description="Strand balance probability for the reference allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SRF and SRR given E(SRF/SRR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=SAP,Number=A,Type=Float,Description="Strand balance probability for the alternate allele: Phred-scaled upper-bounds estimate of the probability of observing the deviation between SAF and SAR given E(SAF/SAR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=AB,Number=A,Type=Float,Description="Allele balance at heterozygous sites: a number between 0 and 1 representing the ratio of reads showing the reference allele to all reads, considering only reads from individuals called as heterozygous">
##INFO=<ID=ABP,Number=A,Type=Float,Description="Allele balance probability at heterozygous sites: Phred-scaled upper-bounds estimate of the probability of observing the deviation between ABR and ABA given E(ABR/ABA) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RUN,Number=A,Type=Integer,Description="Run length: the number of consecutive repeats of the alternate allele in the reference genome">
##INFO=<ID=RPP,Number=A,Type=Float,Description="Read Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPPR,Number=.,Type=Float,Description="Read Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between RPL and RPR given E(RPL/RPR) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=RPL,Number=A,Type=Float,Description="Reads Placed Left: number of reads supporting the alternate balanced to the left (5') of the alternate allele">
##INFO=<ID=RPR,Number=A,Type=Float,Description="Reads Placed Right: number of reads supporting the alternate balanced to the right (3') of the alternate allele">
##INFO=<ID=EPP,Number=A,Type=Float,Description="End Placement Probability: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=EPPR,Number=.,Type=Float,Description="End Placement Probability for reference observations: Phred-scaled upper-bounds estimate of the probability of observing the deviation between EL and ER given E(EL/ER) ~ 0.5, derived using Hoeffding's inequality">
##INFO=<ID=DPRA,Number=A,Type=Float,Description="Alternate allele depth ratio.  Ratio between depth in samples with each called alternate allele and those without.">
##INFO=<ID=ODDS,Number=.,Type=Float,Description="The log odds ratio of the best genotype combination to the second-best.">
##INFO=<ID=GTI,Number=.,Type=Integer,Description="Number of genotyping iterations required to reach convergence or bailout.">
##INFO=<ID=TYPE,Number=A,Type=String,Description="The type of allele, either snp, mnp, ins, del, or complex.">
##INFO=<ID=CIGAR,Number=A,Type=String,Description="The extended CIGAR representation of each alternate allele, with the exception that '=' is replaced by 'M' to ease VCF parsing.  Note that INDEL alleles do not have the first matched base (which is provided by default, per the spec) referred to by the CIGAR.">
##INFO=<ID=NUMALT,Number=.,Type=Integer,Description="Number of unique non-reference alleles in called genotypes at this position.">
##INFO=<ID=MEANALT,Number=A,Type=Float,Description="Mean number of unique non-reference allele observations per sample with the corresponding alternate alleles.">
##INFO=<ID=LEN,Number=A,Type=Integer,Description="allele length">
##INFO=<ID=MQM,Number=A,Type=Float,Description="Mean mapping quality of observed alternate alleles">
##INFO=<ID=MQMR,Number=.,Type=Float,Description="Mean mapping quality of observed reference alleles">
##INFO=<ID=PAIRED,Number=A,Type=Float,Description="Proportion of observed alternate alleles which are supported by properly paired read fragments">
##INFO=<ID=PAIREDR,Number=.,Type=Float,Description="Proportion of observed reference alleles which are supported by properly paired read fragments">
##INFO=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
##INFO=<ID=END,Number=1,Type=Integer,Description="Last position (inclusive) in gVCF output record.">
##INFO=<ID=technology.ILLUMINA,Number=A,Type=Float,Description="Fraction of observations supporting the alternate observed in reads from ILLUMINA">
##FILTER=<ID=off-target,Description="Variant marked as 'off-target'.">
##FILTER=<ID=low_mappability,Description="Variants in reads with low mapping score.">
##FILTER=<ID=mosaic,Description="Putative mosaic variants.">
##FORMAT=<ID=GT,Number=1,Type=String,Description="Genotype">
##FORMAT=<ID=GQ,Number=1,Type=Float,Description="Genotype Quality, the Phred-scaled marginal (or unconditional) probability of the called genotype">
##FORMAT=<ID=GL,Number=G,Type=Float,Description="Genotype Likelihood, log10-scaled likelihoods of the data given the called genotype for each possible genotype generated from the reference and alternate alleles given the sample ploidy">
##FORMAT=<ID=DP,Number=1,Type=Integer,Description="Read Depth">
##FORMAT=<ID=AD,Number=R,Type=Integer,Description="Number of observation for each allele">
##FORMAT=<ID=RO,Number=1,Type=Integer,Description="Reference allele observation count">
##FORMAT=<ID=QR,Number=1,Type=Integer,Description="Sum of quality of the reference observations">
##FORMAT=<ID=AO,Number=A,Type=Integer,Description="Alternate allele observation count">
##FORMAT=<ID=QA,Number=A,Type=Integer,Description="Sum of quality of the alternate observations">
##FORMAT=<ID=MIN_DP,Number=1,Type=Integer,Description="Minimum depth in gVCF output block.">
#CHROM	POS	ID	REF	ALT	QUAL	FILTER	INFO	FORMAT	NA12878_03
chr1	27355949	.	T	TG	2544	off-target	MQM=60;SAP=30;SAR=32;SAF=67;ABP=4	GT:DP:AO:GQ	0/1:191:99:139
chr1	27355990	.	G	A	2190	off-target	MQM=60;SAP=15;SAR=32;SAF=54;ABP=3	GT:DP:AO:GQ	0/1:168:86:143
chr1	27359572	.	G	C	6129	off-target	MQM=60;SAP=5;SAR=106;SAF=92;ABP=0	GT:DP:AO:GQ	1/1:199:198:142
chr1	27360975	.	G	T	9725	.	MQM=60;SAP=4;SAR=182;SAF=194;ABP=5	GT:DP:AO:GQ	0/1:729:376:137
chr1	27363272	.	C	T	362	off-target	MQM=60;SAP=8;SAR=5;SAF=11;ABP=3	GT:DP:AO:GQ	0/1:33:16:160
chr1	27363806	.	G	T	548	off-target	MQM=60;SAP=59;SAR=0;SAF=26;ABP=3	GT:DP:AO:GQ	0/1:54:26:147
chr1	27363868	.	T	C	1456	off-target	MQM=60;SAP=4;SAR=32;SAF=27;ABP=4	GT:DP:AO:GQ	0/1:111:59:160
chr1	27364153	.	A	G	652	off-target	MQM=60;SAP=4;SAR=14;SAF=18;ABP=18	GT:DP:AO:GQ	0/1:89:32:145
chr1	45330597	.	G	C	264	off-target	MQM=60;SAP=25;SAR=0;SAF=10;ABP=0	GT:DP:AO:GQ	1/1:10:10:75
chr1	45331833	.	C	G	3113	.	MQM=60;SAP=5;SAR=64;SAF=54;ABP=3	GT:DP:AO:GQ	0/1:231:118:139
chr1	45332883	.	T	C	5838	off-target	MQM=60;SAP=3;SAR=94;SAF=95;ABP=0	GT:DP:AO:GQ	1/1:189:189:139
chr1	62238462	.	A	G	2105	off-target	MQM=60;SAP=4;SAR=38;SAF=43;ABP=13	GT:DP:AO:GQ	0/1:137:81:138
chr1	62247304	.	CT	C	94	off-target	MQM=60;SAP=7;SAR=0;SAF=2;ABP=4	GT:DP:AO:GQ	0/1:6:2:16
chr1	62247304	.	CTT	C	94	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=3	GT:DP:AO:GQ	0/1:6:3:16
chr1	62247327	.	TG	T	34	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=5	GT:DP:AO:GQ	0/1:9:3:33
chr1	62247552	.	C	G	1165	.	MQM=60;SAP=4;SAR=21;SAF=16;ABP=0	GT:DP:AO:GQ	1/1:37:37:160
chr1	62247574	.	G	A	1316	.	MQM=60;SAP=3;SAR=26;SAF=25;ABP=7	GT:DP:AO:GQ	0/1:117:51:147
chr1	62247797	.	T	C	277	off-target	MQM=60;SAP=40;SAR=17;SAF=0;ABP=6	GT:DP:AO:GQ	0/1:41:17:153
chr1	62262956	.	C	T	54	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=9	GT:DP:AO:GQ	0/1:14:4:54
chr1	62263112	.	A	G	38141	.	MQM=60;SAP=5;SAR=581;SAF=615;ABP=0	GT:DP:AO:GQ	1/1:1196:1196:132
chr1	62263166	.	T	C	35318	.	MQM=60;SAP=4;SAR=554;SAF=581;ABP=0	GT:DP:AO:GQ	1/1:1135:1135:137
chr1	62263189	.	T	C	35829	.	MQM=60;SAP=5;SAR=556;SAF=586;ABP=0	GT:DP:AO:GQ	1/1:1143:1142:133
chr1	62263246	.	G	A	5604	.	MQM=60;SAP=31;SAR=69;SAF=118;ABP=0	GT:DP:AO:GQ	1/1:187:187:160
chr1	62263343	.	G	A	7385	off-target	MQM=60;SAP=11;SAR=127;SAF=98;ABP=0	GT:DP:AO:GQ	1/1:225:225:160
chr1	62266749	.	T	C	11428	.	MQM=60;SAP=3;SAR=226;SAF=232;ABP=5	GT:DP:AO:GQ	0/1:886:458:132
chr1	62268267	.	G	A	1684	off-target	MQM=60;SAP=3;SAR=35;SAF=35;ABP=5	GT:DP:AO:GQ	0/1:151:70:160
chr1	62271700	.	A	C	1498	off-target	MQM=60;SAP=4;SAR=33;SAF=27;ABP=5	GT:DP:AO:GQ	0/1:111:60:160
chr1	62273232	.	T	C	1812	.	MQM=60;SAP=9;SAR=38;SAF=25;ABP=0	GT:DP:AO:GQ	1/1:63:63:160
chr1	62273526	.	G	A	1760	.	MQM=60;SAP=10;SAR=42;SAF=27;ABP=3	GT:DP:AO:GQ	0/1:140:69:138
chr1	62274393	.	A	G	1459	.	MQM=60;SAP=3;SAR=32;SAF=29;ABP=4	GT:DP:AO:GQ	0/1:128:61:160
chr1	62274774	.	T	C	7547	.	MQM=60;SAP=5;SAR=128;SAF=113;ABP=0	GT:DP:AO:GQ	1/1:242:241:160
chr1	62274777	.	T	C	7547	.	MQM=60;SAP=5;SAR=128;SAF=113;ABP=0	GT:DP:AO:GQ	1/1:242:241:160
chr1	62275108	.	TA	T	275	off-target	MQM=60;SAP=3;SAR=11;SAF=12;ABP=95	GT:DP:AO:GQ	0/1:116:23:160
chr1	78112493	.	T	C	4986	.	MQM=60;SAP=4;SAR=99;SAF=89;ABP=10	GT:DP:AO:GQ	0/1:413:188:160
chr1	119915381	.	A	T	1771	.	MQM=60;SAP=3;SAR=35;SAF=37;ABP=6	GT:DP:AO:GQ	0/1:130:72:160
chr1	119918630	.	C	T	275	off-target	MQM=60;SAP=33;SAR=14;SAF=0;ABP=10	GT:DP:AO:GQ	0/1:20:14:70
chr1	119921542	.	C	T	2286	off-target	MQM=60;SAP=255;SAR=0;SAF=116;ABP=3	GT:DP:AO:GQ	0/1:225:116:160
chr1	119922762	.	C	T	45	.	MQM=60;SAP=287;SAR=0;SAF=131;ABP=337	GT:DP:AO:GQ	0/1:554:131:45
chr1	119923485	.	G	A	2706	off-target	MQM=60;SAP=435;SAR=0;SAF=199;ABP=8	GT:DP:AO:GQ	0/1:430:199:135
chr1	119929234	.	C	T	530	off-target	MQM=60;SAP=5;SAR=12;SAF=8;ABP=12	GT:DP:AO:GQ	0/1:29:20:140
chr1	119935375	.	C	A	290	off-target	MQM=60;SAP=3;SAR=6;SAF=6;ABP=6	GT:DP:AO:GQ	0/1:19:12:135
chr1	119935662	.	T	C	11660	off-target	MQM=60;SAP=3;SAR=230;SAF=225;ABP=4	GT:DP:AO:GQ	0/1:891:455:160
chr1	119938086	.	C	T	4896	off-target	MQM=60;SAP=3;SAR=94;SAF=95;ABP=4	GT:DP:AO:GQ	0/1:368:189:160
chr1	119941798	.	G	A	767	off-target	MQM=60;SAP=3;SAR=16;SAF=16;ABP=3	GT:DP:AO:GQ	0/1:65:32:141
chr1	119953496	.	A	T	7162	off-target	MQM=60;SAP=3;SAR=142;SAF=145;ABP=17	GT:DP:AO:GQ	0/1:638:287:151
chr1	119953504	.	A	C	7128	off-target	MQM=60;SAP=3;SAR=142;SAF=145;ABP=17	GT:DP:AO:GQ	0/1:638:287:151
chr1	119963373	.	G	C	2528	off-target	MQM=60;SAP=307;SAR=0;SAF=140;ABP=4	GT:DP:AO:GQ	0/1:290:140:133
chr1	119963485	.	G	A	2779	off-target	MQM=60;SAP=335;SAR=0;SAF=153;ABP=4	GT:DP:AO:GQ	0/1:297:153:140
chr1	119969481	.	T	C	18002	off-target	MQM=60;SAP=4;SAR=294;SAF=277;ABP=0	GT:DP:AO:GQ	1/1:571:571:135
chr1	119987127	.	A	C	11317	off-target	MQM=60;SAP=4;SAR=229;SAF=215;ABP=6	GT:DP:AO:GQ	0/1:921:444:160
chr2	17760156	.	T	G	1007	off-target	MQM=60;SAP=38;SAR=28;SAF=5;ABP=0	GT:DP:AO:GQ	1/1:33:33:151
chr2	17761508	.	T	A	3038	.	MQM=60;SAP=14;SAR=35;SAF=57;ABP=0	GT:DP:AO:GQ	1/1:92:92:150
chr2	17761748	.	T	C	583	off-target	MQM=60;SAP=55;SAR=24;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:24:24:141
chr2	17772760	.	G	A	972	.	MQM=60;SAP=22;SAR=7;SAF=23;ABP=0	GT:DP:AO:GQ	1/1:30:30:158
chr2	17772873	.	A	G	1069	off-target	MQM=60;SAP=16;SAR=23;SAF=9;ABP=0	GT:DP:AO:GQ	1/1:32:32:160
chr2	17773154	.	C	G	3002	off-target	MQM=60;SAP=4;SAR=43;SAF=50;ABP=0	GT:DP:AO:GQ	1/1:93:93:160
chr2	17773380	.	T	G	925	off-target	MQM=60;SAP=8;SAR=19;SAF=11;ABP=0	GT:DP:AO:GQ	1/1:30:30:160
chr2	17779783	.	A	G	581	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=0	GT:DP:AO:GQ	1/1:24:24:141
chr2	17781183	.	A	G	3083	.	MQM=60;SAP=84;SAR=18;SAF=78;ABP=0	GT:DP:AO:GQ	1/1:96:96:153
chr2	17781251	.	C	T	3598	.	MQM=60;SAP=3;SAR=55;SAF=57;ABP=0	GT:DP:AO:GQ	1/1:112:112:160
chr2	47369714	.	C	CG	254	off-target	MQM=60;SAP=4;SAR=8;SAF=6;ABP=6	GT:DP:AO:GQ	0/1:35:14:148
chr2	47373967	.	T	C	747	.	MQM=60;SAP=3;SAR=15;SAF=15;ABP=20	GT:DP:AO:GQ	0/1:42:30:160
chr2	47374118	.	T	C	6235	off-target	MQM=60;SAP=3;SAR=125;SAF=124;ABP=11	GT:DP:AO:GQ	0/1:543:249:160
chr2	47375102	.	T	C	228	off-target	MQM=60;SAP=31;SAR=0;SAF=13;ABP=3	GT:DP:AO:GQ	0/1:27:13:160
chr2	47379635	.	A	G	92	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=3	GT:DP:AO:GQ	0/1:12:6:89
chr2	47385017	.	A	G	730	off-target	MQM=60;SAP=5;SAR=13;SAF=19;ABP=7	GT:DP:AO:GQ	0/1:75:32:148
chr2	47408384	.	C	CT	53	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=7	GT:DP:AO:GQ	0/1:18:6:52
chr2	47412707	.	CT	C	86	off-target	MQM=60;SAP=90;SAR=40;SAF=0;ABP=227	GT:DP:AO:GQ	0/1:236:40:86
chr2	47445430	.	G	A	2070	off-target	MQM=60;SAP=218;SAR=0;SAF=99;ABP=4	GT:DP:AO:GQ	0/1:205:99:160
chr2	47783349	.	G	A	143	.	MQM=60;SAP=3;SAR=3;SAF=4;ABP=3	GT:DP:AO:GQ	0/1:14:7:138
chr2	47790891	.	A	G	10791	off-target	MQM=60;SAP=3;SAR=214;SAF=215;ABP=14	GT:DP:AO:GQ	0/1:927:429:160
chr2	47795761	.	A	G	179	off-target	MQM=60;SAP=18;SAR=0;SAF=7;ABP=0	GT:DP:AO:GQ	1/1:7:7:62
chr2	47795842	.	G	T	281	off-target	MQM=60;SAP=15;SAR=2;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:26:12:149
chr2	47803319	.	G	C	2021	off-target	MQM=60;SAP=37;SAR=17;SAF=49;ABP=0	GT:DP:AO:GQ	1/1:66:66:142
chr2	47803553	.	T	A	247	.	MQM=60;SAP=27;SAR=0;SAF=11;ABP=6	GT:DP:AO:GQ	0/1:17:11:94
chr2	47803699	.	A	T	2490	off-target	MQM=60;SAP=208;SAR=6;SAF=111;ABP=3	GT:DP:AO:GQ	0/1:238:117:160
chr2	47805735	.	ACTAT	A	603	off-target	MQM=60;SAP=8;SAR=9;SAF=17;ABP=6	GT:DP:AO:GQ	0/1:44:26:160
chr2	47805798	.	T	C	1373	off-target	MQM=60;SAP=13;SAR=15;SAF=29;ABP=0	GT:DP:AO:GQ	1/1:44:44:146
chr2	47806412	.	C	G	1514	off-target	MQM=60;SAP=5;SAR=27;SAF=21;ABP=0	GT:DP:AO:GQ	1/1:48:48:160
chr2	47806751	.	CT	C	285	off-target	MQM=60;SAP=7;SAR=5;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:31:15:129
chr2	146839405	.	A	G	10818	.	MQM=60;SAP=3;SAR=211;SAF=205;ABP=4	GT:DP:AO:GQ	0/1:817:416:160
chr2	189805813	.	T	TA	41	off-target	MQM=60;SAP=20;SAR=0;SAF=8;ABP=42	GT:DP:AO:GQ	0/1:44:8:41
chr2	189817906	.	G	C	2264	off-target	MQM=60;SAP=342;SAR=0;SAF=156;ABP=3	GT:DP:AO:GQ	0/1:315:156:145
chr2	214728509	.	T	C	1775	off-target	MQM=60;SAP=205;SAR=0;SAF=93;ABP=6	GT:DP:AO:GQ	0/1:202:93:160
chr2	214728537	.	C	CT	1673	off-target	MQM=60;SAP=93;SAR=10;SAF=66;ABP=166	GT:DP:AO:GQ	0/1:303:76:133
chr2	214729127	.	G	C	477	off-target	MQM=60;SAP=13;SAR=16;SAF=6;ABP=3	GT:DP:AO:GQ	0/1:46:22:160
chr2	214729147	.	T	G	493	off-target	MQM=60;SAP=13;SAR=16;SAF=6;ABP=3	GT:DP:AO:GQ	0/1:46:22:160
chr2	214730440	.	G	A	261	.	MQM=60;SAP=4;SAR=7;SAF=5;ABP=4	GT:DP:AO:GQ	0/1:27:12:152
chr2	214745589	.	G	T	647	off-target	MQM=60;SAP=47;SAR=28;SAF=3;ABP=4	GT:DP:AO:GQ	0/1:58:31:160
chr2	214745914	.	A	G	3825	off-target	MQM=60;SAP=3;SAR=71;SAF=69;ABP=4	GT:DP:AO:GQ	0/1:272:140:160
chr2	214767400	.	ATT	A	1470	off-target	MQM=60;SAP=6;SAR=35;SAF=26;ABP=6	GT:DP:AO:GQ	0/1:109:61:160
chr2	214767431	.	T	C	1555	off-target	MQM=60;SAP=5;SAR=35;SAF=27;ABP=7	GT:DP:AO:GQ	0/1:109:62:142
chr2	214767468	.	G	A	1787	off-target	MQM=60;SAP=4;SAR=35;SAF=30;ABP=8	GT:DP:AO:GQ	0/1:114:65:147
chr2	214767531	.	C	T	3056	.	MQM=60;SAP=29;SAR=44;SAF=17;ABP=6	GT:DP:AO:GQ	0/1:110:61:156
chr2	214767532	.	A	G	3056	.	MQM=60;SAP=18;SAR=32;SAF=14;ABP=9	GT:DP:AO:GQ	1/1:110:61:156
chr2	214769331	.	C	T	2564	off-target	MQM=60;SAP=262;SAR=125;SAF=2;ABP=5	GT:DP:AO:GQ	0/1:270:127:160
chr2	214780740	.	C	G	1090	.	MQM=60;SAP=8;SAR=26;SAF=16;ABP=4	GT:DP:AO:GQ	0/1:79:42:160
chr2	214792150	.	TA	T	242	off-target	MQM=60;SAP=3;SAR=6;SAF=6;ABP=29	GT:DP:AO:GQ	0/1:48:12:16
chr2	214809366	.	T	G	3868	off-target	MQM=60;SAP=3;SAR=60;SAF=60;ABP=0	GT:DP:AO:GQ	1/1:120:120:160
chr2	214809500	.	G	A	8454	.	MQM=60;SAP=3;SAR=193;SAF=190;ABP=5	GT:DP:AO:GQ	0/1:794:383:160
chr2	214809599	.	C	G	3328	off-target	MQM=60;SAP=9;SAR=64;SAF=47;ABP=0	GT:DP:AO:GQ	1/1:111:111:160
chr2	214809617	.	A	G	3281	off-target	MQM=60;SAP=8;SAR=64;SAF=48;ABP=0	GT:DP:AO:GQ	1/1:112:112:160
chr2	214809647	.	C	T	255	off-target	MQM=60;SAP=9;SAR=2;SAF=7;ABP=0	GT:DP:AO:GQ	1/1:9:9:74
chr2	219550873	.	GGA	G	4860	off-target	MQM=60;SAP=3;SAR=80;SAF=75;ABP=0	GT:DP:AO:GQ	1/1:157:155:145
chr2	219550924	.	T	C	4813	off-target	MQM=60;SAP=3;SAR=80;SAF=79;ABP=0	GT:DP:AO:GQ	1/1:161:159:160
chr2	219551442	.	T	C	2769	off-target	MQM=60;SAP=3;SAR=48;SAF=45;ABP=0	GT:DP:AO:GQ	1/1:94:93:147
chr2	219551848	.	C	T	341	off-target	MQM=60;SAP=31;SAR=13;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:13:13:98
chr2	219551869	.	C	T	331	off-target	MQM=60;SAP=31;SAR=13;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:13:13:98
chr2	219552081	.	A	T	37773	off-target	MQM=60;SAP=3;SAR=578;SAF=585;ABP=0	GT:DP:AO:GQ	1/1:1164:1163:160
chr2	219552220	.	G	C	1045	.	MQM=60;SAP=34;SAR=6;SAF=28;ABP=0	GT:DP:AO:GQ	1/1:34:34:148
chr2	219552506	.	G	T	2588	off-target	MQM=60;SAP=129;SAR=79;SAF=8;ABP=0	GT:DP:AO:GQ	1/1:88:87:150
chr2	219552544	.	C	T	4485	.	MQM=60;SAP=89;SAR=113;SAF=36;ABP=0	GT:DP:AO:GQ	1/1:149:149:138
chr2	219553189	.	T	C	104	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:4:4:44
chr2	219554514	.	T	C	14246	.	MQM=60;SAP=517;SAR=67;SAF=399;ABP=0	GT:DP:AO:GQ	1/1:467:466:139
chr2	219554617	.	T	C	21625	.	MQM=60;SAP=3;SAR=344;SAF=351;ABP=0	GT:DP:AO:GQ	1/1:695:695:137
chr2	219556234	.	A	G	1615	.	MQM=60;SAP=48;SAR=13;SAF=49;ABP=0	GT:DP:AO:GQ	1/1:62:62:146
chr2	219556695	.	C	G	23402	.	MQM=60;SAP=10;SAR=390;SAF=342;ABP=0	GT:DP:AO:GQ	1/1:732:732:160
chr2	219556734	.	C	A	22586	off-target	MQM=60;SAP=40;SAR=392;SAF=285;ABP=0	GT:DP:AO:GQ	1/1:677:677:146
chr2	219557307	.	G	A	4744	off-target	MQM=60;SAP=5;SAR=88;SAF=75;ABP=0	GT:DP:AO:GQ	1/1:163:163:160
chr2	219557678	.	C	G	10502	off-target	MQM=60;SAP=487;SAR=47;SAF=341;ABP=0	GT:DP:AO:GQ	1/1:388:388:160
chr2	219557964	.	C	T	525	.	MQM=60;SAP=38;SAR=24;SAF=3;ABP=5	GT:DP:AO:GQ	0/1:62:27:160
chr2	219558052	.	A	G	23993	.	MQM=60;SAP=9;SAR=354;SAF=399;ABP=0	GT:DP:AO:GQ	1/1:753:753:160
chr2	219563274	.	T	C	3272	off-target	MQM=60;SAP=6;SAR=62;SAF=49;ABP=0	GT:DP:AO:GQ	1/1:111:111:160
chr2	219563659	.	A	T	3399	off-target	MQM=60;SAP=15;SAR=76;SAF=50;ABP=9	GT:DP:AO:GQ	0/1:280:126:142
chr2	219565481	.	C	T	23710	.	MQM=60;SAP=15;SAR=402;SAF=337;ABP=0	GT:DP:AO:GQ	1/1:741:739:160
chr2	219567197	.	A	G	2115	off-target	MQM=60;SAP=4;SAR=33;SAF=37;ABP=0	GT:DP:AO:GQ	1/1:70:70:148
chr2	219567987	.	A	T	9163	off-target	MQM=60;SAP=3;SAR=175;SAF=175;ABP=5	GT:DP:AO:GQ	0/1:724:350:160
chr2	219570312	.	A	G	20447	.	MQM=60;SAP=3;SAR=322;SAF=330;ABP=0	GT:DP:AO:GQ	1/1:652:652:135
chr2	219570653	.	G	A	384	.	MQM=60;SAP=4;SAR=7;SAF=9;ABP=22	GT:DP:AO:GQ	0/1:19:16:0
chr3	10034299	.	T	C	2128	off-target	MQM=60;SAP=218;SAR=0;SAF=99;ABP=7	GT:DP:AO:GQ	0/1:217:99:139
chr3	10034307	.	A	G	1907	off-target	MQM=60;SAP=207;SAR=0;SAF=94;ABP=8	GT:DP:AO:GQ	0/1:211:94:137
chr3	10034324	.	CA	C	217	off-target	MQM=60;SAP=33;SAR=0;SAF=14;ABP=114	GT:DP:AO:GQ	0/1:99:14:91
chr3	10035158	.	CTT	C	1941	off-target	MQM=60;SAP=10;SAR=45;SAF=30;ABP=7	GT:DP:AO:GQ	0/1:168:75:160
chr3	10035291	.	A	C	1279	off-target	MQM=60;SAP=12;SAR=17;SAF=31;ABP=3	GT:DP:AO:GQ	0/1:99:48:160
chr3	10035339	.	T	C	1117	off-target	MQM=60;SAP=13;SAR=16;SAF=31;ABP=3	GT:DP:AO:GQ	0/1:94:47:139
chr3	10036271	.	A	G	553	off-target	MQM=60;SAP=66;SAR=0;SAF=29;ABP=10	GT:DP:AO:GQ	0/1:46:29:160
chr3	10039861	.	G	C	5185	off-target	MQM=60;SAP=3;SAR=115;SAF=114;ABP=6	GT:DP:AO:GQ	0/1:484:229:137
chr3	10041485	.	C	T	669	off-target	MQM=60;SAP=94;SAR=0;SAF=42;ABP=25	GT:DP:AO:GQ	0/1:119:42:138
chr3	10041842	.	CTT	C	171	off-target	MQM=60;SAP=3;SAR=6;SAF=6;ABP=5	GT:DP:AO:GQ	0/1:29:12:133
chr3	10042540	.	C	T	14508	off-target	MQM=60;SAP=3;SAR=275;SAF=275;ABP=14	GT:DP:AO:GQ	0/1:1027:550:160
chr3	10043351	.	G	T	1703	off-target	MQM=60;SAP=61;SAR=50;SAF=10;ABP=0	GT:DP:AO:GQ	1/1:60:60:152
chr3	10043446	.	C	G	62	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:10:4:62
chr3	10043852	.	A	G	2392	.	MQM=60;SAP=220;SAR=132;SAF=12;ABP=7	GT:DP:AO:GQ	0/1:312:144:160
chr3	10046838	.	G	A	377	off-target	MQM=23;SAP=15;SAR=25;SAF=11;ABP=13	GT:DP:AO:GQ	0/1:56:36:143
chr3	10048039	.	G	A	90	.	MQM=39;SAP=10;SAR=10;SAF=20;ABP=111	GT:DP:AO:GQ	0/1:145:30:90
chr3	10048089	.	A	C	1150	off-target	MQM=60;SAP=25;SAR=13;SAF=35;ABP=10	GT:DP:AO:GQ	0/1:116:48:143
chr3	10049568	.	A	C	82	off-target	MQM=15;SAP=3;SAR=21;SAF=21;ABP=9	GT:DP:AO:GQ	0/1:101:42:81
chr3	10049715	.	C	G	145	off-target	MQM=60;SAP=25;SAR=10;SAF=0;ABP=6	GT:DP:AO:GQ	0/1:26:10:138
chr3	10052522	.	A	AT	110	off-target	MQM=60;SAP=23;SAR=9;SAF=0;ABP=7	GT:DP:AO:GQ	0/1:25:9:108
chr3	10060167	.	C	CA	174	off-target	MQM=60;SAP=17;SAR=2;SAF=11;ABP=41	GT:DP:AO:GQ	0/1:58:13:140
chr3	10062350	.	C	T	389	off-target	MQM=60;SAP=3;SAR=10;SAF=9;ABP=9	GT:DP:AO:GQ	0/1:50:19:160
chr3	10064848	.	C	T	1274	.	MQM=60;SAP=4;SAR=26;SAF=22;ABP=14	GT:DP:AO:GQ	0/1:76:48:160
chr3	10065836	.	G	T	12204	off-target	MQM=60;SAP=3;SAR=242;SAF=242;ABP=7	GT:DP:AO:GQ	0/1:1013:484:160
chr3	10073118	.	T	C	121	off-target	MQM=60;SAP=18;SAR=0;SAF=7;ABP=5	GT:DP:AO:GQ	0/1:11:7:53
chr3	10077919	.	C	A	246	off-target	MQM=60;SAP=33;SAR=0;SAF=14;ABP=8	GT:DP:AO:GQ	0/1:21:14:58
chr3	10078233	.	T	C	741	off-target	MQM=60;SAP=4;SAR=15;SAF=18;ABP=4	GT:DP:AO:GQ	0/1:72:33:141
chr3	10086951	.	A	G	131	off-target	MQM=60;SAP=27;SAR=0;SAF=11;ABP=16	GT:DP:AO:GQ	0/1:37:11:130
chr3	10087281	.	C	CT	114	off-target	MQM=60;SAP=11;SAR=1;SAF=6;ABP=29	GT:DP:AO:GQ	0/1:34:7:49
chr3	10090440	.	C	G	25	off-target	MQM=57;SAP=29;SAR=12;SAF=0;ABP=13	GT:DP:AO:GQ	0/1:37:12:25
chr3	10092265	.	A	G	2563	off-target	MQM=60;SAP=5;SAR=53;SAF=43;ABP=6	GT:DP:AO:GQ	0/1:176:96:143
chr3	10094466	.	C	T	346	off-target	MQM=60;SAP=42;SAR=18;SAF=0;ABP=6	GT:DP:AO:GQ	0/1:30:18:160
chr3	10096385	.	T	G	9105	.	MQM=60;SAP=3;SAR=188;SAF=181;ABP=9	GT:DP:AO:GQ	0/1:785:369:133
chr3	10096505	.	T	C	2791	off-target	MQM=60;SAP=4;SAR=57;SAF=51;ABP=4	GT:DP:AO:GQ	0/1:206:108:160
chr3	10098987	.	G	A	10311	off-target	MQM=60;SAP=3;SAR=183;SAF=187;ABP=15	GT:DP:AO:GQ	0/1:680:370:132
chr3	10099012	.	A	G	7694	off-target	MQM=60;SAP=3;SAR=148;SAF=154;ABP=9	GT:DP:AO:GQ	0/1:566:302:160
chr3	10101065	.	TA	T	942	off-target	MQM=60;SAP=3;SAR=19;SAF=20;ABP=6	GT:DP:AO:GQ	0/1:90:39:160
chr3	36993455	.	G	A	510	off-target	MQM=60;SAP=5;SAR=10;SAF=15;ABP=3	GT:DP:AO:GQ	0/1:51:25:160
chr3	37006801	.	CA	C	128	off-target	MQM=60;SAP=44;SAR=0;SAF=19;ABP=133	GT:DP:AO:GQ	0/1:124:19:127
chr3	37025606	.	A	T	1529	off-target	MQM=60;SAP=58;SAR=15;SAF=58;ABP=104	GT:DP:AO:GQ	0/1:255:73:160
chr3	37025608	.	A	T	1529	off-target	MQM=60;SAP=58;SAR=15;SAF=58;ABP=104	GT:DP:AO:GQ	0/1:255:73:160
chr3	142449489	.	C	T	1594	.	MQM=60;SAP=4;SAR=22;SAF=27;ABP=0	GT:DP:AO:GQ	1/1:49:49:150
chr3	142459302	.	C	T	1052	.	MQM=60;SAP=8;SAR=26;SAF=16;ABP=4	GT:DP:AO:GQ	0/1:77:42:160
chr3	142465321	.	T	TA	35	off-target	MQM=60;SAP=3;SAR=4;SAF=3;ABP=44	GT:DP:AO:GQ	0/1:42:7:34
chr3	142469495	.	A	C	9936	.	MQM=60;SAP=4;SAR=197;SAF=186;ABP=26	GT:DP:AO:GQ	0/1:681:383:132
chr3	142496279	.	T	A	97	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=4	GT:DP:AO:GQ	0/1:10:6:64
chr3	142496280	.	A	T	97	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=4	GT:DP:AO:GQ	0/1:10:6:64
chr3	142496329	.	T	C	124	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=7	GT:DP:AO:GQ	0/1:8:6:4
chr3	142496336	.	A	C	124	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=7	GT:DP:AO:GQ	0/1:8:6:4
chr3	142498695	.	A	G	3564	.	MQM=60;SAP=345;SAR=5;SAF=172;ABP=3	GT:DP:AO:GQ	0/1:350:177:160
chr3	142512220	.	T	TA	20	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=24	GT:DP:AO:GQ	0/1:23:4:19
chr3	142536248	.	T	C	1313	off-target	MQM=60;SAP=6;SAR=30;SAF=21;ABP=5	GT:DP:AO:GQ	0/1:111:51:160
chr3	142540864	.	CA	C	9092	off-target	MQM=60;SAP=4;SAR=179;SAF=193;ABP=44	GT:DP:AO:GQ	0/1:873:372:160
chr3	142553472	.	G	A	104	off-target	MQM=60;SAP=18;SAR=7;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:12:7:44
chr3	142555897	.	A	AT	5	mosaic	MQM=60;SAP=3;SAR=5;SAF=5;ABP=142	GT:DP:AO:GQ	0/1:100:10:4
chr3	142558523	.	A	AAAAT	2882	off-target	MQM=60;SAP=303;SAR=0;SAF=138;ABP=11	GT:DP:AO:GQ	0/1:310:138:160
chr3	142558585	.	A	G	6988	off-target	MQM=60;SAP=5;SAR=147;SAF=132;ABP=6	GT:DP:AO:GQ	0/1:587:279:160
chr3	142558733	.	A	T	3159	.	MQM=60;SAP=13;SAR=52;SAF=76;ABP=6	GT:DP:AO:GQ	0/1:274:128:160
chr3	142562770	.	A	G	6583	.	MQM=60;SAP=3;SAR=129;SAF=129;ABP=4	GT:DP:AO:GQ	0/1:530:258:160
chr3	156677540	.	G	T	34	off-target	MQM=60;SAP=14;SAR=0;SAF=5;ABP=14	GT:DP:AO:GQ	0/1:20:5:33
chr3	156696129	.	T	C	17860	off-target	MQM=60;SAP=3;SAR=292;SAF=284;ABP=0	GT:DP:AO:GQ	1/1:577:576:139
chr3	156703736	.	G	T	6009	off-target	MQM=60;SAP=3;SAR=124;SAF=121;ABP=4	GT:DP:AO:GQ	0/1:474:245:138
chr3	156705283	.	A	T	83	off-target	MQM=60;SAP=14;SAR=5;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:8:5:28
chr3	179199217	.	A	G	850	off-target	MQM=60;SAP=3;SAR=16;SAF=18;ABP=11	GT:DP:AO:GQ	0/1:54:34:142
chr3	179203370	.	G	A	31	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=4	GT:DP:AO:GQ	0/1:8:3:31
chr3	179203465	.	G	GTAAA	74	off-target	MQM=60;SAP=7;SAR=4;SAF=1;ABP=8	GT:DP:AO:GQ	0/1:16:5:74
chr3	179203851	.	C	A	2511	off-target	MQM=60;SAP=31;SAR=53;SAF=22;ABP=0	GT:DP:AO:GQ	1/1:75:75:147
chr3	179204434	.	G	T	5347	off-target	MQM=60;SAP=334;SAR=217;SAF=25;ABP=3	GT:DP:AO:GQ	0/1:480:242:134
chr3	179204486	.	C	A	13699	off-target	MQM=60;SAP=643;SAR=428;SAF=52;ABP=0	GT:DP:AO:GQ	1/1:480:480:160
chr3	179204642	.	A	G	1931	off-target	MQM=60;SAP=8;SAR=38;SAF=26;ABP=0	GT:DP:AO:GQ	1/1:64:64:160
chr3	179210060	.	AT	A	2869	off-target	MQM=60;SAP=230;SAR=4;SAF=116;ABP=0	GT:DP:AO:GQ	1/1:142:120:160
chr3	179218439	.	T	G	2980	off-target	MQM=60;SAP=3;SAR=58;SAF=59;ABP=3	GT:DP:AO:GQ	0/1:233:117:142
chr3	179220959	.	A	T	4429	off-target	MQM=55;SAP=10;SAR=100;SAF=77;ABP=6	GT:DP:AO:GQ	0/1:375:177:136
chr3	179224643	.	C	G	183	off-target	MQM=60;SAP=18;SAR=7;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:7:7:62
chr4	185078433	.	T	A	686	off-target	MQM=60;SAP=75;SAR=0;SAF=33;ABP=4	GT:DP:AO:GQ	0/1:71:33:155
chr5	58321576	.	G	C	11940	.	MQM=60;SAP=3;SAR=233;SAF=233;ABP=3	GT:DP:AO:GQ	0/1:940:466:160
chr5	80654689	.	C	T	3077	off-target	MQM=60;SAP=4;SAR=53;SAF=59;ABP=0	GT:DP:AO:GQ	1/1:113:112:160
chr5	80654693	.	A	G	3077	off-target	MQM=60;SAP=4;SAR=53;SAF=59;ABP=0	GT:DP:AO:GQ	1/1:113:112:160
chr5	80654962	.	A	G	396	.	MQM=60;SAP=27;SAR=2;SAF=16;ABP=3	GT:DP:AO:GQ	0/1:38:18:160
chr5	80670359	.	G	A	5454	off-target	MQM=60;SAP=3;SAR=105;SAF=101;ABP=3	GT:DP:AO:GQ	0/1:416:206:141
chr5	80678827	.	T	C	3575	off-target	MQM=60;SAP=46;SAR=82;SAF=34;ABP=0	GT:DP:AO:GQ	1/1:116:116:147
chr5	80787812	.	G	A	938	off-target	MQM=60;SAP=81;SAR=36;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:36:36:160
chr5	80792642	.	CAG	C	4004	off-target	MQM=60;SAP=348;SAR=0;SAF=159;ABP=0	GT:DP:AO:GQ	1/1:159:159:160
chr5	80854162	.	A	G	28040	.	MQM=60;SAP=3;SAR=452;SAF=451;ABP=0	GT:DP:AO:GQ	1/1:903:903:140
chr5	80864777	.	AAATG	A	58	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=5	GT:DP:AO:GQ	0/1:16:6:58
chr5	80873118	.	G	A	3771	.	MQM=60;SAP=16;SAR=70;SAF=44;ABP=0	GT:DP:AO:GQ	1/1:114:114:153
chr5	80873351	.	G	A	1064	off-target	MQM=60;SAP=3;SAR=20;SAF=20;ABP=17	GT:DP:AO:GQ	0/1:60:40:160
chr5	112781076	.	A	G	35	off-target	MQM=60;SAP=10;SAR=3;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:7:3:35
chr5	112818847	.	C	CG	24	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=3	GT:DP:AO:GQ	0/1:7:3:23
chr5	112827157	.	T	C	1667	.	MQM=60;SAP=58;SAR=16;SAF=60;ABP=14	GT:DP:AO:GQ	0/1:183:76:160
chr5	112828864	.	G	A	2528	.	MQM=60;SAP=3;SAR=46;SAF=46;ABP=3	GT:DP:AO:GQ	0/1:180:92:160
chr5	112837409	.	T	TAGAA	1238	off-target	MQM=60;SAP=164;SAR=0;SAF=74;ABP=3	GT:DP:AO:GQ	0/1:145:74:160
chr5	112840073	.	G	A	5170	.	MQM=60;SAP=3;SAR=104;SAF=103;ABP=3	GT:DP:AO:GQ	0/1:423:207:160
chr5	112840628	.	G	A	233	.	MQM=60;SAP=31;SAR=13;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:26:13:160
chr5	112840862	.	T	G	3249	.	MQM=60;SAP=4;SAR=67;SAF=61;ABP=3	GT:DP:AO:GQ	0/1:261:128:138
chr5	112841059	.	T	A	4290	.	MQM=60;SAP=8;SAR=76;SAF=96;ABP=11	GT:DP:AO:GQ	0/1:381:172:160
chr5	112841474	.	G	A	9917	.	MQM=60;SAP=4;SAR=191;SAF=203;ABP=5	GT:DP:AO:GQ	0/1:812:394:131
chr5	132557287	.	G	A	1592	off-target	MQM=60;SAP=144;SAR=0;SAF=65;ABP=0	GT:DP:AO:GQ	1/1:66:65:160
chr5	132579521	.	G	A	1499	off-target	MQM=60;SAP=69;SAR=56;SAF=11;ABP=5	GT:DP:AO:GQ	0/1:145:67:160
chr5	132589791	.	G	C	814	.	MQM=60;SAP=3;SAR=16;SAF=17;ABP=3	GT:DP:AO:GQ	0/1:67:33:146
chr5	132595759	.	TA	T	0	mosaic	MQM=60;SAP=3;SAR=16;SAF=16;ABP=0	GT:DP:AO:GQ	0/1:928:32:142
chr5	132604212	.	T	G	291	off-target	MQM=60;SAP=46;SAR=20;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:43:20:144
chr5	132608437	.	G	A	54	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=5	GT:DP:AO:GQ	0/1:4:3:0
chr5	132638371	.	T	A	2451	off-target	MQM=60;SAP=272;SAR=124;SAF=0;ABP=10	GT:DP:AO:GQ	0/1:221:124:160
chr5	176906125	.	C	T	2882	off-target	MQM=60;SAP=223;SAR=118;SAF=6;ABP=3	GT:DP:AO:GQ	0/1:242:124:138
chr5	176907194	.	C	T	11593	off-target	MQM=60;SAP=3;SAR=216;SAF=217;ABP=205	GT:DP:AO:GQ	0/1:625:433:134
chr5	176911170	.	G	A	657	off-target	MQM=60;SAP=75;SAR=0;SAF=33;ABP=44	GT:DP:AO:GQ	0/1:39:33:0
chr5	176911287	.	C	T	3694	off-target	MQM=60;SAP=111;SAR=122;SAF=34;ABP=3	GT:DP:AO:GQ	0/1:318:156:132
chr5	176968372	.	CA	C	17	off-target	MQM=60;SAP=12;SAR=0;SAF=4;ABP=9	GT:DP:AO:GQ	0/1:14:4:16
chr6	35452851	.	A	C	67	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=3	GT:DP:AO:GQ	0/1:8:4:63
chr6	35455712	.	A	G	7908	off-target	MQM=60;SAP=3;SAR=155;SAF=154;ABP=4	GT:DP:AO:GQ	0/1:635:309:134
chr6	35455885	.	A	C	871	.	MQM=60;SAP=3;SAR=19;SAF=20;ABP=12	GT:DP:AO:GQ	0/1:98:39:143
chr6	35456411	.	A	G	1441	off-target	MQM=60;SAP=7;SAR=23;SAF=33;ABP=4	GT:DP:AO:GQ	0/1:106:56:143
chr6	35456491	.	A	G	513	off-target	MQM=60;SAP=3;SAR=10;SAF=10;ABP=26	GT:DP:AO:GQ	0/1:24:20:0
chr6	35456519	.	CT	C	20	off-target	MQM=60;SAP=10;SAR=3;SAF=0;ABP=10	GT:DP:AO:GQ	0/1:12:3:18
chr6	35457639	.	A	G	10898	off-target	MQM=60;SAP=3;SAR=208;SAF=205;ABP=3	GT:DP:AO:GQ	0/1:830:413:134
chr6	130827597	.	G	A	562	off-target	MQM=60;SAP=62;SAR=0;SAF=27;ABP=12	GT:DP:AO:GQ	0/1:41:27:160
chr6	130827723	.	A	T	4396	.	MQM=60;SAP=222;SAR=27;SAF=167;ABP=4	GT:DP:AO:GQ	0/1:373:194:160
chr6	130827751	.	C	CAT	6746	off-target	MQM=60;SAP=6;SAR=154;SAF=134;ABP=53	GT:DP:AO:GQ	0/1:703:288:139
chr6	130827886	.	C	T	2470	off-target	MQM=60;SAP=366;SAR=167;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:331:167:160
chr7	5987144	.	T	C	524	.	MQM=60;SAP=49;SAR=21;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:21:21:142
chr7	5997349	.	G	C	731	.	MQM=60;SAP=4;SAR=10;SAF=13;ABP=0	GT:DP:AO:GQ	1/1:23:23:147
chr7	5997426	.	G	GA	230	.	MQM=60;SAP=6;SAR=8;SAF=4;ABP=4	GT:DP:AO:GQ	0/1:28:12:147
chr7	5998989	.	CA	C	718	off-target	MQM=60;SAP=57;SAR=0;SAF=25;ABP=5	GT:DP:AO:GQ	0/1:44:25:113
chr7	5998989	.	CAA	C	718	off-target	MQM=60;SAP=27;SAR=0;SAF=11;ABP=27	GT:DP:AO:GQ	0/1:44:11:113
chr7	6008925	.	G	A	680	off-target	MQM=60;SAP=3;SAR=14;SAF=13;ABP=5	GT:DP:AO:GQ	0/1:48:27:149
chr7	6009173	.	G	C	58	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=4	GT:DP:AO:GQ	0/1:10:4:58
chr7	129203328	.	C	T	315	off-target	MQM=60;SAP=29;SAR=0;SAF=12;ABP=0	GT:DP:AO:GQ	1/1:12:12:92
chr7	129205177	.	C	T	6757	off-target	MQM=60;SAP=24;SAR=80;SAF=125;ABP=0	GT:DP:AO:GQ	1/1:205:205:150
chr7	129205436	.	G	C	1590	off-target	MQM=60;SAP=83;SAR=5;SAF=50;ABP=0	GT:DP:AO:GQ	1/1:55:55:160
chr7	129205484	.	G	A	1843	off-target	MQM=60;SAP=28;SAR=18;SAF=45;ABP=0	GT:DP:AO:GQ	1/1:63:63:145
chr7	129205861	.	C	T	1256	off-target	MQM=60;SAP=8;SAR=26;SAF=16;ABP=0	GT:DP:AO:GQ	1/1:42:42:151
chr7	129206066	.	T	C	113	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:4:4:44
chr7	129206487	.	G	C	28425	.	MQM=60;SAP=3;SAR=449;SAF=459;ABP=0	GT:DP:AO:GQ	1/1:908:908:160
chr7	129206628	.	A	G	27683	off-target	MQM=60;SAP=3;SAR=428;SAF=429;ABP=0	GT:DP:AO:GQ	1/1:857:857:148
chr7	129206716	.	C	CAG	25501	off-target	MQM=60;SAP=3;SAR=414;SAF=407;ABP=0	GT:DP:AO:GQ	1/1:827:821:139
chr7	129211961	.	G	A	699	off-target	MQM=60;SAP=63;SAR=2;SAF=33;ABP=8	GT:DP:AO:GQ	0/1:58:35:160
chr7	142749281	.	A	C	1605	off-target	MQM=59;SAP=168;SAR=0;SAF=76;ABP=0	GT:DP:AO:GQ	1/1:76:76:160
chr7	142749335	.	A	G	530	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:139
chr7	142749336	.	G	A	530	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:139
chr7	142749349	.	C	A	548	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:142
chr7	142749351	.	C	A	548	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:142
chr7	142749359	.	A	C	554	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:139
chr7	142749360	.	G	A	554	off-target	MQM=58;SAP=83;SAR=0;SAF=37;ABP=30	GT:DP:AO:GQ	0/1:111:37:139
chr7	142749392	.	G	A	1405	off-target	MQM=51;SAP=3;SAR=38;SAF=38;ABP=102	GT:DP:AO:GQ	0/1:261:76:142
chr7	142749413	.	T	A	1300	off-target	MQM=51;SAP=3;SAR=37;SAF=37;ABP=120	GT:DP:AO:GQ	0/1:268:74:146
chr7	142749434	.	G	C	185	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=153	GT:DP:AO:GQ	0/1:191:38:138
chr7	142749435	.	T	A	185	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=153	GT:DP:AO:GQ	0/1:191:38:138
chr7	142749439	.	G	C	185	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=153	GT:DP:AO:GQ	0/1:191:38:138
chr7	142749450	.	A	G	200	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=155	GT:DP:AO:GQ	0/1:192:38:160
chr7	142749452	.	T	C	200	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=155	GT:DP:AO:GQ	0/1:192:38:160
chr7	142749454	.	C	T	200	off-target	MQM=44;SAP=77;SAR=37;SAF=1;ABP=155	GT:DP:AO:GQ	0/1:192:38:160
chr7	142749466	.	T	A	73	off-target	MQM=44;SAP=79;SAR=38;SAF=1;ABP=194	GT:DP:AO:GQ	0/1:216:39:73
chr7	142749472	.	A	G	82	off-target	MQM=44;SAP=79;SAR=38;SAF=1;ABP=191	GT:DP:AO:GQ	0/1:214:39:82
chr7	142749506	.	A	G	228	.	MQM=44;SAP=77;SAR=37;SAF=1;ABP=148	GT:DP:AO:GQ	0/1:188:38:160
chr7	142749516	.	C	G	199	.	MQM=44;SAP=77;SAR=37;SAF=1;ABP=157	GT:DP:AO:GQ	0/1:193:38:135
chr7	142749524	.	C	G	230	.	MQM=44;SAP=83;SAR=37;SAF=0;ABP=112	GT:DP:AO:GQ	0/1:165:37:149
chr7	142749531	.	A	T	215	.	MQM=44;SAP=83;SAR=37;SAF=0;ABP=114	GT:DP:AO:GQ	0/1:166:37:141
chr7	142751804	.	C	T	0	mosaic	MQM=50;SAP=3;SAR=25;SAF=24;ABP=0	GT:DP:AO:GQ	0/1:1073:49:160
chr7	142751878	.	A	T	0	mosaic	MQM=50;SAP=3;SAR=25;SAF=25;ABP=0	GT:DP:AO:GQ	0/1:998:50:131
chr7	142751879	.	G	T	0	mosaic	MQM=50;SAP=3;SAR=25;SAF=25;ABP=0	GT:DP:AO:GQ	0/1:998:50:131
chr7	142751901	.	T	C	0	mosaic	MQM=50;SAP=3;SAR=25;SAF=25;ABP=0	GT:DP:AO:GQ	0/1:1009:50:160
chr7	142751903	.	A	G	0	mosaic	MQM=50;SAP=3;SAR=25;SAF=25;ABP=0	GT:DP:AO:GQ	0/1:1009:50:160
chr7	142752462	.	T	C	4335	.	MQM=60;SAP=13;SAR=68;SAF=96;ABP=225	GT:DP:AO:GQ	0/1:189:164:0
chr7	142752561	.	A	C	101	.	MQM=50;SAP=3;SAR=25;SAF=25;ABP=343	GT:DP:AO:GQ	0/1:326:50:101
chr7	142752564	.	T	C	101	.	MQM=50;SAP=3;SAR=25;SAF=25;ABP=343	GT:DP:AO:GQ	0/1:326:50:101
chr7	142752574	.	T	A	90	.	MQM=50;SAP=3;SAR=24;SAF=25;ABP=345	GT:DP:AO:GQ	0/1:324:49:90
chr7	142752596	.	G	T	801	off-target	MQM=50;SAP=3;SAR=25;SAF=25;ABP=94	GT:DP:AO:GQ	0/1:189:50:141
chr7	142752598	.	C	T	801	off-target	MQM=50;SAP=3;SAR=25;SAF=25;ABP=94	GT:DP:AO:GQ	0/1:189:50:141
chr7	142752612	.	T	C	395	off-target	MQM=40;SAP=57;SAR=25;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:45:25:160
chr7	142752616	.	C	A	395	off-target	MQM=40;SAP=57;SAR=25;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:45:25:160
chr7	142752631	.	G	A	413	off-target	MQM=40;SAP=57;SAR=25;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:51:25:160
chr7	142752643	.	A	C	376	off-target	MQM=40;SAP=55;SAR=24;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:50:24:146
chr7	142752644	.	A	C	376	off-target	MQM=40;SAP=55;SAR=24;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:50:24:146
chr7	142752651	.	GT	G	357	off-target	MQM=40;SAP=55;SAR=24;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:50:24:146
chr7	142752718	.	T	C	364	off-target	MQM=60;SAP=68;SAR=0;SAF=30;ABP=13	GT:DP:AO:GQ	0/1:79:30:142
chr7	142752752	.	A	G	1373	off-target	MQM=60;SAP=3;SAR=30;SAF=30;ABP=15	GT:DP:AO:GQ	0/1:148:60:160
chr7	142752760	.	G	A	1359	off-target	MQM=60;SAP=3;SAR=30;SAF=30;ABP=15	GT:DP:AO:GQ	0/1:148:60:160
chr7	142752812	.	A	C	1404	off-target	MQM=60;SAP=3;SAR=30;SAF=30;ABP=13	GT:DP:AO:GQ	0/1:146:60:146
chr7	142752844	.	C	A	127	off-target	MQM=60;SAP=3;SAR=30;SAF=30;ABP=448	GT:DP:AO:GQ	0/1:410:60:126
chr7	142752861	.	C	A	108	.	MQM=60;SAP=3;SAR=30;SAF=30;ABP=448	GT:DP:AO:GQ	0/1:410:60:108
chr7	142752862	.	C	T	108	.	MQM=60;SAP=3;SAR=30;SAF=30;ABP=448	GT:DP:AO:GQ	0/1:410:60:108
chr7	142752863	.	C	G	108	.	MQM=60;SAP=3;SAR=30;SAF=30;ABP=448	GT:DP:AO:GQ	0/1:410:60:108
chr7	142753014	.	T	C	10156	.	MQM=60;SAP=411;SAR=308;SAF=49;ABP=0	GT:DP:AO:GQ	1/1:357:357:141
chr8	89943130	.	C	T	1166	off-target	MQM=60;SAP=3;SAR=25;SAF=25;ABP=6	GT:DP:AO:GQ	0/1:112:50:141
chr8	89943396	.	T	A	411	off-target	MQM=60;SAP=18;SAR=14;SAF=3;ABP=4	GT:DP:AO:GQ	0/1:31:17:160
chr8	89946194	.	T	C	584	.	MQM=60;SAP=11;SAR=18;SAF=8;ABP=4	GT:DP:AO:GQ	0/1:47:26:160
chr8	89946302	.	T	C	380	.	MQM=60;SAP=12;SAR=12;SAF=4;ABP=4	GT:DP:AO:GQ	0/1:35:16:146
chr8	89955483	.	A	G	349	.	MQM=60;SAP=4;SAR=7;SAF=9;ABP=4	GT:DP:AO:GQ	0/1:37:16:160
chr8	89955634	.	G	T	747	off-target	MQM=60;SAP=6;SAR=17;SAF=11;ABP=4	GT:DP:AO:GQ	0/1:51:28:144
chr8	89958634	.	G	T	163	off-target	MQM=60;SAP=27;SAR=0;SAF=11;ABP=9	GT:DP:AO:GQ	0/1:31:11:137
chr8	89958707	.	G	A	463	off-target	MQM=60;SAP=19;SAR=4;SAF=16;ABP=6	GT:DP:AO:GQ	0/1:48:20:160
chr8	89978251	.	C	G	10738	.	MQM=60;SAP=3;SAR=211;SAF=205;ABP=3	GT:DP:AO:GQ	0/1:828:416:160
chr8	89982791	.	C	T	99	.	MQM=60;SAP=18;SAR=7;SAF=0;ABP=6	GT:DP:AO:GQ	0/1:19:7:98
chr8	106223973	.	A	C	413	off-target	MQM=60;SAP=5;SAR=5;SAF=9;ABP=0	GT:DP:AO:GQ	1/1:15:14:91
chr8	106224052	.	G	T	20602	.	MQM=60;SAP=4;SAR=333;SAF=317;ABP=0	GT:DP:AO:GQ	1/1:650:650:160
chr9	5919543	.	A	AAC	427	off-target	MQM=60;SAP=9;SAR=7;SAF=15;ABP=25	GT:DP:AO:GQ	0/1:71:22:160
chr9	5921881	.	G	A	15245	.	MQM=60;SAP=5;SAR=296;SAF=273;ABP=15	GT:DP:AO:GQ	0/1:1061:569:160
chr9	17235644	.	AT	A	537	off-target	MQM=60;SAP=16;SAR=6;SAF=18;ABP=6	GT:DP:AO:GQ	0/1:40:24:142
chr9	17273880	.	A	G	1161	.	MQM=60;SAP=4;SAR=21;SAF=25;ABP=30	GT:DP:AO:GQ	0/1:64:46:150
chr9	17273928	.	C	G	189	off-target	MQM=60;SAP=3;SAR=4;SAF=4;ABP=3	GT:DP:AO:GQ	0/1:16:8:145
chr9	17298549	.	C	G	78	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:7:4:51
chr9	17308970	.	ATG	A	8824	off-target	MQM=60;SAP=765;SAR=0;SAF=351;ABP=0	GT:DP:AO:GQ	1/1:357:351:160
chr9	17330560	.	T	A	338	off-target	MQM=60;SAP=3;SAR=7;SAF=7;ABP=7	GT:DP:AO:GQ	0/1:22:14:143
chr9	17332486	.	AT	A	393	off-target	MQM=60;SAP=33;SAR=0;SAF=14;ABP=3	GT:DP:AO:GQ	0/1:26:14:71
chr9	17332486	.	ATT	A	393	off-target	MQM=60;SAP=18;SAR=0;SAF=7;ABP=15	GT:DP:AO:GQ	0/1:26:7:71
chr9	17342385	.	C	T	983	.	MQM=60;SAP=13;SAR=21;SAF=9;ABP=0	GT:DP:AO:GQ	1/1:30:30:155
chr9	17394538	.	C	T	1783	.	MQM=60;SAP=3;SAR=28;SAF=28;ABP=0	GT:DP:AO:GQ	1/1:56:56:149
chr9	17394998	.	T	C	3143	.	MQM=60;SAP=3;SAR=49;SAF=49;ABP=0	GT:DP:AO:GQ	1/1:98:98:160
chr9	17395110	.	C	T	6825	off-target	MQM=60;SAP=3;SAR=107;SAF=108;ABP=0	GT:DP:AO:GQ	1/1:215:215:160
chr9	17409193	.	A	G	69	off-target	MQM=60;SAP=12;SAR=0;SAF=4;ABP=3	GT:DP:AO:GQ	0/1:9:4:68
chr9	17409368	.	G	A	12154	.	MQM=60;SAP=3;SAR=192;SAF=192;ABP=0	GT:DP:AO:GQ	1/1:384:384:160
chr9	17457514	.	TA	T	104	.	MQM=60;SAP=12;SAR=4;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:4:4:27
chr9	17457856	.	A	G	6003	off-target	MQM=60;SAP=509;SAR=233;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:233:233:160
chr9	17464404	.	G	C	9088	off-target	MQM=60;SAP=3;SAR=157;SAF=160;ABP=0	GT:DP:AO:GQ	1/1:317:317:160
chr9	17494735	.	C	T	715	off-target	MQM=60;SAP=81;SAR=0;SAF=36;ABP=10	GT:DP:AO:GQ	0/1:58:36:160
chr9	17494876	.	CT	C	218	off-target	MQM=60;SAP=9;SAR=1;SAF=5;ABP=26	GT:DP:AO:GQ	0/1:30:6:36
chr9	17494876	.	CTTT	C	218	off-target	MQM=60;SAP=14;SAR=0;SAF=5;ABP=32	GT:DP:AO:GQ	0/1:30:5:36
chr9	21974623	.	T	C	11	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:6:4:0
chr9	21974672	.	A	C	136	.	MQM=60;SAP=42;SAR=18;SAF=0;ABP=10	GT:DP:AO:GQ	0/1:27:18:0
chr9	21974676	.	A	C	136	.	MQM=60;SAP=42;SAR=18;SAF=0;ABP=10	GT:DP:AO:GQ	0/1:27:18:0
chr9	21975018	.	C	T	803	off-target	MQM=60;SAP=70;SAR=31;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:31:31:145
chr9	35074920	.	T	C	3127	.	MQM=60;SAP=6;SAR=55;SAF=44;ABP=0	GT:DP:AO:GQ	1/1:99:99:160
chr9	35077444	.	T	C	6869	off-target	MQM=60;SAP=3;SAR=104;SAF=103;ABP=0	GT:DP:AO:GQ	1/1:207:207:160
chr9	35079364	.	G	T	5329	off-target	MQM=60;SAP=22;SAR=66;SAF=105;ABP=0	GT:DP:AO:GQ	1/1:171:171:160
chr9	87447908	.	A	G	14935	.	MQM=60;SAP=740;SAR=52;SAF=475;ABP=0	GT:DP:AO:GQ	1/1:527:527:140
chr9	95247331	.	T	TA	56	off-target	MQM=60;SAP=3;SAR=4;SAF=4;ABP=57	GT:DP:AO:GQ	0/1:52:8:55
chr9	95447312	.	G	A	1196	.	MQM=60;SAP=4;SAR=21;SAF=26;ABP=19	GT:DP:AO:GQ	0/1:71:47:147
chr9	95468642	.	A	AT	84	off-target	MQM=60;SAP=4;SAR=6;SAF=9;ABP=123	GT:DP:AO:GQ	0/1:107:15:83
chr9	95469941	.	GA	G	562	.	MQM=60;SAP=72;SAR=32;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:59:32:160
chr9	95476908	.	G	C	1285	off-target	MQM=60;SAP=16;SAR=13;SAF=29;ABP=0	GT:DP:AO:GQ	1/1:42:42:160
chr10	43100333	.	G	T	320	off-target	MQM=60;SAP=31;SAR=13;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:13:13:98
chr10	43100388	.	AT	A	716	off-target	MQM=60;SAP=22;SAR=8;SAF=25;ABP=3	GT:DP:AO:GQ	0/1:67:33:160
chr10	43100520	.	A	G	16260	.	MQM=60;SAP=4;SAR=268;SAF=256;ABP=0	GT:DP:AO:GQ	1/1:524:524:160
chr10	43106301	.	T	C	1737	off-target	MQM=60;SAP=3;SAR=28;SAF=28;ABP=0	GT:DP:AO:GQ	1/1:56:56:160
chr10	43108942	.	A	T	3924	off-target	MQM=60;SAP=121;SAR=25;SAF=111;ABP=0	GT:DP:AO:GQ	1/1:136:136:160
chr10	43114918	.	G	A	1996	off-target	MQM=60;SAP=170;SAR=77;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:77:77:138
chr10	43116417	.	T	C	806	off-target	MQM=60;SAP=62;SAR=0;SAF=27;ABP=0	GT:DP:AO:GQ	1/1:27:27:160
chr10	43116778	.	C	T	2426	off-target	MQM=60;SAP=215;SAR=132;SAF=13;ABP=8	GT:DP:AO:GQ	0/1:317:145:136
chr10	43118395	.	G	T	37788	.	MQM=60;SAP=3;SAR=582;SAF=575;ABP=0	GT:DP:AO:GQ	1/1:1157:1157:140
chr10	43120057	.	G	A	9252	off-target	MQM=60;SAP=3;SAR=189;SAF=183;ABP=3	GT:DP:AO:GQ	0/1:734:372:160
chr10	43126769	.	T	C	1179	off-target	MQM=60;SAP=88;SAR=1;SAF=42;ABP=0	GT:DP:AO:GQ	1/1:43:43:148
chr10	43126920	.	T	A	1115	off-target	MQM=60;SAP=96;SAR=43;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:43:43:148
chr10	43128364	.	C	T	7101	off-target	MQM=60;SAP=9;SAR=148;SAF=121;ABP=10	GT:DP:AO:GQ	0/1:499:269:133
chr10	86876022	.	C	A	850	.	MQM=52;SAP=4;SAR=22;SAF=18;ABP=5	GT:DP:AO:GQ	0/1:71:40:141
chr10	86890006	.	C	T	672	off-target	MQM=60;SAP=15;SAR=7;SAF=19;ABP=3	GT:DP:AO:GQ	0/1:53:26:147
chr10	86918991	.	A	T	159	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=0	GT:DP:AO:GQ	1/1:6:6:56
chr10	86923240	.	A	AGAT	4998	off-target	MQM=60;SAP=559;SAR=0;SAF=256;ABP=11	GT:DP:AO:GQ	0/1:558:256:131
chr10	86923242	.	T	TATATA	4998	off-target	MQM=60;SAP=559;SAR=0;SAF=256;ABP=11	GT:DP:AO:GQ	0/1:558:256:131
chr10	86923365	.	T	C	5533	off-target	MQM=60;SAP=431;SAR=251;SAF=20;ABP=22	GT:DP:AO:GQ	0/1:615:271:131
chr10	87893929	.	A	G	115	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=0	GT:DP:AO:GQ	1/1:4:4:44
chr10	87931195	.	T	TTTATC	915	off-target	MQM=60;SAP=6;SAR=21;SAF=14;ABP=12	GT:DP:AO:GQ	0/1:55:35:142
chr10	87961150	.	T	G	251	off-target	MQM=60;SAP=36;SAR=0;SAF=15;ABP=3	GT:DP:AO:GQ	0/1:29:15:160
chr10	102504350	.	C	T	9851	.	MQM=60;SAP=898;SAR=412;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:412:412:160
chr10	102509460	.	G	A	160	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:6:6:56
chr10	102597065	.	A	G	2286	off-target	MQM=60;SAP=3;SAR=35;SAF=39;ABP=0	GT:DP:AO:GQ	1/1:74:74:160
chr10	102618931	.	CGTGT	C	367	off-target	MQM=60;SAP=3;SAR=5;SAF=6;ABP=13	GT:DP:AO:GQ	0/1:35:11:137
chr10	102618931	.	CGTGTGT	C	367	off-target	MQM=60;SAP=8;SAR=3;SAF=8;ABP=13	GT:DP:AO:GQ	0/1:35:11:137
chr10	102627262	.	T	C	14838	.	MQM=60;SAP=4;SAR=301;SAF=283;ABP=5	GT:DP:AO:GQ	0/1:1198:584:130
chr10	102630175	.	T	G	59563	.	MQM=60;SAP=4;SAR=925;SAF=960;ABP=0	GT:DP:AO:GQ	1/1:1886:1885:160
chr11	13081343	.	C	A	22540	off-target	MQM=60;SAP=3;SAR=444;SAF=435;ABP=3	GT:DP:AO:GQ	0/1:1762:879:131
chr11	13081377	.	G	A	297	.	MQM=60;SAP=19;SAR=12;SAF=2;ABP=3	GT:DP:AO:GQ	0/1:26:14:147
chr11	22624479	.	G	A	925	off-target	MQM=60;SAP=83;SAR=0;SAF=37;ABP=0	GT:DP:AO:GQ	1/1:37:37:160
chr11	64804546	.	T	C	8209	.	MQM=60;SAP=22;SAR=152;SAF=105;ABP=0	GT:DP:AO:GQ	1/1:257:257:160
chr11	64804931	.	C	G	458	off-target	MQM=60;SAP=3;SAR=10;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:42:20:160
chr11	64805085	.	A	G	6551	.	MQM=60;SAP=38;SAR=73;SAF=130;ABP=0	GT:DP:AO:GQ	1/1:203:203:160
chr11	64810148	.	G	C	195	off-target	MQM=60;SAP=36;SAR=0;SAF=15;ABP=4	GT:DP:AO:GQ	0/1:33:15:142
chr11	94479764	.	TA	T	338	mosaic	MQM=60;SAP=3;SAR=10;SAF=10;ABP=937	GT:DP:AO:GQ	0/1:507:59:160
chr11	108229378	.	G	GT	408	off-target	MQM=60;SAP=6;SAR=8;SAF=13;ABP=4	GT:DP:AO:GQ	0/1:47:21:29
chr11	108229378	.	G	GTT	408	off-target	MQM=60;SAP=9;SAR=2;SAF=7;ABP=42	GT:DP:AO:GQ	0/1:47:9:29
chr11	108243934	.	AT	A	63	off-target	MQM=60;SAP=19;SAR=4;SAF=16;ABP=152	GT:DP:AO:GQ	0/1:137:20:63
chr11	108244633	.	AT	A	6784	off-target	MQM=60;SAP=622;SAR=0;SAF=285;ABP=0	GT:DP:AO:GQ	1/1:314:285:160
chr11	108258930	.	A	G	38	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=12	GT:DP:AO:GQ	0/1:16:4:38
chr11	108271228	.	CTT	C	340	off-target	MQM=60;SAP=3;SAR=14;SAF=14;ABP=156	GT:DP:AO:GQ	0/1:163:28:67
chr11	108279480	.	CT	C	889	.	MQM=60;SAP=3;SAR=19;SAF=19;ABP=14	GT:DP:AO:GQ	0/1:98:38:141
chr11	108280980	.	T	TA	1037	off-target	MQM=60;SAP=29;SAR=31;SAF=9;ABP=3	GT:DP:AO:GQ	0/1:76:40:160
chr11	108284670	.	G	A	113	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:15:6:112
chr11	108299544	.	G	A	199	off-target	MQM=60;SAP=29;SAR=0;SAF=12;ABP=7	GT:DP:AO:GQ	0/1:18:12:68
chr11	108304667	.	T	C	161	.	MQM=60;SAP=13;SAR=1;SAF=7;ABP=4	GT:DP:AO:GQ	0/1:14:8:106
chr11	108304735	.	G	A	388	.	MQM=60;SAP=3;SAR=8;SAF=8;ABP=3	GT:DP:AO:GQ	0/1:30:16:149
chr11	108312686	.	ACT	A	150	off-target	MQM=60;SAP=25;SAR=10;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:23:10:138
chr11	108325249	.	GT	G	85	off-target	MQM=60;SAP=7;SAR=1;SAF=4;ABP=3	GT:DP:AO:GQ	0/1:9:5:22
chr11	108325985	.	CATT	C	211	off-target	MQM=60;SAP=15;SAR=2;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:23:12:160
chr11	108347469	.	T	C	103	off-target	MQM=60;SAP=16;SAR=6;SAF=0;ABP=7	GT:DP:AO:GQ	0/1:8:6:4
chr11	108353970	.	G	A	82	off-target	MQM=60;SAP=10;SAR=3;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:3:3:38
chr11	108354070	.	A	C	35	off-target	MQM=60;SAP=10;SAR=3;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:6:3:30
chr11	108354756	.	C	T	1990	off-target	MQM=60;SAP=6;SAR=43;SAF=33;ABP=4	GT:DP:AO:GQ	0/1:159:76:139
chr11	108354934	.	A	G	4410	off-target	MQM=60;SAP=3;SAR=80;SAF=80;ABP=19	GT:DP:AO:GQ	0/1:275:160:140
chr11	117226141	.	CT	C	337	off-target	MQM=60;SAP=3;SAR=9;SAF=9;ABP=13	GT:DP:AO:GQ	0/1:51:18:160
chr11	125627571	.	G	T	1071	off-target	MQM=60;SAP=118;SAR=0;SAF=53;ABP=3	GT:DP:AO:GQ	0/1:108:53:135
chr11	125644678	.	G	A	843	off-target	MQM=60;SAP=56;SAR=39;SAF=6;ABP=9	GT:DP:AO:GQ	0/1:107:45:160
chr11	125655300	.	A	G	1971	.	MQM=60;SAP=11;SAR=22;SAF=37;ABP=0	GT:DP:AO:GQ	1/1:59:59:160
chr12	57748708	.	CT	C	38	off-target	MQM=60;SAP=6;SAR=8;SAF=4;ABP=100	GT:DP:AO:GQ	0/1:86:12:38
chr12	57749071	.	C	A	1485	off-target	MQM=60;SAP=3;SAR=28;SAF=29;ABP=4	GT:DP:AO:GQ	0/1:107:57:160
chr12	57750882	.	C	T	1964	off-target	MQM=60;SAP=9;SAR=32;SAF=47;ABP=3	GT:DP:AO:GQ	0/1:162:79:160
chr12	57751373	.	C	T	5488	off-target	MQM=60;SAP=225;SAR=199;SAF=42;ABP=25	GT:DP:AO:GQ	0/1:417:241:160
chr13	32316435	.	G	A	1359	off-target	MQM=60;SAP=6;SAR=22;SAF=31;ABP=6	GT:DP:AO:GQ	0/1:118:53:160
chr13	32326796	.	T	A	52	off-target	MQM=60;SAP=10;SAR=3;SAF=0;ABP=5	GT:DP:AO:GQ	0/1:4:3:0
chr13	32329548	.	C	T	606	off-target	MQM=60;SAP=6;SAR=15;SAF=9;ABP=4	GT:DP:AO:GQ	0/1:44:24:147
chr13	32331082	.	A	AT	119	off-target	MQM=60;SAP=3;SAR=9;SAF=9;ABP=103	GT:DP:AO:GQ	0/1:106:18:119
chr13	32331128	.	G	A	4204	off-target	MQM=60;SAP=13;SAR=78;SAF=53;ABP=0	GT:DP:AO:GQ	1/1:131:131:160
chr13	32336191	.	T	C	804	off-target	MQM=60;SAP=13;SAR=11;SAF=24;ABP=5	GT:DP:AO:GQ	0/1:79:35:160
chr13	32337751	.	A	G	835	.	MQM=60;SAP=8;SAR=23;SAF=14;ABP=3	GT:DP:AO:GQ	0/1:75:37:156
chr13	32338918	.	A	G	32017	.	MQM=60;SAP=9;SAR=520;SAF=468;ABP=0	GT:DP:AO:GQ	1/1:989:988:160
chr13	32340868	.	G	C	857	.	MQM=60;SAP=15;SAR=7;SAF=19;ABP=0	GT:DP:AO:GQ	1/1:26:26:146
chr13	32346707	.	T	C	122	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=0	GT:DP:AO:GQ	1/1:4:4:44
chr13	32355095	.	A	G	437	.	MQM=60;SAP=4;SAR=8;SAF=11;ABP=3	GT:DP:AO:GQ	0/1:38:19:160
chr13	32355250	.	T	C	19385	.	MQM=60;SAP=5;SAR=311;SAF=287;ABP=0	GT:DP:AO:GQ	1/1:598:598:139
chr13	32362509	.	T	C	2098	off-target	MQM=60;SAP=9;SAR=38;SAF=25;ABP=0	GT:DP:AO:GQ	1/1:63:63:160
chr13	32376521	.	C	CA	139	off-target	MQM=60;SAP=23;SAR=0;SAF=9;ABP=23	GT:DP:AO:GQ	0/1:36:9:84
chr13	32379251	.	T	C	7189	off-target	MQM=60;SAP=312;SAR=32;SAF=222;ABP=0	GT:DP:AO:GQ	1/1:254:254:135
chr13	79192053	.	A	G	10963	.	MQM=60;SAP=4;SAR=206;SAF=221;ABP=5	GT:DP:AO:GQ	0/1:825:427:160
chr14	45137184	.	A	G	593	.	MQM=60;SAP=5;SAR=15;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:53:25:160
chr14	67823655	.	T	G	6800	off-target	MQM=60;SAP=4;SAR=126;SAF=135;ABP=3	GT:DP:AO:GQ	0/1:523:261:142
chr14	67823709	.	T	C	126	off-target	MQM=60;SAP=23;SAR=0;SAF=9;ABP=8	GT:DP:AO:GQ	0/1:26:9:125
chr14	67823747	.	G	A	212	off-target	MQM=60;SAP=10;SAR=9;SAF=3;ABP=11	GT:DP:AO:GQ	0/1:35:12:143
chr14	67823803	.	T	G	149	off-target	MQM=60;SAP=23;SAR=9;SAF=0;ABP=6	GT:DP:AO:GQ	0/1:24:9:142
chr14	67835050	.	G	GA	2995	off-target	MQM=60;SAP=3;SAR=62;SAF=62;ABP=3	GT:DP:AO:GQ	0/1:252:124:136
chr14	67864958	.	A	T	12476	off-target	MQM=60;SAP=1019;SAR=2;SAF=474;ABP=0	GT:DP:AO:GQ	1/1:484:476:160
chr14	67865241	.	CT	C	213	off-target	MQM=60;SAP=3;SAR=7;SAF=7;ABP=18	GT:DP:AO:GQ	0/1:46:14:149
chr14	68477457	.	C	T	173	off-target	MQM=60;SAP=25;SAR=0;SAF=10;ABP=3	GT:DP:AO:GQ	0/1:19:10:139
chr14	68477626	.	CT	C	780	off-target	MQM=60;SAP=103;SAR=6;SAF=62;ABP=357	GT:DP:AO:GQ	0/1:387:68:160
chr14	103699416	.	G	A	12819	.	MQM=60;SAP=3;SAR=247;SAF=248;ABP=5	GT:DP:AO:GQ	0/1:960:495:160
chr14	104773454	.	C	A	0	mosaic	MQM=60;SAP=3;SAR=10;SAF=8;ABP=0	GT:DP:AO:GQ	0/1:305:18:141
chr14	104773959	.	T	G	41	.	MQM=59;SAP=83;SAR=0;SAF=37;ABP=66	GT:DP:AO:GQ	0/1:137:37:40
chr14	104776629	.	T	C	1967	off-target	MQM=60;SAP=13;SAR=49;SAF=30;ABP=16	GT:DP:AO:GQ	0/1:130:79:160
chr14	104792555	.	C	T	3635	off-target	MQM=60;SAP=15;SAR=68;SAF=43;ABP=0	GT:DP:AO:GQ	1/1:111:111:147
chr14	104792556	.	A	G	3635	off-target	MQM=60;SAP=15;SAR=68;SAF=43;ABP=0	GT:DP:AO:GQ	1/1:111:111:147
chr15	40701376	.	CT	C	41	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=17	GT:DP:AO:GQ	0/1:19:4:1
chr15	40706144	.	T	G	1309	off-target	MQM=60;SAP=28;SAR=40;SAF=15;ABP=6	GT:DP:AO:GQ	0/1:99:55:160
chr15	40719057	.	C	CT	17	off-target	MQM=60;SAP=46;SAR=20;SAF=0;ABP=117	GT:DP:AO:GQ	0/1:119:20:5
chr15	40729372	.	CA	C	368	off-target	MQM=60;SAP=20;SAR=0;SAF=8;ABP=91	GT:DP:AO:GQ	0/1:69:8:25
chr15	40729372	.	CAA	C	368	off-target	MQM=60;SAP=27;SAR=0;SAF=11;ABP=73	GT:DP:AO:GQ	0/1:69:8:25
chr15	43408229	.	G	A	2322	off-target	MQM=60;SAP=392;SAR=179;SAF=0;ABP=5	GT:DP:AO:GQ	0/1:377:179:135
chr15	43409748	.	TA	T	548	.	MQM=60;SAP=5;SAR=15;SAF=10;ABP=5	GT:DP:AO:GQ	0/1:58:25:160
chr15	43413472	.	C	T	702	off-target	MQM=60;SAP=6;SAR=18;SAF=12;ABP=3	GT:DP:AO:GQ	0/1:63:30:160
chr15	43415610	.	A	T	1622	.	MQM=60;SAP=14;SAR=23;SAF=41;ABP=4	GT:DP:AO:GQ	0/1:137:64:160
chr15	43420139	.	A	G	1739	off-target	MQM=60;SAP=209;SAR=0;SAF=95;ABP=8	GT:DP:AO:GQ	0/1:211:95:136
chr15	43427957	.	CA	C	1016	off-target	MQM=60;SAP=3;SAR=25;SAF=27;ABP=318	GT:DP:AO:GQ	0/1:319:52:160
chr15	43427999	.	C	T	4282	off-target	MQM=60;SAP=5;SAR=110;SAF=96;ABP=5	GT:DP:AO:GQ	0/1:393:206:138
chr15	43428335	.	G	C	1566	off-target	MQM=60;SAP=129;SAR=58;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:58:58:160
chr15	43432448	.	T	G	20035	.	MQM=60;SAP=3;SAR=315;SAF=318;ABP=0	GT:DP:AO:GQ	1/1:634:633:136
chr15	43438288	.	A	G	11474	off-target	MQM=60;SAP=4;SAR=216;SAF=227;ABP=3	GT:DP:AO:GQ	0/1:893:443:136
chr15	43447488	.	G	GA	21	.	MQM=60;SAP=7;SAR=4;SAF=1;ABP=8	GT:DP:AO:GQ	0/1:16:5:3
chr15	43455720	.	CA	C	151	off-target	MQM=60;SAP=40;SAR=0;SAF=17;ABP=107	GT:DP:AO:GQ	0/1:105:17:130
chr15	43456106	.	A	G	30192	.	MQM=60;SAP=3;SAR=473;SAF=484;ABP=0	GT:DP:AO:GQ	1/1:958:957:160
chr15	43469723	.	A	C	416	off-target	MQM=60;SAP=6;SAR=7;SAF=12;ABP=4	GT:DP:AO:GQ	0/1:34:19:152
chr15	43469998	.	C	T	3267	.	MQM=60;SAP=7;SAR=67;SAF=52;ABP=13	GT:DP:AO:GQ	0/1:207:119:160
chr15	43475576	.	G	C	3605	.	MQM=60;SAP=3;SAR=58;SAF=58;ABP=0	GT:DP:AO:GQ	1/1:116:116:147
chr15	43480838	.	A	C	10489	off-target	MQM=60;SAP=3;SAR=208;SAF=208;ABP=6	GT:DP:AO:GQ	0/1:864:416:160
chr15	43491802	.	C	T	26789	off-target	MQM=60;SAP=5;SAR=439;SAF=409;ABP=0	GT:DP:AO:GQ	1/1:851:848:136
chr15	75351274	.	C	CT	549	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=54	GT:DP:AO:GQ	0/1:95:12:0
chr15	75351842	.	G	A	75	off-target	MQM=60;SAP=14;SAR=0;SAF=5;ABP=3	GT:DP:AO:GQ	0/1:9:5:34
chr15	90803400	.	C	CA	623	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=0	GT:DP:AO:GQ	1/1:24:24:141
chr15	90804072	.	G	A	7391	off-target	MQM=60;SAP=585;SAR=0;SAF=268;ABP=0	GT:DP:AO:GQ	1/1:268:268:141
chr15	90804525	.	A	G	7995	off-target	MQM=60;SAP=704;SAR=323;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:323:323:160
chr15	90804554	.	C	T	4216	off-target	MQM=60;SAP=509;SAR=233;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:236:233:136
chr16	3589138	.	A	G	1350	.	MQM=60;SAP=5;SAR=30;SAF=23;ABP=3	GT:DP:AO:GQ	0/1:102:53:160
chr16	3589229	.	G	A	1429	.	MQM=60;SAP=3;SAR=27;SAF=28;ABP=3	GT:DP:AO:GQ	0/1:111:55:144
chr16	23603721	.	TA	T	263	off-target	MQM=60;SAP=23;SAR=24;SAF=7;ABP=184	GT:DP:AO:GQ	0/1:187:31:160
chr16	23621158	.	C	T	294	off-target	MQM=60;SAP=40;SAR=0;SAF=17;ABP=3	GT:DP:AO:GQ	0/1:33:17:142
chr16	23623200	.	CTT	C	71	off-target	MQM=60;SAP=4;SAR=2;SAF=4;ABP=30	GT:DP:AO:GQ	0/1:32:6:70
chr16	23629146	.	G	A	255	off-target	MQM=60;SAP=13;SAR=2;SAF=9;ABP=3	GT:DP:AO:GQ	0/1:23:11:160
chr16	68737437	.	CTCT	C	575	.	MQM=60;SAP=99;SAR=44;SAF=0;ABP=37	GT:DP:AO:GQ	0/1:134:44:160
chr16	68737469	.	C	T	4120	.	MQM=60;SAP=3;SAR=63;SAF=68;ABP=0	GT:DP:AO:GQ	1/1:132:131:155
chr16	68737515	.	C	CGCCCCAGCCCCGT	2407	off-target	MQM=60;SAP=3;SAR=43;SAF=41;ABP=0	GT:DP:AO:GQ	1/1:84:84:160
chr16	68823237	.	CA	C	97	off-target	MQM=60;SAP=20;SAR=0;SAF=8;ABP=51	GT:DP:AO:GQ	0/1:49:8:86
chr16	68823538	.	T	C	14799	.	MQM=60;SAP=3;SAR=294;SAF=304;ABP=9	GT:DP:AO:GQ	0/1:1140:598:160
chr16	81782975	.	C	G	142	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=0	GT:DP:AO:GQ	1/1:6:6:50
chr16	81783128	.	C	T	4998	.	MQM=60;SAP=291;SAR=24;SAF=194;ABP=3	GT:DP:AO:GQ	0/1:430:218:132
chr16	81783182	.	T	A	24059	off-target	MQM=60;SAP=3;SAR=373;SAF=372;ABP=0	GT:DP:AO:GQ	1/1:746:745:160
chr16	81783213	.	C	T	9049	off-target	MQM=60;SAP=4;SAR=179;SAF=167;ABP=6	GT:DP:AO:GQ	0/1:726:346:135
chr16	89738447	.	C	T	653	off-target	MQM=60;SAP=79;SAR=0;SAF=35;ABP=13	GT:DP:AO:GQ	0/1:54:35:139
chr16	89738853	.	A	G	18040	off-target	MQM=60;SAP=3;SAR=291;SAF=282;ABP=0	GT:DP:AO:GQ	1/1:575:573:160
chr16	89739569	.	G	A	2210	off-target	MQM=60;SAP=10;SAR=35;SAF=52;ABP=4	GT:DP:AO:GQ	0/1:182:87:141
chr16	89739939	.	A	T	879	off-target	MQM=60;SAP=3;SAR=17;SAF=17;ABP=21	GT:DP:AO:GQ	0/1:48:34:160
chr16	89744788	.	T	C	589	off-target	MQM=60;SAP=72;SAR=0;SAF=32;ABP=6	GT:DP:AO:GQ	0/1:55:32:140
chr16	89748809	.	C	T	1916	off-target	MQM=60;SAP=3;SAR=41;SAF=38;ABP=3	GT:DP:AO:GQ	0/1:156:79:151
chr16	89752083	.	T	C	9384	off-target	MQM=60;SAP=3;SAR=181;SAF=188;ABP=3	GT:DP:AO:GQ	0/1:751:369:160
chr16	89765102	.	C	A	11999	off-target	MQM=60;SAP=4;SAR=227;SAF=240;ABP=6	GT:DP:AO:GQ	0/1:972:467:140
chr16	89767366	.	C	G	130	off-target	MQM=60;SAP=23;SAR=9;SAF=0;ABP=12	GT:DP:AO:GQ	0/1:29:9:129
chr16	89769915	.	C	T	829	.	MQM=60;SAP=14;SAR=26;SAF=12;ABP=11	GT:DP:AO:GQ	0/1:95:38:160
chr16	89770099	.	T	C	4535	off-target	MQM=60;SAP=6;SAR=74;SAF=61;ABP=0	GT:DP:AO:GQ	1/1:135:135:153
chr16	89770373	.	G	A	328	off-target	MQM=60;SAP=44;SAR=19;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:41:19:160
chr16	89771670	.	A	G	12928	.	MQM=60;SAP=3;SAR=256;SAF=258;ABP=5	GT:DP:AO:GQ	0/1:1057:514:160
chr16	89775621	.	C	G	71	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=4	GT:DP:AO:GQ	0/1:14:6:71
chr16	89778702	.	A	T	6420	off-target	MQM=60;SAP=709;SAR=325;SAF=0;ABP=8	GT:DP:AO:GQ	0/1:613:325:129
chr16	89778786	.	A	G	6231	off-target	MQM=60;SAP=696;SAR=325;SAF=2;ABP=8	GT:DP:AO:GQ	0/1:616:327:139
chr16	89783072	.	C	T	6739	.	MQM=60;SAP=83;SAR=144;SAF=58;ABP=0	GT:DP:AO:GQ	1/1:202:202:160
chr16	89783175	.	C	T	937	off-target	MQM=60;SAP=3;SAR=19;SAF=19;ABP=3	GT:DP:AO:GQ	0/1:80:38:141
chr16	89783221	.	T	A	913	off-target	MQM=60;SAP=3;SAR=19;SAF=19;ABP=3	GT:DP:AO:GQ	0/1:80:38:141
chr16	89791292	.	A	G	891	off-target	MQM=60;SAP=3;SAR=18;SAF=18;ABP=4	GT:DP:AO:GQ	0/1:68:36:143
chr16	89791556	.	T	C	14549	off-target	MQM=60;SAP=4;SAR=268;SAF=284;ABP=11	GT:DP:AO:GQ	0/1:1042:552:160
chr16	89791616	.	A	G	6256	off-target	MQM=60;SAP=481;SAR=267;SAF=17;ABP=7	GT:DP:AO:GQ	0/1:535:284:130
chr16	89791776	.	A	G	1851	off-target	MQM=60;SAP=3;SAR=29;SAF=29;ABP=0	GT:DP:AO:GQ	1/1:59:58:160
chr16	89792097	.	T	C	4331	off-target	MQM=60;SAP=3;SAR=78;SAF=76;ABP=3	GT:DP:AO:GQ	0/1:304:154:139
chr16	89792117	.	C	G	4358	off-target	MQM=60;SAP=3;SAR=80;SAF=76;ABP=3	GT:DP:AO:GQ	0/1:307:156:160
chr16	89792249	.	C	G	319	off-target	MQM=60;SAP=23;SAR=2;SAF=14;ABP=5	GT:DP:AO:GQ	0/1:27:16:160
chr16	89792351	.	C	T	524	off-target	MQM=60;SAP=14;SAR=7;SAF=18;ABP=6	GT:DP:AO:GQ	0/1:59:25:160
chr16	89792600	.	G	A	948	off-target	MQM=60;SAP=24;SAR=11;SAF=31;ABP=10	GT:DP:AO:GQ	0/1:102:42:160
chr16	89792607	.	GT	G	876	off-target	MQM=60;SAP=22;SAR=11;SAF=30;ABP=13	GT:DP:AO:GQ	0/1:104:41:151
chr16	89798903	.	T	C	389	off-target	MQM=60;SAP=44;SAR=0;SAF=19;ABP=3	GT:DP:AO:GQ	0/1:36:19:160
chr16	89799635	.	T	C	9341	.	MQM=60;SAP=3;SAR=178;SAF=182;ABP=3	GT:DP:AO:GQ	0/1:729:360:142
chr16	89799752	.	A	G	1462	off-target	MQM=60;SAP=4;SAR=32;SAF=28;ABP=13	GT:DP:AO:GQ	0/1:99:60:141
chr16	89799769	.	G	A	44	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:8:4:43
chr16	89803156	.	G	A	12906	off-target	MQM=60;SAP=3;SAR=257;SAF=252;ABP=4	GT:DP:AO:GQ	0/1:1040:509:129
chr16	89803353	.	T	C	3848	off-target	MQM=60;SAP=3;SAR=58;SAF=56;ABP=0	GT:DP:AO:GQ	1/1:114:114:160
chr16	89808151	.	A	C	1883	off-target	MQM=60;SAP=109;SAR=9;SAF=72;ABP=12	GT:DP:AO:GQ	0/1:138:81:160
chr16	89808220	.	C	T	1665	off-target	MQM=60;SAP=91;SAR=9;SAF=63;ABP=15	GT:DP:AO:GQ	0/1:118:72:160
chr17	7673145	.	G	A	60	off-target	MQM=55;SAP=12;SAR=0;SAF=4;ABP=0	GT:DP:AO:GQ	1/1:4:4:43
chr17	7673159	.	G	A	16	off-target	MQM=59;SAP=12;SAR=0;SAF=4;ABP=3	GT:DP:AO:GQ	0/1:8:4:0
chr17	7674797	.	T	C	66	off-target	MQM=60;SAP=14;SAR=0;SAF=5;ABP=4	GT:DP:AO:GQ	0/1:12:5:66
chr17	7675327	.	C	T	16356	off-target	MQM=60;SAP=3;SAR=329;SAF=325;ABP=4	GT:DP:AO:GQ	0/1:1280:654:160
chr17	7675393	.	CTT	C	81	off-target	MQM=60;SAP=12;SAR=4;SAF=0;ABP=13	GT:DP:AO:GQ	0/1:17:4:14
chr17	7675393	.	CTTT	C	81	off-target	MQM=60;SAP=14;SAR=5;SAF=0;ABP=9	GT:DP:AO:GQ	0/1:17:5:14
chr17	7676154	.	G	C	7653	.	MQM=60;SAP=4;SAR=148;SAF=159;ABP=10	GT:DP:AO:GQ	0/1:570:307:133
chr17	7676325	.	CCCCCAGCCCTCCAGGT	C	125	off-target	MQM=60;SAP=15;SAR=8;SAF=1;ABP=3	GT:DP:AO:GQ	0/1:20:9:125
chr17	31201318	.	A	T	264	off-target	MQM=60;SAP=42;SAR=18;SAF=0;ABP=16	GT:DP:AO:GQ	0/1:24:18:63
chr17	31226318	.	G	GACAC	372	off-target	MQM=60;SAP=16;SAR=0;SAF=6;ABP=16	GT:DP:AO:GQ	0/1:24:6:47
chr17	31226318	.	G	GACACAC	372	off-target	MQM=60;SAP=31;SAR=0;SAF=13;ABP=3	GT:DP:AO:GQ	0/1:24:6:47
chr17	31226467	.	G	A	2514	.	MQM=60;SAP=25;SAR=27;SAF=56;ABP=0	GT:DP:AO:GQ	1/1:83:83:143
chr17	31231064	.	T	C	426	off-target	MQM=60;SAP=40;SAR=17;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:17:17:122
chr17	31232043	.	A	AT	478	off-target	MQM=60;SAP=14;SAR=18;SAF=7;ABP=92	GT:DP:AO:GQ	0/1:120:25:130
chr17	31232570	.	G	C	8278	off-target	MQM=60;SAP=948;SAR=0;SAF=435;ABP=0	GT:DP:AO:GQ	1/1:435:435:134
chr17	31232914	.	C	A	1030	off-target	MQM=60;SAP=71;SAR=34;SAF=1;ABP=0	GT:DP:AO:GQ	1/1:35:35:146
chr17	31236055	.	T	TTG	9290	off-target	MQM=60;SAP=505;SAR=37;SAF=327;ABP=0	GT:DP:AO:GQ	1/1:402:364:160
chr17	31236067	.	T	G	10229	off-target	MQM=60;SAP=508;SAR=38;SAF=331;ABP=0	GT:DP:AO:GQ	1/1:371:369:141
chr17	31336154	.	A	C	690	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=0	GT:DP:AO:GQ	1/1:24:24:141
chr17	31336607	.	T	TA	861	off-target	MQM=60;SAP=49;SAR=29;SAF=3;ABP=0	GT:DP:AO:GQ	1/1:40:32:108
chr17	31343172	.	C	G	5223	off-target	MQM=60;SAP=3;SAR=79;SAF=84;ABP=0	GT:DP:AO:GQ	1/1:163:163:160
chr17	35101468	.	A	G	1248	off-target	MQM=60;SAP=7;SAR=28;SAF=19;ABP=6	GT:DP:AO:GQ	0/1:83:47:160
chr17	35106468	.	C	T	2531	.	MQM=60;SAP=46;SAR=63;SAF=22;ABP=0	GT:DP:AO:GQ	1/1:85:85:142
chr17	35106801	.	A	G	8936	off-target	MQM=60;SAP=783;SAR=0;SAF=359;ABP=0	GT:DP:AO:GQ	1/1:359:359:134
chr17	35118530	.	G	A	1662	.	MQM=60;SAP=7;SAR=31;SAF=42;ABP=6	GT:DP:AO:GQ	0/1:133:73:160
chr17	43051308	.	T	A	691	off-target	MQM=60;SAP=66;SAR=29;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:62:29:142
chr17	43067543	.	C	T	439	off-target	MQM=60;SAP=3;SAR=9;SAF=9;ABP=4	GT:DP:AO:GQ	0/1:32:18:160
chr17	43067763	.	T	C	389	off-target	MQM=60;SAP=47;SAR=23;SAF=1;ABP=13	GT:DP:AO:GQ	0/1:35:24:137
chr17	43071077	.	T	C	4362	.	MQM=60;SAP=269;SAR=181;SAF=23;ABP=6	GT:DP:AO:GQ	0/1:432:204:142
chr17	43074584	.	G	C	75	off-target	MQM=60;SAP=14;SAR=5;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:12:5:74
chr17	43074658	.	A	T	365	off-target	MQM=60;SAP=46;SAR=20;SAF=0;ABP=5	GT:DP:AO:GQ	0/1:35:20:160
chr17	43074719	.	GGGGTT	G	259	off-target	MQM=60;SAP=44;SAR=19;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:35:19:153
chr17	43079499	.	C	T	1758	off-target	MQM=60;SAP=3;SAR=32;SAF=32;ABP=9	GT:DP:AO:GQ	0/1:110:64:141
chr17	43082453	.	A	G	343	.	MQM=60;SAP=25;SAR=2;SAF=15;ABP=3	GT:DP:AO:GQ	0/1:34:17:144
chr17	43091173	.	T	G	110	off-target	MQM=60;SAP=18;SAR=7;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:16:7:110
chr17	43091983	.	T	C	4694	.	MQM=60;SAP=4;SAR=91;SAF=81;ABP=3	GT:DP:AO:GQ	0/1:350:172:138
chr17	43092418	.	T	C	10833	.	MQM=60;SAP=4;SAR=231;SAF=246;ABP=5	GT:DP:AO:GQ	0/1:980:477:160
chr17	43092919	.	G	A	2121	.	MQM=60;SAP=9;SAR=45;SAF=31;ABP=11	GT:DP:AO:GQ	0/1:130:76:160
chr17	43093220	.	A	G	1538	.	MQM=60;SAP=3;SAR=28;SAF=30;ABP=5	GT:DP:AO:GQ	0/1:127:58:160
chr17	43093449	.	G	A	464	.	MQM=60;SAP=62;SAR=0;SAF=27;ABP=5	GT:DP:AO:GQ	0/1:62:27:160
chr17	43097077	.	A	G	459	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=4	GT:DP:AO:GQ	0/1:43:24:142
chr17	43097346	.	TA	T	543	off-target	MQM=60;SAP=13;SAR=19;SAF=8;ABP=11	GT:DP:AO:GQ	0/1:70:27:160
chr17	43099629	.	T	A	2604	off-target	MQM=60;SAP=285;SAR=0;SAF=130;ABP=6	GT:DP:AO:GQ	0/1:242:130:160
chr17	43124230	.	A	G	388	off-target	MQM=60;SAP=49;SAR=21;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:43:21:150
chr17	58692526	.	G	A	228	off-target	MQM=60;SAP=29;SAR=0;SAF=12;ABP=3	GT:DP:AO:GQ	0/1:23:12:160
chr17	58692618	.	C	T	11283	off-target	MQM=60;SAP=5;SAR=217;SAF=238;ABP=12	GT:DP:AO:GQ	0/1:974:455:139
chr17	58720846	.	T	C	203	off-target	MQM=60;SAP=29;SAR=12;SAF=0;ABP=4	GT:DP:AO:GQ	0/1:27:12:160
chr17	60656452	.	C	CA	10	off-target	MQM=60;SAP=55;SAR=0;SAF=24;ABP=320	GT:DP:AO:GQ	0/1:232:24:9
chr17	61683138	.	A	G	250	off-target	MQM=60;SAP=25;SAR=0;SAF=10;ABP=0	GT:DP:AO:GQ	1/1:10:10:80
chr17	61683635	.	A	G	7636	.	MQM=60;SAP=676;SAR=0;SAF=310;ABP=0	GT:DP:AO:GQ	1/1:310:310:160
chr17	61685753	.	A	T	391	off-target	MQM=60;SAP=3;SAR=8;SAF=8;ABP=13	GT:DP:AO:GQ	0/1:22:16:76
chr17	61685986	.	A	G	373	.	MQM=60;SAP=6;SAR=8;SAF=4;ABP=0	GT:DP:AO:GQ	1/1:12:12:92
chr17	61686104	.	T	C	3671	.	MQM=60;SAP=107;SAR=20;SAF=94;ABP=0	GT:DP:AO:GQ	1/1:114:114:153
chr17	61742809	.	C	A	39	off-target	MQM=60;SAP=10;SAR=0;SAF=3;ABP=3	GT:DP:AO:GQ	0/1:6:3:35
chr17	61780238	.	CA	C	16	off-target	MQM=60;SAP=3;SAR=3;SAF=3;ABP=19	GT:DP:AO:GQ	0/1:26:6:15
chr17	61780448	.	C	G	183	off-target	MQM=60;SAP=23;SAR=0;SAF=9;ABP=5	GT:DP:AO:GQ	0/1:14:9:78
chr17	61799423	.	CAG	C	290	off-target	MQM=60;SAP=29;SAR=12;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:12:12:92
chr17	61801161	.	C	CA	117	off-target	MQM=60;SAP=20;SAR=8;SAF=0;ABP=3	GT:DP:AO:GQ	0/1:16:8:116
chr18	22415790	.	T	C	438	.	MQM=60;SAP=44;SAR=0;SAF=19;ABP=0	GT:DP:AO:GQ	1/1:19:19:134
chr18	22416048	.	G	A	1512	.	MQM=60;SAP=5;SAR=34;SAF=27;ABP=5	GT:DP:AO:GQ	0/1:133:61:160
chr18	22975256	.	T	C	2177	off-target	MQM=60;SAP=4;SAR=38;SAF=32;ABP=0	GT:DP:AO:GQ	1/1:70:70:148
chr18	22982555	.	G	A	212	off-target	MQM=60;SAP=20;SAR=8;SAF=0;ABP=0	GT:DP:AO:GQ	1/1:8:8:68
chr18	22984837	.	TTCA	T	362	off-target	MQM=60;SAP=3;SAR=7;SAF=8;ABP=3	GT:DP:AO:GQ	0/1:32:15:144
chr18	22996218	.	G	T	79	off-target	MQM=60;SAP=12;SAR=0;SAF=4;ABP=7	GT:DP:AO:GQ	0/1:5:4:0
chr18	22997493	.	T	A	118	off-target	MQM=60;SAP=20;SAR=0;SAF=8;ABP=3	GT:DP:AO:GQ	0/1:18:8:117
chr18	23006282	.	C	T	7076	off-target	MQM=60;SAP=3;SAR=139;SAF=141;ABP=7	GT:DP:AO:GQ	0/1:529:280:138
chr18	23006519	.	A	T	29	off-target	MQM=60;SAP=3;SAR=2;SAF=2;ABP=12	GT:DP:AO:GQ	0/1:16:4:28
chr18	51046898	.	CT	C	44	off-target	MQM=60;SAP=20;SAR=0;SAF=8;ABP=38	GT:DP:AO:GQ	0/1:42:8:43
chr18	51058485	.	A	AT	2161	off-target	MQM=60;SAP=4;SAR=16;SAF=19;ABP=194	GT:DP:AO:GQ	0/1:204:35:136
chr18	51058485	.	A	ATT	2161	off-target	MQM=60;SAP=11;SAR=32;SAF=49;ABP=22	GT:DP:AO:GQ	0/1:204:81:136
chr19	17268649	.	G	A	34	off-target	MQM=60;SAP=12;SAR=0;SAF=4;ABP=9	GT:DP:AO:GQ	0/1:14:4:33
chr19	17268749	.	C	T	1316	off-target	MQM=60;SAP=6;SAR=30;SAF=22;ABP=4	GT:DP:AO:GQ	0/1:109:52:140
chr19	17271696	.	A	T	331	off-target	MQM=60;SAP=3;SAR=10;SAF=8;ABP=10	GT:DP:AO:GQ	0/1:49:18:160
chr19	17273842	.	C	T	201	off-target	MQM=60;SAP=5;SAR=6;SAF=3;ABP=3	GT:DP:AO:GQ	0/1:20:9:145
chr19	17276367	.	A	G	1376	off-target	MQM=60;SAP=3;SAR=26;SAF=26;ABP=4	GT:DP:AO:GQ	0/1:96:52:160
chr19	17276445	.	G	A	1378	off-target	MQM=60;SAP=3;SAR=26;SAF=27;ABP=4	GT:DP:AO:GQ	0/1:101:53:160
chr19	17278839	.	C	T	1232	.	MQM=60;SAP=3;SAR=26;SAF=25;ABP=4	GT:DP:AO:GQ	0/1:108:51:142
chr19	17278895	.	G	A	6312	.	MQM=60;SAP=3;SAR=127;SAF=126;ABP=7	GT:DP:AO:GQ	0/1:539:253:136
chr20	14186437	.	T	C	444	off-target	MQM=60;SAP=40;SAR=0;SAF=17;ABP=0	GT:DP:AO:GQ	1/1:17:17:122
chr20	14186637	.	A	G	905	.	MQM=60;SAP=4;SAR=17;SAF=14;ABP=0	GT:DP:AO:GQ	1/1:31:31:160
chr20	49684453	.	C	T	479	off-target	MQM=60;SAP=46;SAR=0;SAF=20;ABP=0	GT:DP:AO:GQ	1/1:20:20:139
chr20	49684609	.	G	A	39631	.	MQM=60;SAP=5;SAR=587;SAF=619;ABP=0	GT:DP:AO:GQ	1/1:1210:1206:160
chr22	28734312	.	C	T	1766	off-target	MQM=60;SAP=13;SAR=23;SAF=40;ABP=10	GT:DP:AO:GQ	0/1:108:63:160
chr22	28734825	.	G	GA	1108	off-target	MQM=60;SAP=8;SAR=40;SAF=28;ABP=13	GT:DP:AO:GQ	0/1:163:68:160





chr6	32664992	.	T	C	6310	.	quality=DP%3D233%3BQD%3D27.08%3BAF%3D0.29%3BMQM%3D49%3BSAP%3D5%3BABP%3D94%3BSAR%3D37%3BSAF%3D30;gene=HLA-DQB1%2CHLA-DQB1-AS1;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=HLA-DQB1:ENST00000399082.7:intron_variant:MODIFIER:intron1/2:c.109+1507A>G::%2CHLA-DQB1:ENST00000434651.7:missense_variant:MODERATE:exon2/5:c.185A>G:p.Tyr62Cys:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399079.7:missense_variant:MODERATE:exon2/4:c.185A>G:p.Tyr62Cys:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000374943.8:missense_variant:MODERATE:exon2/6:c.185A>G:p.Tyr62Cys:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399084.5:missense_variant:MODERATE:exon3/6:c.185A>G:p.Tyr62Cys:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1-AS1:ENST00000419852.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604305_[GENE%3DHLA-DQB1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive%3B%20{Multiple%20sclerosis%2C%20susceptibility%20to%2C%201}%2C%20126200%20(3)%2C%20Multifactorial%3B%20{Creutzfeldt-Jakob%20disease%2C%20variant%2C%20resistance%20to}%2C%20123400%20(3)%2C%20Autosomal%20dominant];dbSNP=rs767838657;gnomAD=0.00533;gnomAD_sub=0.00482%2C0.00371%2C0.00328%2C0.00655%2C0.00517;gnomAD_hom_hemi=4%2C;gnomAD_het=635;gnomAD_wt=120083;phyloP=-1.0220;CADD=18.73;REVEL=0.130;MaxEntScan=/6.4>6.8/0.0>0.0;COSMIC=COSV66569199;SpliceAI=HLA-DQB1|0.00|0.00|0.00|0.00|30|2|-18|20;NGSD_hom=1657;NGSD_het=12643;NGSD_mosaic=142;NGSD_group=161%20/%201451;gene_info=HLA-DQB1%20(inh%3DAR+AD%20oe_syn%3D0.60%20oe_mis%3D0.68%20oe_lof%3D0.45)%2C%20HLA-DQB1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	32664993	.	A	T	6310	.	quality=DP%3D233%3BQD%3D27.08%3BAF%3D0.70%3BMQM%3D49%3BSAP%3D5%3BABP%3D94%3BSAR%3D37%3BSAF%3D30;gene=HLA-DQB1%2CHLA-DQB1-AS1;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=HLA-DQB1:ENST00000399082.7:intron_variant:MODIFIER:intron1/2:c.109+1506T>A::%2CHLA-DQB1:ENST00000434651.7:missense_variant:MODERATE:exon2/5:c.184T>A:p.Tyr62Asn:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399079.7:missense_variant:MODERATE:exon2/4:c.184T>A:p.Tyr62Asn:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000374943.8:missense_variant:MODERATE:exon2/6:c.184T>A:p.Tyr62Asn:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399084.5:missense_variant:MODERATE:exon3/6:c.184T>A:p.Tyr62Asn:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1-AS1:ENST00000419852.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604305_[GENE%3DHLA-DQB1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive%3B%20{Multiple%20sclerosis%2C%20susceptibility%20to%2C%201}%2C%20126200%20(3)%2C%20Multifactorial%3B%20{Creutzfeldt-Jakob%20disease%2C%20variant%2C%20resistance%20to}%2C%20123400%20(3)%2C%20Autosomal%20dominant];dbSNP=rs281862065;gnomAD=0.00543;gnomAD_sub=0.00494%2C0.00381%2C0.00310%2C0.00665%2C0.00519;gnomAD_hom_hemi=4%2C;gnomAD_het=644;gnomAD_wt=119324;phyloP=-1.0100;CADD=4.88;REVEL=0.163;MaxEntScan=/6.4>5.8/0.0>0.0;COSMIC=COSV66569115%2CCOSV66569205%2CCOSV66574347;SpliceAI=HLA-DQB1|0.00|0.00|0.00|0.00|29|1|-19|19;NGSD_hom=1657;NGSD_het=12646;NGSD_mosaic=138;NGSD_group=161%20/%201453;gene_info=HLA-DQB1%20(inh%3DAR+AD%20oe_syn%3D0.60%20oe_mis%3D0.68%20oe_lof%3D0.45)%2C%20HLA-DQB1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	32664998	.	G	C	1366	.	quality=DP%3D235%3BQD%3D5.81%3BAF%3D0.31%3BMQM%3D49%3BSAP%3D7%3BABP%3D76%3BSAR%3D42%3BSAF%3D31;gene=HLA-DQB1%2CHLA-DQB1-AS1;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=HLA-DQB1:ENST00000399082.7:intron_variant:MODIFIER:intron1/2:c.109+1501C>G::%2CHLA-DQB1:ENST00000434651.7:missense_variant:MODERATE:exon2/5:c.179C>G:p.Thr60Ser:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399079.7:missense_variant:MODERATE:exon2/4:c.179C>G:p.Thr60Ser:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000374943.8:missense_variant:MODERATE:exon2/6:c.179C>G:p.Thr60Ser:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399084.5:missense_variant:MODERATE:exon3/6:c.179C>G:p.Thr60Ser:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1-AS1:ENST00000419852.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604305_[GENE%3DHLA-DQB1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive%3B%20{Multiple%20sclerosis%2C%20susceptibility%20to%2C%201}%2C%20126200%20(3)%2C%20Multifactorial%3B%20{Creutzfeldt-Jakob%20disease%2C%20variant%2C%20resistance%20to}%2C%20123400%20(3)%2C%20Autosomal%20dominant];dbSNP=rs9274405;gnomAD=0.00549;gnomAD_sub=0.00488%2C0.00373%2C0.00332%2C0.00678%2C0.00525;gnomAD_hom_hemi=4%2C;gnomAD_het=648;gnomAD_wt=118814;phyloP=-3.0570;CADD=0.01;REVEL=0.084;MaxEntScan=/6.4>5.3/0.0>3.4;COSMIC=COSV66569211;SpliceAI=HLA-DQB1|0.02|0.00|0.00|0.00|-4|-23|5|-24;NGSD_hom=1652;NGSD_het=12721;NGSD_mosaic=94;NGSD_group=161%20/%201455;gene_info=HLA-DQB1%20(inh%3DAR+AD%20oe_syn%3D0.60%20oe_mis%3D0.68%20oe_lof%3D0.45)%2C%20HLA-DQB1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	32665018	.	C	T	1672	.	quality=DP%3D231%3BQD%3D7.24%3BAF%3D0.35%3BMQM%3D51%3BSAP%3D18%3BABP%3D45%3BSAR%3D53%3BSAF%3D29;gene=HLA-DQB1%2CHLA-DQB1-AS1;variant_type=intron%2Csynonymous%2Cdownstream_gene;coding_and_splicing=HLA-DQB1:ENST00000399082.7:intron_variant:MODIFIER:intron1/2:c.109+1481G>A::%2CHLA-DQB1:ENST00000434651.7:synonymous_variant:LOW:exon2/5:c.159G>A:p.Thr53%3D:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399079.7:synonymous_variant:LOW:exon2/4:c.159G>A:p.Thr53%3D:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000374943.8:synonymous_variant:LOW:exon2/6:c.159G>A:p.Thr53%3D:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1:ENST00000399084.5:synonymous_variant:LOW:exon3/6:c.159G>A:p.Thr53%3D:PF00969%20[Class%20II%20histocompatibility%20antigen%20beta%20domain]%2CHLA-DQB1-AS1:ENST00000419852.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=604305_[GENE%3DHLA-DQB1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive%3B%20{Multiple%20sclerosis%2C%20susceptibility%20to%2C%201}%2C%20126200%20(3)%2C%20Multifactorial%3B%20{Creutzfeldt-Jakob%20disease%2C%20variant%2C%20resistance%20to}%2C%20123400%20(3)%2C%20Autosomal%20dominant];dbSNP=rs1049079;gnomAD=0.00582;gnomAD_sub=0.00480%2C0.00420%2C0.00335%2C0.00733%2C0.00514;gnomAD_hom_hemi=3%2C;gnomAD_het=697;gnomAD_wt=120083;phyloP=-0.5820;CADD=13.63;MaxEntScan=/0.0>0.4/2.3>0.0;COSMIC=COSV66574890;SpliceAI=HLA-DQB1|0.03|0.00|0.00|0.00|-24|32|-2|26;PubMed=34506591%2C36792371;NGSD_hom=1221;NGSD_het=9122;NGSD_mosaic=33;NGSD_group=114%20/%201036;gene_info=HLA-DQB1%20(inh%3DAR+AD%20oe_syn%3D0.60%20oe_mis%3D0.68%20oe_lof%3D0.45)%2C%20HLA-DQB1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	32665073	.	G	A	863	.	quality=DP%3D135%3BQD%3D6.39%3BAF%3D0.33%3BMQM%3D56%3BSAP%3D62%3BABP%3D36%3BSAR%3D40%3BSAF%3D5;gene=HLA-DQB1%2CHLA-DQB1-AS1;variant_type=intron%2Csplice_region&intron%2Cdownstream_gene;coding_and_splicing=HLA-DQB1:ENST00000399082.7:intron_variant:MODIFIER:intron1/2:c.109+1426C>T::%2CHLA-DQB1:ENST00000434651.7:splice_region_variant&intron_variant:LOW:intron1/4:c.110-6C>T::%2CHLA-DQB1:ENST00000399079.7:splice_region_variant&intron_variant:LOW:intron1/3:c.110-6C>T::%2CHLA-DQB1:ENST00000374943.8:splice_region_variant&intron_variant:LOW:intron1/5:c.110-6C>T::%2CHLA-DQB1:ENST00000399084.5:splice_region_variant&intron_variant:LOW:intron2/5:c.110-6C>T::%2CHLA-DQB1-AS1:ENST00000419852.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604305_[GENE%3DHLA-DQB1_PHENOS%3D{Celiac%20disease%2C%20susceptibility%20to}%2C%20212750%20(3)%2C%20Multifactorial%2C%20Autosomal%20recessive%3B%20{Multiple%20sclerosis%2C%20susceptibility%20to%2C%201}%2C%20126200%20(3)%2C%20Multifactorial%3B%20{Creutzfeldt-Jakob%20disease%2C%20variant%2C%20resistance%20to}%2C%20123400%20(3)%2C%20Autosomal%20dominant];dbSNP=rs9274408;gnomAD=0.00615;gnomAD_sub=0.00582%2C0.00615%2C0.00309%2C0.00692%2C0.00789;gnomAD_hom_hemi=3%2C;gnomAD_het=742;gnomAD_wt=120936;phyloP=0.5160;CADD=16.20;MaxEntScan=7.7>6.0/7.7>6.0/0.0>0.0%2C/7.7>6.0/0.0>0.0;COSMIC=COSV66569838;SpliceAI=HLA-DQB1|0.08|0.03|0.00|0.00|-23|-6|-29|-23;NGSD_hom=1223;NGSD_het=9098;NGSD_mosaic=6;NGSD_group=114%20/%201039;gene_info=HLA-DQB1%20(inh%3DAR+AD%20oe_syn%3D0.60%20oe_mis%3D0.68%20oe_lof%3D0.45)%2C%20HLA-DQB1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr6	85490559	.	T	A	2380	.	quality=DP%3D169%3BQD%3D14.08%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D6%3BABP%3D6%3BSAR%3D52%3BSAF%3D40;gene=NT5E;variant_type=intron%2Cmissense;coding_and_splicing=NT5E:ENST00000369651.7:intron_variant:MODIFIER:intron6/7:c.1210+960T>A::%2CNT5E:ENST00000257770.8:missense_variant:MODERATE:exon7/9:c.1262T>A:p.Phe421Tyr:PF02872%20[5'-nucleotidase%20C-terminal%20domain];regulatory=regulatory_region_variant:enhancer%2CTF_binding_site_variant;OMIM=129190_[GENE%3DNT5E_PHENOS%3DCalcification%20of%20joints%20and%20arteries%2C%20211800%20(3)%2C%20Autosomal%20recessive];HGMD=CM1914100%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Cardiac%20calcification"%20GENE%3DNT5E]%3B;dbSNP=rs72905321;gnomAD=0.00030;gnomAD_sub=0.00000%2C0.00118%2C0.00000%2C0.00041%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=46;gnomAD_wt=152312;phyloP=4.6510;CADD=22.50;REVEL=0.194;AlphaMissense=0.26;MaxEntScan=/0.3>0.0/0.0>0.0;SpliceAI=NT5E|0.00|0.00|0.00|0.00|0|21|-7|20;NGSD_hom=0;NGSD_het=34;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=NT5E%20(inh%3DAR%20oe_syn%3D0.89%20oe_mis%3D0.91%20oe_lof%3D0.81)	GT	1/0
chr6	90548027	.	C	G	977	.	quality=DP%3D90%3BQD%3D10.86%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D62%3BABP%3D3%3BSAR%3D5%3BSAF%3D40;gene=MAP3K7;variant_type=splice_region&intron%2Cintron;coding_and_splicing=MAP3K7:ENST00000369325.7:splice_region_variant&intron_variant:LOW:intron10/15:c.1080+20G>C::%2CMAP3K7:ENST00000369327.7:splice_region_variant&intron_variant:LOW:intron10/14:c.1080+20G>C::%2CMAP3K7:ENST00000369332.7:splice_region_variant&intron_variant:LOW:intron10/15:c.1080+20G>C::%2CMAP3K7:ENST00000369329.8:splice_region_variant&intron_variant:LOW:intron10/16:c.1080+20G>C::%2CMAP3K7:ENST00000700591.1:splice_region_variant&intron_variant:LOW:intron9/14:c.1014+20G>C::%2CMAP3K7:ENST00000700592.1:splice_region_variant&intron_variant:LOW:intron10/15:c.1155+20G>C::%2CMAP3K7:ENST00000700593.1:splice_region_variant&intron_variant:LOW:intron10/15:c.771+20G>C::%2CMAP3K7:ENST00000703101.1:intron_variant:MODIFIER:intron1/4:c.121-24244G>C::;OMIM=602614_[GENE%3DMAP3K7_PHENOS%3DFrontometaphyseal%20dysplasia%202%2C%20617137%20(3)%2C%20Autosomal%20dominant%3B%20Cardiospondylocarpofacial%20syndrome%2C%20157800%20(3)%2C%20Autosomal%20dominant];ClinVar=1660844%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DMAP3K7]%3B;dbSNP=rs34247123;gnomAD=0.00385;gnomAD_sub=0.00060%2C0.00046%2C0.00000%2C0.00594%2C0.00000;gnomAD_hom_hemi=3%2C;gnomAD_het=580;gnomAD_wt=151678;phyloP=-0.5770;CADD=6.45;MaxEntScan=/1.4>0.0/1.9>0.0;SpliceAI=MAP3K7|0.00|0.00|0.00|0.00|31|1|-8|32;NGSD_hom=1;NGSD_het=436;NGSD_mosaic=1;NGSD_group=0%20/%2071;gene_info=MAP3K7%20(inh%3DAR+AD%20oe_syn%3D0.97%20oe_mis%3D0.57%20oe_lof%3D0.08)	GT	1/0
chr6	106655669	.	G	A	1035	.	quality=DP%3D83%3BQD%3D12.47%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D10%3BABP%3D3%3BSAR%3D27%3BSAF%3D15;gene=QRSL1;variant_type=missense%2Cdownstream_gene;coding_and_splicing=QRSL1:ENST00000369046.8:missense_variant:MODERATE:exon9/11:c.1097G>A:p.Arg366Gln:PF01425%20[Amidase]%2CQRSL1:ENST00000369044.1:downstream_gene_variant:MODIFIER::::;OMIM=617209_[GENE%3DQRSL1_PHENOS%3DCombined%20oxidative%20phosphorylation%20deficiency%2040%2C%20618835%20(3)%2C%20Autosomal%20recessive];ClinVar=1479822%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C2x3)%20DISEASE%3DInborn%20genetic%20diseases%2Cnot%20provided%20GENE%3DQRSL1]%3B;dbSNP=rs72946534;gnomAD=0.00062;gnomAD_sub=0.00019%2C0.00078%2C0.00000%2C0.00104%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=95;gnomAD_wt=152183;phyloP=4.6990;CADD=20.90;REVEL=0.050;AlphaMissense=0.09;MaxEntScan=/2.4>2.2/0.0>0.0;SpliceAI=QRSL1|0.00|0.00|0.00|0.00|-47|1|19|16;NGSD_hom=0;NGSD_het=58;NGSD_mosaic=0;NGSD_group=0%20/%208;gene_info=QRSL1%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.82%20oe_lof%3D0.59)	GT	1/0
chr6	152463486	.	T	C	1166	.	quality=DP%3D88%3BQD%3D13.25%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D57%3BABP%3D5%3BSAR%3D42%3BSAF%3D7;gene=SYNE1;variant_type=missense;coding_and_splicing=SYNE1:ENST00000423061.6:missense_variant:MODERATE:exon19/146:c.1985A>G:p.Gln662Arg:%2CSYNE1:ENST00000367255.10:missense_variant:MODERATE:exon19/146:c.1964A>G:p.Gln655Arg:%2CSYNE1:ENST00000367253.8:missense_variant:MODERATE:exon17/36:c.1964A>G:p.Gln655Arg:%2CSYNE1:ENST00000367248.7:missense_variant:MODERATE:exon18/32:c.1934A>G:p.Gln645Arg:%2CSYNE1:ENST00000672122.1:missense_variant:MODERATE:exon17/31:c.1907A>G:p.Gln636Arg:%2CSYNE1:ENST00000413186.6:missense_variant:MODERATE:exon17/31:c.1964A>G:p.Gln655Arg:%2CSYNE1:ENST00000495090.6:missense_variant:MODERATE:exon6/12:c.665A>G:p.Gln222Arg:%2CSYNE1:ENST00000535896.7:missense_variant:MODERATE:exon18/19:c.1958A>G:p.Gln653Arg:%2CSYNE1:ENST00000466159.6:missense_variant:MODERATE:exon17/18:c.1964A>G:p.Gln655Arg:;OMIM=608441_[GENE%3DSYNE1_PHENOS%3DArthrogryposis%20multiplex%20congenita%203%2C%20myogenic%20type%2C%20618484%20(3)%2C%20Autosomal%20recessive%3B%20Emery-Dreifuss%20muscular%20dystrophy%204%2C%20autosomal%20dominant%2C%20612998%20(3)%2C%20Autosomal%20dominant%3B%20Spinocerebellar%20ataxia%2C%20autosomal%20recessive%208%2C%20610743%20(3)%2C%20Autosomal%20recessive];ClinVar=130417%20[benign/likely%20benign%20DISEASE%3DEmery-Dreifuss%20muscular%20dystrophy%204%2C%20autosomal%20dominant%2CAutosomal%20recessive%20ataxia%2C%20Beauce%20type%2CSYNE1-related%20disorder%2Cnot%20provided%2Cnot%20specified%20GENE%3DSYNE1]%3B%2092124%20[uncertain%20significance%20DISEASE%3DIntellectual%20disability%20GENE%3DSYNE1]%3B;HGMD=CM186942%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Cerebellar%20ataxia%20late-onset%20with%20pyramidal%20signs"%20GENE%3DSYNE1]%3B;dbSNP=rs9397509;gnomAD=0.00594;gnomAD_sub=0.00171%2C0.00654%2C0.00019%2C0.00789%2C0.00021;gnomAD_hom_hemi=6%2C;gnomAD_het=892;gnomAD_wt=151376;phyloP=7.8750;CADD=23.70;REVEL=0.145;AlphaMissense=0.12;MaxEntScan=/2.7>1.1/0.0>0.0;COSMIC=COSV104543085;PubMed=25741868%2C24123876%2C30610203;NGSD_hom=4;NGSD_het=480;NGSD_mosaic=1;NGSD_group=1%20/%2049;gene_info=SYNE1%20(inh%3DAR+AD%20oe_syn%3D1.05%20oe_mis%3D1.01%20oe_lof%3D0.37)	GT	1/0
chr6	160706469	.	A	G	1651	.	quality=DP%3D128%3BQD%3D12.90%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D30%3BSAF%3D36;gene=PLG;variant_type=missense%2Cintron%2C5'UTR;coding_and_splicing=PLG:ENST00000418964.2:missense_variant:MODERATE:exon2/19:c.112A>G:p.Lys38Glu:PF00024%20[PAN%20domain]%2CPLG:ENST00000366924.6:missense_variant:MODERATE:exon2/4:c.112A>G:p.Lys38Glu:PF00024%20[PAN%20domain]%2CPLG:ENST00000308192.14:missense_variant:MODERATE:exon2/19:c.112A>G:p.Lys38Glu:PF00024%20[PAN%20domain]%2CPLG:ENST00000297289.9:intron_variant:MODIFIER:intron1/10:c.49+4116A>G::%2CPLG:ENST00000494325.2:5_prime_UTR_variant:MODIFIER:exon2/4:c.-114A>G::;OMIM=173350_[GENE%3DPLG_PHENOS%3DDysplasminogenemia%2C%20217090%20(3)%2C%20Autosomal%20recessive%3B%20Angioedema%2C%20hereditary%2C%204%2C%20619360%20(3)%2C%20Autosomal%20dominant%3B%20Plasminogen%20deficiency%2C%20type%20I%2C%20217090%20(3)%2C%20Autosomal%20recessive];ClinVar=13583%20[likely%20pathogenic(replaced%20by%20megSAP%20based%20on%20classifications:3x3%2C2x4%2C8x5)%20DISEASE%3DOtitis%20media%2C%20susceptibility%20to%2CDeep%20venous%20thrombosis%2CPlasminogen%20deficiency%2C%20type%20I%2Cnot%20provided%20GENE%3DPLG]%3B;HGMD=CM991050%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Plasminogen%20deficiency"%20GENE%3DPLG]%3B;dbSNP=rs73015965;gnomAD=0.00277;gnomAD_sub=0.00125%2C0.00196%2C0.00000%2C0.00475%2C0.00021;gnomAD_hom_hemi=2%2C;gnomAD_het=418;gnomAD_wt=151900;phyloP=1.6620;CADD=16.80;REVEL=0.642;AlphaMissense=0.15;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV51987550;SpliceAI=PLG|0.00|0.00|0.00|0.00|-24|3|45|-37;PubMed=25741868%2C30409984%2C27976734%2C24029428%2C20981092%2C22995991%2C27182965%2C27194806%2C10233898%2C12850227%2C16849641%2C35337356%2C15269832%2C36167494%2C30487145%2C34322716%2C32929111%2C32007292%2C28928442%2C31980526%2C23629776%2C31064749%2C2797673%2C34355501%2C2362977%2C26340456%2C12876630%2C31589614;NGSD_hom=2;NGSD_het=227;NGSD_mosaic=0;NGSD_group=0%20/%2018;gene_info=PLG%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.97%20oe_lof%3D0.28)	GT	1/0
chr7	551459	.	G	A	1170	.	quality=DP%3D113%3BQD%3D10.35%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D15%3BABP%3D5%3BSAR%3D34%3BSAF%3D17;gene=PRKAR1B;variant_type=synonymous;coding_and_splicing=PRKAR1B:ENST00000544935.5:synonymous_variant:LOW:exon10/11:c.903C>T:p.Ser301%3D:PF00027%20[Cyclic%20nucleotide-binding%20domain]%2CPRKAR1B:ENST00000406797.5:synonymous_variant:LOW:exon10/11:c.903C>T:p.Ser301%3D:PF00027%20[Cyclic%20nucleotide-binding%20domain]%2CPRKAR1B:ENST00000537384.6:synonymous_variant:LOW:exon10/11:c.903C>T:p.Ser301%3D:PF00027%20[Cyclic%20nucleotide-binding%20domain]%2CPRKAR1B:ENST00000403562.5:synonymous_variant:LOW:exon10/11:c.903C>T:p.Ser301%3D:PF00027%20[Cyclic%20nucleotide-binding%20domain]%2CPRKAR1B:ENST00000360274.8:synonymous_variant:LOW:exon10/11:c.903C>T:p.Ser301%3D:PF00027%20[Cyclic%20nucleotide-binding%20domain];OMIM=176911_[GENE%3DPRKAR1B_PHENOS%3DMarbach-Schaaf%20neurodevelopmental%20syndrome%2C%20619680%20(3)%2C%20Autosomal%20dominant];ClinVar=719391%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DPRKAR1B]%3B;dbSNP=rs78260651;gnomAD=0.00324;gnomAD_sub=0.00169%2C0.00020%2C0.00000%2C0.00175%2C0.00062;gnomAD_hom_hemi=7%2C;gnomAD_het=479;gnomAD_wt=151751;phyloP=-2.1370;CADD=0.01;REVEL=0.005;MaxEntScan=/5.9>6.3/0.0>0.0;COSMIC=COSV64320324;SpliceAI=PRKAR1B|0.00|0.00|0.00|0.00|-10|11|-10|-29;NGSD_hom=1;NGSD_het=182;NGSD_mosaic=1;NGSD_group=0%20/%2024;gene_info=PRKAR1B%20(inh%3DAD%20oe_syn%3D1.07%20oe_mis%3D0.64%20oe_lof%3D0.26)	GT	1/0
chr7	55201256	.	A	G	2273	.	quality=DP%3D217%3BQD%3D10.47%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D4%3BABP%3D11%3BSAR%3D50%3BSAF%3D44;gene=EGFR;variant_type=synonymous;coding_and_splicing=EGFR:ENST00000275493.7:synonymous_variant:LOW:exon25/28:c.3015A>G:p.Glu1005%3D:%2CEGFR:ENST00000455089.5:synonymous_variant:LOW:exon24/26:c.2880A>G:p.Glu960%3D:%2CEGFR:ENST00000450046.2:synonymous_variant:LOW:exon25/28:c.2856A>G:p.Glu952%3D:;OMIM=131550_[GENE%3DEGFR_PHENOS%3D?Inflammatory%20skin%20and%20bowel%20disease%2C%20neonatal%2C%202%2C%20616069%20(3)%2C%20Autosomal%20recessive%3B%20Nonsmall%20cell%20lung%20cancer%2C%20response%20to%20tyrosine%20kinase%20inhibitor%20in%2C%20211980%20(3)%2C%20Somatic%20mutation%2C%20Autosomal%20dominant%3B%20Adenocarcinoma%20of%20lung%2C%20response%20to%20tyrosine%20kinase%20inhibitor%20in%2C%20211980%20(3)%2C%20Somatic%20mutation%2C%20Autosomal%20dominant%3B%20{Nonsmall%20cell%20lung%20cancer%2C%20susceptibility%20to}%2C%20211980%20(3)%2C%20Somatic%20mutation%2C%20Autosomal%20dominant];ClinVar=360468%20[benign/likely%20benign%20DISEASE%3DHereditary%20cancer-predisposing%20syndrome%2Cnot%20provided%2CEGFR-related%20lung%20cancer%20GENE%3DEGFR]%3B;dbSNP=rs55737335;gnomAD=0.00236;gnomAD_sub=0.00089%2C0.00183%2C0.00000%2C0.00409%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=357;gnomAD_wt=151927;phyloP=1.7930;CADD=7.70;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV51774050;SpliceAI=EGFR|0.00|0.00|0.00|0.00|-42|2|12|29;PubMed=36873279;NGSD_hom=1;NGSD_het=241;NGSD_mosaic=0;NGSD_group=0%20/%2033;gene_info=EGFR%20(inh%3DAR+AD%20oe_syn%3D1.13%20oe_mis%3D0.80%20oe_lof%3D0.23)	GT	1/0
chr7	92065429	.	A	G	469	.	quality=DP%3D66%3BQD%3D7.11%3BAF%3D0.35%3BMQM%3D60%3BSAP%3D24%3BABP%3D16%3BSAR%3D19%3BSAF%3D4;gene=AKAP9;variant_type=missense;coding_and_splicing=AKAP9:ENST00000680072.1:missense_variant:MODERATE:exon25/49:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000680513.1:missense_variant:MODERATE:exon24/49:c.6035A>G:p.Glu2012Gly:%2CAKAP9:ENST00000680534.1:missense_variant:MODERATE:exon26/51:c.6215A>G:p.Glu2072Gly:%2CAKAP9:ENST00000679821.1:missense_variant:MODERATE:exon24/49:c.5918A>G:p.Glu1973Gly:%2CAKAP9:ENST00000681722.1:missense_variant:MODERATE:exon25/49:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000680181.1:missense_variant:MODERATE:exon24/49:c.6083A>G:p.Glu2028Gly:%2CAKAP9:ENST00000356239.8:missense_variant:MODERATE:exon25/50:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000679521.1:missense_variant:MODERATE:exon24/49:c.6122A>G:p.Glu2041Gly:%2CAKAP9:ENST00000680952.1:missense_variant:MODERATE:exon25/48:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000681412.1:missense_variant:MODERATE:exon25/49:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000680766.1:missense_variant:MODERATE:exon25/50:c.6176A>G:p.Glu2059Gly:%2CAKAP9:ENST00000359028.7:missense_variant:MODERATE:exon26/51:c.6272A>G:p.Glu2091Gly:%2CAKAP9:ENST00000491695.2:missense_variant:MODERATE:exon4/29:c.821A>G:p.Glu274Gly:;OMIM=604001_[GENE%3DAKAP9_PHENOS%3D?Long%20QT%20syndrome%2011%2C%20611820%20(3)%2C%20Autosomal%20dominant];ClinVar=191519%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:6x2%2C2x3)%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CCongenital%20long%20QT%20syndrome%2CLong%20QT%20syndrome%2CLong%20QT%20syndrome%2011%2CCardiovascular%20phenotype%20GENE%3DAKAP9]%3B;HGMD=CM1515196%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Sudden%20cardiac%20death"%20GENE%3DAKAP9]%3B;dbSNP=rs73226383;gnomAD=0.00066;gnomAD_sub=0.00029%2C0.00007%2C0.00000%2C0.00125%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=101;gnomAD_wt=152211;phyloP=6.8180;CADD=25.20;REVEL=0.291;AlphaMissense=0.36;MaxEntScan=/0.0>0.0/0.0>0.7;COSMIC=COSV100662397;SpliceAI=AKAP9|0.00|0.00|0.00|0.01|34|-20|-43|34;PubMed=23861362%2C25467552;NGSD_hom=0;NGSD_het=80;NGSD_mosaic=0;NGSD_group=0%20/%204;gene_info=AKAP9%20(inh%3DAD%20oe_syn%3D0.96%20oe_mis%3D1.01%20oe_lof%3D0.33)	GT	1/0
chr7	100097308	.	C	T	2517	.	quality=DP%3D205%3BQD%3D12.28%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D9%3BABP%3D3%3BSAR%3D42%3BSAF%3D58;gene=MCM7%2CMIR25%2CMIR93%2CMIR106B%2CAP4M1;variant_type=synonymous%2Cintron%2Cupstream_gene;coding_and_splicing=MCM7:ENST00000710813.1:synonymous_variant:LOW:exon10/15:c.873G>A:p.Ala291%3D:PF00493%20[MCM%20P-loop%20domain]%2CMCM7:ENST00000425308.6:synonymous_variant:LOW:exon10/15:c.873G>A:p.Ala291%3D:PF00493%20[MCM%20P-loop%20domain]%2CMCM7:ENST00000303887.10:synonymous_variant:LOW:exon10/15:c.1194G>A:p.Ala398%3D:PF00493%20[MCM%20P-loop%20domain]%2CMCM7:ENST00000710815.1:synonymous_variant:LOW:exon10/15:c.873G>A:p.Ala291%3D:PF00493%20[MCM%20P-loop%20domain]%2CMCM7:ENST00000343023.10:intron_variant:MODIFIER:intron8/8:c.985+526G>A::%2CMIR25:ENST00000384816.1:upstream_gene_variant:MODIFIER::::%2CMIR93:ENST00000385024.1:upstream_gene_variant:MODIFIER::::%2CMIR106B:ENST00000385301.1:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000713791.1:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000713591.1:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000713792.1:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000429084.5:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000450807.6:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000359593.9:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000421755.5:upstream_gene_variant:MODIFIER::::%2CAP4M1:ENST00000445295.2:upstream_gene_variant:MODIFIER::::;OMIM=602296_[GENE%3DAP4M1_PHENOS%3DSpastic%20paraplegia%2050%2C%20autosomal%20recessive%2C%20612936%20(3)%2C%20Autosomal%20recessive];dbSNP=rs61752703;gnomAD=0.00328;gnomAD_sub=0.00118%2C0.00033%2C0.00000%2C0.00263%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=497;gnomAD_wt=151761;phyloP=-1.3060;CADD=1.47;MaxEntScan=/2.9>1.8/0.0>0.0;SpliceAI=MCM7|0.00|0.00|0.00|0.00|44|32|-7|-11;NGSD_hom=0;NGSD_het=107;NGSD_mosaic=2;NGSD_group=0%20/%2015;gene_info=MCM7%20(inh%3Dn/a%20oe_syn%3D1.34%20oe_mis%3D1.10%20oe_lof%3D0.97)%2C%20MIR25%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20MIR93%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20MIR106B%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20AP4M1%20(inh%3DAR%20oe_syn%3D1.39%20oe_mis%3D1.21%20oe_lof%3D0.95)	GT	1/0
chr7	101163167	.	C	G	1944	.	quality=DP%3D168%3BQD%3D11.57%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D40%3BSAF%3D39;gene=VGF%2CAP1S1%2CMIR4653;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=VGF:ENST00000249330.3:synonymous_variant:LOW:exon2/2:c.1677G>C:p.Ser559%3D:%2CVGF:ENST00000445482.2:synonymous_variant:LOW:exon2/2:c.1677G>C:p.Ser559%3D:%2CAP1S1:ENST00000337619.11:downstream_gene_variant:MODIFIER::::%2CAP1S1:ENST00000646560.1:downstream_gene_variant:MODIFIER::::%2CMIR4653:ENST00000585107.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=603531_[GENE%3DAP1S1_PHENOS%3DMEDNIK%20syndrome%2C%20609313%20(3)%2C%20Autosomal%20recessive];dbSNP=rs79302583;gnomAD=0.00020;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00025%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=30;gnomAD_wt=151870;phyloP=-0.7140;CADD=4.30;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=VGF|0.00|0.00|0.00|0.00|8|-4|32|0;NGSD_hom=0;NGSD_het=26;NGSD_mosaic=1;NGSD_group=0%20/%203;gene_info=AP1S1%20(inh%3DAR%20oe_syn%3D0.92%20oe_mis%3D0.47%20oe_lof%3D0.33)%2C%20MIR4653%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20VGF%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D0.96%20oe_lof%3D0.19)	GT	1/0
chr7	128313185	.	G	A	1326	.	quality=DP%3D130%3BQD%3D10.20%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D22%3BABP%3D5%3BSAR%3D18%3BSAF%3D41;gene=RBM28;variant_type=missense;coding_and_splicing=RBM28:ENST00000223073.6:missense_variant:MODERATE:exon18/19:c.2135C>T:p.Ser712Leu:%2CRBM28:ENST00000415472.6:missense_variant:MODERATE:exon14/15:c.1712C>T:p.Ser571Leu:;OMIM=612074_[GENE%3DRBM28_PHENOS%3D?Alopecia%2C%20neurologic%20defects%2C%20and%20endocrinopathy%20syndrome%2C%20612079%20(3)%2C%20Autosomal%20recessive];ClinVar=788269%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CRBM28-related%20disorder%20GENE%3DRBM28]%3B;dbSNP=rs73230638;gnomAD=0.00271;gnomAD_sub=0.00084%2C0.00294%2C0.00000%2C0.00419%2C0.00083;gnomAD_hom_hemi=2%2C;gnomAD_het=409;gnomAD_wt=151857;phyloP=2.2460;CADD=20.60;REVEL=0.072;AlphaMissense=0.07;MaxEntScan=/4.3>3.7/0.0>0.0;COSMIC=COSV56161951;SpliceAI=RBM28|0.00|0.00|0.00|0.00|-11|46|-6|-10;NGSD_hom=2;NGSD_het=288;NGSD_mosaic=0;NGSD_group=0%20/%2040;gene_info=RBM28%20(inh%3DAR%20oe_syn%3D0.92%20oe_mis%3D0.97%20oe_lof%3D0.58)	GT	1/0
chr7	128775760	.	G	A	2009	.	quality=DP%3D188%3BQD%3D10.69%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D5%3BSAR%3D43%3BSAF%3D45;gene=OPN1SW%2CCALU;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=OPN1SW:ENST00000249389.3:synonymous_variant:LOW:exon1/5:c.22C>T:p.Leu8%3D:%2CCALU:ENST00000535011.6:downstream_gene_variant:MODIFIER::::%2CCALU:ENST00000249364.9:downstream_gene_variant:MODIFIER::::%2CCALU:ENST00000449187.7:downstream_gene_variant:MODIFIER::::%2CCALU:ENST00000542996.7:downstream_gene_variant:MODIFIER::::;OMIM=613522_[GENE%3DOPN1SW_PHENOS%3DColorblindness%2C%20tritan%2C%20190900%20(3)%2C%20Autosomal%20dominant];ClinVar=781655%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DOPN1SW]%3B;dbSNP=rs55974922;gnomAD=0.00704;gnomAD_sub=0.00173%2C0.00314%2C0.00000%2C0.01115%2C0.00333;gnomAD_hom_hemi=5%2C;gnomAD_het=1062;gnomAD_wt=151142;phyloP=4.1280;CADD=3.22;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV50821514%2CCOSV50823790;SpliceAI=OPN1SW|0.00|0.00|0.00|0.00|-10|-22|-1|-9;NGSD_hom=6;NGSD_het=562;NGSD_mosaic=1;NGSD_group=0%20/%2077;gene_info=CALU%20(inh%3Dn/a%20oe_syn%3D0.99%20oe_mis%3D0.72%20oe_lof%3D0.36)%2C%20OPN1SW%20(inh%3DAD%20oe_syn%3D1.31%20oe_mis%3D1.00%20oe_lof%3D0.37)	GT	1/0
chr7	148409373	.	C	CTCTT	2790	.	quality=DP%3D103%3BQD%3D27.09%3BAF%3D0.93%3BMQM%3D60%3BSAP%3D55%3BABP%3D0%3BSAR%3D24%3BSAF%3D72;gene=CNTNAP2;variant_type=splice_region&intron;coding_and_splicing=CNTNAP2:ENST00000361727.8:splice_region_variant&intron_variant:LOW:intron22/23:c.3716-10_3716-7dup::%2CCNTNAP2:ENST00000628930.2:splice_region_variant&intron_variant:LOW:intron7/8:c.893-10_893-7dup::%2CCNTNAP2:ENST00000463592.3:splice_region_variant&intron_variant:LOW:intron2/3:c.47-10_47-7dup::;OMIM=604569_[GENE%3DCNTNAP2_PHENOS%3DPitt-Hopkins%20like%20syndrome%201%2C%20610042%20(3)%2C%20Autosomal%20recessive%3B%20{Autism%20susceptibility%2015}%2C%20612100%20(3)];ClinVar=95571%20[benign/likely%20benign%20DISEASE%3DCortical%20dysplasia-focal%20epilepsy%20syndrome%2Cnot%20specified%20GENE%3DCNTNAP2]%3B;dbSNP=rs142426153;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00008%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=28929;CADD=1.53;MaxEntScan=/10.7>12.4/0.0>0.0;SpliceAI=CNTNAP2|0.09|0.00|0.00|0.00|22|45|-48|20;PubMed=25741868%2C18414213%2C23757202%2C35454361;NGSD_hom=6055;NGSD_het=6843;NGSD_mosaic=293;NGSD_group=630%20/%20650;classification=2;classification_comment="[2]%20auto-classification%2015.09.2017%20%20";gene_info=CNTNAP2%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D1.03%20oe_lof%3D0.40)	GT	1/1
chr7	148409385	.	C	G	3571	.	quality=DP%3D119%3BQD%3D30.01%3BAF%3D0.97%3BMQM%3D60%3BSAP%3D52%3BABP%3D0%3BSAR%3D32%3BSAF%3D83;gene=CNTNAP2;variant_type=splice_region&intron;coding_and_splicing=CNTNAP2:ENST00000361727.8:splice_region_variant&intron_variant:LOW:intron22/23:c.3716-6C>G::%2CCNTNAP2:ENST00000628930.2:splice_region_variant&intron_variant:LOW:intron7/8:c.893-6C>G::%2CCNTNAP2:ENST00000463592.3:splice_region_variant&intron_variant:LOW:intron2/3:c.47-6C>G::;OMIM=604569_[GENE%3DCNTNAP2_PHENOS%3DPitt-Hopkins%20like%20syndrome%201%2C%20610042%20(3)%2C%20Autosomal%20recessive%3B%20{Autism%20susceptibility%2015}%2C%20612100%20(3)];ClinVar=95572%20[benign(replaced%20by%20megSAP%20based%20on%20classifications:7x1%2C1x2%2C1x3)%20DISEASE%3DCortical%20dysplasia-focal%20epilepsy%20syndrome%2Cnot%20specified%2CAutism%2C%20susceptibility%20to%2C%2015%20GENE%3DCNTNAP2]%3B;dbSNP=rs77025884;gnomAD=0.00003;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=5;gnomAD_wt=151499;phyloP=-0.3170;CADD=2.35;MaxEntScan=10.7>8.9/10.7>8.9/0.0>0.0;COSMIC=COSV62164105;SpliceAI=CNTNAP2|0.12|0.00|0.00|0.00|10|6|6|8;PubMed=25741868%2C18414213%2C23757202%2C35454361;NGSD_hom=3554;NGSD_het=3934;NGSD_mosaic=295;NGSD_group=317%20/%20335;gene_info=CNTNAP2%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D1.03%20oe_lof%3D0.40)	GT	1/1
chr8	10613063	.	C	T	4622	.	quality=DP%3D373%3BQD%3D12.39%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D34%3BABP%3D4%3BSAR%3D65%3BSAF%3D116;gene=RP1L1;variant_type=synonymous;coding_and_splicing=RP1L1:ENST00000382483.4:synonymous_variant:LOW:exon4/4:c.1035G>A:p.Arg345%3D:;OMIM=608581_[GENE%3DRP1L1_PHENOS%3DOccult%20macular%20dystrophy%2C%20613587%20(3)%2C%20Autosomal%20dominant%3B%20Retinitis%20pigmentosa%2088%2C%20618826%20(3)%2C%20Autosomal%20recessive];ClinVar=910474%20[benign%20DISEASE%3DOccult%20macular%20dystrophy%20GENE%3DRP1L1]%3B;dbSNP=rs73201157;gnomAD=0.00028;gnomAD_sub=0.00005%2C0.00007%2C0.00000%2C0.00057%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=42;gnomAD_wt=152302;phyloP=0.2660;CADD=2.82;MaxEntScan=/1.8>1.4/0.0>0.0;COSMIC=COSV66757796;SpliceAI=RP1L1|0.00|0.00|0.07|0.00|-48|42|-48|42;NGSD_hom=0;NGSD_het=19;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=RP1L1%20(inh%3DAR+AD%20oe_syn%3D1.51%20oe_mis%3D1.77%20oe_lof%3D1.72)	GT	1/0
chr8	11845732	.	C	G	2781	.	quality=DP%3D257%3BQD%3D10.82%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D56%3BABP%3D9%3BSAR%3D84%3BSAF%3D31;gene=CTSB;variant_type=missense%2Csynonymous;coding_and_splicing=CTSB:ENST00000679121.1:missense_variant:MODERATE:exon8/9:c.803G>C:p.Gly268Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000676952.1:missense_variant:MODERATE:exon8/9:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000676825.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000353047.11:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677650.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000676691.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678598.1:missense_variant:MODERATE:exon9/10:c.902G>C:p.Gly301Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677873.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000679128.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678092.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677671.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678242.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677366.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677544.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000530640.7:missense_variant:MODERATE:exon9/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677418.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677047.1:missense_variant:MODERATE:exon8/9:c.707G>C:p.Gly236Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000676502.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000531089.6:missense_variant:MODERATE:exon10/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678629.1:missense_variant:MODERATE:exon7/8:c.635G>C:p.Gly212Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678145.1:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678929.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677819.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677415.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678357.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000676755.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000679051.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000453527.7:missense_variant:MODERATE:exon9/10:c.848G>C:p.Gly283Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678067.1:missense_variant:MODERATE:exon6/6:c.473G>C:p.Gly158Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000679140.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000533455.6:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000677082.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000534382.6:missense_variant:MODERATE:exon9/10:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000534510.6:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000531502.6:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000533572.6:missense_variant:MODERATE:exon8/9:c.707G>C:p.Gly236Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000345125.8:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000526645.6:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000505496.7:missense_variant:MODERATE:exon11/12:c.947G>C:p.Gly316Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000534149.6:synonymous_variant:LOW:exon10/11:c.906G>C:p.Gly302%3D:%2CCTSB:ENST00000676843.1:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000524500.6:missense_variant:MODERATE:exon9/10:c.707G>C:p.Gly236Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000527215.7:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000532656.7:missense_variant:MODERATE:exon11/12:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000526195.6:missense_variant:MODERATE:exon10/11:c.947G>C:p.Gly316Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000678615.1:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000530296.6:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease]%2CCTSB:ENST00000527243.6:missense_variant:MODERATE:exon10/11:c.851G>C:p.Gly284Ala:PF00112%20[Papain%20family%20cysteine%20protease];regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:enhancer;OMIM=116810_[GENE%3DCTSB_PHENOS%3DKeratolytic%20winter%20erythema%2C%20148370%20(4)%2C%20Autosomal%20dominant];dbSNP=rs73209021;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152344;phyloP=7.3490;CADD=27.60;REVEL=0.874;AlphaMissense=0.94;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV61540384;SpliceAI=CTSB|0.00|0.00|0.00|0.00|33|43|-34|25;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CTSB%20(inh%3DAD%20oe_syn%3D2.03%20oe_mis%3D1.65%20oe_lof%3D0.89)	GT	1/0
chr8	41661785	.	G	A	1946	.	quality=DP%3D126%3BQD%3D15.44%3BAF%3D0.61%3BMQM%3D60%3BSAP%3D71%3BABP%3D17%3BSAR%3D14%3BSAF%3D63;gene=ANK1%2CMIR486-1%2CMIR486-2;variant_type=splice_region&intron%2Cintron%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=ANK1:ENST00000347528.8:splice_region_variant&intron_variant:LOW:intron41/41:c.5619+16C>T::%2CANK1:ENST00000522543.6:splice_region_variant&intron_variant:LOW:intron3/3:c.444+16C>T::%2CANK1:ENST00000289734.13:intron_variant:MODIFIER:intron41/42:c.5544+91C>T::%2CANK1:ENST00000265709.14:intron_variant:MODIFIER:intron42/42:c.5667+91C>T::%2CANK1:ENST00000522231.5:intron_variant:MODIFIER:intron3/3:c.369+91C>T::%2CANK1:ENST00000314214.12:intron_variant:MODIFIER:intron3/4:c.369+91C>T::%2CANK1:ENST00000705521.1:intron_variant:MODIFIER:intron43/44:c.5763+91C>T::%2CANK1:ENST00000705522.1:intron_variant:MODIFIER:intron41/41:c.5538+49C>T::%2CANK1:ENST00000348036.8:intron_variant:MODIFIER:intron2/2:c.303+1874C>T::%2CMIR486-1:ENST00000612171.2:upstream_gene_variant:MODIFIER::::%2CMIR486-2:ENST00000637446.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=612641_[GENE%3DANK1_PHENOS%3DSpherocytosis%2C%20type%201%2C%20182900%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=261318%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C4x2%2C1x3)%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CHereditary%20spherocytosis%20type%201%20GENE%3DANK1]%3B;HGMD=CM960063%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Spherocytosis"%20GENE%3DANK1]%3B;dbSNP=rs72638959;gnomAD=0.00804;gnomAD_sub=0.00229%2C0.00255%2C0.00000%2C0.00894%2C0.00000;gnomAD_hom_hemi=12%2C;gnomAD_het=1201;gnomAD_wt=151081;phyloP=-0.0710;CADD=0.92;MaxEntScan=/0.8>1.2/0.0>0.0;SpliceAI=ANK1|0.00|0.00|0.03|0.00|49|15|49|16;PubMed=25741868%2C24033266;NGSD_hom=3;NGSD_het=567;NGSD_mosaic=1;NGSD_group=0%20/%2075;gene_info=ANK1%20(inh%3DAR+AD%20oe_syn%3D1.04%20oe_mis%3D0.83%20oe_lof%3D0.10)%2C%20MIR486-1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20MIR486-2%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr8	42316862	.	G	A	921	.	quality=DP%3D91%3BQD%3D10.12%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D68%3BABP%3D5%3BSAR%3D38%3BSAF%3D3;gene=IKBKB;variant_type=synonymous%2Cintron;coding_and_splicing=IKBKB:ENST00000520810.6:synonymous_variant:LOW:exon11/22:c.1083G>A:p.Leu361%3D:%2CIKBKB:ENST00000520835.7:synonymous_variant:LOW:exon10/21:c.891G>A:p.Leu297%3D:%2CIKBKB:ENST00000522147.4:intron_variant:MODIFIER:intron1/1:c.106-14345G>A::;regulatory=regulatory_region_variant:enhancer;OMIM=603258_[GENE%3DIKBKB_PHENOS%3DImmunodeficiency%2015B%2C%20615592%20(3)%2C%20Autosomal%20recessive%3B%20Immunodeficiency%2015A%2C%20618204%20(3)%2C%20Autosomal%20dominant];ClinVar=474788%20[benign%20DISEASE%3DSevere%20combined%20immunodeficiency%20due%20to%20IKK2%20deficiency%20GENE%3DIKBKB]%3B;dbSNP=rs56230731;gnomAD=0.00977;gnomAD_sub=0.00250%2C0.00419%2C0.00019%2C0.01690%2C0.00000;gnomAD_hom_hemi=4%2C;gnomAD_het=1480;gnomAD_wt=150796;phyloP=4.0600;CADD=5.15;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=IKBKB|0.00|0.00|0.00|0.00|25|-40|37|42;NGSD_hom=9;NGSD_het=960;NGSD_mosaic=0;NGSD_group=3%20/%20122;gene_info=IKBKB%20(inh%3DAR+AD%20oe_syn%3D0.80%20oe_mis%3D0.65%20oe_lof%3D0.17)	GT	1/0
chr8	67422547	.	G	A	1026	.	quality=DP%3D71%3BQD%3D14.45%3BAF%3D0.58%3BMQM%3D60%3BSAP%3D31%3BABP%3D7%3BSAR%3D9%3BSAF%3D32;gene=CPA6;variant_type=missense;coding_and_splicing=CPA6:ENST00000297770.10:missense_variant:MODERATE:exon11/11:c.1271C>T:p.Ala424Val:;OMIM=609562_[GENE%3DCPA6_PHENOS%3DFebrile%20seizures%2C%20familial%2C%2011%2C%20614418%20(3)%2C%20Autosomal%20recessive%3B%20Epilepsy%2C%20familial%20temporal%20lobe%2C%205%2C%20614417%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=472761%20[uncertain%20significance%20DISEASE%3DFamilial%20temporal%20lobe%20epilepsy%205%2CFebrile%20seizures%2C%20familial%2C%2011%20GENE%3DCPA6]%3B;HGMD=CM1212272%20[CLASS%3DFP%20MUT%3DALT%20PHEN%3D"Reduced%20protein%20expression"%20GENE%3DCPA6]%3B;dbSNP=rs72654981;gnomAD=0.00024;gnomAD_sub=0.00007%2C0.00000%2C0.00000%2C0.00046%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=36;gnomAD_wt=152272;phyloP=9.5710;CADD=29.70;REVEL=0.711;AlphaMissense=0.79;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CPA6|0.00|0.00|0.00|0.00|-49|39|2|-8;PubMed=23105115;NGSD_hom=0;NGSD_het=18;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=CPA6%20(inh%3DAR+AD%20oe_syn%3D1.00%20oe_mis%3D1.09%20oe_lof%3D0.90)	GT	1/0
chr8	104223730	.	G	A	1670	.	quality=DP%3D138%3BQD%3D12.10%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D6%3BABP%3D3%3BSAR%3D29%3BSAF%3D38;gene=RIMS2;variant_type=intron%2Cmissense;coding_and_splicing=RIMS2:ENST00000696799.1:intron_variant:MODIFIER:intron25/29:c.4109-21186G>A::%2CRIMS2:ENST00000666250.1:intron_variant:MODIFIER:intron26/30:c.4064-21186G>A::%2CRIMS2:ENST00000705941.1:intron_variant:MODIFIER:intron20/24:c.3410-21186G>A::%2CRIMS2:ENST00000705942.1:intron_variant:MODIFIER:intron21/25:c.3656-21186G>A::%2CRIMS2:ENST00000705943.1:intron_variant:MODIFIER:intron23/27:c.3737-21186G>A::%2CRIMS2:ENST00000705944.1:intron_variant:MODIFIER:intron18/22:c.3140-21186G>A::%2CRIMS2:ENST00000705945.1:intron_variant:MODIFIER:intron22/26:c.3851-21186G>A::%2CRIMS2:ENST00000705946.1:intron_variant:MODIFIER:intron20/24:c.3623-21186G>A::%2CRIMS2:ENST00000705947.1:intron_variant:MODIFIER:intron19/23:c.3494-21186G>A::%2CRIMS2:ENST00000668113.1:intron_variant:MODIFIER:intron21/25:c.3590-21186G>A::%2CRIMS2:ENST00000705948.1:intron_variant:MODIFIER:intron20/24:c.3407-21186G>A::%2CRIMS2:ENST00000504942.6:intron_variant:MODIFIER:intron19/23:c.3335-21186G>A::%2CRIMS2:ENST00000696802.1:intron_variant:MODIFIER:intron20/24:c.3260-21186G>A::%2CRIMS2:ENST00000705949.1:intron_variant:MODIFIER:intron16/20:c.2597-21186G>A::%2CRIMS2:ENST00000705950.1:intron_variant:MODIFIER:intron15/19:c.2531-21186G>A::%2CRIMS2:ENST00000408894.7:intron_variant:MODIFIER:intron22/26:c.3356-21186G>A::%2CRIMS2:ENST00000507740.6:intron_variant:MODIFIER:intron17/21:c.2777-21186G>A::%2CRIMS2:ENST00000262231.14:intron_variant:MODIFIER:intron16/20:c.2852-21186G>A::%2CRIMS2:ENST00000705951.1:intron_variant:MODIFIER:intron18/22:c.2780-21186G>A::%2CRIMS2:ENST00000436393.6:intron_variant:MODIFIER:intron23/27:c.3389-21186G>A::%2CRIMS2:ENST00000523362.6:missense_variant:MODERATE:exon1/6:c.79G>A:p.Ala27Thr:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=606630_[GENE%3DRIMS2_PHENOS%3DCone-rod%20synaptic%20disorder%20syndrome%2C%20congenital%20nonprogressive%2C%20618970%20(3)%2C%20Autosomal%20recessive];dbSNP=rs115168750;gnomAD=0.00870;gnomAD_sub=0.00305%2C0.00692%2C0.00000%2C0.01501%2C0.00331;gnomAD_hom_hemi=12%2C;gnomAD_het=1302;gnomAD_wt=151032;phyloP=9.3700;CADD=20.90;REVEL=0.208;MaxEntScan=/4.1>3.0/0.0>0.0;SpliceAI=RIMS2|0.00|0.00|0.00|0.00|12|-27|11|-5;NGSD_hom=12;NGSD_het=1108;NGSD_mosaic=0;NGSD_group=3%20/%20150;gene_info=RIMS2%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.92%20oe_lof%3D0.12)	GT	1/0
chr8	144082820	.	G	T	793	.	quality=DP%3D73%3BQD%3D10.86%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D22%3BABP%3D3%3BSAR%3D28%3BSAF%3D10;gene=GPAA1%2CEXOSC4%2CMIR6847;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=GPAA1:ENST00000361036.11:splice_region_variant&intron_variant:LOW:intron1/10:c.74+16G>T::%2CGPAA1:ENST00000703648.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000703622.1:splice_region_variant&intron_variant:LOW:intron1/10:c.74+16G>T::%2CGPAA1:ENST00000703621.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000703620.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000704806.1:splice_region_variant&intron_variant:LOW:intron1/10:c.74+16G>T::%2CGPAA1:ENST00000704807.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000355091.9:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000704789.1:splice_region_variant&intron_variant:LOW:intron1/9:c.74+16G>T::%2CGPAA1:ENST00000704794.1:splice_region_variant&intron_variant:LOW:intron1/9:c.-1+16G>T::%2CGPAA1:ENST00000704809.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000524418.6:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000703633.1:splice_region_variant&intron_variant:LOW:intron1/11:c.74+16G>T::%2CGPAA1:ENST00000703649.1:splice_region_variant&intron_variant:LOW:intron1/12:c.74+16G>T::%2CEXOSC4:ENST00000525936.1:downstream_gene_variant:MODIFIER::::%2CEXOSC4:ENST00000316052.6:downstream_gene_variant:MODIFIER::::%2CMIR6847:ENST00000618235.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=603048_[GENE%3DGPAA1_PHENOS%3DGlycosylphosphatidylinositol%20biosynthesis%20defect%2015%2C%20617810%20(3)%2C%20Autosomal%20recessive];ClinVar=1601488%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DGPAA1]%3B;dbSNP=rs56164102;gnomAD=0.00129;gnomAD_sub=0.00041%2C0.00026%2C0.00000%2C0.00246%2C0.00021;gnomAD_hom_hemi=1%2C;gnomAD_het=194;gnomAD_wt=152024;phyloP=-1.7160;CADD=2.68;MaxEntScan=/0.0>0.0/1.7>0.0;SpliceAI=GPAA1|0.00|0.00|0.01|0.00|-16|-40|-19|-16;NGSD_hom=0;NGSD_het=188;NGSD_mosaic=0;NGSD_group=0%20/%2024;gene_info=EXOSC4%20(inh%3Dn/a%20oe_syn%3D0.88%20oe_mis%3D0.87%20oe_lof%3D0.38)%2C%20MIR6847%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20GPAA1%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.87%20oe_lof%3D0.65)	GT	1/0
chr8	144096762	.	TGGCAGTGGGCATGTGGAATACTTCTC	T	3486	.	quality=DP%3D115%3BQD%3D30.31%3BAF%3D0.99%3BMQM%3D60%3BSAP%3D131%3BABP%3D0%3BSAR%3D98%3BSAF%3D16;gene=CYC1%2CGPAA1%2CSHARPIN;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=CYC1:ENST00000318911.5:splice_region_variant&intron_variant:LOW:intron5/6:c.772+19_772+44del::%2CGPAA1:ENST00000703649.1:downstream_gene_variant:MODIFIER::::%2CSHARPIN:ENST00000398712.7:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region;OMIM=603048_[GENE%3DGPAA1_PHENOS%3DGlycosylphosphatidylinositol%20biosynthesis%20defect%2015%2C%20617810%20(3)%2C%20Autosomal%20recessive]&123980_[GENE%3DCYC1_PHENOS%3DMitochondrial%20complex%20III%20deficiency%2C%20nuclear%20type%206%2C%20615453%20(3)%2C%20Autosomal%20recessive];dbSNP=rs553839760;phyloP=1.7690;MaxEntScan=/7.1>6.8/0.0>0.0;SpliceAI=CYC1|0.00|0.00|0.00|0.00|-38|39|-18|8;NGSD_hom=21304;NGSD_het=4362;NGSD_mosaic=882;NGSD_group=1734%20/%20357;gene_info=GPAA1%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.87%20oe_lof%3D0.65)%2C%20CYC1%20(inh%3DAR%20oe_syn%3D1.35%20oe_mis%3D0.97%20oe_lof%3D0.28)%2C%20SHARPIN%20(inh%3Dn/a%20oe_syn%3D1.25%20oe_mis%3D1.01%20oe_lof%3D0.58)	GT	1/1
chr9	2096706	.	A	T	567	.	quality=DP%3D111%3BQD%3D5.11%3BAF%3D0.29%3BMQM%3D60%3BSAP%3D7%3BABP%3D46%3BSAR%3D12%3BSAF%3D20;gene=SMARCA2;variant_type=missense%2Cintron;coding_and_splicing=SMARCA2:ENST00000357248.8:missense_variant:MODERATE:exon20/33:c.2933A>T:p.Tyr978Phe:PF00176%20[SNF2-related%20domain]%2CSMARCA2:ENST00000450198.6:missense_variant:MODERATE:exon20/33:c.2759A>T:p.Tyr920Phe:PF00176%20[SNF2-related%20domain]%2CSMARCA2:ENST00000704350.1:missense_variant:MODERATE:exon18/31:c.2573A>T:p.Tyr858Phe:PF00176%20[SNF2-related%20domain]%2CSMARCA2:ENST00000349721.8:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:PF00176%20[SNF2-related%20domain]%2CSMARCA2:ENST00000704352.1:intron_variant:MODIFIER:intron6/11:c.1173+41983A>T::%2CSMARCA2:ENST00000704353.1:intron_variant:MODIFIER:intron6/12:c.1173+41983A>T::%2CSMARCA2:ENST00000382194.6:missense_variant:MODERATE:exon20/33:c.2933A>T:p.Tyr978Phe:PF00176%20[SNF2-related%20domain]%2CSMARCA2:ENST00000382203.5:missense_variant:MODERATE:exon20/34:c.2933A>T:p.Tyr978Phe:PF00176%20[SNF2-related%20domain];regulatory=regulatory_region_variant:enhancer;OMIM=600014_[GENE%3DSMARCA2_PHENOS%3DNicolaides-Baraitser%20syndrome%2C%20601358%20(3)%2C%20Autosomal%20dominant%3B%20Blepharophimosis-impaired%20intellectual%20development%20syndrome%2C%20619293%20(3)%2C%20Autosomal%20dominant];ClinVar=366215%20[uncertain%20significance%20DISEASE%3DNicolaides-Baraitser%20syndrome%20GENE%3DSMARCA2]%3B;HGMD=CM2327647%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Neurodevelopmental%20disorder"%20GENE%3DSMARCA2]%3B;dbSNP=rs78915420;phyloP=9.3180;CADD=26.20;REVEL=0.927;AlphaMissense=0.57;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SMARCA2|0.00|0.00|0.00|0.00|-49|-42|50|-3;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=SMARCA2%20(inh%3DAD%20oe_syn%3D1.29%20oe_mis%3D0.53%20oe_lof%3D0.12)	GT	1/0
chr9	4117933	.	C	G	2254	.	quality=DP%3D233%3BQD%3D9.67%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D23%3BABP%3D19%3BSAR%3D63%3BSAF%3D33;gene=GLIS3;variant_type=missense;coding_and_splicing=GLIS3:ENST00000324333.14:missense_variant:MODERATE:exon3/10:c.1080G>C:p.Glu360Asp:%2CGLIS3:ENST00000381971.8:missense_variant:MODERATE:exon4/11:c.1545G>C:p.Glu515Asp:%2CGLIS3:ENST00000682749.1:missense_variant:MODERATE:exon3/10:c.1080G>C:p.Glu360Asp:;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:TF_binding_site%2CTF_binding_site_variant;OMIM=610192_[GENE%3DGLIS3_PHENOS%3DDiabetes%20mellitus%2C%20neonatal%2C%20with%20congenital%20hypothyroidism%2C%20610199%20(3)%2C%20Autosomal%20recessive];ClinVar=196581%20[likely%20benign%20DISEASE%3Dnot%20provided%2CNeonatal%20diabetes%20mellitus%20with%20congenital%20hypothyroidism%2Cnot%20specified%20GENE%3DGLIS3]%3B;HGMD=CM178103%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Hypothyroidism"%20GENE%3DGLIS3]%3B;dbSNP=rs72687988;gnomAD=0.00304;gnomAD_sub=0.00091%2C0.00307%2C0.00000%2C0.00481%2C0.00021;gnomAD_hom_hemi=2%2C;gnomAD_het=459;gnomAD_wt=151857;phyloP=3.3400;CADD=25.60;REVEL=0.241;AlphaMissense=0.30;MaxEntScan=/1.4>2.2/0.0>0.0;COSMIC=COSV60924965;SpliceAI=GLIS3|0.00|0.00|0.00|0.00|-25|2|-6|-24;PubMed=25741868;NGSD_hom=3;NGSD_het=402;NGSD_mosaic=0;NGSD_group=1%20/%2042;gene_info=GLIS3%20(inh%3DAR%20oe_syn%3D1.38%20oe_mis%3D1.37%20oe_lof%3D0.50)	GT	1/0
chr9	14116328	.	C	G	1627	.	quality=DP%3D120%3BQD%3D13.56%3BAF%3D0.57%3BMQM%3D60%3BSAP%3D83%3BABP%3D8%3BSAR%3D59%3BSAF%3D9;gene=NFIB;variant_type=missense%2Cintron;coding_and_splicing=NFIB:ENST00000543693.5:missense_variant:MODERATE:exon8/11:c.508G>C:p.Val170Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000380959.7:intron_variant:MODIFIER:intron8/8:c.1245+4112G>C::%2CNFIB:ENST00000380953.6:missense_variant:MODERATE:exon9/11:c.1264G>C:p.Val422Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000397581.7:missense_variant:MODERATE:exon9/12:c.1264G>C:p.Val422Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000397575.7:missense_variant:MODERATE:exon9/12:c.1264G>C:p.Val422Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000397579.6:intron_variant:MODIFIER:intron8/9:c.1245+4112G>C::%2CNFIB:ENST00000646622.1:missense_variant:MODERATE:exon9/12:c.1252G>C:p.Val418Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000606230.2:intron_variant:MODIFIER:intron8/8:c.1233+4112G>C::%2CNFIB:ENST00000637742.1:intron_variant:MODIFIER:intron8/10:c.1245+4112G>C::%2CNFIB:ENST00000636735.1:intron_variant:MODIFIER:intron7/8:c.708+4112G>C::%2CNFIB:ENST00000636432.1:missense_variant:MODERATE:exon9/11:c.1027G>C:p.Val343Leu:PF00859%20[CTF/NF-I%20family%20transcription%20modulation%20region]%2CNFIB:ENST00000380934.8:intron_variant:MODIFIER:intron8/8:c.1323+4112G>C::%2CNFIB:ENST00000380924.1:intron_variant:MODIFIER:intron7/7:c.489+4112G>C::;OMIM=600728_[GENE%3DNFIB_PHENOS%3DMacrocephaly%2C%20acquired%2C%20with%20impaired%20intellectual%20development%2C%20618286%20(3)%2C%20Autosomal%20dominant];ClinVar=2499087%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CNFIB-related%20disorder%20GENE%3DNFIB]%3B;dbSNP=rs72698746;gnomAD=0.00175;gnomAD_sub=0.00036%2C0.00039%2C0.00000%2C0.00344%2C0.00083;gnomAD_hom_hemi=0%2C;gnomAD_het=267;gnomAD_wt=152055;phyloP=7.4700;CADD=26.70;REVEL=0.128;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV66625503;NGSD_hom=0;NGSD_het=160;NGSD_mosaic=0;NGSD_group=0%20/%2017;gene_info=NFIB%20(inh%3DAD%20oe_syn%3D1.18%20oe_mis%3D0.57%20oe_lof%3D0.07)	GT	1/0
chr9	20944630	.	G	A	1754	.	quality=DP%3D160%3BQD%3D10.96%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D44%3BABP%3D6%3BSAR%3D18%3BSAF%3D55;gene=FOCAD;variant_type=synonymous;coding_and_splicing=FOCAD:ENST00000380249.5:synonymous_variant:LOW:exon31/46:c.3411G>A:p.Thr1137%3D:%2CFOCAD:ENST00000338382.11:synonymous_variant:LOW:exon29/44:c.3411G>A:p.Thr1137%3D:;OMIM=614606_[GENE%3DFOCAD_PHENOS%3DLiver%20disease%2C%20severe%20congenital%2C%20619991%20(3)%2C%20Autosomal%20recessive];ClinVar=774672%20[benign%20DISEASE%3Dnot%20provided%2CFOCAD-related%20disorder%20GENE%3DFOCAD]%3B;dbSNP=rs56037765;gnomAD=0.00667;gnomAD_sub=0.00185%2C0.00301%2C0.00000%2C0.01116%2C0.00746;gnomAD_hom_hemi=5%2C;gnomAD_het=1005;gnomAD_wt=151231;phyloP=0.0550;CADD=23.40;MaxEntScan=/0.0>1.2/0.0>0.0;COSMIC=COSV100620659;SpliceAI=FOCAD|0.99|0.01|0.00|0.00|2|-3|2|-12;NGSD_hom=1;NGSD_het=643;NGSD_mosaic=0;NGSD_group=0%20/%2083;gene_info=FOCAD%20(inh%3DAR%20oe_syn%3D1.18%20oe_mis%3D1.27%20oe_lof%3D0.72)	GT	1/0
chr9	32500834	.	C	T	813	.	quality=DP%3D74%3BQD%3D10.99%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D25%3BABP%3D3%3BSAR%3D8%3BSAF%3D27;gene=RIGI;variant_type=5'UTR%2Cmissense;coding_and_splicing=RIGI:ENST00000679665.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-257G>A::%2CRIGI:ENST00000379883.3:missense_variant:MODERATE:exon2/18:c.212G>A:p.Arg71His:PF16739%20[Caspase%20recruitment%20domain]%2CRIGI:ENST00000715270.1:missense_variant:MODERATE:exon2/18:c.212G>A:p.Arg71His:PF16739%20[Caspase%20recruitment%20domain]%2CRIGI:ENST00000715271.1:missense_variant:MODERATE:exon2/18:c.209G>A:p.Arg70His:PF16739%20[Caspase%20recruitment%20domain]%2CRIGI:ENST00000679859.1:missense_variant:MODERATE:exon2/8:c.212G>A:p.Arg71His:PF16739%20[Caspase%20recruitment%20domain];regulatory=regulatory_region_variant:enhancer;OMIM=609631_[GENE%3DRIGI_PHENOS%3DSingleton-Merten%20syndrome%202%2C%20616298%20(3)%2C%20Autosomal%20dominant];ClinVar=774885%20[benign%20DISEASE%3Dnot%20provided%2CRIGI-related%20disorder%20GENE%3DRIGI]%3B;HGMD=CM1825491%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Influenza%20virus%20infection"%20GENE%3DDDX58]%3B;dbSNP=rs72710678;gnomAD=0.00971;gnomAD_sub=0.00286%2C0.00784%2C0.00000%2C0.01666%2C0.00850;gnomAD_hom_hemi=13%2C;gnomAD_het=1453;gnomAD_wt=150767;phyloP=0.3940;CADD=21.40;REVEL=0.151;AlphaMissense=0.16;MaxEntScan=/1.1>0.6/0.0>0.0;COSMIC=COSV101152402;SpliceAI=DDX58|0.00|0.00|0.00|0.00|-29|34|-33|-29;PubMed=33184476%2C31574965%2C36113963%2C36228008;NGSD_hom=9;NGSD_het=1003;NGSD_mosaic=1;NGSD_group=0%20/%20121;gene_info=RIGI%20(inh%3DAD%20oe_syn%3D0.87%20oe_mis%3D0.89%20oe_lof%3D0.83)	GT	1/0
chr9	35555461	.	G	A	3054	.	quality=DP%3D306%3BQD%3D9.98%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D4%3BABP%3D7%3BSAR%3D66%3BSAF%3D75;gene=RUSC2;variant_type=missense;coding_and_splicing=RUSC2:ENST00000361226.8:missense_variant:MODERATE:exon3/12:c.2416G>A:p.Glu806Lys:%2CRUSC2:ENST00000455600.1:missense_variant:MODERATE:exon3/12:c.2416G>A:p.Glu806Lys:;OMIM=611053_[GENE%3DRUSC2_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20recessive%2061%2C%20617773%20(3)%2C%20Autosomal%20recessive];ClinVar=771168%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DRUSC2]%3B;dbSNP=rs41277053;gnomAD=0.00530;gnomAD_sub=0.00075%2C0.00438%2C0.00000%2C0.00682%2C0.00124;gnomAD_hom_hemi=4%2C;gnomAD_het=799;gnomAD_wt=151511;phyloP=4.7240;CADD=21.10;REVEL=0.043;AlphaMissense=0.08;MaxEntScan=/10.1>6.1/0.0>0.0;COSMIC=COSV99057117;SpliceAI=RUSC2|0.08|0.00|0.00|0.00|3|1|3|1;NGSD_hom=3;NGSD_het=604;NGSD_mosaic=0;NGSD_group=0%20/%2066;gene_info=RUSC2%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.91%20oe_lof%3D0.14)	GT	1/0
chr9	37441316	.	A	G	2424	.	quality=DP%3D180%3BQD%3D13.47%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D19%3BABP%3D4%3BSAR%3D34%3BSAF%3D60;gene=ZBTB5%2CGRHPR;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=ZBTB5:ENST00000307750.5:synonymous_variant:LOW:exon2/2:c.1236T>C:p.Phe412%3D:%2CGRHPR:ENST00000318158.11:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604296_[GENE%3DGRHPR_PHENOS%3DHyperoxaluria%2C%20primary%2C%20type%20II%2C%20260000%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72739647;gnomAD=0.00074;gnomAD_sub=0.00029%2C0.00118%2C0.00000%2C0.00110%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=113;gnomAD_wt=152183;phyloP=1.4620;CADD=5.19;MaxEntScan=/2.8>2.3/0.0>0.0;SpliceAI=ZBTB5|0.00|0.00|0.00|0.00|-1|-15|5|31;NGSD_hom=0;NGSD_het=111;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=GRHPR%20(inh%3DAR%20oe_syn%3D1.06%20oe_mis%3D0.85%20oe_lof%3D0.72)%2C%20ZBTB5%20(inh%3Dn/a%20oe_syn%3D1.05%20oe_mis%3D0.82%20oe_lof%3D0.19)	GT	1/0
chr9	77315426	.	C	G	1237	.	quality=DP%3D145%3BQD%3D8.53%3BAF%3D0.38%3BMQM%3D60%3BSAP%3D36%3BABP%3D21%3BSAR%3D42%3BSAF%3D13;gene=VPS13A;variant_type=missense;coding_and_splicing=VPS13A:ENST00000376636.7:missense_variant:MODERATE:exon37/71:c.4469C>G:p.Thr1490Ser:%2CVPS13A:ENST00000360280.8:missense_variant:MODERATE:exon38/72:c.4586C>G:p.Thr1529Ser:%2CVPS13A:ENST00000645632.1:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:%2CVPS13A:ENST00000643348.1:missense_variant:MODERATE:exon38/69:c.4586C>G:p.Thr1529Ser:;OMIM=605978_[GENE%3DVPS13A_PHENOS%3DChoreoacanthocytosis%2C%20200150%20(3)%2C%20Autosomal%20recessive];ClinVar=913551%20[uncertain%20significance%20DISEASE%3DChorea-acanthocytosis%2CInborn%20genetic%20diseases%20GENE%3DVPS13A]%3B;dbSNP=rs72744294;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152264;phyloP=0.0330;CADD=0.34;REVEL=0.054;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/1.3>0.0;SpliceAI=VPS13A|0.00|0.00|0.00|0.00|1|-16|48|44;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;classification=2;classification_comment="[3]%20ahsturm1%2030.09.2019%20test%20[2]%20ahsturm1%2030.09.2019%20test2%20[3]%20ahsturm1%2030.09.2019%20test3%20[2]%20ahsturm1%2010.01.2020";gene_info=VPS13A%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.88%20oe_lof%3D0.40)	GT	1/0
chr9	78248296	.	T	C	309	.	quality=DP%3D37%3BQD%3D8.35%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D18%3BABP%3D4%3BSAR%3D3%3BSAF%3D14;gene=CEP78;variant_type=missense;coding_and_splicing=CEP78:ENST00000424347.6:missense_variant:MODERATE:exon7/16:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000645398.1:missense_variant:MODERATE:exon7/16:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000643347.1:missense_variant:MODERATE:exon7/16:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000643273.2:missense_variant:MODERATE:exon7/17:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000647199.1:missense_variant:MODERATE:exon7/17:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000643847.1:missense_variant:MODERATE:exon6/17:c.784T>C:p.Ser262Pro:%2CCEP78:ENST00000643499.1:missense_variant:MODERATE:exon7/17:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000415759.6:missense_variant:MODERATE:exon7/15:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000376597.9:missense_variant:MODERATE:exon7/16:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000277082.9:missense_variant:MODERATE:exon7/15:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000642669.1:missense_variant:MODERATE:exon7/15:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000642214.1:missense_variant:MODERATE:exon7/15:c.898T>C:p.Ser300Pro:%2CCEP78:ENST00000376598.3:missense_variant:MODERATE:exon7/18:c.898T>C:p.Ser300Pro:;OMIM=617110_[GENE%3DCEP78_PHENOS%3DCone-rod%20dystrophy%20and%20hearing%20loss%2C%20617236%20(3)%2C%20Autosomal%20recessive];ClinVar=667088%20[likely%20benign%20DISEASE%3Dnot%20specified%2CCEP78-related%20disorder%2Cnot%20provided%20GENE%3DCEP78]%3B;dbSNP=rs72743760;gnomAD=0.00148;gnomAD_sub=0.00051%2C0.00150%2C0.00000%2C0.00231%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=225;gnomAD_wt=152113;phyloP=1.3730;CADD=21.50;REVEL=0.160;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CEP78|0.00|0.00|0.00|0.00|-5|16|11|-5;NGSD_hom=2;NGSD_het=135;NGSD_mosaic=0;NGSD_group=1%20/%2016;gene_info=CEP78%20(inh%3DAR%20oe_syn%3D0.81%20oe_mis%3D1.09%20oe_lof%3D0.71)	GT	1/0
chr9	95469941	.	GA	G	567	.	quality=DP%3D56%3BQD%3D10.13%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D38%3BABP%3D3%3BSAR%3D24%3BSAF%3D3;gene=PTCH1;variant_type=splice_region&intron;coding_and_splicing=PTCH1:ENST00000331920.11:splice_region_variant&intron_variant:LOW:intron12/23:c.1729-11del::%2CPTCH1:ENST00000437951.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1726-11del::%2CPTCH1:ENST00000711046.1:splice_region_variant&intron_variant:LOW:intron12/23:c.1531-11del::%2CPTCH1:ENST00000430669.6:splice_region_variant&intron_variant:LOW:intron12/22:c.1531-11del::%2CPTCH1:ENST00000692981.1:splice_region_variant&intron_variant:LOW:intron11/22:c.1276-11del::%2CPTCH1:ENST00000429896.6:splice_region_variant&intron_variant:LOW:intron12/23:c.1276-11del::;OMIM=601309_[GENE%3DPTCH1_PHENOS%3DBasal%20cell%20nevus%20syndrome%201%2C%20109400%20(3)%2C%20Autosomal%20dominant%3B%20Basal%20cell%20carcinoma%2C%20somatic%2C%20605462%20(3)%3B%20Holoprosencephaly%207%2C%20610828%20(3)%2C%20Autosomal%20dominant];ClinVar=1290901%20[benign/likely%20benign%20DISEASE%3DGorlin%20syndrome%2CHereditary%20cancer-predisposing%20syndrome%2Cnot%20provided%20GENE%3DPTCH1]%3B;dbSNP=rs779000277;gnomAD=0.00079;gnomAD_sub=0.00017%2C0.00059%2C0.00000%2C0.00146%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=120;gnomAD_wt=151994;phyloP=0.9180;CADD=0.25;MaxEntScan=/8.7>9.0/0.0>0.0;COSMIC=COSV59495096;SpliceAI=PTCH1|0.00|0.00|0.00|0.00|49|-14|25|-14;NGSD_hom=0;NGSD_het=91;NGSD_mosaic=3;NGSD_group=0%20/%2017;gene_info=PTCH1%20(inh%3DAD%20oe_syn%3D1.25%20oe_mis%3D0.84%20oe_lof%3D0.02)	GT	1/0
chr9	104856017	.	G	A	2020	.	quality=DP%3D168%3BQD%3D12.02%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D5%3BABP%3D4%3BSAR%3D44%3BSAF%3D36;gene=ABCA1;variant_type=intron%2Csynonymous;coding_and_splicing=ABCA1:ENST00000374736.8:intron_variant:MODIFIER:intron7/49:c.720+2505C>T::%2CABCA1:ENST00000678995.1:intron_variant:MODIFIER:intron7/49:c.720+2505C>T::%2CABCA1:ENST00000423487.6:synonymous_variant:LOW:exon8/8:c.792C>T:p.Thr264%3D:;OMIM=600046_[GENE%3DABCA1_PHENOS%3DTangier%20disease%2C%20205400%20(3)%2C%20Autosomal%20recessive%3B%20HDL%20deficiency%2C%20familial%2C%201%2C%20604091%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72732679;gnomAD=0.00927;gnomAD_sub=0.00245%2C0.00615%2C0.00000%2C0.01299%2C0.00207;gnomAD_hom_hemi=13%2C;gnomAD_het=1386;gnomAD_wt=150882;phyloP=3.0860;CADD=10.51;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ABCA1|0.00|0.00|0.00|0.00|-50|35|39|-49;NGSD_hom=6;NGSD_het=873;NGSD_mosaic=0;NGSD_group=0%20/%20115;gene_info=ABCA1%20(inh%3DAR+AD%20oe_syn%3D1.08%20oe_mis%3D0.86%20oe_lof%3D0.38)	GT	1/0
chr9	114196007	.	C	T	120	.	quality=DP%3D230%3BQD%3D0.52%3BAF%3D0.16%3BMQM%3D60%3BSAP%3D10%3BABP%3D233%3BSAR%3D24%3BSAF%3D13;gene=COL27A1;variant_type=stop_gained;coding_and_splicing=COL27A1:ENST00000356083.8:stop_gained:HIGH:exon7/61:c.2119C>T:p.Arg707Ter:PF01391%20[Collagen%20triple%20helix%20repeat%20(20%20copies)];OMIM=608461_[GENE%3DCOL27A1_PHENOS%3DSteel%20syndrome%2C%20615155%20(3)%2C%20Autosomal%20recessive];ClinVar=559387%20[pathogenic%20DISEASE%3DSteel%20syndrome%2Cnot%20provided%20GENE%3DCOL27A1]%3B;HGMD=CM1711556%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Steel%20syndrome"%20GENE%3DCOL27A1]%3B;dbSNP=rs1401322428;phyloP=0.8190;CADD=40.00;MaxEntScan=/0.0>0.0/1.5>0.5;COSMIC=COSV61927484;SpliceAI=COL27A1|0.00|0.00|0.00|0.03|40|-48|-48|5;PubMed=24986830%2C28276056;NGSD_hom=0;NGSD_het=2;NGSD_mosaic=2;NGSD_group=0%20/%201;gene_info=COL27A1%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.95%20oe_lof%3D0.22)	GT	1/0
chr9	123373279	.	C	T	1093	.	quality=DP%3D115%3BQD%3D9.50%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D11%3BABP%3D11%3BSAR%3D30%3BSAF%3D17;gene=CRB2;variant_type=synonymous;coding_and_splicing=CRB2:ENST00000359999.7:synonymous_variant:LOW:exon10/10:c.2748C>T:p.Ala916%3D:%2CCRB2:ENST00000373631.8:synonymous_variant:LOW:exon10/13:c.2748C>T:p.Ala916%3D:;regulatory=regulatory_region_variant:enhancer;OMIM=609720_[GENE%3DCRB2_PHENOS%3DFocal%20segmental%20glomerulosclerosis%209%2C%20616220%20(3)%2C%20Autosomal%20recessive%3B%20Ventriculomegaly%20with%20cystic%20kidney%20disease%2C%20219730%20(3)%2C%20Autosomal%20recessive];ClinVar=774677%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CVentriculomegaly-cystic%20kidney%20disease%2CFocal%20segmental%20glomerulosclerosis%209%20GENE%3DCRB2]%3B;dbSNP=rs372726074;gnomAD=0.00416;gnomAD_sub=0.00154%2C0.00399%2C0.00000%2C0.00683%2C0.00372;gnomAD_hom_hemi=2%2C;gnomAD_het=628;gnomAD_wt=151470;phyloP=0.2210;CADD=4.30;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CRB2|0.00|0.00|0.00|0.00|7|21|7|21;NGSD_hom=5;NGSD_het=408;NGSD_mosaic=0;NGSD_group=1%20/%2051;gene_info=CRB2%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D0.89%20oe_lof%3D0.65)	GT	1/0
chr9	128533596	.	G	A	968	.	quality=DP%3D76%3BQD%3D12.74%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D7%3BABP%3D3%3BSAR%3D15%3BSAF%3D23;gene=GLE1;variant_type=missense%2Cintron;coding_and_splicing=GLE1:ENST00000683748.1:missense_variant:MODERATE:exon11/17:c.1423G>A:p.Val475Ile:PF07817%20[GLE1-like%20protein]%2CGLE1:ENST00000684314.1:missense_variant:MODERATE:exon10/15:c.1396G>A:p.Val466Ile:PF07817%20[GLE1-like%20protein]%2CGLE1:ENST00000684331.1:missense_variant:MODERATE:exon10/15:c.1396G>A:p.Val466Ile:PF07817%20[GLE1-like%20protein]%2CGLE1:ENST00000684646.1:intron_variant:MODIFIER:intron8/13:c.1243-165G>A::%2CGLE1:ENST00000309971.9:missense_variant:MODERATE:exon10/16:c.1396G>A:p.Val466Ile:PF07817%20[GLE1-like%20protein]%2CGLE1:ENST00000684139.1:missense_variant:MODERATE:exon7/13:c.931G>A:p.Val311Ile:PF07817%20[GLE1-like%20protein]%2CGLE1:ENST00000372770.4:missense_variant:MODERATE:exon10/14:c.1396G>A:p.Val466Ile:PF07817%20[GLE1-like%20protein];OMIM=603371_[GENE%3DGLE1_PHENOS%3DLethal%20congenital%20contracture%20syndrome%201%2C%20253310%20(3)%2C%20Autosomal%20recessive%3B%20Congenital%20arthrogryposis%20with%20anterior%20horn%20cell%20disease%2C%20611890%20(3)%2C%20Autosomal%20recessive];ClinVar=914004%20[uncertain%20significance%20DISEASE%3DLethal%20arthrogryposis-anterior%20horn%20cell%20disease%20syndrome%2CLethal%20congenital%20contracture%20syndrome%201%20GENE%3DGLE1]%3B;dbSNP=rs72756895;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152281;phyloP=2.7320;CADD=13.58;REVEL=0.064;AlphaMissense=0.07;MaxEntScan=/9.0>8.3/0.0>0.0;SpliceAI=GLE1|0.00|0.00|0.03|0.00|-18|18|-18|-5;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=GLE1%20(inh%3DAR%20oe_syn%3D0.91%20oe_mis%3D0.88%20oe_lof%3D0.53)	GT	1/0
chr9	131525948	.	C	A	5030	.	quality=DP%3D187%3BQD%3D26.90%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D10%3BABP%3D3%3BSAR%3D56%3BSAF%3D38;gene=UCK1%2CPOMT1;variant_type=synonymous%2Cmissense%2Cdownstream_gene;coding_and_splicing=UCK1:ENST00000372210.7:synonymous_variant:LOW:exon6/7:c.606G>T:p.Pro202%3D:PF00485%20[Phosphoribulokinase%20/%20Uridine%20kinase%20family]%2CUCK1:ENST00000372211.7:synonymous_variant:LOW:exon6/7:c.648G>T:p.Pro216%3D:PF00485%20[Phosphoribulokinase%20/%20Uridine%20kinase%20family]%2CUCK1:ENST00000372208.7:missense_variant:MODERATE:exon5/6:c.538G>T:p.Ala180Ser:%2CUCK1:ENST00000372215.5:synonymous_variant:LOW:exon6/7:c.633G>T:p.Pro211%3D:PF00485%20[Phosphoribulokinase%20/%20Uridine%20kinase%20family]%2CPOMT1:ENST00000372228.9:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000341012.13:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000677216.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000676640.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000402686.8:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000677029.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000676803.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000678303.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000677626.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000372220.5:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000679189.1:downstream_gene_variant:MODIFIER::::%2CPOMT1:ENST00000423007.6:downstream_gene_variant:MODIFIER::::;OMIM=607423_[GENE%3DPOMT1_PHENOS%3DMuscular%20dystrophy-dystroglycanopathy%20(congenital%20with%20brain%20and%20eye%20anomalies)%2C%20type%20A%2C%201%2C%20236670%20(3)%2C%20Autosomal%20recessive%3B%20Muscular%20dystrophy-dystroglycanopathy%20(limb-girdle)%2C%20type%20C%2C%201%2C%20609308%20(3)%2C%20Autosomal%20recessive%3B%20Muscular%20dystrophy-dystroglycanopathy%20(congenital%20with%20impaired%20intellectual%20development)%2C%20type%20B%2C%201%2C%20613155%20(3)%2C%20Autosomal%20recessive];dbSNP=rs2296957;gnomAD=0.01000;gnomAD_sub=0.00186%2C0.00452%2C0.00000%2C0.01264%2C0.00062;gnomAD_hom_hemi=23%2C;gnomAD_het=1475;gnomAD_wt=150591;phyloP=-1.7710;CADD=0.27;REVEL=0.047;MaxEntScan=/1.2>1.8/0.0>0.0;COSMIC=COSV61226032%2CCOSV61227626;SpliceAI=UCK1|0.00|0.00|0.00|0.00|-5|29|22|-19;PubMed=24192812;NGSD_hom=9;NGSD_het=1178;NGSD_mosaic=0;NGSD_group=0%20/%20155;gene_info=POMT1%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.92%20oe_lof%3D0.70)%2C%20UCK1%20(inh%3Dn/a%20oe_syn%3D1.08%20oe_mis%3D0.82%20oe_lof%3D0.65)	GT	1/0
chr9	135792138	.	A	G	1640	.	quality=DP%3D180%3BQD%3D9.11%3BAF%3D0.39%3BMQM%3D60%3BSAP%3D3%3BABP%3D20%3BSAR%3D37%3BSAF%3D34;gene=KCNT1;variant_type=missense;coding_and_splicing=KCNT1:ENST00000487664.5:missense_variant:MODERATE:exon32/32:c.3748A>G:p.Thr1250Ala:%2CKCNT1:ENST00000371757.7:missense_variant:MODERATE:exon31/31:c.3685A>G:p.Thr1229Ala:%2CKCNT1:ENST00000628528.2:missense_variant:MODERATE:exon31/31:c.3613A>G:p.Thr1205Ala:%2CKCNT1:ENST00000674572.1:missense_variant:MODERATE:exon32/32:c.3589A>G:p.Thr1197Ala:%2CKCNT1:ENST00000486577.6:missense_variant:MODERATE:exon32/32:c.3631A>G:p.Thr1211Ala:%2CKCNT1:ENST00000630792.2:missense_variant:MODERATE:exon31/31:c.3583A>G:p.Thr1195Ala:%2CKCNT1:ENST00000263604.5:missense_variant:MODERATE:exon31/31:c.3649A>G:p.Thr1217Ala:%2CKCNT1:ENST00000491806.6:missense_variant:MODERATE:exon31/31:c.3628A>G:p.Thr1210Ala:%2CKCNT1:ENST00000631073.2:missense_variant:MODERATE:exon32/32:c.3691A>G:p.Thr1231Ala:%2CKCNT1:ENST00000488444.6:missense_variant:MODERATE:exon31/31:c.3670A>G:p.Thr1224Ala:%2CKCNT1:ENST00000490355.6:missense_variant:MODERATE:exon32/32:c.3685A>G:p.Thr1229Ala:%2CKCNT1:ENST00000675090.1:missense_variant:MODERATE:exon30/30:c.3433A>G:p.Thr1145Ala:%2CKCNT1:ENST00000675399.1:missense_variant:MODERATE:exon31/31:c.3496A>G:p.Thr1166Ala:%2CKCNT1:ENST00000676421.1:missense_variant:MODERATE:exon31/31:c.3505A>G:p.Thr1169Ala:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=608167_[GENE%3DKCNT1_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2014%2C%20614959%20(3)%2C%20Autosomal%20dominant%3B%20Epilepsy%20nocturnal%20frontal%20lobe%2C%205%2C%20615005%20(3)%2C%20Autosomal%20dominant];ClinVar=378038%20[benign/likely%20benign%20DISEASE%3DInborn%20genetic%20diseases%2CAutosomal%20dominant%20nocturnal%20frontal%20lobe%20epilepsy%205%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2014%2CKCNT1-related%20disorder%2Cnot%20provided%20GENE%3DKCNT1]%3B;dbSNP=rs74533482;gnomAD=0.00055;gnomAD_sub=0.00007%2C0.00033%2C0.00000%2C0.00112%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=84;gnomAD_wt=151902;phyloP=4.5960;CADD=19.93;REVEL=0.141;AlphaMissense=0.09;MaxEntScan=/0.0>1.1/0.0>0.0;SpliceAI=KCNT1|0.00|0.00|0.00|0.00|0|18|-1|-17;NGSD_hom=0;NGSD_het=107;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=KCNT1%20(inh%3DAD%20oe_syn%3D1.25%20oe_mis%3D0.72%20oe_lof%3D0.32)	GT	1/0
chr9	136431867	.	C	T	1841	.	quality=DP%3D169%3BQD%3D10.89%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D66%3BABP%3D3%3BSAR%3D17%3BSAF%3D66;gene=INPP5E;variant_type=synonymous;coding_and_splicing=INPP5E:ENST00000371712.4:synonymous_variant:LOW:exon7/10:c.1506G>A:p.Pro502%3D:%2CINPP5E:ENST00000676019.1:synonymous_variant:LOW:exon7/10:c.1404G>A:p.Pro468%3D:;OMIM=613037_[GENE%3DINPP5E_PHENOS%3DJoubert%20syndrome%201%2C%20213300%20(3)%2C%20Autosomal%20recessive%3B%20Mental%20retardation%2C%20truncal%20obesity%2C%20retinal%20dystrophy%2C%20and%20micropenis%2C%20610156%20(3)%2C%20Autosomal%20recessive];ClinVar=365880%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x2%2C1x3)%20DISEASE%3DJoubert%20syndrome%201%2CFamilial%20aplasia%20of%20the%20vermis%2Cnot%20provided%20GENE%3DINPP5E]%3B;dbSNP=rs74880446;gnomAD=0.00104;gnomAD_sub=0.00020%2C0.00007%2C0.00000%2C0.00193%2C0.00066;gnomAD_hom_hemi=0%2C;gnomAD_het=156;gnomAD_wt=149340;phyloP=-0.0160;CADD=0.58;MaxEntScan=/4.0>0.2/0.0>0.0;SpliceAI=INPP5E|0.00|0.00|0.00|0.00|-2|-13|-43|-38;NGSD_hom=0;NGSD_het=161;NGSD_mosaic=0;NGSD_group=0%20/%2019;classification=2;classification_comment="[2]%20benkert%2029.01.2016%20[n/a]%20comment%20imported%20from%20detected%20variant:%2029.01.2016%2C%20TCB:%20Einzig%20HSF%20gibt%20das%20Entstehen%20einer%20neuen%20Akzeptorsite%20an%20(>80)%3B%20somit%20VUS2";gene_info=INPP5E%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.93%20oe_lof%3D0.37)	GT	1/0
chr9	136438951	.	C	A	2380	.	quality=DP%3D187%3BQD%3D12.73%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D46%3BSAF%3D49;gene=INPP5E%2CSEC16A;variant_type=missense%2Cdownstream_gene;coding_and_splicing=INPP5E:ENST00000371712.4:missense_variant:MODERATE:exon1/10:c.469G>T:p.Gly157Trp:%2CINPP5E:ENST00000676019.1:missense_variant:MODERATE:exon1/10:c.469G>T:p.Gly157Trp:%2CSEC16A:ENST00000313050.11:downstream_gene_variant:MODIFIER::::%2CSEC16A:ENST00000290037.10:downstream_gene_variant:MODIFIER::::%2CSEC16A:ENST00000313084.9:downstream_gene_variant:MODIFIER::::%2CSEC16A:ENST00000684901.1:downstream_gene_variant:MODIFIER::::%2CSEC16A:ENST00000690691.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=613037_[GENE%3DINPP5E_PHENOS%3DJoubert%20syndrome%201%2C%20213300%20(3)%2C%20Autosomal%20recessive%3B%20Mental%20retardation%2C%20truncal%20obesity%2C%20retinal%20dystrophy%2C%20and%20micropenis%2C%20610156%20(3)%2C%20Autosomal%20recessive];ClinVar=837758%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:2x2%2C3x3)%20DISEASE%3Dnot%20provided%2CFamilial%20aplasia%20of%20the%20vermis%2CJoubert%20syndrome%201%2CINPP5E-related%20disorder%20GENE%3DINPP5E]%3B;dbSNP=rs78211353;gnomAD=0.00060;gnomAD_sub=0.00014%2C0.00000%2C0.00000%2C0.00115%2C0.00062;gnomAD_hom_hemi=0%2C;gnomAD_het=91;gnomAD_wt=152187;phyloP=0.3330;CADD=12.93;REVEL=0.048;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV51521677;SpliceAI=INPP5E|0.00|0.00|0.00|0.00|-32|24|-3|24;NGSD_hom=0;NGSD_het=94;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=INPP5E%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.93%20oe_lof%3D0.37)%2C%20SEC16A%20(inh%3Dn/a%20oe_syn%3D1.16%20oe_mis%3D1.04%20oe_lof%3D0.23)	GT	1/0
chr9	136505847	.	C	A	2025	.	quality=DP%3D168%3BQD%3D12.05%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D47%3BSAF%3D38;gene=NOTCH1;variant_type=missense;coding_and_splicing=NOTCH1:ENST00000680778.1:missense_variant:MODERATE:exon11/20:c.1646G>T:p.Arg549Leu:%2CNOTCH1:ENST00000651671.1:missense_variant:MODERATE:exon25/34:c.4049G>T:p.Arg1350Leu:%2CNOTCH1:ENST00000680218.1:missense_variant:MODERATE:exon25/34:c.3929G>T:p.Arg1310Leu:%2CNOTCH1:ENST00000680668.1:missense_variant:MODERATE:exon24/33:c.3935G>T:p.Arg1312Leu:%2CNOTCH1:ENST00000680133.1:missense_variant:MODERATE:exon24/33:c.3935G>T:p.Arg1312Leu:;OMIM=190198_[GENE%3DNOTCH1_PHENOS%3DAdams-Oliver%20syndrome%205%2C%20616028%20(3)%2C%20Autosomal%20dominant%3B%20Aortic%20valve%20disease%201%2C%20109730%20(3)%2C%20Autosomal%20dominant];ClinVar=134937%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:6x2%2C1x3)%20DISEASE%3DConnective%20tissue%20disorder%2Cnot%20provided%2Cnot%20specified%2CNOTCH1-related%20disorder%2CAdams-Oliver%20syndrome%205%2CFamilial%20thoracic%20aortic%20aneurysm%20and%20aortic%20dissection%20GENE%3DNOTCH1]%3B;dbSNP=rs150343794;gnomAD=0.00069;gnomAD_sub=0.00012%2C0.00000%2C0.00000%2C0.00135%2C0.00062;gnomAD_hom_hemi=0%2C;gnomAD_het=105;gnomAD_wt=152177;phyloP=2.0890;CADD=19.19;REVEL=0.386;AlphaMissense=0.14;MaxEntScan=/1.6>2.4/0.1>0.0;SpliceAI=NOTCH1|0.05|0.00|0.00|0.00|-13|34|16|1;PubMed=24728327%2C27855558;NGSD_hom=0;NGSD_het=129;NGSD_mosaic=0;NGSD_group=0%20/%2011;gene_info=NOTCH1%20(inh%3DAD%20oe_syn%3D1.17%20oe_mis%3D0.76%20oe_lof%3D0.05)	GT	1/0
chr9	137020441	.	C	T	3303	.	quality=DP%3D302%3BQD%3D10.94%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D30%3BABP%3D9%3BSAR%3D89%3BSAF%3D48;gene=ABCA2;variant_type=synonymous;coding_and_splicing=ABCA2:ENST00000341511.11:synonymous_variant:LOW:exon10/49:c.1320G>A:p.Thr440%3D:%2CABCA2:ENST00000371605.7:synonymous_variant:LOW:exon9/48:c.1317G>A:p.Thr439%3D:%2CABCA2:ENST00000614293.5:synonymous_variant:LOW:exon10/49:c.1410G>A:p.Thr470%3D:;OMIM=600047_[GENE%3DABCA2_PHENOS%3DIntellectual%20developmental%20disorder%20with%20poor%20growth%20and%20with%20or%20without%20seizures%20or%20ataxia%2C%20618808%20(3)%2C%20Autosomal%20recessive];ClinVar=1299165%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DABCA2]%3B;dbSNP=rs56164699;gnomAD=0.00515;gnomAD_sub=0.00183%2C0.01385%2C0.00000%2C0.00532%2C0.00331;gnomAD_hom_hemi=3%2C;gnomAD_het=779;gnomAD_wt=151539;phyloP=-0.1830;CADD=4.07;REVEL=0.296;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ABCA2|0.09|0.00|0.00|0.00|-3|-7|-1|21;NGSD_hom=1;NGSD_het=410;NGSD_mosaic=0;NGSD_group=0%20/%2043;gene_info=ABCA2%20(inh%3DAR%20oe_syn%3D1.16%20oe_mis%3D0.65%20oe_lof%3D0.10)	GT	1/0
chr9	137188094	.	G	T	2561	.	quality=DP%3D176%3BQD%3D14.55%3BAF%3D0.57%3BMQM%3D60%3BSAP%3D92%3BABP%3D10%3BSAR%3D82%3BSAF%3D18;gene=ANAPC2%2CSSNA1%2CTPRN;variant_type=synonymous%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=ANAPC2:ENST00000323927.3:synonymous_variant:LOW:exon2/13:c.127C>A:p.Arg43%3D:%2CSSNA1:ENST00000322310.10:upstream_gene_variant:MODIFIER::::%2CSSNA1:ENST00000464553.2:upstream_gene_variant:MODIFIER::::%2CTPRN:ENST00000409012.6:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=613354_[GENE%3DTPRN_PHENOS%3DDeafness%2C%20autosomal%20recessive%2079%2C%20613307%20(3)%2C%20Autosomal%20recessive];dbSNP=rs55750716;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152306;phyloP=3.4660;CADD=16.49;MaxEntScan=/4.1>3.3/0.0>0.0;SpliceAI=ANAPC2|0.12|0.00|0.00|0.00|-2|9|-2|10;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=ANAPC2%20(inh%3Dn/a%20oe_syn%3D1.20%20oe_mis%3D0.70%20oe_lof%3D0.06)%2C%20SSNA1%20(inh%3Dn/a%20oe_syn%3D1.22%20oe_mis%3D1.21%20oe_lof%3D1.05)%2C%20TPRN%20(inh%3DAR%20oe_syn%3D1.21%20oe_mis%3D1.08%20oe_lof%3D0.40)	GT	1/0
chr9	137199451	.	G	A	3973	.	quality=DP%3D303%3BQD%3D13.11%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D74%3BSAF%3D80;gene=TPRN%2CTMEM203;variant_type=missense%2Cdownstream_gene;coding_and_splicing=TPRN:ENST00000409012.6:missense_variant:MODERATE:exon1/4:c.1261C>T:p.Pro421Ser:%2CTMEM203:ENST00000343666.6:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region;OMIM=613354_[GENE%3DTPRN_PHENOS%3DDeafness%2C%20autosomal%20recessive%2079%2C%20613307%20(3)%2C%20Autosomal%20recessive];ClinVar=377178%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x2%2C1x3)%20DISEASE%3Dnot%20provided%20GENE%3DTPRN]%3B;dbSNP=rs72763296;gnomAD=0.00161;gnomAD_sub=0.00075%2C0.00209%2C0.00000%2C0.00256%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=246;gnomAD_wt=152110;phyloP=0.9150;CADD=19.40;REVEL=0.029;AlphaMissense=0.11;MaxEntScan=/2.9>3.8/0.0>0.0;SpliceAI=TPRN|0.00|0.00|0.00|0.00|25|7|-12|26;PubMed=25741868;NGSD_hom=0;NGSD_het=158;NGSD_mosaic=0;NGSD_group=0%20/%2020;gene_info=TPRN%20(inh%3DAR%20oe_syn%3D1.21%20oe_mis%3D1.08%20oe_lof%3D0.40)%2C%20TMEM203%20(inh%3DAR%20oe_syn%3D0.92%20oe_mis%3D0.42%20oe_lof%3D0.00)	GT	1/0
chr10	3166391	.	A	C	1722	.	quality=DP%3D60%3BQD%3D28.70%3BAF%3D1.00%3BMQM%3D60%3BSAP%3D86%3BABP%3D0%3BSAR%3D54%3BSAF%3D6;gene=PITRM1;variant_type=splice_region&intron;coding_and_splicing=PITRM1:ENST00000224949.9:splice_region_variant&intron_variant:LOW:intron3/26:c.267-11T>G::%2CPITRM1:ENST00000380989.6:splice_region_variant&intron_variant:LOW:intron3/26:c.267-11T>G::%2CPITRM1:ENST00000451104.6:splice_region_variant&intron_variant:LOW:intron2/23:c.171-11T>G::%2CPITRM1:ENST00000380994.6:splice_region_variant&intron_variant:LOW:intron2/25:c.-305-11T>G::%2CPITRM1:ENST00000676953.1:splice_region_variant&intron_variant:LOW:intron3/25:c.267-11T>G::%2CPITRM1:ENST00000678987.1:splice_region_variant&intron_variant:LOW:intron3/26:c.267-11T>G::%2CPITRM1:ENST00000678436.1:splice_region_variant&intron_variant:LOW:intron3/24:c.267-11T>G::%2CPITRM1:ENST00000678441.1:splice_region_variant&intron_variant:LOW:intron3/25:c.267-11T>G::%2CPITRM1:ENST00000678370.1:splice_region_variant&intron_variant:LOW:intron3/25:c.267-11T>G::%2CPITRM1:ENST00000430362.2:splice_region_variant&intron_variant:LOW:intron3/14:c.267-11T>G::;OMIM=618211_[GENE%3DPITRM1_PHENOS%3DSpinocerebellar%20ataxia%2C%20autosomal%20recessive%2030%2C%20619405%20(3)%2C%20Autosomal%20recessive];ClinVar=1621380%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPITRM1]%3B;dbSNP=rs4242748;gnomAD=0.00019;gnomAD_sub=0.00033%2C0.00020%2C0.00020%2C0.00013%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=29;gnomAD_wt=148851;phyloP=0.8330;CADD=5.55;MaxEntScan=8.2>6.6/8.2>6.6/0.0>0.0%2C/8.2>6.6/0.0>0.0;COSMIC=COSV56537278;SpliceAI=PITRM1|0.02|0.01|0.00|0.00|33|-11|8|-21;PubMed=19962426;NGSD_hom=15146;NGSD_het=13923;NGSD_mosaic=2648;NGSD_group=1279%20/%201293;classification=2;classification_comment="[2]%20auto-classification%2016.09.2017%20%20";gene_info=PITRM1%20(inh%3DAR%20oe_syn%3D1.22%20oe_mis%3D1.10%20oe_lof%3D0.72)%2C%20PITRM1-AS1%20(inh%3DAR%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/1
chr10	15684089	.	C	T	867	.	quality=DP%3D99%3BQD%3D8.76%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D6%3BABP%3D11%3BSAR%3D24%3BSAF%3D16;gene=ITGA8;variant_type=synonymous;coding_and_splicing=ITGA8:ENST00000378076.4:synonymous_variant:LOW:exon4/30:c.483G>A:p.Pro161%3D:;OMIM=604063_[GENE%3DITGA8_PHENOS%3DRenal%20hypodysplasia/aplasia%201%2C%20191830%20(3)%2C%20Autosomal%20recessive];ClinVar=783031%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DITGA8]%3B;dbSNP=rs72781816;gnomAD=0.00562;gnomAD_sub=0.00243%2C0.00366%2C0.00019%2C0.00938%2C0.00622;gnomAD_hom_hemi=4%2C;gnomAD_het=848;gnomAD_wt=151368;phyloP=-5.0640;CADD=1.33;MaxEntScan=/0.0>0.8/0.0>0.0;COSMIC=COSV65229883;SpliceAI=ITGA8|0.00|0.00|0.00|0.00|-8|38|38|-33;NGSD_hom=3;NGSD_het=556;NGSD_mosaic=1;NGSD_group=1%20/%2072;gene_info=ITGA8%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D1.03%20oe_lof%3D0.49)	GT	1/0
chr10	26088402	.	C	T	1660	.	quality=DP%3D127%3BQD%3D13.07%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D69%3BABP%3D4%3BSAR%3D56%3BSAF%3D11;gene=MYO3A;variant_type=missense;coding_and_splicing=MYO3A:ENST00000642920.2:missense_variant:MODERATE:exon15/35:c.1559C>T:p.Ala520Val:PF00063%20[Myosin%20head%20(motor%20domain)]%2CMYO3A:ENST00000543632.5:missense_variant:MODERATE:exon14/17:c.1559C>T:p.Ala520Val:PF00063%20[Myosin%20head%20(motor%20domain)];OMIM=606808_[GENE%3DMYO3A_PHENOS%3DDeafness%2C%20autosomal%20recessive%2030%2C%20607101%20(3)%2C%20Autosomal%20recessive];ClinVar=45799%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C5x2%2C1x3)%20DISEASE%3DMYO3A-related%20disorder%2Cnot%20specified%2Cnot%20provided%2CAutosomal%20recessive%20nonsyndromic%20hearing%20loss%2030%20GENE%3DMYO3A]%3B;dbSNP=rs72787346;gnomAD=0.00207;gnomAD_sub=0.00075%2C0.00092%2C0.00000%2C0.00370%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=316;gnomAD_wt=151990;phyloP=7.9020;CADD=27.00;REVEL=0.767;AlphaMissense=0.21;MaxEntScan=/0.0>0.0/1.5>1.3;SpliceAI=MYO3A|0.00|0.00|0.05|0.01|-2|1|-2|3;PubMed=24033266;NGSD_hom=1;NGSD_het=269;NGSD_mosaic=0;NGSD_group=1%20/%2038;gene_info=MYO3A%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D1.01%20oe_lof%3D0.86)	GT	1/0
chr10	73911598	.	G	T	4063	.	quality=DP%3D387%3BQD%3D10.50%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D89%3BABP%3D15%3BSAR%3D44%3BSAF%3D126;gene=C10orf55%2CPLAU;variant_type=non_coding_transcript_exon%2C5'UTR%2Cmissense;coding_and_splicing=C10orf55:ENST00000409178.5:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.884C>A::%2CPLAU:ENST00000446342.5:5_prime_UTR_variant:MODIFIER:exon2/10:c.-294G>T::%2CPLAU:ENST00000372764.4:missense_variant:MODERATE:exon2/11:c.43G>T:p.Val15Leu:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=191840_[GENE%3DPLAU_PHENOS%3DQuebec%20platelet%20disorder%2C%20601709%20(3)%2C%20Autosomal%20dominant%3B%20{Alzheimer%20disease%2C%20late-onset%2C%20susceptibility%20to}%2C%20104300%20(3)%2C%20Autosomal%20dominant];ClinVar=300740%20[benign%20DISEASE%3DQuebec%20platelet%20disorder%20GENE%3DPLAU]%3B;dbSNP=rs2227580;gnomAD=0.00765;gnomAD_sub=0.00185%2C0.00608%2C0.00000%2C0.01066%2C0.02361;gnomAD_hom_hemi=16%2C;gnomAD_het=1133;gnomAD_wt=151173;phyloP=0.9950;CADD=15.25;REVEL=0.102;AlphaMissense=0.11;MaxEntScan=/1.2>0.0/0.0>0.0%2C/0.0>0.0/2.9>0.0;COSMIC=COSV65641865;SpliceAI=C10orf55|0.00|0.00|0.00|0.00|41|-7|-17|-21%2CPLAU|0.00|0.00|0.00|0.00|5|-1|16|-1;PubMed=27782108;NGSD_hom=16;NGSD_het=1312;NGSD_mosaic=1;NGSD_group=0%20/%20127;gene_info=C10ORF55%20(inh%3Dn/a%20oe_syn%3D0.70%20oe_mis%3D0.87%20oe_lof%3D1.83)%2C%20PLAU%20(inh%3DAD%20oe_syn%3D0.91%20oe_mis%3D0.88%20oe_lof%3D0.54)	GT	1/0
chr10	80166110	.	T	C	661	.	quality=DP%3D70%3BQD%3D9.44%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D8%3BABP%3D6%3BSAR%3D11%3BSAF%3D19;gene=ANXA11;variant_type=missense;coding_and_splicing=ANXA11:ENST00000422982.8:missense_variant:MODERATE:exon8/16:c.832A>G:p.Ile278Val:PF00191%20[Annexin]%2CANXA11:ENST00000372231.7:missense_variant:MODERATE:exon7/15:c.832A>G:p.Ile278Val:PF00191%20[Annexin]%2CANXA11:ENST00000438331.5:missense_variant:MODERATE:exon9/17:c.832A>G:p.Ile278Val:PF00191%20[Annexin]%2CANXA11:ENST00000265447.8:missense_variant:MODERATE:exon7/15:c.733A>G:p.Ile245Val:PF00191%20[Annexin];regulatory=regulatory_region_variant:enhancer;OMIM=602572_[GENE%3DANXA11_PHENOS%3DAmyotrophic%20lateral%20sclerosis%2023%2C%20617839%20(3)%2C%20Autosomal%20dominant%3B%20Inclusion%20body%20myopathy%20and%20brain%20white%20matter%20abnormalities%2C%20619733%20(3)%2C%20Autosomal%20dominant];ClinVar=1606169%20[benign%20DISEASE%3Dnot%20provided%2CANXA11-related%20disorder%20GENE%3DANXA11]%3B;HGMD=CM1828295%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Amyotrophic%20lateral%20sclerosis/Frontotemporal%20dementia"%20GENE%3DANXA11]%3B;dbSNP=rs72807973;gnomAD=0.00401;gnomAD_sub=0.00097%2C0.00609%2C0.00000%2C0.00627%2C0.00104;gnomAD_hom_hemi=2%2C;gnomAD_het=605;gnomAD_wt=151233;phyloP=3.7540;CADD=4.40;REVEL=0.076;AlphaMissense=0.05;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ANXA11|0.00|0.00|0.02|0.00|39|11|-30|-28;PubMed=33897758;NGSD_hom=3;NGSD_het=372;NGSD_mosaic=0;NGSD_group=0%20/%2042;gene_info=ANXA11%20(inh%3DAD%20oe_syn%3D1.00%20oe_mis%3D1.04%20oe_lof%3D0.67)	GT	1/0
chr10	99235506	.	G	A	1299	.	quality=DP%3D95%3BQD%3D13.67%3BAF%3D0.58%3BMQM%3D59%3BSAP%3D36%3BABP%3D8%3BSAR%3D13%3BSAF%3D42;gene=HPSE2;variant_type=splice_region&intron;coding_and_splicing=HPSE2:ENST00000370552.8:splice_region_variant&intron_variant:LOW:intron1/11:c.290+7C>T::%2CHPSE2:ENST00000370549.5:splice_region_variant&intron_variant:LOW:intron1/10:c.290+7C>T::%2CHPSE2:ENST00000628193.2:splice_region_variant&intron_variant:LOW:intron1/9:c.290+7C>T::%2CHPSE2:ENST00000370546.5:splice_region_variant&intron_variant:LOW:intron1/12:c.290+7C>T::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=613469_[GENE%3DHPSE2_PHENOS%3DUrofacial%20syndrome%201%2C%20236730%20(3)%2C%20Autosomal%20recessive];ClinVar=784210%20[benign/likely%20benign%20DISEASE%3DUrofacial%20syndrome%20type%201%2CHPSE2-related%20disorder%2Cnot%20provided%20GENE%3DHPSE2]%3B;dbSNP=rs72840396;gnomAD=0.00166;gnomAD_sub=0.00053%2C0.00477%2C0.00000%2C0.00197%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=250;gnomAD_wt=151908;phyloP=3.4400;CADD=20.90;MaxEntScan=/0.0>0.0/1.0>8.8;SpliceAI=HPSE2|0.00|0.00|0.48|0.00|50|-46|2|7;NGSD_hom=0;NGSD_het=118;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=HPSE2%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.96%20oe_lof%3D0.41)	GT	1/0
chr10	100947740	.	C	T	125	.	quality=DP%3D36%3BQD%3D3.47%3BAF%3D0.31%3BMQM%3D60%3BSAP%3D19%3BABP%3D15%3BSAR%3D1%3BSAF%3D10;gene=SLF2;variant_type=splice_region&intron;coding_and_splicing=SLF2:ENST00000238961.9:splice_region_variant&intron_variant:LOW:intron14/19:c.3033-20C>T::%2CSLF2:ENST00000370269.3:splice_region_variant&intron_variant:LOW:intron14/18:c.3033-20C>T::;OMIM=610348_[GENE%3DSLF2_PHENOS%3DAtelis%20syndrome%201%2C%20620184%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72842157;gnomAD=0.00005;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00010%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=8;gnomAD_wt=152272;phyloP=-0.3040;CADD=11.39;MaxEntScan=8.6>8.7/8.6>8.7/0.0>0.0;SpliceAI=SLF2|0.00|0.00|0.00|0.00|20|33|44|20;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=SLF2%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.89%20oe_lof%3D0.37)	GT	1/0
chr10	103139440	.	C	G	334	.	quality=DP%3D38%3BQD%3D8.79%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D3%3BABP%3D5%3BSAR%3D8%3BSAF%3D8;gene=NT5C2;variant_type=missense;coding_and_splicing=NT5C2:ENST00000343289.9:missense_variant:MODERATE:exon3/18:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000404739.8:missense_variant:MODERATE:exon4/19:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000674860.1:missense_variant:MODERATE:exon5/21:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000676449.1:missense_variant:MODERATE:exon3/18:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000676428.1:missense_variant:MODERATE:exon4/19:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000675985.1:missense_variant:MODERATE:exon2/17:c.54G>C:p.Lys18Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000674696.1:missense_variant:MODERATE:exon3/18:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000675326.1:missense_variant:MODERATE:exon4/19:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family]%2CNT5C2:ENST00000675645.1:missense_variant:MODERATE:exon3/18:c.141G>C:p.Lys47Asn:PF05761%20[5'%20nucleotidase%20family];OMIM=600417_[GENE%3DNT5C2_PHENOS%3DSpastic%20paraplegia%2045%2C%20autosomal%20recessive%2C%20613162%20(3)%2C%20Autosomal%20recessive];ClinVar=943906%20[uncertain%20significance%20DISEASE%3DHereditary%20spastic%20paraplegia%2045%2CInborn%20genetic%20diseases%20GENE%3DNT5C2]%3B;dbSNP=rs72846108;gnomAD=0.00009;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00021%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152268;phyloP=2.2180;CADD=24.10;REVEL=0.182;AlphaMissense=0.71;MaxEntScan=/0.0>0.0/0.9>0.0;SpliceAI=NT5C2|0.00|0.00|0.00|0.00|39|-1|-34|-33;PubMed=21712425;NGSD_hom=0;NGSD_het=17;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=NT5C2%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.58%20oe_lof%3D0.46)	GT	1/0
chr10	112394904	.	GT	G	838	.	quality=DP%3D87%3BQD%3D9.63%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D61%3BABP%3D4%3BSAR%3D4%3BSAF%3D37;gene=ACSL5;variant_type=splice_region&intron;coding_and_splicing=ACSL5:ENST00000354655.9:splice_region_variant&intron_variant:LOW:intron1/20:c.-29-4del::%2CACSL5:ENST00000393081.6:splice_region_variant&intron_variant:LOW:intron1/20:c.-29-4del::%2CACSL5:ENST00000433418.6:splice_region_variant&intron_variant:LOW:intron1/19:c.140-4del::%2CACSL5:ENST00000356116.6:splice_region_variant&intron_variant:LOW:intron1/20:c.140-4del::%2CACSL5:ENST00000354273.5:splice_region_variant&intron_variant:LOW:intron1/18:c.140-4del::;regulatory=regulatory_region_variant:enhancer%2CTF_binding_site_variant;OMIM=605677_[GENE%3DACSL5_PHENOS%3D?Diarrhea%2013%2C%20620357%20(3)%2C%20Autosomal%20recessive];dbSNP=rs144016944;gnomAD=0.00045;gnomAD_sub=0.00035%2C0.00014%2C0.00238%2C0.00045%2C0.00151;gnomAD_hom_hemi=0%2C;gnomAD_het=66;gnomAD_wt=147058;phyloP=0.0960;CADD=0.56;MaxEntScan=/12.5>12.2/0.0>0.0;SpliceAI=ACSL5|0.00|0.01|0.00|0.00|43|14|42|13;NGSD_hom=0;NGSD_het=33;NGSD_mosaic=302;NGSD_group=0%20/%204;gene_info=ACSL5%20(inh%3DAR%20oe_syn%3D0.90%20oe_mis%3D0.90%20oe_lof%3D0.51)	GT	1/0
chr10	113165732	.	C	T	2015	.	quality=DP%3D182%3BQD%3D11.07%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D4%3BABP%3D8%3BSAR%3D44%3BSAF%3D37;gene=TCF7L2;variant_type=synonymous%2C3'UTR%2Cdownstream_gene;coding_and_splicing=TCF7L2:ENST00000355995.9:synonymous_variant:LOW:exon15/15:c.1620C>T:p.Pro540%3D:%2CTCF7L2:ENST00000627217.3:synonymous_variant:LOW:exon14/14:c.1569C>T:p.Pro523%3D:%2CTCF7L2:ENST00000277945.12:synonymous_variant:LOW:exon13/13:c.1500C>T:p.Pro500%3D:%2CTCF7L2:ENST00000534894.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*98C>T::%2CTCF7L2:ENST00000538897.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*98C>T::%2CTCF7L2:ENST00000369397.8:synonymous_variant:LOW:exon14/14:c.1551C>T:p.Pro517%3D:%2CTCF7L2:ENST00000355717.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::%2CTCF7L2:ENST00000545257.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*208C>T::%2CTCF7L2:ENST00000704414.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*98C>T::%2CTCF7L2:ENST00000629706.2:synonymous_variant:LOW:exon13/13:c.1515C>T:p.Pro505%3D:%2CTCF7L2:ENST00000352065.10:downstream_gene_variant:MODIFIER::::%2CTCF7L2:ENST00000369395.6:downstream_gene_variant:MODIFIER::::%2CTCF7L2:ENST00000349937.8:downstream_gene_variant:MODIFIER::::%2CTCF7L2:ENST00000369389.7:downstream_gene_variant:MODIFIER::::%2CTCF7L2:ENST00000704420.1:downstream_gene_variant:MODIFIER::::;OMIM=602228_[GENE%3DTCF7L2_PHENOS%3D{Diabetes%20mellitus%2C%20type%202%2C%20susceptibility%20to}%2C%20125853%20(3)%2C%20Autosomal%20dominant];dbSNP=rs76249005;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=151680;phyloP=0.8140;CADD=9.63;MaxEntScan=/5.8>5.6/0.0>0.0;COSMIC=COSV53340782;SpliceAI=TCF7L2|0.00|0.00|0.00|0.00|16|-2|-2|24;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TCF7L2%20(inh%3DAD%20oe_syn%3D1.21%20oe_mis%3D0.64%20oe_lof%3D0.12)	GT	1/0
chr10	125827646	.	G	A	720	.	quality=DP%3D89%3BQD%3D8.09%3BAF%3D0.38%3BMQM%3D60%3BSAP%3D12%3BABP%3D14%3BSAR%3D23%3BSAF%3D11;gene=BCCIP%2CUROS;variant_type=splice_region&intron%2Cupstream_gene;coding_and_splicing=BCCIP:ENST00000278100.11:splice_region_variant&intron_variant:LOW:intron3/6:c.321+8G>A::%2CBCCIP:ENST00000299130.7:splice_region_variant&intron_variant:LOW:intron3/6:c.321+8G>A::%2CBCCIP:ENST00000368759.5:splice_region_variant&intron_variant:LOW:intron3/7:c.321+8G>A::%2CUROS:ENST00000649536.1:upstream_gene_variant:MODIFIER::::%2CUROS:ENST00000368797.10:upstream_gene_variant:MODIFIER::::%2CUROS:ENST00000713579.1:upstream_gene_variant:MODIFIER::::%2CUROS:ENST00000368778.7:upstream_gene_variant:MODIFIER::::%2CUROS:ENST00000368774.1:upstream_gene_variant:MODIFIER::::;OMIM=606938_[GENE%3DUROS_PHENOS%3DPorphyria%2C%20congenital%20erythropoietic%2C%20263700%20(3)%2C%20Autosomal%20recessive];dbSNP=rs17153600;gnomAD=0.00615;gnomAD_sub=0.00140%2C0.00216%2C0.00000%2C0.01028%2C0.00062;gnomAD_hom_hemi=4%2C;gnomAD_het=928;gnomAD_wt=151326;phyloP=1.5170;CADD=6.90;MaxEntScan=/0.0>0.0/0.9>5.2;SpliceAI=BCCIP|0.00|0.00|0.00|0.00|2|-31|-4|-19;NGSD_hom=4;NGSD_het=683;NGSD_mosaic=1;NGSD_group=1%20/%2068;gene_info=UROS%20(inh%3DAR%20oe_syn%3D0.95%20oe_mis%3D1.02%20oe_lof%3D0.35)%2C%20BCCIP%20(inh%3Dn/a%20oe_syn%3D0.94%20oe_mis%3D1.02%20oe_lof%3D0.40)	GT	1/0
chr11	299471	.	C	T	2069	.	quality=DP%3D214%3BQD%3D9.67%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D4%3BABP%3D18%3BSAR%3D47%3BSAF%3D41;gene=IFITM5%2CPGGHG;variant_type=missense%2Cdownstream_gene;coding_and_splicing=IFITM5:ENST00000382614.2:missense_variant:MODERATE:exon1/2:c.20G>A:p.Arg7His:%2CPGGHG:ENST00000409548.7:downstream_gene_variant:MODIFIER::::%2CPGGHG:ENST00000409655.5:downstream_gene_variant:MODIFIER::::%2CPGGHG:ENST00000409479.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:enhancer;OMIM=614757_[GENE%3DIFITM5_PHENOS%3DOsteogenesis%20imperfecta%2C%20type%20V%2C%20610967%20(3)%2C%20Autosomal%20dominant];dbSNP=rs74557511;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00007%2C0.00019%2C0.00003%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=5;gnomAD_wt=152285;phyloP=0.4700;CADD=23.90;REVEL=0.356;AlphaMissense=0.17;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=IFITM5|0.00|0.00|0.00|0.00|-5|50|9|-31;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PGGHG%20(inh%3DAD%20oe_syn%3D1.13%20oe_mis%3D0.98%20oe_lof%3D0.75)%2C%20IFITM5%20(inh%3DAD%20oe_syn%3D1.02%20oe_mis%3D1.21%20oe_lof%3D1.70)	GT	1/0
chr11	613605	.	G	A	703	.	quality=DP%3D93%3BQD%3D7.56%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D73%3BABP%3D7%3BSAR%3D38%3BSAF%3D2;gene=IRF7%2CPHRF1%2CCDHR5;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=IRF7:ENST00000397566.5:splice_region_variant&intron_variant:LOW:intron6/8:c.887-10C>T::%2CIRF7:ENST00000348655.11:splice_region_variant&intron_variant:LOW:intron7/9:c.761-10C>T::%2CIRF7:ENST00000525445.6:splice_region_variant&intron_variant:LOW:intron8/10:c.848-10C>T::%2CIRF7:ENST00000397570.5:splice_region_variant&intron_variant:LOW:intron5/7:c.800-10C>T::%2CIRF7:ENST00000330243.9:splice_region_variant&intron_variant:LOW:intron7/9:c.887-10C>T::%2CPHRF1:ENST00000416188.3:downstream_gene_variant:MODIFIER::::%2CPHRF1:ENST00000264555.10:downstream_gene_variant:MODIFIER::::%2CPHRF1:ENST00000413872.6:downstream_gene_variant:MODIFIER::::%2CPHRF1:ENST00000533464.5:downstream_gene_variant:MODIFIER::::%2CCDHR5:ENST00000358353.8:downstream_gene_variant:MODIFIER::::%2CCDHR5:ENST00000397542.7:downstream_gene_variant:MODIFIER::::%2CCDHR5:ENST00000349570.11:downstream_gene_variant:MODIFIER::::%2CCDHR5:ENST00000674088.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=605047_[GENE%3DIRF7_PHENOS%3D?Immunodeficiency%2039%2C%20616345%20(3)%2C%20Autosomal%20recessive];ClinVar=2050531%20[likely%20benign%20DISEASE%3DImmunodeficiency%2039%20GENE%3DIRF7]%3B;dbSNP=rs113389008;gnomAD=0.00004;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00008%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=5;gnomAD_wt=142619;phyloP=0.2590;CADD=4.69;MaxEntScan=6.1>5.8/6.1>5.8/0.0>0.0;SpliceAI=IRF7|0.01|0.00|0.00|0.00|-17|6|-22|-43;NGSD_hom=0;NGSD_het=14;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=PHRF1%20(inh%3Dn/a%20oe_syn%3D1.25%20oe_mis%3D1.14%20oe_lof%3D0.25)%2C%20IRF7%20(inh%3DAR%20oe_syn%3D1.30%20oe_mis%3D1.13%20oe_lof%3D1.09)%2C%20CDHR5%20(inh%3Dn/a%20oe_syn%3D1.33%20oe_mis%3D1.15%20oe_lof%3D0.94)	GT	1/0
chr11	1241791	.	G	T	2763	.	quality=DP%3D243%3BQD%3D11.37%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D3%3BABP%3D6%3BSAR%3D57%3BSAF%3D55;gene=MUC5B%2CMUC5B-AS1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=MUC5B:ENST00000529681.5:synonymous_variant:LOW:exon31/49:c.4911G>T:p.Pro1637%3D:%2CMUC5B-AS1:ENST00000532061.2:downstream_gene_variant:MODIFIER::::;OMIM=600770_[GENE%3DMUC5B_PHENOS%3D{Pulmonary%20fibrosis%2C%20idiopathic%2C%20susceptibility%20to}%2C%20178500%20(3)%2C%20Autosomal%20dominant];dbSNP=rs56257795;gnomAD=0.00661;gnomAD_sub=0.00171%2C0.00249%2C0.00000%2C0.00863%2C0.01974;gnomAD_hom_hemi=7%2C;gnomAD_het=990;gnomAD_wt=151002;phyloP=0.0870;CADD=0.76;MaxEntScan=/0.0>0.9/0.0>0.0;SpliceAI=MUC5B|0.00|0.00|0.00|0.00|-35|-14|-2|-8;NGSD_hom=10;NGSD_het=840;NGSD_mosaic=0;NGSD_group=0%20/%2080;gene_info=MUC5B%20(inh%3DAD%20oe_syn%3D1.34%20oe_mis%3D1.14%20oe_lof%3D0.18)%2C%20MUC5B-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	1246320	.	C	G	540	.	quality=DP%3D356%3BQD%3D1.52%3BAF%3D0.19%3BMQM%3D47%3BSAP%3D12%3BABP%3D304%3BSAR%3D25%3BSAF%3D42;gene=MUC5B%2CMUC5B-AS1;variant_type=missense%2Cintron&non_coding_transcript;coding_and_splicing=MUC5B:ENST00000529681.5:missense_variant:MODERATE:exon31/49:c.9440C>G:p.Ala3147Gly:%2CMUC5B-AS1:ENST00000532061.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.56+3301G>C::;OMIM=600770_[GENE%3DMUC5B_PHENOS%3D{Pulmonary%20fibrosis%2C%20idiopathic%2C%20susceptibility%20to}%2C%20178500%20(3)%2C%20Autosomal%20dominant];dbSNP=rs201362727;gnomAD=0.00098;gnomAD_sub=0.00039%2C0.00033%2C0.00000%2C0.00130%2C0.00104;gnomAD_hom_hemi=0%2C;gnomAD_het=149;gnomAD_wt=151447;phyloP=-1.9930;CADD=3.60;REVEL=0.064;AlphaMissense=0.12;MaxEntScan=/0.8>2.1/0.0>1.3%2C/0.0>0.0/0.0>0.0;COSMIC=COSV71589930%2CCOSV71591844;SpliceAI=MUC5B|0.00|0.00|0.00|0.00|0|-30|-1|-30;NGSD_hom=0;NGSD_het=183;NGSD_mosaic=36;NGSD_group=0%20/%2016;gene_info=MUC5B%20(inh%3DAD%20oe_syn%3D1.34%20oe_mis%3D1.14%20oe_lof%3D0.18)%2C%20MUC5B-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	3002069	.	C	G	1415	.	quality=DP%3D107%3BQD%3D13.22%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D34%3BABP%3D5%3BSAR%3D44%3BSAF%3D15;gene=CARS1;variant_type=splice_region&intron;coding_and_splicing=CARS1:ENST00000397111.9:splice_region_variant&intron_variant:LOW:intron20/21:c.2029-16G>C::%2CCARS1:ENST00000278224.13:splice_region_variant&intron_variant:LOW:intron20/21:c.2029-16G>C::%2CCARS1:ENST00000380525.9:splice_region_variant&intron_variant:LOW:intron21/22:c.2278-16G>C::%2CCARS1:ENST00000529772.5:splice_region_variant&intron_variant:LOW:intron21/22:c.2068-16G>C::;regulatory=regulatory_region_variant:enhancer;OMIM=123859_[GENE%3DCARS1_PHENOS%3DMicrocephaly%2C%20developmental%20delay%2C%20and%20brittle%20hair%20syndrome%2C%20618891%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72850071;gnomAD=0.00349;gnomAD_sub=0.00094%2C0.00190%2C0.00000%2C0.00606%2C0.00021;gnomAD_hom_hemi=1%2C;gnomAD_het=529;gnomAD_wt=151761;phyloP=0.0920;CADD=0.54;MaxEntScan=9.5>10.0/9.5>10.0/0.0>0.0;SpliceAI=CARS|0.00|0.00|0.00|0.00|-16|40|10|-49;NGSD_hom=1;NGSD_het=463;NGSD_mosaic=0;NGSD_group=0%20/%2063;gene_info=CARS1%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.85%20oe_lof%3D0.32)	GT	1/0
chr11	6392136	.	C	T	2577	.	quality=DP%3D194%3BQD%3D13.28%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D32%3BABP%3D4%3BSAR%3D69%3BSAF%3D32;gene=SMPD1%2CAPBB1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=SMPD1:ENST00000342245.9:synonymous_variant:LOW:exon2/6:c.1071C>T:p.Ala357%3D:PF00149%20[Calcineurin-like%20phosphoesterase]%2CSMPD1:ENST00000527275.5:synonymous_variant:LOW:exon2/6:c.1068C>T:p.Ala356%3D:PF00149%20[Calcineurin-like%20phosphoesterase]%2CAPBB1:ENST00000608655.6:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000608704.5:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000299402.10:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000609360.6:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000311051.7:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000608394.5:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000529519.5:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000608645.5:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000609331.5:downstream_gene_variant:MODIFIER::::%2CAPBB1:ENST00000530885.5:downstream_gene_variant:MODIFIER::::;OMIM=607608_[GENE%3DSMPD1_PHENOS%3DNiemann-Pick%20disease%2C%20type%20B%2C%20607616%20(3)%2C%20Autosomal%20recessive%3B%20Niemann-Pick%20disease%2C%20type%20A%2C%20257200%20(3)%2C%20Autosomal%20recessive];ClinVar=93310%20[benign/likely%20benign%20DISEASE%3DNiemann-Pick%20disease%2C%20type%20A%2Cnot%20provided%2CSphingomyelin/cholesterol%20lipidosis%2CInborn%20genetic%20diseases%2CNiemann-Pick%20disease%2C%20type%20B%2Cnot%20specified%20GENE%3DSMPD1]%3B;dbSNP=rs72896268;gnomAD=0.00562;gnomAD_sub=0.00176%2C0.00503%2C0.00000%2C0.00920%2C0.00145;gnomAD_hom_hemi=3%2C;gnomAD_het=849;gnomAD_wt=151371;phyloP=-0.2960;CADD=8.80;REVEL=0.028;MaxEntScan=/1.3>1.4/0.0>0.0;SpliceAI=SMPD1|0.00|0.00|0.00|0.00|21|4|20|29;PubMed=25741868%2C23757202%2C25933391;NGSD_hom=4;NGSD_het=740;NGSD_mosaic=1;NGSD_group=0%20/%2093;gene_info=SMPD1%20(inh%3DAR%20oe_syn%3D1.10%20oe_mis%3D1.01%20oe_lof%3D0.73)%2C%20APBB1%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.79%20oe_lof%3D0.15)	GT	1/0
chr11	6617154	.	C	T	1604	.	quality=DP%3D166%3BQD%3D9.66%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D5%3BABP%3D9%3BSAR%3D40%3BSAF%3D32;gene=TPP1%2CTAF10%2CDCHS1%2CDCHS1-AS1;variant_type=splice_acceptor%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=TPP1:ENST00000299427.12:splice_acceptor_variant:HIGH:intron5/12:c.509-1G>A:p.?:%2CTPP1:ENST00000533371.6:splice_acceptor_variant:HIGH:intron4/11:c.-221-1G>A:p.?:%2CTPP1:ENST00000682424.1:splice_acceptor_variant:HIGH:intron4/11:c.395-1G>A:p.?:%2CTPP1:ENST00000644810.1:splice_acceptor_variant:HIGH:intron3/10:c.230-1G>A:p.?:%2CTPP1:ENST00000642892.1:splice_acceptor_variant:HIGH:intron4/11:c.-221-1G>A:p.?:%2CTPP1:ENST00000644218.1:splice_acceptor_variant:HIGH:intron5/11:c.509-1G>A:p.?:%2CTPP1:ENST00000645620.1:splice_acceptor_variant:HIGH:intron4/11:c.-221-1G>A:p.?:%2CTPP1:ENST00000647152.1:splice_acceptor_variant:HIGH:intron3/10:c.-221-1G>A:p.?:%2CTAF10:ENST00000299424.9:upstream_gene_variant:MODIFIER::::%2CTAF10:ENST00000527248.3:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000531754.2:downstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000528657.2:downstream_gene_variant:MODIFIER::::%2CDCHS1:ENST00000299441.5:downstream_gene_variant:MODIFIER::::%2CDCHS1-AS1:ENST00000526456.1:upstream_gene_variant:MODIFIER::::;OMIM=607998_[GENE%3DTPP1_PHENOS%3DCeroid%20lipofuscinosis%2C%20neuronal%2C%202%2C%20204500%20(3)%2C%20Autosomal%20recessive%3B%20Spinocerebellar%20ataxia%2C%20autosomal%20recessive%207%2C%20609270%20(3)%2C%20Autosomal%20recessive]&603057_[GENE%3DDCHS1_PHENOS%3DMitral%20valve%20prolapse%202%2C%20607829%20(3)%2C%20Autosomal%20dominant%3B%20Van%20Maldergem%20syndrome%201%2C%20601390%20(3)%2C%20Autosomal%20recessive];ClinVar=207574%20[pathogenic%20DISEASE%3DNeuronal%20ceroid%20lipofuscinosis%2CInborn%20genetic%20diseases%2CNeuronal%20ceroid%20lipofuscinosis%202%2Cnot%20provided%20GENE%3DTPP1]%3B;HGMD=CS991344%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Neuronal%20ceroid%20lipofuscinosis%20late%20infantile"%20GENE%3DTPP1]%3B;dbSNP=rs56144125;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152231;phyloP=4.6080;CADD=32.00;MaxEntScan=7.3>0.0/7.3>0.0/0.0>0.0%2C/7.3>0.0/0.0>0.0;COSMIC=COSV54994519%2CCOSV99067420;SpliceAI=TPP1|0.26|0.98|0.00|0.00|-41|-1|50|-1;PubMed=25741868%2C25356970%2C20301601%2C23539563%2C10330339%2C9295267%2C9788728%2C15520412%2C23418007%2C26224725%2C11339651%2C18684116%2C12376936%2C22344438%2C34828358%2C32329550%2C16199547%2C28335910%2C10356316%2C31283065%2C22832778;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TAF10%20(inh%3Dn/a%20oe_syn%3D1.21%20oe_mis%3D0.77%20oe_lof%3D0.00)%2C%20TPP1%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D1.04%20oe_lof%3D0.51)%2C%20DCHS1%20(inh%3DAR+AD%20oe_syn%3D0.93%20oe_mis%3D0.85%20oe_lof%3D0.16)%2C%20DCHS1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	6623570	.	A	C	1331	.	quality=DP%3D117%3BQD%3D11.38%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D26%3BSAF%3D29;gene=DCHS1%2CTPP1%2CDCHS1-AS1;variant_type=missense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=DCHS1:ENST00000299441.5:missense_variant:MODERATE:exon21/21:c.8106T>G:p.His2702Gln:%2CTPP1:ENST00000299427.12:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000533371.6:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000682424.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000644810.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000642892.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000644218.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000645620.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000647152.1:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000531754.2:upstream_gene_variant:MODIFIER::::%2CTPP1:ENST00000528657.2:upstream_gene_variant:MODIFIER::::%2CDCHS1-AS1:ENST00000526456.1:downstream_gene_variant:MODIFIER::::;OMIM=607998_[GENE%3DTPP1_PHENOS%3DCeroid%20lipofuscinosis%2C%20neuronal%2C%202%2C%20204500%20(3)%2C%20Autosomal%20recessive%3B%20Spinocerebellar%20ataxia%2C%20autosomal%20recessive%207%2C%20609270%20(3)%2C%20Autosomal%20recessive]&603057_[GENE%3DDCHS1_PHENOS%3DMitral%20valve%20prolapse%202%2C%20607829%20(3)%2C%20Autosomal%20dominant%3B%20Van%20Maldergem%20syndrome%201%2C%20601390%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72911012;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152341;phyloP=-0.2200;CADD=9.56;REVEL=0.176;AlphaMissense=0.29;MaxEntScan=/0.0>0.1/0.0>0.0;SpliceAI=DCHS1|0.00|0.00|0.00|0.00|-1|31|-1|21;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TPP1%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D1.04%20oe_lof%3D0.51)%2C%20DCHS1%20(inh%3DAR+AD%20oe_syn%3D0.93%20oe_mis%3D0.85%20oe_lof%3D0.16)%2C%20DCHS1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	26565443	.	T	C	3078	.	quality=DP%3D270%3BQD%3D11.40%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D5%3BSAR%3D65%3BSAF%3D62;gene=ANO3%2CMUC15;variant_type=intron%2Cmissense;coding_and_splicing=ANO3:ENST00000672621.1:intron_variant:MODIFIER:intron15/27:c.1630+5664T>C::%2CANO3:ENST00000525139.5:intron_variant:MODIFIER:intron14/26:c.1399+5664T>C::%2CANO3:ENST00000256737.8:intron_variant:MODIFIER:intron14/26:c.1447+5664T>C::%2CANO3:ENST00000531568.1:intron_variant:MODIFIER:intron11/23:c.1009+5664T>C::%2CMUC15:ENST00000529533.6:missense_variant:MODERATE:exon3/5:c.497A>G:p.Asn166Ser:PF15672%20[Cell-membrane%20associated%20Mucin15]%2CMUC15:ENST00000281268.12:missense_variant:MODERATE:exon2/3:c.497A>G:p.Asn166Ser:PF15672%20[Cell-membrane%20associated%20Mucin15]%2CMUC15:ENST00000436318.6:missense_variant:MODERATE:exon2/4:c.497A>G:p.Asn166Ser:PF15672%20[Cell-membrane%20associated%20Mucin15]%2CMUC15:ENST00000455601.6:missense_variant:MODERATE:exon2/4:c.416A>G:p.Asn139Ser:PF15672%20[Cell-membrane%20associated%20Mucin15]%2CMUC15:ENST00000527569.1:missense_variant:MODERATE:exon3/4:c.497A>G:p.Asn166Ser:PF15672%20[Cell-membrane%20associated%20Mucin15];OMIM=610110_[GENE%3DANO3_PHENOS%3DDystonia%2024%2C%20615034%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72877805;gnomAD=0.00032;gnomAD_sub=0.00031%2C0.00013%2C0.00000%2C0.00049%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=48;gnomAD_wt=151848;phyloP=0.1200;CADD=6.43;REVEL=0.022;AlphaMissense=0.07;MaxEntScan=/0.0>0.0/0.0>0.5%2C/0.0>0.0/0.0>0.0;COSMIC=COSV55553816;SpliceAI=ANO3|0.00|0.00|0.00|0.00|42|-2|42|-34%2CMUC15|0.00|0.00|0.00|0.00|36|-24|-43|15;NGSD_hom=0;NGSD_het=39;NGSD_mosaic=0;NGSD_group=0%20/%203;gene_info=ANO3%20(inh%3DAD%20oe_syn%3D1.01%20oe_mis%3D0.70%20oe_lof%3D0.58)%2C%20MUC15%20(inh%3Dn/a%20oe_syn%3D0.87%20oe_mis%3D1.11%20oe_lof%3D0.70)	GT	1/0
chr11	45903402	.	C	T	1785	.	quality=DP%3D170%3BQD%3D10.50%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D18%3BABP%3D5%3BSAR%3D28%3BSAF%3D51;gene=MAPK8IP1%2CFREY1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=MAPK8IP1:ENST00000241014.6:synonymous_variant:LOW:exon6/12:c.1455C>T:p.Asn485%3D:%2CMAPK8IP1:ENST00000395629.2:synonymous_variant:LOW:exon6/12:c.1425C>T:p.Asn475%3D:%2CFREY1:ENST00000449465.2:downstream_gene_variant:MODIFIER::::;OMIM=604641_[GENE%3DMAPK8IP1_PHENOS%3D{Diabetes%20mellitus%2C%20noninsulin-dependent}%2C%20125853%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72902473;gnomAD=0.00031;gnomAD_sub=0.00029%2C0.00007%2C0.00000%2C0.00049%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=47;gnomAD_wt=152257;phyloP=-0.7420;CADD=0.76;MaxEntScan=/0.2>0.0/1.5>0.0;SpliceAI=MAPK8IP1|0.00|0.00|0.00|0.00|13|-37|-38|38;NGSD_hom=0;NGSD_het=18;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=MAPK8IP1%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.79%20oe_lof%3D0.03)%2C%20FREY1%20(inh%3Dn/a%20oe_syn%3D1.11%20oe_mis%3D1.19%20oe_lof%3D0.67)	GT	1/0
chr11	47448803	.	C	T	2905	.	quality=DP%3D236%3BQD%3D12.31%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D94%3BABP%3D4%3BSAR%3D26%3BSAF%3D98;gene=RAPSN;variant_type=synonymous;coding_and_splicing=RAPSN:ENST00000298854.7:synonymous_variant:LOW:exon1/8:c.162G>A:p.Ser54%3D:PF10579%20[Rapsyn%20N-terminal%20myristoylation%20and%20linker%20region]%2CRAPSN:ENST00000352508.7:synonymous_variant:LOW:exon1/6:c.162G>A:p.Ser54%3D:PF10579%20[Rapsyn%20N-terminal%20myristoylation%20and%20linker%20region]%2CRAPSN:ENST00000524487.5:synonymous_variant:LOW:exon1/7:c.162G>A:p.Ser54%3D:PF10579%20[Rapsyn%20N-terminal%20myristoylation%20and%20linker%20region]%2CRAPSN:ENST00000529341.1:synonymous_variant:LOW:exon1/5:c.162G>A:p.Ser54%3D:PF10579%20[Rapsyn%20N-terminal%20myristoylation%20and%20linker%20region];regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region;OMIM=601592_[GENE%3DRAPSN_PHENOS%3DFetal%20akinesia%20deformation%20sequence%202%2C%20618388%20(3)%2C%20Autosomal%20recessive%3B%20Myasthenic%20syndrome%2C%20congenital%2C%2011%2C%20associated%20with%20acetylcholine%20receptor%20deficiency%2C%20616326%20(3)%2C%20Autosomal%20recessive];ClinVar=259625%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:2x1%2C3x2%2C1x3)%20DISEASE%3DFetal%20akinesia%20deformation%20sequence%201%2CCongenital%20myasthenic%20syndrome%2011%2Cnot%20specified%2Cnot%20provided%20GENE%3DRAPSN]%3B;dbSNP=rs72905825;gnomAD=0.00333;gnomAD_sub=0.00077%2C0.00340%2C0.00000%2C0.00513%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=507;gnomAD_wt=151847;phyloP=-2.7040;CADD=5.20;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV100100470;SpliceAI=RAPSN|0.00|0.00|0.00|0.00|-2|-4|-36|-30;PubMed=25741868;NGSD_hom=0;NGSD_het=272;NGSD_mosaic=0;NGSD_group=0%20/%2030;gene_info=RAPSN%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.90%20oe_lof%3D0.41)	GT	1/0
chr11	62666426	.	G	A	2676	.	quality=DP%3D254%3BQD%3D10.54%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D37%3BABP%3D9%3BSAR%3D36%3BSAF%3D78;gene=LBHD1%2CCSKMT%2CC11orf98%2CSNORA57%2CUQCC3;variant_type=intron%2Cmissense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=LBHD1:ENST00000354588.8:intron_variant:MODIFIER:intron4/6:c.538+1097C>T::%2CLBHD1:ENST00000431002.6:intron_variant:MODIFIER:intron2/4:c.616+1097C>T::%2CLBHD1:ENST00000532208.5:intron_variant:MODIFIER:intron4/6:c.538+1097C>T::%2CCSKMT:ENST00000532971.2:missense_variant:MODERATE:exon3/3:c.98G>A:p.Arg33His:%2CC11orf98:ENST00000524958.6:upstream_gene_variant:MODIFIER::::%2CC11orf98:ENST00000525675.1:upstream_gene_variant:MODIFIER::::%2CSNORA57:ENST00000383870.1:downstream_gene_variant:MODIFIER::::%2CUQCC3:ENST00000531323.1:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=616097_[GENE%3DUQCC3_PHENOS%3D?Mitochondrial%20complex%20III%20deficiency%2C%20nuclear%20type%209%2C%20616111%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72927292;gnomAD=0.00351;gnomAD_sub=0.00099%2C0.00144%2C0.00000%2C0.00466%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=535;gnomAD_wt=151741;phyloP=2.2500;CADD=23.80;REVEL=0.022;AlphaMissense=0.12;MaxEntScan=/0.0>0.0/0.4>0.0%2C/0.0>0.0/0.0>0.0;SpliceAI=LBHD1|0.00|0.00|0.00|0.00|-43|-10|2|-24%2CMETTL12|0.00|0.07|0.00|0.00|2|-30|5|-30;NGSD_hom=2;NGSD_het=275;NGSD_mosaic=0;NGSD_group=0%20/%2030;gene_info=C11ORF98%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20LBHD1%20(inh%3DAR%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20CSKMT%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D1.25%20oe_lof%3D0.65)%2C%20SNORA57%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20UQCC3%20(inh%3DAR%20oe_syn%3D0.89%20oe_mis%3D0.97%20oe_lof%3D0.82)	GT	1/0
chr11	65552241	.	G	A	5627	.	quality=DP%3D423%3BQD%3D13.30%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D4%3BABP%3D5%3BSAR%3D106%3BSAF%3D115;gene=LTBP3;variant_type=splice_region&intron;coding_and_splicing=LTBP3:ENST00000301873.11:splice_region_variant&intron_variant:LOW:intron7/27:c.1345+7C>T::%2CLTBP3:ENST00000689505.1:splice_region_variant&intron_variant:LOW:intron6/26:c.1222+7C>T::%2CLTBP3:ENST00000530866.6:splice_region_variant&intron_variant:LOW:intron8/28:c.1078+7C>T::%2CLTBP3:ENST00000322147.8:splice_region_variant&intron_variant:LOW:intron7/26:c.1345+7C>T::%2CLTBP3:ENST00000526927.6:splice_region_variant&intron_variant:LOW:intron2/21:c.490+7C>T::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=602090_[GENE%3DLTBP3_PHENOS%3DDental%20anomalies%20and%20short%20stature%2C%20601216%20(3)%2C%20Autosomal%20recessive%3B%20Geleophysic%20dysplasia%203%2C%20617809%20(3)%2C%20Autosomal%20dominant];ClinVar=767573%20[likely%20benign%20DISEASE%3DBrachyolmia-amelogenesis%20imperfecta%20syndrome%20GENE%3DLTBP3]%3B;dbSNP=rs72939112;gnomAD=0.00045;gnomAD_sub=0.00005%2C0.00046%2C0.00000%2C0.00085%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=66;gnomAD_wt=152230;phyloP=1.3210;CADD=6.11;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=LTBP3|0.00|0.00|0.00|0.00|-47|7|3|7;NGSD_hom=0;NGSD_het=75;NGSD_mosaic=0;NGSD_group=0%20/%207;gene_info=LTBP3%20(inh%3DAR+AD%20oe_syn%3D0.94%20oe_mis%3D0.71%20oe_lof%3D0.21)	GT	1/0
chr11	66061986	.	G	A	1209	.	quality=DP%3D117%3BQD%3D10.33%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D49%3BABP%3D5%3BSAR%3D44%3BSAF%3D10;gene=SF3B2;variant_type=synonymous;coding_and_splicing=SF3B2:ENST00000528302.5:synonymous_variant:LOW:exon15/21:c.1914G>A:p.Ser638%3D:%2CSF3B2:ENST00000322535.11:synonymous_variant:LOW:exon16/22:c.1965G>A:p.Ser655%3D:;OMIM=605591_[GENE%3DSF3B2_PHENOS%3DCraniofacial%20microsomia%2C%20164210%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72932689;gnomAD=0.00358;gnomAD_sub=0.00048%2C0.00163%2C0.00000%2C0.00550%2C0.00415;gnomAD_hom_hemi=5%2C;gnomAD_het=535;gnomAD_wt=151693;phyloP=-3.2300;CADD=3.04;REVEL=0.048;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV59427804;SpliceAI=SF3B2|0.00|0.00|0.00|0.00|2|6|-34|12;NGSD_hom=3;NGSD_het=637;NGSD_mosaic=1;NGSD_group=0%20/%2078;gene_info=SF3B2%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.55%20oe_lof%3D0.11)	GT	1/0
chr11	66510683	.	T	C	2113	.	quality=DP%3D161%3BQD%3D13.12%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D7%3BABP%3D3%3BSAR%3D35%3BSAF%3D48;gene=BBS1%2CDPP3;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=BBS1:ENST00000318312.12:synonymous_variant:LOW:exon1/17:c.24T>C:p.Asp8%3D:%2CBBS1:ENST00000455748.6:synonymous_variant:LOW:exon1/13:c.24T>C:p.Asp8%3D:%2CBBS1:ENST00000393994.4:synonymous_variant:LOW:exon1/13:c.24T>C:p.Asp8%3D:%2CBBS1:ENST00000630659.2:synonymous_variant:LOW:exon1/16:c.24T>C:p.Asp8%3D:%2CDPP3:ENST00000532677.5:downstream_gene_variant:MODIFIER::::%2CDPP3:ENST00000541961.5:downstream_gene_variant:MODIFIER::::%2CDPP3:ENST00000531863.6:downstream_gene_variant:MODIFIER::::%2CDPP3:ENST00000530165.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=209901_[GENE%3DBBS1_PHENOS%3DBardet-Biedl%20syndrome%201%2C%20209900%20(3)%2C%20Digenic%20recessive%2C%20Autosomal%20recessive];ClinVar=193457%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:5x1%2C3x2%2C1x3)%20DISEASE%3Dnot%20provided%2CBBS1-related%20disorder%2CBardet-Biedl%20syndrome%2CBardet-Biedl%20syndrome%201%2Cnot%20specified%20GENE%3DBBS1]%3B;HGMD=CM085270%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Bardet-Biedl%20syndrome"%20GENE%3DBBS1]%3B;dbSNP=rs55848325;gnomAD=0.00287;gnomAD_sub=0.00041%2C0.00118%2C0.00000%2C0.00453%2C0.00642;gnomAD_hom_hemi=2%2C;gnomAD_het=433;gnomAD_wt=151909;phyloP=2.0430;CADD=11.84;MaxEntScan=/0.9>0.8/0.0>0.0;SpliceAI=BBS1|0.00|0.00|0.00|0.00|29|-39|23|29%2CCTD-3074O7.11|0.00|0.00|0.01|0.00|-39|-23|23|29;PubMed=25741868%2C15770229%2C21344540%2C17980398;NGSD_hom=2;NGSD_het=554;NGSD_mosaic=1;NGSD_group=0%20/%2057;classification=2;classification_comment="[2]%20Stephan%20Waldmller%2013.10.2015%20[n/a]%20comment%20imported%20from%20detected%20variant:%20HGMD:%20DM?%20fr%20Bardet%20Biedl%20S.%2C%20prima%20vista%20kein%20Anhalt%20fr%20Splice-Defekt%2C%20VUS2%2C%20swal%20151013";gene_info=DPP3%20(inh%3Dn/a%20oe_syn%3D0.94%20oe_mis%3D0.83%20oe_lof%3D0.57)%2C%20BBS1%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.98%20oe_lof%3D0.69)	GT	1/0
chr11	67991572	.	C	A	35	.	quality=DP%3D8%3BQD%3D4.38%3BAF%3D0.38%3BMQM%3D53%3BSAP%3D10%3BABP%3D4%3BSAR%3D0%3BSAF%3D3;gene=UNC93B1;variant_type=missense;coding_and_splicing=UNC93B1:ENST00000227471.7:missense_variant:MODERATE:exon11/11:c.1768G>T:p.Gly590Trp:;OMIM=608204_[GENE%3DUNC93B1_PHENOS%3D{Encephalopathy%2C%20acute%2C%20infection-induced%20(herpes-specific)%2C%20susceptibility%20to%2C%201}%2C%20610551%20(3)%2C%20Autosomal%20recessive];ClinVar=470495%20[benign%20DISEASE%3DHerpes%20simplex%20encephalitis%2C%20susceptibility%20to%2C%201%20GENE%3DUNC93B1]%3B;dbSNP=rs2375182;gnomAD=0.00888;gnomAD_sub=0.02316%2C0.00484%2C0.00039%2C0.00426%2C0.00021;gnomAD_hom_hemi=12%2C;gnomAD_het=1327;gnomAD_wt=150705;phyloP=3.3830;CADD=23.90;REVEL=0.189;AlphaMissense=0.33;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV57097970;PubMed=34440442;NGSD_hom=6;NGSD_het=301;NGSD_mosaic=0;NGSD_group=2%20/%2038;classification=2;classification_comment="[2]%20old%20entry%20-%20no%20details%20available";gene_info=UNC93B1%20(inh%3DAR%20oe_syn%3D0.89%20oe_mis%3D0.71%20oe_lof%3D0.26)	GT	1/0
chr11	70111211	.	G	A	1021	.	quality=DP%3D80%3BQD%3D12.76%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D18%3BABP%3D3%3BSAR%3D29%3BSAF%3D12;gene=ANO1;variant_type=splice_region&intron%2Cintron;coding_and_splicing=ANO1:ENST00000531349.6:splice_region_variant&intron_variant:LOW:intron8/27:c.988+20G>A::%2CANO1:ENST00000355303.10:intron_variant:MODIFIER:intron6/25:c.800-496G>A::%2CANO1:ENST00000316296.9:intron_variant:MODIFIER:intron6/16:c.716-496G>A::%2CANO1:ENST00000530676.5:intron_variant:MODIFIER:intron6/24:c.452-496G>A::;regulatory=regulatory_region_variant:enhancer;OMIM=610108_[GENE%3DANO1_PHENOS%3D?Intestinal%20dysmotility%20syndrome%2C%20620045%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72941226;gnomAD=0.00909;gnomAD_sub=0.00337%2C0.01039%2C0.00000%2C0.01391%2C0.00145;gnomAD_hom_hemi=11%2C;gnomAD_het=1363;gnomAD_wt=150947;phyloP=0.2840;CADD=9.03;MaxEntScan=/0.0>3.4/0.0>0.0;SpliceAI=ANO1|0.00|0.00|0.00|0.00|-20|-45|-14|-20;NGSD_hom=3;NGSD_het=880;NGSD_mosaic=0;NGSD_group=0%20/%2096;gene_info=ANO1%20(inh%3DAR%20oe_syn%3D0.90%20oe_mis%3D0.68%20oe_lof%3D0.20)	GT	1/0
chr11	71435791	.	C	T	2780	.	quality=DP%3D209%3BQD%3D13.30%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D21%3BABP%3D6%3BSAR%3D72%3BSAF%3D41;gene=DHCR7;variant_type=missense%2Csynonymous%2Cdownstream_gene;coding_and_splicing=DHCR7:ENST00000355527.8:missense_variant:MODERATE:exon9/9:c.1012G>A:p.Val338Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000407721.6:missense_variant:MODERATE:exon9/9:c.1012G>A:p.Val338Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000526780.6:missense_variant:MODERATE:exon8/8:c.1012G>A:p.Val338Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000685320.1:missense_variant:MODERATE:exon8/8:c.427G>A:p.Val143Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000682708.1:missense_variant:MODERATE:exon10/10:c.1063G>A:p.Val355Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000683287.1:missense_variant:MODERATE:exon9/9:c.1048G>A:p.Val350Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000683714.1:synonymous_variant:LOW:exon9/9:c.1020G>A:p.Pro340%3D:%2CDHCR7:ENST00000527316.6:missense_variant:MODERATE:exon9/9:c.838G>A:p.Val280Met:PF01222%20[Ergosterol%20biosynthesis%20ERG4/ERG24%20family]%2CDHCR7:ENST00000682880.1:downstream_gene_variant:MODIFIER::::;OMIM=602858_[GENE%3DDHCR7_PHENOS%3DSmith-Lemli-Opitz%20syndrome%2C%20270400%20(3)%2C%20Autosomal%20recessive];ClinVar=93706%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C5x2%2C3x3)%20DISEASE%3DSmith-Lemli-Opitz%20syndrome%2Cnot%20provided%2Cnot%20specified%2CDHCR7-related%20disorder%2CInborn%20genetic%20diseases%20GENE%3DDHCR7]%3B;HGMD=CM178162%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Autism%20spectrum%20disorder"%20GENE%3DDHCR7]%3B;dbSNP=rs72954276;gnomAD=0.00078;gnomAD_sub=0.00022%2C0.00124%2C0.00290%2C0.00103%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=119;gnomAD_wt=152233;phyloP=-1.0670;CADD=0.10;REVEL=0.255;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV105276652;SpliceAI=DHCR7|0.00|0.00|0.00|0.00|27|18|48|-23;PubMed=23757202%2C28972118%2C24813812%2C35795205%2C28250423%2C29300326;NGSD_hom=0;NGSD_het=107;NGSD_mosaic=0;NGSD_group=0%20/%208;gene_info=DHCR7%20(inh%3DAR%20oe_syn%3D1.21%20oe_mis%3D1.07%20oe_lof%3D0.93)	GT	1/0
chr11	101128522	.	T	C	3454	.	quality=DP%3D277%3BQD%3D12.47%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D72%3BSAF%3D69;gene=PGR%2CPGR-AS1;variant_type=synonymous%2Cintron%2Cupstream_gene;coding_and_splicing=PGR:ENST00000325455.10:synonymous_variant:LOW:exon1/8:c.549A>G:p.Lys183%3D:PF02161%20[Progesterone%20receptor]%2CPGR:ENST00000534013.5:intron_variant:MODIFIER:intron1/7:c.-146+906A>G::%2CPGR:ENST00000263463.9:synonymous_variant:LOW:exon1/7:c.549A>G:p.Lys183%3D:PF02161%20[Progesterone%20receptor]%2CPGR:ENST00000619228.2:synonymous_variant:LOW:exon1/5:c.549A>G:p.Lys183%3D:PF02161%20[Progesterone%20receptor]%2CPGR-AS1:ENST00000632820.1:upstream_gene_variant:MODIFIER::::;OMIM=607311_[GENE%3DPGR_PHENOS%3D?Progesterone%20resistance%2C%20264080%20(2)%2C%20Autosomal%20recessive];ClinVar=787546%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPGR]%3B;dbSNP=rs201378964;gnomAD=0.00243;gnomAD_sub=0.00087%2C0.00098%2C0.00000%2C0.00426%2C0.00104;gnomAD_hom_hemi=1%2C;gnomAD_het=368;gnomAD_wt=151920;phyloP=-1.3520;CADD=7.45;MaxEntScan=/0.0>0.0/0.0>4.0;SpliceAI=PGR|0.00|0.00|0.01|0.00|35|-26|0|36;NGSD_hom=0;NGSD_het=239;NGSD_mosaic=0;NGSD_group=0%20/%2025;gene_info=PGR%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.84%20oe_lof%3D0.27)%2C%20PGR-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	102952005	.	G	A	1055	.	quality=DP%3D108%3BQD%3D9.77%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D49%3BABP%3D6%3BSAR%3D8%3BSAF%3D40;gene=MMP13;variant_type=splice_region&intron;coding_and_splicing=MMP13:ENST00000260302.8:splice_region_variant&intron_variant:LOW:intron5/9:c.799+7C>T::%2CMMP13:ENST00000340273.4:splice_region_variant&intron_variant:LOW:intron5/10:c.799+7C>T::;OMIM=600108_[GENE%3DMMP13_PHENOS%3D?Spondyloepimetaphyseal%20dysplasia%2C%20Missouri%20type%2C%20602111%20(3)%2C%20Autosomal%20dominant%3B%20Metaphyseal%20anadysplasia%201%2C%20602111%20(3)%2C%20Autosomal%20dominant%3B%20Metaphyseal%20dysplasia%2C%20Spahr%20type%2C%20250400%20(3)%2C%20Autosomal%20recessive];ClinVar=301986%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CMetaphyseal%20anadysplasia%2CSpondyloepimetaphyseal%20dysplasia%2C%20Missouri%20type%2CMetaphyseal%20chondrodysplasia%2C%20Spahr%20type%20GENE%3DMMP13]%3B;dbSNP=rs72987505;gnomAD=0.00279;gnomAD_sub=0.00992%2C0.00052%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=4%2C;gnomAD_het=417;gnomAD_wt=151775;phyloP=1.1520;CADD=4.32;MaxEntScan=/3.0>2.7/0.0>0.0;SpliceAI=MMP13|0.00|0.00|0.00|0.00|36|30|7|32;NGSD_hom=0;NGSD_het=35;NGSD_mosaic=0;NGSD_group=0%20/%203;gene_info=MMP13%20(inh%3DAR+AD%20oe_syn%3D1.01%20oe_mis%3D1.04%20oe_lof%3D1.09)	GT	1/0
chr11	102954623	.	G	C	666	.	quality=DP%3D66%3BQD%3D10.09%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D47%3BABP%3D4%3BSAR%3D28%3BSAF%3D3;gene=MMP13;variant_type=splice_region&intron;coding_and_splicing=MMP13:ENST00000260302.8:splice_region_variant&intron_variant:LOW:intron2/9:c.363-17C>G::%2CMMP13:ENST00000340273.4:splice_region_variant&intron_variant:LOW:intron2/10:c.363-17C>G::;OMIM=600108_[GENE%3DMMP13_PHENOS%3D?Spondyloepimetaphyseal%20dysplasia%2C%20Missouri%20type%2C%20602111%20(3)%2C%20Autosomal%20dominant%3B%20Metaphyseal%20anadysplasia%201%2C%20602111%20(3)%2C%20Autosomal%20dominant%3B%20Metaphyseal%20dysplasia%2C%20Spahr%20type%2C%20250400%20(3)%2C%20Autosomal%20recessive];ClinVar=1599949%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DMMP13]%3B;dbSNP=rs72987512;gnomAD=0.00307;gnomAD_sub=0.01088%2C0.00072%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=5%2C;gnomAD_het=457;gnomAD_wt=151733;phyloP=-0.5160;CADD=0.13;MaxEntScan=5.4>4.5/5.4>4.5/0.0>0.4;SpliceAI=MMP13|0.01|0.12|0.00|0.00|-1|-17|-17|-48;NGSD_hom=0;NGSD_het=35;NGSD_mosaic=0;NGSD_group=0%20/%203;gene_info=MMP13%20(inh%3DAR+AD%20oe_syn%3D1.01%20oe_mis%3D1.04%20oe_lof%3D1.09)	GT	1/0
chr11	111926180	.	A	G	1841	.	quality=DP%3D171%3BQD%3D10.77%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D19%3BABP%3D8%3BSAR%3D50%3BSAF%3D26;gene=C11orf52%2CCRYAB%2CDIXDC1%2CRNA5SP351;variant_type=missense%2Cupstream_gene;coding_and_splicing=C11orf52:ENST00000278601.6:missense_variant:MODERATE:exon4/4:c.353A>G:p.Lys118Arg:PF15147%20[Domain%20of%20unknown%20function%20(DUF4578)]%2CCRYAB:ENST00000527950.5:upstream_gene_variant:MODIFIER::::%2CDIXDC1:ENST00000529225.5:upstream_gene_variant:MODIFIER::::%2CRNA5SP351:ENST00000459480.1:upstream_gene_variant:MODIFIER::::;OMIM=123590_[GENE%3DCRYAB_PHENOS%3DMyopathy%2C%20myofibrillar%2C%20fatal%20infantile%20hypertonic%2C%20alpha-B%20crystallin-related%2C%20613869%20(3)%2C%20Autosomal%20recessive%3B%20Myopathy%2C%20myofibrillar%2C%202%2C%20608810%20(3)%2C%20Autosomal%20dominant%3B%20Cataract%2016%2C%20multiple%20types%2C%20613763%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20Cardiomyopathy%2C%20dilated%2C%201II%2C%20615184%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72991415;gnomAD=0.00010;gnomAD_sub=0.00005%2C0.00007%2C0.00000%2C0.00016%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=15;gnomAD_wt=152371;phyloP=3.5920;CADD=21.60;REVEL=0.075;AlphaMissense=0.09;MaxEntScan=/3.0>2.5/0.0>2.7;SpliceAI=C11orf52|0.00|0.00|0.00|0.00|1|-22|15|34;NGSD_hom=0;NGSD_het=18;NGSD_mosaic=0;NGSD_group=0%20/%203;gene_info=CRYAB%20(inh%3DAR+AD%20oe_syn%3D0.85%20oe_mis%3D0.87%20oe_lof%3D0.57)%2C%20C11ORF52%20(inh%3Dn/a%20oe_syn%3D0.73%20oe_mis%3D0.75%20oe_lof%3D0.94)%2C%20DIXDC1%20(inh%3DAR+AD%20oe_syn%3D0.92%20oe_mis%3D0.79%20oe_lof%3D0.53)%2C%20RNA5SP351%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr11	121157872	.	C	G	1750	.	quality=DP%3D161%3BQD%3D10.87%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D102%3BABP%3D5%3BSAR%3D8%3BSAF%3D66;gene=TECTA;variant_type=missense;coding_and_splicing=TECTA:ENST00000392793.6:missense_variant:MODERATE:exon14/24:c.4337C>G:p.Thr1446Arg:PF12714%20[TILa%20domain]%2CTECTA:ENST00000642222.1:missense_variant:MODERATE:exon14/24:c.4337C>G:p.Thr1446Arg:PF12714%20[TILa%20domain]%2CTECTA:ENST00000264037.2:missense_variant:MODERATE:exon13/23:c.4337C>G:p.Thr1446Arg:PF12714%20[TILa%20domain];OMIM=602574_[GENE%3DTECTA_PHENOS%3DDeafness%2C%20autosomal%20dominant%208/12%2C%20601543%20(3)%2C%20Autosomal%20dominant%3B%20Deafness%2C%20autosomal%20recessive%2021%2C%20603629%20(3)%2C%20Autosomal%20recessive];ClinVar=303025%20[uncertain%20significance%20DISEASE%3DAutosomal%20dominant%20nonsyndromic%20hearing%20loss%2012%2CAutosomal%20recessive%20nonsyndromic%20hearing%20loss%2021%20GENE%3DTECTA]%3B;dbSNP=rs72998913;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152372;phyloP=3.9060;CADD=26.00;REVEL=0.291;AlphaMissense=0.21;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV50689693;SpliceAI=TECTA|0.00|0.00|0.00|0.00|-31|38|0|36;NGSD_hom=0;NGSD_het=21;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TECTA%20(inh%3DAR+AD%20oe_syn%3D0.99%20oe_mis%3D0.87%20oe_lof%3D0.45)	GT	1/0
chr11	130159985	.	G	A	917	.	quality=DP%3D79%3BQD%3D11.61%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D16%3BSAF%3D22;gene=ST14;variant_type=synonymous;coding_and_splicing=ST14:ENST00000278742.6:synonymous_variant:LOW:exon1/19:c.6G>A:p.Gly2%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=606797_[GENE%3DST14_PHENOS%3DIchthyosis%2C%20congenital%2C%20autosomal%20recessive%2011%2C%20602400%20(3)%2C%20Autosomal%20recessive];ClinVar=2849266%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DST14]%3B;dbSNP=rs370051145;gnomAD=0.00131;gnomAD_sub=0.00058%2C0.00131%2C0.00020%2C0.00196%2C0.00041;gnomAD_hom_hemi=0%2C;gnomAD_het=199;gnomAD_wt=151801;phyloP=1.5320;CADD=10.49;MaxEntScan=/0.0>0.0/0.6>1.6;SpliceAI=ST14|0.00|0.00|0.00|0.00|-44|19|3|-34;NGSD_hom=0;NGSD_het=79;NGSD_mosaic=0;NGSD_group=0%20/%2015;gene_info=ST14%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.85%20oe_lof%3D0.21)	GT	1/0
chr11	134168023	.	C	T	942	.	quality=DP%3D100%3BQD%3D9.42%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D54%3BABP%3D6%3BSAR%3D6%3BSAF%3D38;gene=NCAPD3;variant_type=synonymous;coding_and_splicing=NCAPD3:ENST00000534548.7:synonymous_variant:LOW:exon27/35:c.3546G>A:p.Gln1182%3D:%2CNCAPD3:ENST00000688672.1:synonymous_variant:LOW:exon28/36:c.3546G>A:p.Gln1182%3D:%2CNCAPD3:ENST00000688263.1:synonymous_variant:LOW:exon27/35:c.3546G>A:p.Gln1182%3D:%2CNCAPD3:ENST00000685324.1:synonymous_variant:LOW:exon28/36:c.3546G>A:p.Gln1182%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=609276_[GENE%3DNCAPD3_PHENOS%3DMicrocephaly%2022%2C%20primary%2C%20autosomal%20recessive%2C%20617984%20(3)%2C%20Autosomal%20recessive];ClinVar=734324%20[benign/likely%20benign%20DISEASE%3DNCAPD3-related%20disorder%2Cnot%20provided%20GENE%3DNCAPD3]%3B;dbSNP=rs61752298;gnomAD=0.00202;gnomAD_sub=0.00034%2C0.00124%2C0.00000%2C0.00340%2C0.00041;gnomAD_hom_hemi=2%2C;gnomAD_het=304;gnomAD_wt=151954;phyloP=1.2460;CADD=8.60;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=NCAPD3|0.00|0.00|0.00|0.00|34|7|-33|-31;NGSD_hom=0;NGSD_het=294;NGSD_mosaic=0;NGSD_group=0%20/%2024;gene_info=NCAPD3%20(inh%3DAR%20oe_syn%3D1.24%20oe_mis%3D1.07%20oe_lof%3D0.36)	GT	1/0
chr12	2504904	.	G	T	1016	.	quality=DP%3D86%3BQD%3D11.81%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D24%3BSAF%3D19;gene=CACNA1C;variant_type=synonymous%2Cintron;coding_and_splicing=CACNA1C:ENST00000682544.1:synonymous_variant:LOW:exon8/50:c.1266G>T:p.Gly422%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000683781.1:intron_variant:MODIFIER:intron8/46:c.1307+365G>T::%2CCACNA1C:ENST00000682462.1:intron_variant:MODIFIER:intron8/46:c.1307+365G>T::%2CCACNA1C:ENST00000683840.1:intron_variant:MODIFIER:intron8/46:c.1307+365G>T::%2CCACNA1C:ENST00000683956.1:intron_variant:MODIFIER:intron8/46:c.1307+365G>T::%2CCACNA1C:ENST00000683824.1:intron_variant:MODIFIER:intron8/47:c.1307+365G>T::%2CCACNA1C:ENST00000399634.6:intron_variant:MODIFIER:intron8/46:c.1217+365G>T::%2CCACNA1C:ENST00000406454.8:intron_variant:MODIFIER:intron8/47:c.1217+365G>T::%2CCACNA1C:ENST00000327702.12:synonymous_variant:LOW:exon8/48:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000347598.9:synonymous_variant:LOW:exon8/49:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399603.6:intron_variant:MODIFIER:intron8/46:c.1217+365G>T::%2CCACNA1C:ENST00000399641.6:intron_variant:MODIFIER:intron8/46:c.1217+365G>T::%2CCACNA1C:ENST00000399655.6:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000335762.10:synonymous_variant:LOW:exon8/48:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000682835.1:intron_variant:MODIFIER:intron8/46:c.1217+365G>T::%2CCACNA1C:ENST00000399617.6:intron_variant:MODIFIER:intron8/47:c.1217+365G>T::%2CCACNA1C:ENST00000683482.1:synonymous_variant:LOW:exon8/47:c.1167G>T:p.Gly389%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000682336.1:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000344100.7:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399591.5:synonymous_variant:LOW:exon8/46:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399595.5:synonymous_variant:LOW:exon8/46:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399597.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399601.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399606.5:synonymous_variant:LOW:exon8/48:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399621.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399629.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399637.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399638.5:synonymous_variant:LOW:exon8/48:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399644.5:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000399649.5:synonymous_variant:LOW:exon8/46:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000402845.7:synonymous_variant:LOW:exon8/47:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1C:ENST00000682686.1:synonymous_variant:LOW:exon8/46:c.1176G>T:p.Gly392%3D:PF00520%20[Ion%20transport%20protein];OMIM=114205_[GENE%3DCACNA1C_PHENOS%3DTimothy%20syndrome%2C%20601005%20(3)%2C%20Autosomal%20dominant%3B%20Long%20QT%20syndrome%208%2C%20618447%20(3)%2C%20Autosomal%20dominant%3B%20Neurodevelopmental%20disorder%20with%20hypotonia%2C%20language%20delay%2C%20and%20skeletal%20defects%20with%20or%20without%20seizures%2C%20620029%20(3)%2C%20Autosomal%20dominant%3B%20Brugada%20syndrome%203%2C%20611875%20(3)%2C%20Autosomal%20dominant];ClinVar=166767%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2CLong%20QT%20syndrome%2CCACNA1C-related%20disorder%2Cnot%20provided%2CCardiovascular%20phenotype%20GENE%3DCACNA1C]%3B;dbSNP=rs1051360;gnomAD=0.00200;gnomAD_sub=0.00065%2C0.00098%2C0.00000%2C0.00352%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=301;gnomAD_wt=151433;phyloP=1.4910;CADD=9.50;MaxEntScan=/4.8>5.2/0.0>0.0;COSMIC=COSV59762972;SpliceAI=CACNA1C|0.00|0.00|0.00|0.04|39|28|-2|41;PubMed=26159999%2C25633834;NGSD_hom=0;NGSD_het=216;NGSD_mosaic=1;NGSD_group=0%20/%2015;gene_info=CACNA1C%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.50%20oe_lof%3D0.05)	GT	1/0
chr12	5967474	.	A	G	1469	.	quality=DP%3D145%3BQD%3D10.13%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D44%3BABP%3D6%3BSAR%3D15%3BSAF%3D50;gene=VWF;variant_type=splice_region&intron;coding_and_splicing=VWF:ENST00000261405.10:splice_region_variant&intron_variant:LOW:intron47/51:c.7887+12T>C::;OMIM=613160_[GENE%3DVWF_PHENOS%3Dvon%20Willebrand%20disease%2C%20type%201%2C%20193400%20(3)%2C%20Autosomal%20dominant%3B%20von%20Willebrand%20disease%2C%20types%202A%2C%202B%2C%202M%2C%20and%202N%2C%20613554%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20von%20Willebrand%20disease%2C%20type%203%2C%20277480%20(3)%2C%20Autosomal%20recessive];ClinVar=256701%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x1%2C1x3)%20DISEASE%3DHereditary%20von%20Willebrand%20disease%2Cnot%20specified%2Cnot%20provided%20GENE%3DVWF]%3B;dbSNP=rs55687637;gnomAD=0.00809;gnomAD_sub=0.00193%2C0.00759%2C0.00000%2C0.01241%2C0.00166;gnomAD_hom_hemi=7%2C;gnomAD_het=1217;gnomAD_wt=150969;phyloP=-0.9530;CADD=1.96;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=VWF|0.00|0.00|0.00|0.00|12|35|15|12;PubMed=25741868;NGSD_hom=8;NGSD_het=954;NGSD_mosaic=0;NGSD_group=0%20/%2098;gene_info=VWF%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.93%20oe_lof%3D0.48)	GT	1/0
chr12	8834689	.	G	A	1246	.	quality=DP%3D122%3BQD%3D10.21%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D9%3BABP%3D6%3BSAR%3D33%3BSAF%3D21;gene=A2ML1%2CA2ML1-AS1;variant_type=splice_region&intron%2Cupstream_gene;coding_and_splicing=A2ML1:ENST00000299698.12:splice_region_variant&intron_variant:LOW:intron5/35:c.483+7G>A::%2CA2ML1-AS1:ENST00000537288.1:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:enhancer;OMIM=610627_[GENE%3DA2ML1_PHENOS%3D{Otitis%20media%2C%20susceptibility%20to}%2C%20166760%20(3)%2C%20Autosomal%20dominant];ClinVar=241910%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DA2ML1]%3B;dbSNP=rs73037000;gnomAD=0.00611;gnomAD_sub=0.00113%2C0.00360%2C0.00000%2C0.00806%2C0.00124;gnomAD_hom_hemi=2%2C;gnomAD_het=926;gnomAD_wt=151370;phyloP=-0.1680;CADD=3.54;MaxEntScan=/0.0>0.0/2.4>0.0;COSMIC=COSV100229123;SpliceAI=A2ML1|0.00|0.00|0.00|0.01|26|-27|4|-7;PubMed=31009165;NGSD_hom=1;NGSD_het=466;NGSD_mosaic=1;NGSD_group=1%20/%2054;classification=2;classification_comment="[2]%20ahwalds1%2003.03.2017";gene_info=A2ML1-AS1%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20A2ML1%20(inh%3DAD%20oe_syn%3D1.00%20oe_mis%3D0.97%20oe_lof%3D0.77)	GT	1/0
chr12	8932856	.	C	A	106	.	quality=DP%3D45%3BQD%3D2.36%3BAF%3D0.31%3BMQM%3D29%3BSAP%3D33%3BABP%3D17%3BSAR%3D14%3BSAF%3D0;gene=PHC1;variant_type=missense;coding_and_splicing=PHC1:ENST00000544916.6:missense_variant:MODERATE:exon8/15:c.1399C>A:p.Gln467Lys:%2CPHC1:ENST00000543824.5:missense_variant:MODERATE:exon9/16:c.1399C>A:p.Gln467Lys:%2CPHC1:ENST00000433083.6:missense_variant:MODERATE:exon7/14:c.1264C>A:p.Gln422Lys:;OMIM=602978_[GENE%3DPHC1_PHENOS%3D?Microcephaly%2011%2C%20primary%2C%20autosomal%20recessive%2C%20615414%20(3)%2C%20Autosomal%20recessive];ClinVar=2498544%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DPHC1]%3B;dbSNP=rs12810327;gnomAD=0.00622;gnomAD_sub=0.00111%2C0.00154%2C0.00020%2C0.00897%2C0.00607;gnomAD_hom_hemi=0%2C;gnomAD_het=931;gnomAD_wt=148661;phyloP=4.4670;CADD=21.40;REVEL=0.020;AlphaMissense=0.17;MaxEntScan=/0.0>1.4/0.0>0.0;SpliceAI=PHC1|0.00|0.00|0.00|0.00|36|-24|-25|14;NGSD_hom=1;NGSD_het=483;NGSD_mosaic=0;NGSD_group=0%20/%2058;gene_info=PHC1%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D0.76%20oe_lof%3D0.12)	GT	1/0
chr12	21486487	.	T	A	359	.	quality=DP%3D41%3BQD%3D8.76%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D6%3BABP%3D3%3BSAR%3D7%3BSAF%3D12;gene=RECQL;variant_type=missense;coding_and_splicing=RECQL:ENST00000444129.7:missense_variant:MODERATE:exon5/15:c.493A>T:p.Ser165Cys:PF00270%20[DEAD/DEAH%20box%20helicase]%2CRECQL:ENST00000421138.6:missense_variant:MODERATE:exon6/16:c.493A>T:p.Ser165Cys:PF00270%20[DEAD/DEAH%20box%20helicase];OMIM=600537_[GENE%3DRECQL_PHENOS%3DRECON%20progeroid%20syndrome%2C%20620370%20(3)%2C%20Autosomal%20recessive];ClinVar=1040722%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C3x3)%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DRECQL]%3B;dbSNP=rs73082680;gnomAD=0.00002;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00004%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=151031;phyloP=7.2640;CADD=23.40;REVEL=0.216;AlphaMissense=0.14;MaxEntScan=/4.4>6.5/0.0>0.0;SpliceAI=RECQL|0.00|0.00|0.00|0.00|29|-2|-8|-12;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=RECQL%20(inh%3DAR%20oe_syn%3D1.04%20oe_mis%3D0.96%20oe_lof%3D0.97)	GT	1/0
chr12	26550237	.	A	T	237	.	quality=DP%3D21%3BQD%3D11.29%3BAF%3D0.62%3BMQM%3D60%3BSAP%3D31%3BABP%3D6%3BSAR%3D0%3BSAF%3D13;gene=ITPR2;variant_type=splice_region&intron;coding_and_splicing=ITPR2:ENST00000381340.8:splice_region_variant&intron_variant:LOW:intron37/56:c.5073+10T>A::;OMIM=600144_[GENE%3DITPR2_PHENOS%3D?Anhidrosis%2C%20isolated%2C%20with%20normal%20sweat%20glands%2C%20106190%20(3)%2C%20Autosomal%20recessive];ClinVar=709610%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DITPR2]%3B;dbSNP=rs73087256;gnomAD=0.00058;gnomAD_sub=0.00014%2C0.00085%2C0.00000%2C0.00062%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=89;gnomAD_wt=152071;phyloP=-0.5830;CADD=0.12;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ITPR2|0.00|0.00|0.00|0.00|11|22|7|10;NGSD_hom=3;NGSD_het=129;NGSD_mosaic=0;NGSD_group=0%20/%2014;gene_info=ITPR2%20(inh%3DAR%20oe_syn%3D1.03%20oe_mis%3D0.72%20oe_lof%3D0.50)	GT	1/0
chr12	27692876	.	C	T	864	.	quality=DP%3D77%3BQD%3D11.22%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D57%3BABP%3D3%3BSAR%3D35%3BSAF%3D4;gene=PPFIBP1%2CMRPS35-DT%2CREP15;variant_type=synonymous%2Cdownstream_gene%2Cupstream_gene;coding_and_splicing=PPFIBP1:ENST00000537927.5:synonymous_variant:LOW:exon27/27:c.2571C>T:p.Asn857%3D:%2CPPFIBP1:ENST00000228425.11:synonymous_variant:LOW:exon30/30:c.3012C>T:p.Asn1004%3D:%2CPPFIBP1:ENST00000318304.12:synonymous_variant:LOW:exon29/29:c.3030C>T:p.Asn1010%3D:%2CPPFIBP1:ENST00000542629.5:synonymous_variant:LOW:exon28/28:c.2937C>T:p.Asn979%3D:%2CMRPS35-DT:ENST00000536317.5:downstream_gene_variant:MODIFIER::::%2CREP15:ENST00000310791.4:upstream_gene_variant:MODIFIER::::;OMIM=603141_[GENE%3DPPFIBP1_PHENOS%3DNeurodevelopmental%20disorder%20with%20seizures%2C%20microcephaly%2C%20and%20brain%20abnormalities%2C%20620024%20(3)%2C%20Autosomal%20recessive];dbSNP=rs55923847;gnomAD=0.00011;gnomAD_sub=0.00002%2C0.00013%2C0.00000%2C0.00019%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=16;gnomAD_wt=152282;phyloP=-0.6800;CADD=3.55;REVEL=0.359;MaxEntScan=/3.0>4.8/0.0>0.0;SpliceAI=PPFIBP1|0.00|0.00|0.00|0.00|13|-27|32|-27;NGSD_hom=0;NGSD_het=15;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PPFIBP1%20(inh%3DAR%20oe_syn%3D0.92%20oe_mis%3D0.91%20oe_lof%3D0.57)%2C%20MRPS35-DT%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20REP15%20(inh%3Dn/a%20oe_syn%3D1.05%20oe_mis%3D0.89%20oe_lof%3D1.04)	GT	1/0
chr12	31103995	.	G	A	1332	.	quality=DP%3D105%3BQD%3D12.69%3BAF%3D0.51%3BMQM%3D57%3BSAP%3D49%3BABP%3D3%3BSAR%3D44%3BSAF%3D10;gene=DDX11;variant_type=3'UTR%2Cmissense;coding_and_splicing=DDX11:ENST00000228264.10:3_prime_UTR_variant:MODIFIER:exon27/27:c.*159G>A::%2CDDX11:ENST00000542838.6:3_prime_UTR_variant:MODIFIER:exon27/27:c.*159G>A::%2CDDX11:ENST00000545668.5:missense_variant:MODERATE:exon27/27:c.2875G>A:p.Val959Ile:%2CDDX11:ENST00000350437.8:3_prime_UTR_variant:MODIFIER:exon26/26:c.*159G>A::;regulatory=regulatory_region_variant:enhancer;OMIM=601150_[GENE%3DDDX11_PHENOS%3DWarsaw%20breakage%20syndrome%2C%20613398%20(3)%2C%20Autosomal%20recessive];ClinVar=2570823%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DDDX11]%3B;dbSNP=rs56136512;gnomAD=0.00916;gnomAD_sub=0.00226%2C0.01157%2C0.00019%2C0.01389%2C0.00995;gnomAD_hom_hemi=10%2C;gnomAD_het=1375;gnomAD_wt=150945;phyloP=-0.0230;CADD=4.94;REVEL=0.031;AlphaMissense=0.08;MaxEntScan=/0.3>0.0/0.0>0.0;COSMIC=COSV52504264;NGSD_hom=16;NGSD_het=1144;NGSD_mosaic=0;NGSD_group=1%20/%20139;gene_info=DDX11%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D1.03%20oe_lof%3D0.74)	GT	1/0
chr12	49033325	.	G	A	1887	.	quality=DP%3D148%3BQD%3D12.75%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D35%3BABP%3D3%3BSAR%3D54%3BSAF%3D21;gene=KMT2D;variant_type=missense;coding_and_splicing=KMT2D:ENST00000683543.2:missense_variant:MODERATE:exon40/56:c.11380C>T:p.Pro3794Ser:%2CKMT2D:ENST00000301067.12:missense_variant:MODERATE:exon40/55:c.11380C>T:p.Pro3794Ser:%2CKMT2D:ENST00000685166.1:missense_variant:MODERATE:exon39/54:c.11389C>T:p.Pro3797Ser:%2CKMT2D:ENST00000692637.1:missense_variant:MODERATE:exon39/54:c.11377C>T:p.Pro3793Ser:;OMIM=602113_[GENE%3DKMT2D_PHENOS%3DBranchial%20arch%20abnormalities%2C%20choanal%20atresia%2C%20athelia%2C%20hearing%20loss%2C%20and%20hypothyroidism%20syndrome%2C%20620186%20(3)%2C%20Autosomal%20dominant%3B%20Kabuki%20syndrome%201%2C%20147920%20(3)%2C%20Autosomal%20dominant];ClinVar=309028%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CKabuki%20syndrome%20GENE%3DKMT2D]%3B;dbSNP=rs113997424;gnomAD=0.00066;gnomAD_sub=0.00010%2C0.00196%2C0.00000%2C0.00096%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=101;gnomAD_wt=152215;phyloP=2.7840;CADD=17.78;REVEL=0.316;AlphaMissense=0.07;MaxEntScan=/7.4>8.6/0.0>0.0;COSMIC=COSV56469999;SpliceAI=KMT2D|0.00|0.00|0.00|0.00|-9|40|22|-38;NGSD_hom=0;NGSD_het=118;NGSD_mosaic=0;NGSD_group=0%20/%2014;classification=3;classification_comment="[3]%20ahschak1%2018.11.2016";gene_info=KMT2D%20(inh%3DAD%20oe_syn%3D1.05%20oe_mis%3D0.81%20oe_lof%3D0.07)	GT	1/0
chr12	49297274	.	G	A	4756	.	quality=DP%3D421%3BQD%3D11.30%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D13%3BABP%3D10%3BSAR%3D111%3BSAF%3D81;gene=TROAP-AS1%2CPRPH;variant_type=non_coding_transcript_exon%2Csplice_donor;coding_and_splicing=TROAP-AS1:ENST00000553259.1:non_coding_transcript_exon_variant:MODIFIER:exon5/8:n.929C>T::%2CPRPH:ENST00000257860.9:splice_donor_variant:HIGH:intron5/8:c.996+1G>A:p.?:;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:enhancer%2CTF_binding_site_variant;OMIM=170710_[GENE%3DPRPH_PHENOS%3D{Amyotrophic%20lateral%20sclerosis%2C%20susceptibility%20to}%2C%20105400%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=425005%20[benign/likely%20benign%20DISEASE%3DPRPH-related%20disorder%2Cnot%20provided%20GENE%3DPRPH]%3B;HGMD=CS195098%20[CLASS%3DDFP%20MUT%3DALT%20PHEN%3D"Peripheral%20neuropathy%20increased%20risk"%20GENE%3DPRPH]%3B;dbSNP=rs73112142;gnomAD=0.00396;gnomAD_sub=0.00065%2C0.00039%2C0.00000%2C0.00482%2C0.00021;gnomAD_hom_hemi=2%2C;gnomAD_het=598;gnomAD_wt=151562;phyloP=10.0020;CADD=35.00;MaxEntScan=11.5>3.3/0.0>0.0/11.5>3.3%2C/3.7>4.6/0.0>0.0;COSMIC=COSV57679547;SpliceAI=PRPH|0.00|0.00|0.33|1.00|-36|-32|3|-1;PubMed=30992453;NGSD_hom=0;NGSD_het=332;NGSD_mosaic=1;NGSD_group=0%20/%2041;gene_info=TROAP-AS1%20(inh%3DAR%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20PRPH%20(inh%3DAR+AD%20oe_syn%3D0.98%20oe_mis%3D0.90%20oe_lof%3D0.96)	GT	1/0
chr12	50674626	.	G	A	1653	.	quality=DP%3D155%3BQD%3D10.66%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D107%3BABP%3D4%3BSAR%3D66%3BSAF%3D7;gene=DIP2B;variant_type=missense;coding_and_splicing=DIP2B:ENST00000301180.10:missense_variant:MODERATE:exon6/38:c.793G>A:p.Asp265Asn:;OMIM=611379_[GENE%3DDIP2B_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%2C%20FRA12A%20type%2C%20136630%20(3)%2C%20Autosomal%20dominant];ClinVar=377262%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DDIP2B]%3B;dbSNP=rs73093419;gnomAD=0.00643;gnomAD_sub=0.00202%2C0.00425%2C0.00000%2C0.01060%2C0.00000;gnomAD_hom_hemi=6%2C;gnomAD_het=968;gnomAD_wt=151332;phyloP=9.3560;CADD=25.10;REVEL=0.251;AlphaMissense=0.15;MaxEntScan=/1.6>1.1/0.0>1.2;COSMIC=COSV105189907;SpliceAI=DIP2B|0.00|0.00|0.00|0.00|-32|-50|3|20;PubMed=25741868;NGSD_hom=1;NGSD_het=369;NGSD_mosaic=0;NGSD_group=1%20/%2043;gene_info=DIP2B%20(inh%3DAD%20oe_syn%3D0.97%20oe_mis%3D0.70%20oe_lof%3D0.18)	GT	1/0
chr12	52651831	.	A	ACCTCCAAAGCCGCTGCCG	878	.	quality=DP%3D126%3BQD%3D6.97%3BAF%3D0.39%3BMQM%3D60%3BSAP%3D13%3BABP%3D17%3BSAR%3D17%3BSAF%3D32;gene=KRT2;variant_type=inframe_insertion;coding_and_splicing=KRT2:ENST00000309680.4:inframe_insertion:MODERATE:exon1/9:c.311_312insCGGCAGCGGCTTTGGAGG:p.Gly103_Phe108dup:PF16208%20[Keratin%20type%20II%20head];OMIM=600194_[GENE%3DKRT2_PHENOS%3DIchthyosis%20bullosa%20of%20Siemens%2C%20146800%20(3)%2C%20Autosomal%20dominant];ClinVar=790863%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DKRT2]%3B;dbSNP=rs532019270;gnomAD=0.00172;gnomAD_sub=0.00019%2C0.00141%2C0.00391%2C0.00019%2C0.04711;gnomAD_hom_hemi=4%2C;gnomAD_het=172;gnomAD_wt=104468;CADD=6.24;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=KRT2|0.00|0.00|0.10|0.00|36|31|0|2;NGSD_hom=979;NGSD_het=9940;NGSD_mosaic=2272;NGSD_group=92%20/%20935;gene_info=KRT2%20(inh%3DAD%20oe_syn%3D1.30%20oe_mis%3D1.11%20oe_lof%3D0.38)	GT	1/0
chr12	55683815	.	A	T	1294	.	quality=DP%3D121%3BQD%3D10.69%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D41%3BABP%3D5%3BSAR%3D12%3BSAF%3D43;gene=TMT1B%2CITGA7;variant_type=splice_region&synonymous%2Cdownstream_gene;coding_and_splicing=TMT1B:ENST00000394252.4:splice_region_variant&synonymous_variant:LOW:exon2/2:c.501A>T:p.Gly167%3D:PF08241%20[Methyltransferase%20domain]%2CITGA7:ENST00000257879.11:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000553804.6:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000347027.10:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000452168.6:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000691973.1:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000555728.5:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000557555.3:downstream_gene_variant:MODIFIER::::%2CITGA7:ENST00000557257.2:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=600536_[GENE%3DITGA7_PHENOS%3DMuscular%20dystrophy%2C%20congenital%2C%20due%20to%20ITGA7%20deficiency%2C%20613204%20(3)%2C%20Autosomal%20recessive];ClinVar=769824%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DTMT1B]%3B;dbSNP=rs73117273;gnomAD=0.00576;gnomAD_sub=0.00217%2C0.00583%2C0.00000%2C0.00900%2C0.00311;gnomAD_hom_hemi=8%2C;gnomAD_het=861;gnomAD_wt=151301;phyloP=-0.0390;CADD=8.08;MaxEntScan=8.6>8.5/8.6>8.5/5.4>1.8;SpliceAI=METTL7B|0.00|0.00|0.00|0.00|-2|2|-2|1;NGSD_hom=1;NGSD_het=533;NGSD_mosaic=0;NGSD_group=0%20/%2050;gene_info=TMT1B%20(inh%3Dn/a%20oe_syn%3D1.01%20oe_mis%3D1.04%20oe_lof%3D0.38)%2C%20ITGA7%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.96%20oe_lof%3D0.60)	GT	1/0
chr12	88080353	.	C	T	713	.	quality=DP%3D73%3BQD%3D9.77%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D42%3BABP%3D5%3BSAR%3D28%3BSAF%3D4;gene=CEP290;variant_type=synonymous;coding_and_splicing=CEP290:ENST00000552810.6:synonymous_variant:LOW:exon38/54:c.5055G>A:p.Ala1685%3D:%2CCEP290:ENST00000309041.12:synonymous_variant:LOW:exon38/55:c.5055G>A:p.Ala1685%3D:%2CCEP290:ENST00000673058.2:synonymous_variant:LOW:exon38/53:c.5055G>A:p.Ala1685%3D:%2CCEP290:ENST00000675230.1:synonymous_variant:LOW:exon37/53:c.5034G>A:p.Ala1678%3D:%2CCEP290:ENST00000675408.1:synonymous_variant:LOW:exon38/53:c.5055G>A:p.Ala1685%3D:%2CCEP290:ENST00000675476.1:synonymous_variant:LOW:exon40/56:c.5916G>A:p.Ala1972%3D:%2CCEP290:ENST00000675833.1:synonymous_variant:LOW:exon39/55:c.5823G>A:p.Ala1941%3D:;OMIM=610142_[GENE%3DCEP290_PHENOS%3DLeber%20congenital%20amaurosis%2010%2C%20611755%20(3)%3B%20Joubert%20syndrome%205%2C%20610188%20(3)%2C%20Autosomal%20recessive%3B%20Senior-Loken%20syndrome%206%2C%20610189%20(3)%2C%20Autosomal%20recessive%3B%20?Bardet-Biedl%20syndrome%2014%2C%20615991%20(3)%2C%20Autosomal%20recessive%3B%20Meckel%20syndrome%204%2C%20611134%20(3)%2C%20Autosomal%20recessive];ClinVar=166834%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C7x3)%20DISEASE%3DFamilial%20aplasia%20of%20the%20vermis%2CMeckel-Gruber%20syndrome%2CNephronophthisis%2CRetinal%20dystrophy%2CMeckel%20syndrome%2C%20type%204%2CJoubert%20syndrome%205%2Cnot%20provided%2CBardet-Biedl%20syndrome%2014%2CSenior-Loken%20syndrome%206%2CLeber%20congenital%20amaurosis%2010%20GENE%3DCEP290]%3B;dbSNP=rs73192874;gnomAD=0.00009;gnomAD_sub=0.00012%2C0.00000%2C0.00000%2C0.00013%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152164;phyloP=0.2070;CADD=10.22;MaxEntScan=/0.0>0.0/2.4>0.0;COSMIC=COSV58352472;SpliceAI=CEP290|0.00|0.00|0.00|0.00|-34|42|9|-17;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CEP290%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.96%20oe_lof%3D0.84)	GT	1/0
chr12	102840474	.	T	C	1374	.	quality=DP%3D103%3BQD%3D13.34%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D4%3BABP%3D4%3BSAR%3D29%3BSAF%3D25;gene=PAH;variant_type=missense;coding_and_splicing=PAH:ENST00000553106.6:missense_variant:MODERATE:exon12/13:c.1241A>G:p.Tyr414Cys:PF00351%20[Biopterin-dependent%20aromatic%20amino%20acid%20hydroxylase]%2CPAH:ENST00000307000.7:missense_variant:MODERATE:exon13/14:c.1226A>G:p.Tyr409Cys:PF00351%20[Biopterin-dependent%20aromatic%20amino%20acid%20hydroxylase];OMIM=612349_[GENE%3DPAH_PHENOS%3DHyperphenylalaninemia%2C%20non-PKU%20mild%2C%20261600%20(3)%2C%20Autosomal%20recessive%3B%20Phenylketonuria%2C%20261600%20(3)%2C%20Autosomal%20recessive];ClinVar=593%20[pathogenic%20DISEASE%3DSee%20cases%2CPAH-related%20disorder%2CHyperphenylalaninemia%2Cnot%20provided%2CPhenylketonuria%20GENE%3DPAH]%3B;HGMD=CM910294%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Phenylketonuria"%20GENE%3DPAH]%3B;dbSNP=rs5030860;gnomAD=0.00026;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00056%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=39;gnomAD_wt=152281;phyloP=7.6280;CADD=26.40;REVEL=0.982;AlphaMissense=0.81;MaxEntScan=/3.4>3.7/0.0>0.0;SpliceAI=PAH|0.00|0.03|0.00|0.00|6|41|41|-25;PubMed=23757202%2C22112818%2C26666653%2C17935162%2C23500595%2C2044609%2C12655553%2C11385716%2C23764561%2C12501224%2C15557004%2C18538294%2C22526846%2C12655546%2C8889590%2C10479481%2C25596310%2C21953985%2C2014036%2C21871829%2C9399896%2C35887629%2C36046396%2C20063067%2C26542770%2C30747360%2C12655544%2C19036622%2C30648773%2C8556304%2C14741196%2C9450897%2C37509538;NGSD_hom=0;NGSD_het=39;NGSD_mosaic=0;NGSD_group=0%20/%206;gene_info=PAH%20(inh%3DAR%20oe_syn%3D1.11%20oe_mis%3D1.12%20oe_lof%3D1.12)	GT	1/0
chr12	109503195	.	G	A	402	.	quality=DP%3D64%3BQD%3D6.28%3BAF%3D0.36%3BMQM%3D60%3BSAP%3D24%3BABP%3D14%3BSAR%3D19%3BSAF%3D4;gene=UBE3B;variant_type=splice_region&intron;coding_and_splicing=UBE3B:ENST00000434735.6:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::%2CUBE3B:ENST00000342494.8:splice_region_variant&intron_variant:LOW:intron14/27:c.1450+5G>A::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=608047_[GENE%3DUBE3B_PHENOS%3DKaufman%20oculocerebrofacial%20syndrome%2C%20244450%20(3)%2C%20Autosomal%20recessive];dbSNP=rs201130963;gnomAD=0.00002;gnomAD_sub=0.00007%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=3;gnomAD_wt=152285;phyloP=2.6210;CADD=20.50;MaxEntScan=5.3>1.2/0.0>0.0/5.3>1.2;SpliceAI=UBE3B|0.00|0.00|0.00|0.04|-26|-50|43|-5;NGSD_hom=0;NGSD_het=8;NGSD_mosaic=2;NGSD_group=0%20/%203;gene_info=UBE3B%20(inh%3DAR%20oe_syn%3D0.93%20oe_mis%3D0.85%20oe_lof%3D0.39)	GT	1/0
chr12	124817558	.	G	A	864	.	quality=DP%3D94%3BQD%3D9.19%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D40%3BABP%3D4%3BSAR%3D8%3BSAF%3D35;gene=SCARB1;variant_type=synonymous;coding_and_splicing=SCARB1:ENST00000261693.11:synonymous_variant:LOW:exon2/13:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000339570.9:synonymous_variant:LOW:exon2/12:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000680596.1:synonymous_variant:LOW:exon2/12:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000680556.1:synonymous_variant:LOW:exon2/10:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000415380.6:synonymous_variant:LOW:exon2/12:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000546215.5:synonymous_variant:LOW:exon2/13:c.276C>T:p.Tyr92%3D:PF01130%20[CD36%20family]%2CSCARB1:ENST00000544327.1:synonymous_variant:LOW:exon1/10:c.114C>T:p.Tyr38%3D:PF01130%20[CD36%20family];OMIM=601040_[GENE%3DSCARB1_PHENOS%3DHigh%20density%20lipoprotein%20cholesterol%20level%20QTL6%2C%20610762%20(3)];ClinVar=720609%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DSCARB1]%3B;dbSNP=rs73227571;gnomAD=0.00108;gnomAD_sub=0.00067%2C0.00209%2C0.00000%2C0.00121%2C0.00124;gnomAD_hom_hemi=0%2C;gnomAD_het=164;gnomAD_wt=152084;phyloP=-0.6420;CADD=9.98;MaxEntScan=/7.7>7.3/0.0>0.0;COSMIC=COSV99909639;SpliceAI=SCARB1|0.00|0.00|0.23|0.00|21|48|21|-24;PubMed=25245032;NGSD_hom=0;NGSD_het=115;NGSD_mosaic=0;NGSD_group=0%20/%2010;gene_info=SCARB1%20(inh%3Dn/a%20oe_syn%3D1.02%20oe_mis%3D0.74%20oe_lof%3D0.28)	GT	1/0
chr13	20005246	.	AT	A	216	.	quality=DP%3D27%3BQD%3D8.00%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D29%3BABP%3D4%3BSAR%3D12%3BSAF%3D0;gene=ZMYM2;variant_type=splice_region&intron;coding_and_splicing=ZMYM2:ENST00000382874.6:splice_region_variant&intron_variant:LOW:intron6/25:c.1299+15del::%2CZMYM2:ENST00000610343.5:splice_region_variant&intron_variant:LOW:intron5/24:c.1299+15del::%2CZMYM2:ENST00000382871.3:splice_region_variant&intron_variant:LOW:intron6/25:c.1299+15del::;OMIM=602221_[GENE%3DZMYM2_PHENOS%3DNeurodevelopmental-craniofacial%20syndrome%20with%20variable%20renal%20and%20cardiac%20abnormalities%2C%20619522%20(3)%2C%20Autosomal%20dominant];dbSNP=rs563583187;gnomAD=0.00099;gnomAD_sub=0.00039%2C0.00203%2C0.00000%2C0.00144%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=149;gnomAD_wt=151863;phyloP=1.3700;CADD=3.58;MaxEntScan=/0.1>0.0/0.0>0.0;NGSD_hom=0;NGSD_het=79;NGSD_mosaic=0;NGSD_group=0%20/%2011;gene_info=ZMYM2%20(inh%3DAD%20oe_syn%3D0.90%20oe_mis%3D0.67%20oe_lof%3D0.22)	GT	1/0
chr13	23756612	.	G	A	1491	.	quality=DP%3D142%3BQD%3D10.50%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D47%3BABP%3D6%3BSAR%3D50%3BSAF%3D14;gene=MIPEP;variant_type=synonymous;coding_and_splicing=MIPEP:ENST00000382172.4:synonymous_variant:LOW:exon18/19:c.1977C>T:p.Ala659%3D:PF01432%20[Peptidase%20family%20M3];OMIM=602241_[GENE%3DMIPEP_PHENOS%3DCombined%20oxidative%20phosphorylation%20deficiency%2031%2C%20617228%20(3)%2C%20Autosomal%20recessive];ClinVar=770419%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DMIPEP]%3B;dbSNP=rs73158528;gnomAD=0.00777;gnomAD_sub=0.00847%2C0.01098%2C0.00000%2C0.00872%2C0.00374;gnomAD_hom_hemi=6%2C;gnomAD_het=1171;gnomAD_wt=151121;phyloP=-0.3270;CADD=0.10;REVEL=0.100;MaxEntScan=/0.0>0.0/1.0>0.4;COSMIC=COSV101193307;SpliceAI=MIPEP|0.00|0.12|0.00|0.00|35|6|6|-40;NGSD_hom=6;NGSD_het=634;NGSD_mosaic=0;NGSD_group=0%20/%2075;gene_info=MIPEP%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.97%20oe_lof%3D0.76)	GT	1/0
chr13	25372280	.	C	G	1303	.	quality=DP%3D103%3BQD%3D12.65%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D4%3BABP%3D4%3BSAR%3D30%3BSAF%3D24;gene=ATP8A2;variant_type=missense;coding_and_splicing=ATP8A2:ENST00000381655.7:missense_variant:MODERATE:exon1/37:c.68C>G:p.Ser23Trp:%2CATP8A2:ENST00000682472.1:missense_variant:MODERATE:exon1/36:c.68C>G:p.Ser23Trp:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=605870_[GENE%3DATP8A2_PHENOS%3D?Cerebellar%20ataxia%2C%20impaired%20intellectual%20development%2C%20and%20dysequilibrium%20syndrome%204%2C%20615268%20(3)%2C%20Autosomal%20recessive];ClinVar=1417260%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CInborn%20genetic%20diseases%20GENE%3DATP8A2]%3B;dbSNP=rs200068509;gnomAD=0.00026;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00053%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=40;gnomAD_wt=151406;phyloP=0.7360;CADD=29.00;REVEL=0.055;AlphaMissense=0.18;MaxEntScan=/0.0>0.0/0.0>3.3;COSMIC=COSV101087643;SpliceAI=ATP8A2|0.00|0.00|0.30|0.00|-8|4|0|4;NGSD_hom=0;NGSD_het=34;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=ATP8A2%20(inh%3DAR%20oe_syn%3D0.95%20oe_mis%3D0.75%20oe_lof%3D0.45)	GT	1/0
chr13	27253824	.	T	C	890	.	quality=DP%3D78%3BQD%3D11.41%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D12%3BABP%3D4%3BSAR%3D12%3BSAF%3D24;gene=RPL21%2CLINC00412%2CSNORD102%2CSNORA27;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=RPL21:ENST00000311549.11:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16%3D:PF01157%20[Ribosomal%20protein%20L21e]%2CRPL21:ENST00000272274.8:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16%3D:PF01157%20[Ribosomal%20protein%20L21e]%2CRPL21:ENST00000319826.8:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16%3D:PF01157%20[Ribosomal%20protein%20L21e]%2CRPL21:ENST00000326092.8:synonymous_variant:LOW:exon2/6:c.48T>C:p.Ser16%3D:PF01157%20[Ribosomal%20protein%20L21e]%2CLINC00412:ENST00000715722.1:upstream_gene_variant:MODIFIER::::%2CLINC00412:ENST00000667032.1:upstream_gene_variant:MODIFIER::::%2CSNORD102:ENST00000384769.1:upstream_gene_variant:MODIFIER::::%2CSNORA27:ENST00000384323.1:upstream_gene_variant:MODIFIER::::;OMIM=603636_[GENE%3DRPL21_PHENOS%3DHypotrichosis%2012%2C%20615885%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73161790;gnomAD=0.00003;gnomAD_sub=0.00007%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152358;phyloP=0.0450;CADD=9.92;MaxEntScan=/7.4>6.8/0.0>0.0;SpliceAI=RPL21|0.00|0.00|0.00|0.00|32|-32|19|23;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=LINC00412%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20RPL21%20(inh%3DAD%20oe_syn%3D1.15%20oe_mis%3D0.54%20oe_lof%3D0.10)%2C%20SNORD102%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20SNORA27%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr13	28037245	.	T	G	1598	.	quality=DP%3D136%3BQD%3D11.75%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D31%3BSAF%3D34;gene=FLT3;variant_type=missense;coding_and_splicing=FLT3:ENST00000241453.12:missense_variant:MODERATE:exon10/24:c.1249A>C:p.Ile417Leu:;OMIM=136351_[GENE%3DFLT3_PHENOS%3DLeukemia%2C%20acute%20lymphoblastic%2C%20somatic%2C%20613065%20(3)%3B%20Leukemia%2C%20acute%20myeloid%2C%20reduced%20survival%20in%2C%20somatic%2C%20601626%20(3)%3B%20Leukemia%2C%20acute%20myeloid%2C%20somatic%2C%20601626%20(3)];ClinVar=134433%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DFLT3]%3B;dbSNP=rs56090538;gnomAD=0.00926;gnomAD_sub=0.03127%2C0.00444%2C0.00000%2C0.00041%2C0.00000;gnomAD_hom_hemi=31%2C;gnomAD_het=1348;gnomAD_wt=150912;phyloP=0.1230;CADD=12.79;REVEL=0.072;AlphaMissense=0.07;MaxEntScan=/4.8>5.3/0.0>0.0;COSMIC=COSV99058810;SpliceAI=FLT3|0.00|0.00|0.00|0.00|43|47|5|43;PubMed=24728327;NGSD_hom=4;NGSD_het=101;NGSD_mosaic=0;NGSD_group=0%20/%207;gene_info=FLT3%20(inh%3DAD%20oe_syn%3D1.01%20oe_mis%3D0.88%20oe_lof%3D0.22)	GT	1/0
chr13	51934843	.	C	T	2627	.	quality=DP%3D252%3BQD%3D10.42%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D18%3BABP%3D10%3BSAR%3D42%3BSAF%3D70;gene=ATP7B;variant_type=synonymous;coding_and_splicing=ATP7B:ENST00000713659.1:synonymous_variant:LOW:exon17/17:c.3663G>A:p.Lys1221%3D:%2CATP7B:ENST00000242839.10:synonymous_variant:LOW:exon21/21:c.4311G>A:p.Lys1437%3D:%2CATP7B:ENST00000713660.1:synonymous_variant:LOW:exon18/18:c.3825G>A:p.Lys1275%3D:%2CATP7B:ENST00000674147.2:synonymous_variant:LOW:exon17/17:c.3690G>A:p.Lys1230%3D:%2CATP7B:ENST00000448424.7:synonymous_variant:LOW:exon19/19:c.4059G>A:p.Lys1353%3D:%2CATP7B:ENST00000400370.8:synonymous_variant:LOW:exon13/13:c.3021G>A:p.Lys1007%3D:%2CATP7B:ENST00000634844.1:synonymous_variant:LOW:exon21/21:c.4167G>A:p.Lys1389%3D:%2CATP7B:ENST00000673772.1:synonymous_variant:LOW:exon20/20:c.4077G>A:p.Lys1359%3D:%2CATP7B:ENST00000418097.7:synonymous_variant:LOW:exon20/20:c.4116G>A:p.Lys1372%3D:%2CATP7B:ENST00000400366.6:synonymous_variant:LOW:exon22/22:c.3978G>A:p.Lys1326%3D:;regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=606882_[GENE%3DATP7B_PHENOS%3DWilson%20disease%2C%20277900%20(3)%2C%20Autosomal%20recessive];ClinVar=35732%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CInborn%20genetic%20diseases%2CWilson%20disease%20GENE%3DATP7B]%3B;dbSNP=rs73202048;gnomAD=0.00714;gnomAD_sub=0.00240%2C0.00569%2C0.00000%2C0.01155%2C0.00435;gnomAD_hom_hemi=4%2C;gnomAD_het=1080;gnomAD_wt=151268;phyloP=2.3740;CADD=1.97;MaxEntScan=/2.0>3.8/0.0>0.0;SpliceAI=ATP7B|0.03|0.00|0.00|0.00|-15|-1|48|47;PubMed=25741868%2C18414213%2C17823867%2C10544227%2C14962673;NGSD_hom=11;NGSD_het=912;NGSD_mosaic=0;NGSD_group=2%20/%2093;gene_info=ATP7B%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D1.09%20oe_lof%3D0.93)	GT	1/0
chr13	75326374	.	G	A	1731	.	quality=DP%3D157%3BQD%3D11.03%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D63%3BABP%3D5%3BSAR%3D59%3BSAF%3D14;gene=TBC1D4;variant_type=missense;coding_and_splicing=TBC1D4:ENST00000648194.1:missense_variant:MODERATE:exon11/20:c.1313C>T:p.Pro438Leu:%2CTBC1D4:ENST00000377636.8:missense_variant:MODERATE:exon10/21:c.1856C>T:p.Pro619Leu:%2CTBC1D4:ENST00000377625.6:missense_variant:MODERATE:exon10/19:c.1856C>T:p.Pro619Leu:%2CTBC1D4:ENST00000431480.6:missense_variant:MODERATE:exon10/20:c.1856C>T:p.Pro619Leu:;regulatory=regulatory_region_variant:promoter;OMIM=612465_[GENE%3DTBC1D4_PHENOS%3D{Diabetes%20mellitus%2C%20noninsulin-dependent%2C%205}%2C%20616087%20(3)];ClinVar=436950%20[likely%20benign%20DISEASE%3Dnot%20specified%2CTBC1D4-related%20disorder%20GENE%3DTBC1D4]%3B;dbSNP=rs56223054;gnomAD=0.00336;gnomAD_sub=0.00075%2C0.00477%2C0.00000%2C0.00540%2C0.00145;gnomAD_hom_hemi=1%2C;gnomAD_het=509;gnomAD_wt=151705;phyloP=3.9570;CADD=16.22;REVEL=0.099;AlphaMissense=0.04;MaxEntScan=/5.7>6.2/0.0>0.0;COSMIC=COSV100884917;SpliceAI=TBC1D4|0.00|0.00|0.00|0.00|-9|21|21|-18;PubMed=25741868;NGSD_hom=2;NGSD_het=308;NGSD_mosaic=0;NGSD_group=0%20/%2041;gene_info=TBC1D4%20(inh%3Dn/a%20oe_syn%3D1.03%20oe_mis%3D0.93%20oe_lof%3D0.72)	GT	1/0
chr13	80337376	.	G	A	3109	.	quality=DP%3D234%3BQD%3D13.29%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D4%3BABP%3D4%3BSAR%3D57%3BSAF%3D65;gene=SPRY2;variant_type=synonymous;coding_and_splicing=SPRY2:ENST00000377102.5:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110%3D:%2CSPRY2:ENST00000377104.4:synonymous_variant:LOW:exon2/2:c.330C>T:p.Ser110%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=602466_[GENE%3DSPRY2_PHENOS%3D{?IgA%20nephropathy%2C%20susceptibility%20to%2C%203}%2C%20616818%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73245373;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152314;phyloP=1.3680;CADD=9.94;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SPRY2|0.00|0.00|0.00|0.00|-15|3|36|-20;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=SPRY2%20(inh%3DAD%20oe_syn%3D1.21%20oe_mis%3D0.79%20oe_lof%3D0.00)	GT	1/0
chr13	110450371	.	C	T	1238	.	quality=DP%3D120%3BQD%3D10.32%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D9%3BABP%3D8%3BSAR%3D32%3BSAF%3D20;gene=COL4A2;variant_type=missense%2Cdownstream_gene;coding_and_splicing=COL4A2:ENST00000400163.8:missense_variant:MODERATE:exon20/48:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000494852.3:missense_variant:MODERATE:exon20/30:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000714396.1:missense_variant:MODERATE:exon20/47:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000617564.3:missense_variant:MODERATE:exon20/22:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000649951.2:missense_variant:MODERATE:exon20/45:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000480609.2:missense_variant:MODERATE:exon20/47:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000714399.1:missense_variant:MODERATE:exon21/49:c.1337C>T:p.Ala446Val:%2CCOL4A2:ENST00000360467.7:missense_variant:MODERATE:exon20/48:c.1256C>T:p.Ala419Val:%2CCOL4A2:ENST00000650540.1:downstream_gene_variant:MODIFIER::::;OMIM=120090_[GENE%3DCOL4A2_PHENOS%3DBrain%20small%20vessel%20disease%202%2C%20614483%20(3)%2C%20Autosomal%20dominant%3B%20{Hemorrhage%2C%20intracerebral%2C%20susceptibility%20to}%2C%20614519%20(3)];ClinVar=311122%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:2x1%2C1x2%2C1x3)%20DISEASE%3DPorencephaly%202%2CCOL4A2-related%20disorder%2Cnot%20provided%20GENE%3DCOL4A2]%3B;dbSNP=rs72657933;gnomAD=0.00009;gnomAD_sub=0.00012%2C0.00000%2C0.00019%2C0.00009%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=13;gnomAD_wt=152311;phyloP=3.8230;CADD=23.10;REVEL=0.332;AlphaMissense=0.21;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=COL4A2|0.00|0.00|0.00|0.00|35|-15|-2|-46;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=COL4A2%20(inh%3DAD%20oe_syn%3D0.95%20oe_mis%3D0.81%20oe_lof%3D0.45)	GT	1/0
chr13	110508071	.	C	T	3889	.	quality=DP%3D278%3BQD%3D13.99%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D5%3BABP%3D6%3BSAR%3D80%3BSAF%3D69;gene=COL4A2%2CCOL4A2-AS1;variant_type=synonymous%2Cintron&non_coding_transcript%2Cdownstream_gene;coding_and_splicing=COL4A2:ENST00000400163.8:synonymous_variant:LOW:exon47/48:c.4731C>T:p.Pro1577%3D:PF01413%20[C-terminal%20tandem%20repeated%20domain%20in%20type%204%20procollagen]%2CCOL4A2:ENST00000714396.1:synonymous_variant:LOW:exon46/47:c.4509C>T:p.Pro1503%3D:PF01413%20[C-terminal%20tandem%20repeated%20domain%20in%20type%204%20procollagen]%2CCOL4A2:ENST00000480609.2:synonymous_variant:LOW:exon47/47:c.4731C>T:p.Pro1577%3D:PF01413%20[C-terminal%20tandem%20repeated%20domain%20in%20type%204%20procollagen]%2CCOL4A2:ENST00000714399.1:synonymous_variant:LOW:exon48/49:c.4812C>T:p.Pro1604%3D:PF01413%20[C-terminal%20tandem%20repeated%20domain%20in%20type%204%20procollagen]%2CCOL4A2:ENST00000360467.7:synonymous_variant:LOW:exon47/48:c.4731C>T:p.Pro1577%3D:PF01413%20[C-terminal%20tandem%20repeated%20domain%20in%20type%204%20procollagen]%2CCOL4A2-AS1:ENST00000417970.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.81+28G>A::%2CCOL4A2:ENST00000649951.2:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=120090_[GENE%3DCOL4A2_PHENOS%3DBrain%20small%20vessel%20disease%202%2C%20614483%20(3)%2C%20Autosomal%20dominant%3B%20{Hemorrhage%2C%20intracerebral%2C%20susceptibility%20to}%2C%20614519%20(3)];ClinVar=311185%20[likely%20benign%20DISEASE%3Dnot%20provided%2CPorencephaly%202%20GENE%3DCOL4A2]%3B;dbSNP=rs72659607;gnomAD=0.00009;gnomAD_sub=0.00005%2C0.00007%2C0.00000%2C0.00016%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152354;phyloP=-4.4980;CADD=1.35;MaxEntScan=/0.0>0.0/0.0>0.0%2C/1.5>7.0/0.0>0.0;COSMIC=COSV64626480%2CCOSV64634335;SpliceAI=COL4A2|0.00|0.00|0.00|0.00|16|10|46|44;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=COL4A2%20(inh%3DAD%20oe_syn%3D0.95%20oe_mis%3D0.81%20oe_lof%3D0.45)%2C%20COL4A2-AS1%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr14	22842737	.	G	A	1925	.	quality=DP%3D187%3BQD%3D10.29%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D76%3BABP%3D11%3BSAR%3D66%3BSAF%3D14;gene=MMP14;variant_type=splice_region&intron;coding_and_splicing=MMP14:ENST00000548162.2:splice_region_variant&intron_variant:LOW:intron4/9:c.688+20G>A::%2CMMP14:ENST00000311852.11:splice_region_variant&intron_variant:LOW:intron4/9:c.688+20G>A::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=600754_[GENE%3DMMP14_PHENOS%3D?Winchester%20syndrome%2C%20277950%20(3)];ClinVar=1594080%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DMMP14]%3B;dbSNP=rs17884962;gnomAD=0.00939;gnomAD_sub=0.00335%2C0.01340%2C0.00019%2C0.01279%2C0.00249;gnomAD_hom_hemi=7%2C;gnomAD_het=1415;gnomAD_wt=150819;phyloP=0.1080;CADD=8.49;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV61287553;SpliceAI=MMP14|0.00|0.00|0.00|0.00|-36|-11|-11|-20;NGSD_hom=15;NGSD_het=1203;NGSD_mosaic=0;NGSD_group=2%20/%20135;gene_info=MMP14%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.78%20oe_lof%3D0.10)	GT	1/0
chr14	31129221	.	T	C	1501	.	quality=DP%3D136%3BQD%3D11.04%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D28%3BABP%3D5%3BSAR%3D18%3BSAF%3D45;gene=AP4S1%2CHECTD1;variant_type=3'UTR%2Cmissense%2Cintron;coding_and_splicing=AP4S1:ENST00000673317.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*158T>C::%2CHECTD1:ENST00000399332.6:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:%2CHECTD1:ENST00000553700.5:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:%2CHECTD1:ENST00000611816.5:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:%2CHECTD1:ENST00000554882.6:intron_variant:MODIFIER:intron24/41:c.3923-1215A>G::%2CHECTD1:ENST00000692835.1:missense_variant:MODERATE:exon25/43:c.4009A>G:p.Ser1337Gly:%2CHECTD1:ENST00000691390.1:intron_variant:MODIFIER:intron24/40:c.3923-1215A>G::%2CHECTD1:ENST00000553957.6:missense_variant:MODERATE:exon25/43:c.4150A>G:p.Ser1384Gly:;OMIM=607243_[GENE%3DAP4S1_PHENOS%3DSpastic%20paraplegia%2052%2C%20autosomal%20recessive%2C%20614067%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72670356;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152337;phyloP=7.4120;CADD=32.00;REVEL=0.194;AlphaMissense=0.31;MaxEntScan=/4.6>5.1/0.0>0.0%2C/1.4>1.2/0.0>0.0;SpliceAI=HECTD1|0.00|0.00|0.00|0.00|2|20|-11|-48;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=AP4S1%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D1.00%20oe_lof%3D0.96)%2C%20HECTD1%20(inh%3Dn/a%20oe_syn%3D0.94%20oe_mis%3D0.62%20oe_lof%3D0.10)	GT	1/0
chr14	35761018	.	T	G	561	.	quality=DP%3D47%3BQD%3D11.94%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D30%3BABP%3D4%3BSAR%3D22%3BSAF%3D4;gene=RALGAPA1%2CQRSL1P3;variant_type=splice_region&intron%2Cupstream_gene;coding_and_splicing=RALGAPA1:ENST00000389698.7:splice_region_variant&intron_variant:LOW:intron5/40:c.370-12A>C::%2CRALGAPA1:ENST00000307138.10:splice_region_variant&intron_variant:LOW:intron5/39:c.370-12A>C::%2CRALGAPA1:ENST00000680220.1:splice_region_variant&intron_variant:LOW:intron5/41:c.370-12A>C::%2CRALGAPA1:ENST00000554259.6:splice_region_variant&intron_variant:LOW:intron5/41:c.370-12A>C::%2CRALGAPA1:ENST00000637992.1:splice_region_variant&intron_variant:LOW:intron5/40:c.370-12A>C::%2CRALGAPA1:ENST00000382366.7:splice_region_variant&intron_variant:LOW:intron5/41:c.370-12A>C::%2CRALGAPA1:ENST00000553892.2:splice_region_variant&intron_variant:LOW:intron5/40:c.370-12A>C::%2CQRSL1P3:ENST00000552666.1:upstream_gene_variant:MODIFIER::::;OMIM=608884_[GENE%3DRALGAPA1_PHENOS%3DNeurodevelopmental%20disorder%20with%20hypotonia%2C%20neonatal%20respiratory%20insufficiency%2C%20and%20thermodysregulation%2C%20618797%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72668490;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152257;phyloP=-0.5340;CADD=7.07;MaxEntScan=10.0>10.7/10.0>10.7/0.0>0.0;SpliceAI=RALGAPA1|0.00|0.00|0.00|0.00|-12|-7|-24|-12;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=RALGAPA1%20(inh%3DAR%20oe_syn%3D0.95%20oe_mis%3D0.69%20oe_lof%3D0.15)%2C%20QRSL1P3%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr14	49622239	.	C	G	2942	.	quality=DP%3D437%3BQD%3D6.73%3BAF%3D0.32%3BMQM%3D60%3BSAP%3D5%3BABP%3D132%3BSAR%3D75%3BSAF%3D63;gene=MGAT2%2CRPL36AL%2CDNAAF2;variant_type=missense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=MGAT2:ENST00000305386.4:missense_variant:MODERATE:exon1/1:c.971C>G:p.Thr324Ser:PF05060%20[N-acetylglucosaminyltransferase%20II%20(MGAT2)]%2CRPL36AL:ENST00000298289.7:upstream_gene_variant:MODIFIER::::%2CDNAAF2:ENST00000406043.3:downstream_gene_variant:MODIFIER::::%2CDNAAF2:ENST00000298292.13:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=602616_[GENE%3DMGAT2_PHENOS%3DCongenital%20disorder%20of%20glycosylation%2C%20type%20IIa%2C%20212066%20(3)%2C%20Autosomal%20recessive]&612517_[GENE%3DDNAAF2_PHENOS%3DCiliary%20dyskinesia%2C%20primary%2C%2010%2C%20612518%20(3)%2C%20Autosomal%20recessive];ClinVar=313257%20[uncertain%20significance%20DISEASE%3DMGAT2-congenital%20disorder%20of%20glycosylation%20GENE%3DMGAT2]%3B;dbSNP=rs78391102;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152287;phyloP=2.0960;CADD=19.03;REVEL=0.239;AlphaMissense=0.06;MaxEntScan=/2.6>1.1/0.0>0.0;COSMIC=COSV53566793;SpliceAI=MGAT2|0.00|0.00|0.00|0.00|1|-24|50|44;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=RPL36AL%20(inh%3Dn/a%20oe_syn%3D0.93%20oe_mis%3D0.58%20oe_lof%3D0.62)%2C%20MGAT2%20(inh%3DAR%20oe_syn%3D1.05%20oe_mis%3D0.91%20oe_lof%3D0.34)%2C%20DNAAF2%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D1.03%20oe_lof%3D0.70)	GT	1/0
chr14	64210033	.	C	T	1345	.	quality=DP%3D120%3BQD%3D11.21%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D7%3BABP%3D3%3BSAR%3D24%3BSAF%3D34;gene=SYNE2%2CESR2;variant_type=missense%2Cintron;coding_and_splicing=SYNE2:ENST00000358025.7:missense_variant:MODERATE:exon103/116:c.18632C>T:p.Thr6211Met:PF00435%20[Spectrin%20repeat]%2CSYNE2:ENST00000344113.8:missense_variant:MODERATE:exon103/115:c.18632C>T:p.Thr6211Met:PF00435%20[Spectrin%20repeat]%2CSYNE2:ENST00000555002.6:missense_variant:MODERATE:exon103/116:c.18632C>T:p.Thr6211Met:PF00435%20[Spectrin%20repeat]%2CSYNE2:ENST00000554584.5:missense_variant:MODERATE:exon104/115:c.18509C>T:p.Thr6170Met:%2CESR2:ENST00000556275.5:intron_variant:MODIFIER:intron8/8:c.1406+24937G>A::;regulatory=regulatory_region_variant:enhancer;OMIM=608442_[GENE%3DSYNE2_PHENOS%3DEmery-Dreifuss%20muscular%20dystrophy%205%2C%20autosomal%20dominant%2C%20612999%20(3)%2C%20Autosomal%20dominant]&601663_[GENE%3DESR2_PHENOS%3D?Ovarian%20dysgenesis%208%2C%20618187%20(3)%2C%20Autosomal%20dominant];ClinVar=2324%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CEmery-Dreifuss%20muscular%20dystrophy%205%2C%20autosomal%20dominant%2CSYNE2-related%20disorder%2Cnot%20specified%20GENE%3DSYNE2]%3B;HGMD=CM075030%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Muscular%20dystrophy%20Emery-Dreifuss"%20GENE%3DSYNE2]%3B;dbSNP=rs36215895;gnomAD=0.00403;gnomAD_sub=0.00130%2C0.00150%2C0.00000%2C0.00660%2C0.00166;gnomAD_hom_hemi=3%2C;gnomAD_het=608;gnomAD_wt=151698;phyloP=4.7190;CADD=24.90;REVEL=0.153;AlphaMissense=0.10;MaxEntScan=/0.0>0.0/0.0>0.0%2C/1.0>0.8/0.0>0.0;SpliceAI=SYNE2|0.00|0.00|0.00|0.00|10|-37|-36|22;PubMed=25741868%2C22995991%2C17761684%2C25214167%2C33462484%2C34226706;NGSD_hom=1;NGSD_het=479;NGSD_mosaic=0;NGSD_group=0%20/%2060;comment="GS150468_02:%2025.11.2015%2C%20TCB:%20bei%20GS150468%20nicht%20in%20Befund%20erwhnt.";gene_info=SYNE2%20(inh%3DAD%20oe_syn%3D1.08%20oe_mis%3D1.07%20oe_lof%3D0.32)%2C%20ESR2%20(inh%3DAD%20oe_syn%3D1.29%20oe_mis%3D0.94%20oe_lof%3D0.65)	GT	1/0
chr14	64795408	.	C	T	2446	.	quality=DP%3D190%3BQD%3D12.87%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D44%3BSAF%3D52;gene=SPTB;variant_type=missense;coding_and_splicing=SPTB:ENST00000644917.1:missense_variant:MODERATE:exon12/36:c.1573G>A:p.Glu525Lys:PF00435%20[Spectrin%20repeat]%2CSPTB:ENST00000389722.7:missense_variant:MODERATE:exon11/35:c.1573G>A:p.Glu525Lys:PF00435%20[Spectrin%20repeat]%2CSPTB:ENST00000389720.4:missense_variant:MODERATE:exon12/32:c.1573G>A:p.Glu525Lys:PF00435%20[Spectrin%20repeat];OMIM=182870_[GENE%3DSPTB_PHENOS%3DAnemia%2C%20neonatal%20hemolytic%2C%20fatal%20or%20near-fatal%2C%20617948%20(3)%3B%20Elliptocytosis-3%2C%20617948%20(3)%3B%20Spherocytosis%2C%20type%202%2C%20616649%20(3)%2C%20Autosomal%20dominant];ClinVar=2683259%20[uncertain%20significance%20DISEASE%3Dnot%20provided%20GENE%3DSPTB]%3B;dbSNP=rs55752508;gnomAD=0.00005;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00010%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=7;gnomAD_wt=152291;phyloP=3.3970;CADD=21.40;REVEL=0.262;AlphaMissense=0.20;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV67630267;SpliceAI=SPTB|0.00|0.00|0.00|0.00|-21|30|-21|5;NGSD_hom=0;NGSD_het=19;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=SPTB%20(inh%3DAD%20oe_syn%3D1.12%20oe_mis%3D0.94%20oe_lof%3D0.08)	GT	1/0
chr14	88385844	.	G	A	1284	.	quality=DP%3D143%3BQD%3D8.98%3BAF%3D0.38%3BMQM%3D59%3BSAP%3D4%3BABP%3D20%3BSAR%3D25%3BSAF%3D30;gene=SPATA7;variant_type=splice_region&intron;coding_and_splicing=SPATA7:ENST00000556553.5:splice_region_variant&intron_variant:LOW:intron2/11:c.19+7G>A::%2CSPATA7:ENST00000393545.9:splice_region_variant&intron_variant:LOW:intron1/11:c.19+7G>A::%2CSPATA7:ENST00000356583.9:splice_region_variant&intron_variant:LOW:intron1/10:c.19+7G>A::%2CSPATA7:ENST00000045347.11:splice_region_variant&intron_variant:LOW:intron1/12:c.19+7G>A::;regulatory=regulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=609868_[GENE%3DSPATA7_PHENOS%3DLeber%20congenital%20amaurosis%203%2C%20604232%20(3)%2C%20Autosomal%20recessive%3B%20Retinitis%20pigmentosa%2094%2C%20variable%20age%20at%20onset%2C%20autosomal%20recessive%2C%20604232%20(3)%2C%20Autosomal%20recessive];ClinVar=766822%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C2x3)%20DISEASE%3DRetinitis%20pigmentosa%2CLeber%20congenital%20amaurosis%203%20GENE%3DSPATA7]%3B;dbSNP=rs199560035;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152316;phyloP=1.5280;CADD=15.12;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SPATA7|0.00|0.00|0.00|0.00|5|42|-7|-1;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=SPATA7%20(inh%3DAR%20oe_syn%3D0.82%20oe_mis%3D0.99%20oe_lof%3D0.80)	GT	1/0
chr14	100334994	.	C	T	1331	.	quality=DP%3D126%3BQD%3D10.56%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D31%3BABP%3D5%3BSAR%3D42%3BSAF%3D15;gene=WARS1%2CSLC25A47;variant_type=missense%2Cdownstream_gene;coding_and_splicing=WARS1:ENST00000392882.7:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CWARS1:ENST00000358655.8:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CWARS1:ENST00000355338.6:missense_variant:MODERATE:exon11/11:c.1297G>A:p.Ala433Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CWARS1:ENST00000344102.9:missense_variant:MODERATE:exon10/10:c.1174G>A:p.Ala392Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CWARS1:ENST00000557135.5:missense_variant:MODERATE:exon12/12:c.1297G>A:p.Ala433Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CWARS1:ENST00000556645.5:missense_variant:MODERATE:exon11/11:c.1174G>A:p.Ala392Thr:PF00579%20[tRNA%20synthetases%20class%20I%20(W%20and%20Y)]%2CSLC25A47:ENST00000361529.5:downstream_gene_variant:MODIFIER::::%2CSLC25A47:ENST00000557052.1:downstream_gene_variant:MODIFIER::::;OMIM=191050_[GENE%3DWARS1_PHENOS%3DNeurodevelopmental%20disorder%20with%20microcephaly%20and%20speech%20delay%2C%20with%20or%20without%20brain%20abnormalities%2C%20620317%20(3)%2C%20Autosomal%20recessive%3B%20Neuronopathy%2C%20distal%20hereditary%20motor%2C%20type%20IX%2C%20617721%20(3)%2C%20Autosomal%20dominant];ClinVar=2557277%20[likely%20benign%20DISEASE%3DInborn%20genetic%20diseases%20GENE%3DWARS1]%3B;dbSNP=rs72713916;gnomAD=0.00011;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00025%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=17;gnomAD_wt=152245;phyloP=-0.7590;CADD=2.34;REVEL=0.074;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=WARS|0.00|0.00|0.00|0.00|31|-34|-11|15;NGSD_hom=0;NGSD_het=12;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=SLC25A47%20(inh%3Dn/a%20oe_syn%3D1.11%20oe_mis%3D0.93%20oe_lof%3D1.16)%2C%20WARS1%20(inh%3DAD%20oe_syn%3D0.88%20oe_mis%3D0.67%20oe_lof%3D0.23)	GT	1/0
chr14	103587371	.	G	A	441	.	quality=DP%3D95%3BQD%3D4.64%3BAF%3D0.26%3BMQM%3D60%3BSAP%3D5%3BABP%3D49%3BSAR%3D15%3BSAF%3D10;gene=COA8;variant_type=splice_region&intron;coding_and_splicing=COA8:ENST00000409074.8:splice_region_variant&intron_variant:LOW:intron4/4:c.476+7G>A::%2CCOA8:ENST00000674165.1:splice_region_variant&intron_variant:LOW:intron4/4:c.515+7G>A::%2CCOA8:ENST00000556253.6:splice_region_variant&intron_variant:LOW:intron5/5:c.*30+7G>A::%2CCOA8:ENST00000492189.5:splice_region_variant&intron_variant:LOW:intron2/2:c.62+7G>A::%2CCOA8:ENST00000477116.5:splice_region_variant&intron_variant:LOW:intron4/4:c.62+7G>A::%2CCOA8:ENST00000473127.5:splice_region_variant&intron_variant:LOW:intron3/3:c.62+7G>A::%2CCOA8:ENST00000476323.5:splice_region_variant&intron_variant:LOW:intron3/4:c.62+7G>A::;OMIM=616003_[GENE%3DCOA8_PHENOS%3DMitochondrial%20complex%20IV%20deficiency%2C%20nuclear%20type%2017%2C%20619061%20(3)%2C%20Autosomal%20recessive];ClinVar=559338%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DCOA8]%3B;dbSNP=rs114895750;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00006%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=5;gnomAD_wt=152163;phyloP=0.1110;CADD=0.46;MaxEntScan=/0.0>0.0/0.0>5.4;SpliceAI=APOPT1|0.00|0.00|0.00|0.00|-3|-26|-3|42%2CRP11-73M18.2|0.00|0.00|0.00|0.00|-3|-26|-3|42;NGSD_hom=0;NGSD_het=9;NGSD_mosaic=1;NGSD_group=0%20/%202;gene_info=COA8%20(inh%3DAR%20oe_syn%3D1.25%20oe_mis%3D1.14%20oe_lof%3D0.67)	GT	1/0
chr14	105250237	.	C	T	2917	.	quality=DP%3D238%3BQD%3D12.26%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D5%3BABP%3D4%3BSAR%3D63%3BSAF%3D52;gene=BRF1%2CBTBD6;variant_type=intron%2Csynonymous%2Cupstream_gene;coding_and_splicing=BRF1:ENST00000379937.6:intron_variant:MODIFIER:intron4/16:c.463+2270G>A::%2CBRF1:ENST00000547530.7:intron_variant:MODIFIER:intron5/17:c.544+2270G>A::%2CBRF1:ENST00000619151.4:intron_variant:MODIFIER:intron5/10:c.-69+2270G>A::%2CBRF1:ENST00000327359.7:intron_variant:MODIFIER:intron5/17:c.199+2270G>A::%2CBRF1:ENST00000440513.7:intron_variant:MODIFIER:intron5/17:c.199+2270G>A::%2CBTBD6:ENST00000392554.8:synonymous_variant:LOW:exon4/4:c.1182C>T:p.Phe394%3D:PF08005%20[PHR%20domain]%2CBTBD6:ENST00000463376.6:synonymous_variant:LOW:exon3/3:c.798C>T:p.Phe266%3D:PF08005%20[PHR%20domain]%2CBRF1:ENST00000392557.8:upstream_gene_variant:MODIFIER::::%2CBRF1:ENST00000446501.6:upstream_gene_variant:MODIFIER::::%2CBRF1:ENST00000551787.5:upstream_gene_variant:MODIFIER::::;OMIM=604902_[GENE%3DBRF1_PHENOS%3DCerebellofaciodental%20syndrome%2C%20616202%20(3)%2C%20Autosomal%20recessive];ClinVar=2644912%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DBRF1]%3B;dbSNP=rs61740085;gnomAD=0.00920;gnomAD_sub=0.00236%2C0.00954%2C0.00058%2C0.01479%2C0.00849;gnomAD_hom_hemi=12%2C;gnomAD_het=1377;gnomAD_wt=150957;phyloP=1.1360;CADD=13.13;MaxEntScan=/0.0>0.0/0.0>0.0%2C/0.8>1.6/0.0>0.0;SpliceAI=BRF1|0.00|0.00|0.00|0.00|16|44|16|37%2CBTBD6|0.00|0.00|0.00|0.00|21|-14|-13|32;NGSD_hom=23;NGSD_het=1369;NGSD_mosaic=0;NGSD_group=1%20/%20164;gene_info=BRF1%20(inh%3DAR%20oe_syn%3D1.36%20oe_mis%3D0.98%20oe_lof%3D0.38)%2C%20BTBD6%20(inh%3Dn/a%20oe_syn%3D1.27%20oe_mis%3D0.86%20oe_lof%3D0.64)	GT	1/0
chr15	34342117	.	G	A	2211	.	quality=DP%3D197%3BQD%3D11.22%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D42%3BABP%3D6%3BSAR%3D65%3BSAF%3D25;gene=NOP10%2CSLC12A6%2CNUTM1;variant_type=splice_region&intron%2Csynonymous%2Cintron%2Cupstream_gene;coding_and_splicing=NOP10:ENST00000699934.1:splice_region_variant&intron_variant:LOW:intron1/2:c.55-9C>T::%2CNOP10:ENST00000699926.1:splice_region_variant&intron_variant:LOW:intron1/1:c.55-6C>T::%2CNOP10:ENST00000699935.1:synonymous_variant:LOW:exon2/2:c.70C>T:p.Leu24%3D:%2CNOP10:ENST00000699936.1:splice_region_variant&intron_variant:LOW:intron1/1:c.-12-9C>T::%2CNOP10:ENST00000557912.2:intron_variant:MODIFIER:intron1/1:c.55-67C>T::%2CNOP10:ENST00000328848.6:splice_region_variant&intron_variant:LOW:intron1/1:c.55-9C>T::%2CNOP10:ENST00000699937.1:splice_region_variant&intron_variant:LOW:intron1/1:c.40-9C>T::%2CNOP10:ENST00000699938.1:splice_region_variant&intron_variant:LOW:intron1/2:c.55-9C>T::%2CSLC12A6:ENST00000354181.8:upstream_gene_variant:MODIFIER::::%2CSLC12A6:ENST00000676379.1:upstream_gene_variant:MODIFIER::::%2CSLC12A6:ENST00000458406.6:upstream_gene_variant:MODIFIER::::%2CSLC12A6:ENST00000397702.6:upstream_gene_variant:MODIFIER::::%2CSLC12A6:ENST00000558667.5:upstream_gene_variant:MODIFIER::::%2CSLC12A6:ENST00000558589.5:upstream_gene_variant:MODIFIER::::%2CNUTM1:ENST00000537011.6:upstream_gene_variant:MODIFIER::::%2CNUTM1:ENST00000333756.5:upstream_gene_variant:MODIFIER::::%2CNUTM1:ENST00000438749.7:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604878_[GENE%3DSLC12A6_PHENOS%3DAgenesis%20of%20the%20corpus%20callosum%20with%20peripheral%20neuropathy%2C%20218000%20(3)%2C%20Autosomal%20recessive%3B%20Charcot-Marie-Tooth%20disease%2C%20axonal%2C%20type%202II%2C%20620068%20(3)%2C%20Autosomal%20dominant]&606471_[GENE%3DNOP10_PHENOS%3D?Pulmonary%20fibrosis%20and/or%20bone%20marrow%20failure%20syndrome%2C%20telomere-related%2C%209%2C%20620400%20(3)%2C%20Autosomal%20dominant%3B%20?Cataracts%2C%20hearing%20impairment%2C%20nephrotic%20syndrome%2C%20and%20enterocolitis%202%2C%20620425%20(3)%2C%20Autosomal%20recessive%3B%20?Dyskeratosis%20congenita%2C%20autosomal%20recessive%201%2C%20224230%20(3)%2C%20Autosomal%20recessive];ClinVar=315637%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:2x2%2C3x3)%20DISEASE%3DHereditary%20cancer-predisposing%20syndrome%2Cnot%20provided%2Cnot%20specified%2CDyskeratosis%20congenita%2C%20autosomal%20recessive%201%20GENE%3DNOP10]%3B;dbSNP=rs72720799;gnomAD=0.00035;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00074%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=53;gnomAD_wt=152157;phyloP=0.2960;CADD=7.04;MaxEntScan=4.2>4.4/4.2>4.4/0.0>0.0%2C0.0>0.1/4.2>4.4/0.0>0.0%2C/4.2>4.4/0.0>0.0;SpliceAI=NOP10|0.00|0.00|0.00|0.00|-9|-6|-39|17;NGSD_hom=0;NGSD_het=32;NGSD_mosaic=0;NGSD_group=0%20/%203;gene_info=SLC12A6%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.67%20oe_lof%3D0.26)%2C%20NOP10%20(inh%3DAR%20oe_syn%3D0.68%20oe_mis%3D0.86%20oe_lof%3D0.00)%2C%20NUTM1%20(inh%3Dn/a%20oe_syn%3D0.90%20oe_mis%3D0.95%20oe_lof%3D0.32)	GT	1/0
chr15	40937433	.	T	G	1270	.	quality=DP%3D175%3BQD%3D7.26%3BAF%3D0.35%3BMQM%3D60%3BSAP%3D27%3BABP%3D35%3BSAR%3D18%3BSAF%3D44;gene=DLL4;variant_type=missense;coding_and_splicing=DLL4:ENST00000249749.7:missense_variant:MODERATE:exon10/11:c.1959T>G:p.Cys653Trp:;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:enhancer;OMIM=605185_[GENE%3DDLL4_PHENOS%3DAdams-Oliver%20syndrome%206%2C%20616589%20(3)%2C%20Autosomal%20dominant];dbSNP=rs533126562;phyloP=4.6840;CADD=31.00;REVEL=0.785;AlphaMissense=0.91;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=DLL4|0.00|0.00|0.00|0.00|-4|27|35|-2;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=DLL4%20(inh%3DAD%20oe_syn%3D0.94%20oe_mis%3D0.63%20oe_lof%3D0.06)	GT	1/0
chr15	51465629	.	T	C	283	.	quality=DP%3D49%3BQD%3D5.78%3BAF%3D0.31%3BMQM%3D60%3BSAP%3D4%3BABP%3D19%3BSAR%3D9%3BSAF%3D6;gene=DMXL2;variant_type=missense;coding_and_splicing=DMXL2:ENST00000251076.9:missense_variant:MODERATE:exon31/43:c.7540A>G:p.Met2514Val:%2CDMXL2:ENST00000543779.6:missense_variant:MODERATE:exon31/43:c.7543A>G:p.Met2515Val:%2CDMXL2:ENST00000560891.6:missense_variant:MODERATE:exon31/44:c.7543A>G:p.Met2515Val:%2CDMXL2:ENST00000449909.7:missense_variant:MODERATE:exon29/41:c.5632A>G:p.Met1878Val:;OMIM=612186_[GENE%3DDMXL2_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2081%2C%20618663%20(3)%2C%20Autosomal%20recessive%3B%20?Deafness%2C%20autosomal%20dominant%2071%2C%20617605%20(3)%2C%20Autosomal%20dominant%3B%20?Polyendocrine-polyneuropathy%20syndrome%2C%20616113%20(3)%2C%20Autosomal%20recessive];ClinVar=1471673%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CHearing%20loss%2C%20autosomal%20dominant%2071%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2081%2CPolyendocrine-polyneuropathy%20syndrome%2CInborn%20genetic%20diseases%20GENE%3DDMXL2]%3B;dbSNP=rs72729259;gnomAD=0.00049;gnomAD_sub=0.00048%2C0.00151%2C0.00019%2C0.00044%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=75;gnomAD_wt=152175;phyloP=2.9430;CADD=18.73;REVEL=0.066;AlphaMissense=0.07;MaxEntScan=/0.0>3.8/0.0>0.0;SpliceAI=DMXL2|0.12|0.01|0.00|0.00|-1|22|-1|-2;NGSD_hom=0;NGSD_het=36;NGSD_mosaic=0;NGSD_group=0%20/%204;gene_info=DMXL2%20(inh%3DAR+AD%20oe_syn%3D1.03%20oe_mis%3D0.83%20oe_lof%3D0.10)	GT	1/0
chr15	61919367	.	G	C	698	.	quality=DP%3D89%3BQD%3D7.84%3BAF%3D0.37%3BMQM%3D60%3BSAP%3D3%3BABP%3D16%3BSAR%3D16%3BSAF%3D17;gene=VPS13C;variant_type=synonymous;coding_and_splicing=VPS13C:ENST00000644861.2:synonymous_variant:LOW:exon58/85:c.7560C>G:p.Ala2520%3D:PF06650%20[SHR-binding%20domain%20of%20vacuolar-sorting%20associated%20protein%2013]%2CVPS13C:ENST00000249837.7:synonymous_variant:LOW:exon56/83:c.7431C>G:p.Ala2477%3D:PF06650%20[SHR-binding%20domain%20of%20vacuolar-sorting%20associated%20protein%2013]%2CVPS13C:ENST00000645819.1:synonymous_variant:LOW:exon58/82:c.7560C>G:p.Ala2520%3D:PF06650%20[SHR-binding%20domain%20of%20vacuolar-sorting%20associated%20protein%2013]%2CVPS13C:ENST00000395898.3:synonymous_variant:LOW:exon56/80:c.7431C>G:p.Ala2477%3D:PF06650%20[SHR-binding%20domain%20of%20vacuolar-sorting%20associated%20protein%2013];OMIM=608879_[GENE%3DVPS13C_PHENOS%3DParkinson%20disease%2023%2C%20autosomal%20recessive%2C%20early%20onset%2C%20616840%20(3)%2C%20Autosomal%20recessive];ClinVar=725846%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DVPS13C]%3B;dbSNP=rs72747888;gnomAD=0.00046;gnomAD_sub=0.00029%2C0.00059%2C0.00000%2C0.00072%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=70;gnomAD_wt=152094;phyloP=0.1260;CADD=6.01;MaxEntScan=/1.0>0.0/0.0>0.0;SpliceAI=VPS13C|0.00|0.00|0.00|0.00|3|-3|-21|25;NGSD_hom=0;NGSD_het=45;NGSD_mosaic=0;NGSD_group=0%20/%206;gene_info=VPS13C%20(inh%3DAR%20oe_syn%3D1.13%20oe_mis%3D1.08%20oe_lof%3D0.58)	GT	1/0
chr15	63656169	.	C	T	2805	.	quality=DP%3D228%3BQD%3D12.30%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D56%3BSAF%3D53;gene=HERC1;variant_type=synonymous;coding_and_splicing=HERC1:ENST00000443617.7:synonymous_variant:LOW:exon49/78:c.9789G>A:p.Leu3263%3D:;OMIM=605109_[GENE%3DHERC1_PHENOS%3DMacrocephaly%2C%20dysmorphic%20facies%2C%20and%20psychomotor%20retardation%2C%20617011%20(3)%2C%20Autosomal%20recessive];ClinVar=1494486%20[uncertain%20significance%20DISEASE%3Dnot%20provided%20GENE%3DHERC1]%3B;dbSNP=rs56318707;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152317;phyloP=0.2250;CADD=17.23;MaxEntScan=/1.3>3.8/0.0>0.0;SpliceAI=HERC1|0.54|0.00|0.00|0.00|-2|-17|38|-17;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=HERC1%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D0.72%20oe_lof%3D0.19)	GT	1/0
chr15	71256656	.	C	T	730	.	quality=DP%3D96%3BQD%3D7.60%3BAF%3D0.35%3BMQM%3D60%3BSAP%3D4%3BABP%3D21%3BSAR%3D15%3BSAF%3D19;gene=THSD4;variant_type=missense;coding_and_splicing=THSD4:ENST00000355327.7:missense_variant:MODERATE:exon6/18:c.956C>T:p.Ala319Val:%2CTHSD4:ENST00000261862.8:missense_variant:MODERATE:exon6/18:c.956C>T:p.Ala319Val:;OMIM=614476_[GENE%3DTHSD4_PHENOS%3DAortic%20aneurysm%2C%20familial%20thoracic%2012%2C%20619825%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72759649;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152253;phyloP=6.0600;CADD=25.20;REVEL=0.392;AlphaMissense=0.24;MaxEntScan=/0.0>0.0/0.0>2.3;SpliceAI=THSD4|0.00|0.00|0.00|0.00|-33|-43|-11|-33;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=THSD4%20(inh%3DAD%20oe_syn%3D0.98%20oe_mis%3D0.95%20oe_lof%3D0.39)	GT	1/0
chr15	71660560	.	G	A	3445	.	quality=DP%3D255%3BQD%3D13.51%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D47%3BABP%3D4%3BSAR%3D40%3BSAF%3D92;gene=THSD4;variant_type=missense;coding_and_splicing=THSD4:ENST00000355327.7:missense_variant:MODERATE:exon8/18:c.1183G>A:p.Asp395Asn:PF19236%20[ADAM%20cysteine-rich%20domain]%2CTHSD4:ENST00000261862.8:missense_variant:MODERATE:exon8/18:c.1183G>A:p.Asp395Asn:PF19236%20[ADAM%20cysteine-rich%20domain]%2CTHSD4:ENST00000357769.4:missense_variant:MODERATE:exon2/12:c.103G>A:p.Asp35Asn:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=614476_[GENE%3DTHSD4_PHENOS%3DAortic%20aneurysm%2C%20familial%20thoracic%2012%2C%20619825%20(3)%2C%20Autosomal%20dominant];ClinVar=1879297%20[benign%20DISEASE%3DFamilial%20thoracic%20aortic%20aneurysm%20and%20aortic%20dissection%2Cnot%20provided%20GENE%3DTHSD4]%3B;dbSNP=rs72742760;gnomAD=0.00780;gnomAD_sub=0.00176%2C0.00327%2C0.00000%2C0.01128%2C0.00000;gnomAD_hom_hemi=8%2C;gnomAD_het=1171;gnomAD_wt=151013;phyloP=9.6780;CADD=26.60;REVEL=0.237;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=THSD4|0.00|0.00|0.00|0.00|-28|-5|-2|23;NGSD_hom=5;NGSD_het=942;NGSD_mosaic=1;NGSD_group=0%20/%20123;gene_info=THSD4%20(inh%3DAD%20oe_syn%3D0.98%20oe_mis%3D0.95%20oe_lof%3D0.39)	GT	1/0
chr15	79896865	.	C	G	3670	.	quality=DP%3D267%3BQD%3D13.75%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D33%3BABP%3D4%3BSAR%3D48%3BSAF%3D92;gene=MTHFS%2CST20-MTHFS%2CST20;variant_type=splice_region&intron%2Cintron%2Cdownstream_gene;coding_and_splicing=MTHFS:ENST00000258874.4:splice_region_variant&intron_variant:LOW:intron1/2:c.117+7G>C::%2CMTHFS:ENST00000559722.2:intron_variant:MODIFIER:intron1/2:c.204+296G>C::%2CST20-MTHFS:ENST00000615374.5:intron_variant:MODIFIER:intron2/3:c.46-7511G>C::%2CST20-MTHFS:ENST00000479961.1:intron_variant:MODIFIER:intron2/3:c.46-7511G>C::%2CST20:ENST00000562759.1:downstream_gene_variant:MODIFIER::::%2CST20:ENST00000478497.5:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=604197_[GENE%3DMTHFS_PHENOS%3DNeurodevelopmental%20disorder%20with%20microcephaly%2C%20epilepsy%2C%20and%20hypomyelination%2C%20618367%20(3)%2C%20Autosomal%20recessive];ClinVar=1675582%20[benign/likely%20benign%20DISEASE%3DMTHFS-related%20disorder%2Cnot%20provided%20GENE%3DMTHFS]%3B;dbSNP=rs544557204;gnomAD=0.00181;gnomAD_sub=0.00067%2C0.00046%2C0.00000%2C0.00347%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=275;gnomAD_wt=152077;phyloP=0.5620;CADD=5.36;MaxEntScan=/0.0>2.6/0.0>0.0;SpliceAI=MTHFS|0.00|0.00|0.00|0.06|-12|-1|-41|7%2CST20-MTHFS|0.00|0.00|0.00|0.00|9|-1|-41|7;NGSD_hom=0;NGSD_het=202;NGSD_mosaic=0;NGSD_group=0%20/%2028;gene_info=MTHFS%20(inh%3DAR%20oe_syn%3D1.08%20oe_mis%3D0.85%20oe_lof%3D0.80)%2C%20ST20-MTHFS%20(inh%3DAR%20oe_syn%3D1.00%20oe_mis%3D0.84%20oe_lof%3D0.59)%2C%20ST20%20(inh%3Dn/a%20oe_syn%3D1.35%20oe_mis%3D0.98%20oe_lof%3D0.00)	GT	1/0
chr15	82138804	.	C	T	955	.	quality=DP%3D104%3BQD%3D9.18%3BAF%3D0.39%3BMQM%3D60%3BSAP%3D4%3BABP%3D13%3BSAR%3D23%3BSAF%3D18;gene=EFL1;variant_type=missense;coding_and_splicing=EFL1:ENST00000359445.8:missense_variant:MODERATE:exon17/18:c.2875G>A:p.Val959Ile:PF00679%20[Elongation%20factor%20G%20C-terminus]%2CEFL1:ENST00000561340.2:missense_variant:MODERATE:exon4/5:c.1141G>A:p.Val381Ile:PF00679%20[Elongation%20factor%20G%20C-terminus]%2CEFL1:ENST00000696330.1:missense_variant:MODERATE:exon19/20:c.3028G>A:p.Val1010Ile:PF00679%20[Elongation%20factor%20G%20C-terminus]%2CEFL1:ENST00000696327.1:missense_variant:MODERATE:exon5/6:c.1291G>A:p.Val431Ile:PF00679%20[Elongation%20factor%20G%20C-terminus]%2CEFL1:ENST00000268206.12:missense_variant:MODERATE:exon19/20:c.3028G>A:p.Val1010Ile:PF00679%20[Elongation%20factor%20G%20C-terminus]%2CEFL1:ENST00000557939.2:missense_variant:MODERATE:exon18/19:c.2890G>A:p.Val964Ile:PF00679%20[Elongation%20factor%20G%20C-terminus];OMIM=617538_[GENE%3DEFL1_PHENOS%3DShwachman-Diamond%20syndrome%202%2C%20617941%20(3)%2C%20Autosomal%20recessive];ClinVar=715816%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DEFL1]%3B;dbSNP=rs72749527;gnomAD=0.00691;gnomAD_sub=0.00157%2C0.00386%2C0.00039%2C0.00814%2C0.00083;gnomAD_hom_hemi=10%2C;gnomAD_het=1032;gnomAD_wt=151150;phyloP=7.6140;CADD=23.20;REVEL=0.170;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/5.4>4.9;SpliceAI=EFTUD1|0.00|0.00|0.00|0.00|38|-48|-34|6;NGSD_hom=5;NGSD_het=645;NGSD_mosaic=0;NGSD_group=0%20/%2075;gene_info=EFL1%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.86%20oe_lof%3D0.40)	GT	1/0
chr15	82151813	.	G	T	2176	.	quality=DP%3D180%3BQD%3D12.09%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D6%3BABP%3D5%3BSAR%3D47%3BSAF%3D37;gene=EFL1;variant_type=missense;coding_and_splicing=EFL1:ENST00000359445.8:missense_variant:MODERATE:exon16/18:c.2488C>A:p.Pro830Thr:%2CEFL1:ENST00000561340.2:missense_variant:MODERATE:exon3/5:c.754C>A:p.Pro252Thr:%2CEFL1:ENST00000696330.1:missense_variant:MODERATE:exon18/20:c.2641C>A:p.Pro881Thr:%2CEFL1:ENST00000696327.1:missense_variant:MODERATE:exon4/6:c.904C>A:p.Pro302Thr:%2CEFL1:ENST00000268206.12:missense_variant:MODERATE:exon18/20:c.2641C>A:p.Pro881Thr:%2CEFL1:ENST00000557939.2:missense_variant:MODERATE:exon17/19:c.2503C>A:p.Pro835Thr:;OMIM=617538_[GENE%3DEFL1_PHENOS%3DShwachman-Diamond%20syndrome%202%2C%20617941%20(3)%2C%20Autosomal%20recessive];ClinVar=715817%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DEFL1]%3B;dbSNP=rs72749532;gnomAD=0.00690;gnomAD_sub=0.00154%2C0.00386%2C0.00039%2C0.00816%2C0.00083;gnomAD_hom_hemi=10%2C;gnomAD_het=1029;gnomAD_wt=151089;phyloP=9.4950;CADD=25.00;REVEL=0.908;AlphaMissense=0.66;MaxEntScan=/0.1>0.0/0.0>0.0;COSMIC=COSV104572135;SpliceAI=EFTUD1|0.00|0.00|0.00|0.00|14|34|-6|34;NGSD_hom=5;NGSD_het=644;NGSD_mosaic=0;NGSD_group=0%20/%2077;gene_info=EFL1%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.86%20oe_lof%3D0.40)	GT	1/0
chr15	89274209	.	G	A	906	.	quality=DP%3D111%3BQD%3D8.16%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D27%3BABP%3D13%3BSAR%3D11%3BSAF%3D33;gene=FANCI;variant_type=synonymous;coding_and_splicing=FANCI:ENST00000674831.1:synonymous_variant:LOW:exon12/39:c.1017G>A:p.Lys339%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000300027.12:synonymous_variant:LOW:exon12/37:c.1017G>A:p.Lys339%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000310775.12:synonymous_variant:LOW:exon12/38:c.1017G>A:p.Lys339%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000696717.1:synonymous_variant:LOW:exon12/38:c.738G>A:p.Lys246%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000676003.1:synonymous_variant:LOW:exon13/39:c.1017G>A:p.Lys339%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000696718.1:synonymous_variant:LOW:exon11/37:c.480G>A:p.Lys160%3D:PF14679%20[FANCI%20helical%20domain%201]%2CFANCI:ENST00000696719.1:synonymous_variant:LOW:exon13/39:c.1017G>A:p.Lys339%3D:PF14679%20[FANCI%20helical%20domain%201];OMIM=611360_[GENE%3DFANCI_PHENOS%3DFanconi%20anemia%2C%20complementation%20group%20I%2C%20609053%20(3)%2C%20Autosomal%20recessive];ClinVar=886651%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C2x3)%20DISEASE%3DFanconi%20anemia%2CFanconi%20anemia%20complementation%20group%20I%20GENE%3DFANCI]%3B;dbSNP=rs72762644;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152202;phyloP=4.0290;CADD=6.04;MaxEntScan=/1.4>1.6/0.0>0.0;SpliceAI=FANCI|0.00|0.00|0.00|0.00|-41|-23|-42|-23;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=FANCI%20(inh%3DAR%20oe_syn%3D1.15%20oe_mis%3D1.15%20oe_lof%3D0.83)	GT	1/0
chr16	285708	.	G	A	2149	.	quality=DP%3D157%3BQD%3D13.69%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D73%3BABP%3D7%3BSAR%3D70%3BSAF%3D17;gene=PDIA2%2CARHGDIG%2CAXIN1;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=PDIA2:ENST00000219406.11:splice_region_variant&intron_variant:LOW:intron7/10:c.1119+5G>A::%2CPDIA2:ENST00000404312.5:splice_region_variant&intron_variant:LOW:intron7/10:c.1110+5G>A::%2CARHGDIG:ENST00000219409.8:downstream_gene_variant:MODIFIER::::%2CAXIN1:ENST00000262320.8:downstream_gene_variant:MODIFIER::::%2CAXIN1:ENST00000354866.7:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2CTF_binding_site_variant;OMIM=603816_[GENE%3DAXIN1_PHENOS%3DHepatocellular%20carcinoma%2C%20somatic%2C%20114550%20(3)%3B%20?Caudal%20duplication%20anomaly%2C%20607864%20(3)];dbSNP=rs45574340;gnomAD=0.00070;gnomAD_sub=0.00029%2C0.00039%2C0.00039%2C0.00125%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=106;gnomAD_wt=152048;phyloP=3.9830;CADD=17.81;MaxEntScan=5.0>0.0/0.0>0.0/5.0>0.0;SpliceAI=PDIA2|0.00|0.00|0.01|0.17|49|-24|-11|-5;NGSD_hom=1;NGSD_het=71;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=ARHGDIG%20(inh%3Dn/a%20oe_syn%3D1.42%20oe_mis%3D1.00%20oe_lof%3D0.00)%2C%20PDIA2%20(inh%3DAD%20oe_syn%3D1.56%20oe_mis%3D1.27%20oe_lof%3D1.75)%2C%20AXIN1%20(inh%3DAR%20oe_syn%3D1.18%20oe_mis%3D0.88%20oe_lof%3D0.22)	GT	1/0
chr16	552370	.	C	T	5157	.	quality=DP%3D361%3BQD%3D14.29%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D87%3BABP%3D12%3BSAR%3D56%3BSAF%3D144;gene=CAPN15;variant_type=synonymous;coding_and_splicing=CAPN15:ENST00000219611.7:synonymous_variant:LOW:exon11/14:c.2577C>T:p.Ser859%3D:;OMIM=603267_[GENE%3DCAPN15_PHENOS%3DOculogastrointestinal%20neurodevelopmental%20syndrome%2C%20619318%20(3)%2C%20Autosomal%20recessive];ClinVar=3053063%20[likely%20benign%20DISEASE%3DCAPN15-related%20disorder%20GENE%3DCAPN15]%3B;dbSNP=rs75045595;gnomAD=0.00020;gnomAD_sub=0.00005%2C0.00000%2C0.00000%2C0.00013%2C0.00373;gnomAD_hom_hemi=0%2C;gnomAD_het=30;gnomAD_wt=152112;phyloP=-1.7310;CADD=1.09;MaxEntScan=/2.0>1.4/0.0>0.0;SpliceAI=CAPN15|0.02|0.00|0.00|0.00|39|-48|-24|37;NGSD_hom=0;NGSD_het=24;NGSD_mosaic=1;NGSD_group=0%20/%202;gene_info=CAPN15%20(inh%3DAR%20oe_syn%3D1.31%20oe_mis%3D0.81%20oe_lof%3D0.17)	GT	1/0
chr16	683424	.	C	G	2115	.	quality=DP%3D218%3BQD%3D9.70%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D10%3BABP%3D19%3BSAR%3D53%3BSAF%3D36;gene=JMJD8%2CSTUB1-DT%2CSTUB1%2CWDR24;variant_type=missense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=JMJD8:ENST00000609261.6:missense_variant:MODERATE:exon6/9:c.409G>C:p.Gly137Arg:PF13621%20[Cupin-like%20domain]%2CJMJD8:ENST00000562824.5:missense_variant:MODERATE:exon5/8:c.319G>C:p.Gly107Arg:PF13621%20[Cupin-like%20domain]%2CJMJD8:ENST00000562111.1:missense_variant:MODERATE:exon6/8:c.409G>C:p.Gly137Arg:%2CSTUB1-DT:ENST00000567091.1:upstream_gene_variant:MODIFIER::::%2CSTUB1-DT:ENST00000571933.1:upstream_gene_variant:MODIFIER::::%2CSTUB1:ENST00000565677.5:downstream_gene_variant:MODIFIER::::%2CSTUB1:ENST00000219548.9:downstream_gene_variant:MODIFIER::::%2CSTUB1:ENST00000564370.5:downstream_gene_variant:MODIFIER::::%2CWDR24:ENST00000293883.9:downstream_gene_variant:MODIFIER::::%2CWDR24:ENST00000647644.1:downstream_gene_variant:MODIFIER::::%2CWDR24:ENST00000248142.7:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=607207_[GENE%3DSTUB1_PHENOS%3DSpinocerebellar%20ataxia%2048%2C%20618093%20(3)%2C%20Autosomal%20dominant%3B%20Spinocerebellar%20ataxia%2C%20autosomal%20recessive%2016%2C%20615768%20(3)%2C%20Autosomal%20recessive];ClinVar=2645849%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DJMJD8]%3B;dbSNP=rs72773413;gnomAD=0.00409;gnomAD_sub=0.00116%2C0.00288%2C0.00000%2C0.00691%2C0.00124;gnomAD_hom_hemi=1%2C;gnomAD_het=620;gnomAD_wt=151634;phyloP=7.2380;CADD=32.00;REVEL=0.584;AlphaMissense=0.98;MaxEntScan=/0.0>1.7/0.0>0.0;COSMIC=COSV99556005;SpliceAI=JMJD8|0.00|0.00|0.00|0.00|47|-19|-19|11;NGSD_hom=0;NGSD_het=495;NGSD_mosaic=0;NGSD_group=0%20/%2058;gene_info=STUB1-DT%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20STUB1%20(inh%3DAR+AD%20oe_syn%3D1.40%20oe_mis%3D0.76%20oe_lof%3D0.34)%2C%20JMJD8%20(inh%3Dn/a%20oe_syn%3D1.55%20oe_mis%3D1.43%20oe_lof%3D1.27)%2C%20WDR24%20(inh%3Dn/a%20oe_syn%3D1.27%20oe_mis%3D0.67%20oe_lof%3D0.43)	GT	1/0
chr16	2089874	.	G	A	2183	.	quality=DP%3D160%3BQD%3D13.64%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D26%3BABP%3D4%3BSAR%3D27%3BSAF%3D57;gene=PKD1%2CTSC2%2CMIR1225%2CPKD1-AS1;variant_type=synonymous%2Cdownstream_gene%2Cupstream_gene;coding_and_splicing=PKD1:ENST00000262304.9:synonymous_variant:LOW:exon46/46:c.12765C>T:p.Pro4255%3D:%2CPKD1:ENST00000423118.5:synonymous_variant:LOW:exon46/46:c.12762C>T:p.Pro4254%3D:%2CTSC2:ENST00000643088.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000643946.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000642206.2:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000382538.10:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000219476.9:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000645186.2:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000642936.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000401874.7:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000644335.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000646388.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000439673.6:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000350773.9:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000642365.2:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000644329.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000642797.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000644043.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000642561.1:downstream_gene_variant:MODIFIER::::%2CTSC2:ENST00000568454.6:downstream_gene_variant:MODIFIER::::%2CMIR1225:ENST00000408729.1:downstream_gene_variant:MODIFIER::::%2CPKD1-AS1:ENST00000563284.3:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=191092_[GENE%3DTSC2_PHENOS%3DLymphangioleiomyomatosis%2C%20somatic%2C%20606690%20(3)%3B%20?Focal%20cortical%20dysplasia%2C%20type%20II%2C%20somatic%2C%20607341%20(3)%3B%20Tuberous%20sclerosis-2%2C%20613254%20(3)%2C%20Autosomal%20dominant]&601313_[GENE%3DPKD1_PHENOS%3DPolycystic%20kidney%20disease%201%2C%20173900%20(3)%2C%20Autosomal%20dominant];ClinVar=434011%20[benign/likely%20benign%20DISEASE%3DPolycystic%20kidney%20disease%2C%20adult%20type%2CPolycystic%20kidney%20disease%2Cnot%20provided%20GENE%3DPKD1]%3B;dbSNP=rs62038811;gnomAD=0.00426;gnomAD_sub=0.00178%2C0.00118%2C0.00000%2C0.00783%2C0.00021;gnomAD_hom_hemi=1%2C;gnomAD_het=647;gnomAD_wt=151705;phyloP=-1.6200;CADD=2.52;MaxEntScan=/0.6>0.7/0.0>0.0;SpliceAI=PKD1|0.00|0.00|0.00|0.00|38|50|23|20;PubMed=25741868%2C22008521%2C22383692%2C10200984%2C11058904%2C24374109;NGSD_hom=3;NGSD_het=431;NGSD_mosaic=0;NGSD_group=0%20/%2063;gene_info=TSC2%20(inh%3DAD%20oe_syn%3D1.48%20oe_mis%3D1.03%20oe_lof%3D0.02)%2C%20PKD1%20(inh%3DAD%20oe_syn%3D1.63%20oe_mis%3D1.23%20oe_lof%3D0.12)%2C%20MIR1225%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20PKD1-AS1%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr16	2295708	.	G	A	2814	.	quality=DP%3D206%3BQD%3D13.66%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D22%3BABP%3D5%3BSAR%3D70%3BSAF%3D39;gene=ABCA3;variant_type=missense;coding_and_splicing=ABCA3:ENST00000301732.10:missense_variant:MODERATE:exon18/33:c.2296C>T:p.Pro766Ser:%2CABCA3:ENST00000382381.7:missense_variant:MODERATE:exon17/32:c.2122C>T:p.Pro708Ser:;OMIM=601615_[GENE%3DABCA3_PHENOS%3DSurfactant%20metabolism%20dysfunction%2C%20pulmonary%2C%203%2C%20610921%20(3)%2C%20Autosomal%20recessive];ClinVar=178696%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:2x2%2C5x3)%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CHereditary%20pulmonary%20alveolar%20proteinosis%2CInterstitial%20lung%20disease%20due%20to%20ABCA3%20deficiency%20GENE%3DABCA3]%3B;HGMD=CM1417244%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Neonatal%20respiratory%20distress%20/%20interstitial%20lung%20disease"%20GENE%3DABCA3]%3B;dbSNP=rs45592239;gnomAD=0.00169;gnomAD_sub=0.00046%2C0.00020%2C0.00000%2C0.00329%2C0.00186;gnomAD_hom_hemi=1%2C;gnomAD_het=256;gnomAD_wt=152100;phyloP=3.5570;CADD=21.10;REVEL=0.113;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ABCA3|0.00|0.00|0.00|0.00|32|3|33|10;PubMed=24033266%2C22866751%2C24871971%2C16641205%2C18024538%2C23625987;NGSD_hom=0;NGSD_het=247;NGSD_mosaic=0;NGSD_group=0%20/%2037;gene_info=ABCA3%20(inh%3DAR%20oe_syn%3D1.16%20oe_mis%3D0.97%20oe_lof%3D0.36)	GT	1/0
chr16	2497033	.	C	G	2265	.	quality=DP%3D195%3BQD%3D11.62%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D8%3BABP%3D5%3BSAR%3D53%3BSAF%3D38;gene=TBC1D24;variant_type=missense;coding_and_splicing=TBC1D24:ENST00000567020.6:missense_variant:MODERATE:exon2/7:c.885C>G:p.Phe295Leu:%2CTBC1D24:ENST00000646147.1:missense_variant:MODERATE:exon2/8:c.885C>G:p.Phe295Leu:%2CTBC1D24:ENST00000627285.1:missense_variant:MODERATE:exon2/7:c.885C>G:p.Phe295Leu:;OMIM=613577_[GENE%3DTBC1D24_PHENOS%3DDeafness%2C%20autosomal%20recessive%2086%2C%20614617%20(3)%2C%20Autosomal%20recessive%3B%20Epilepsy%2C%20rolandic%2C%20with%20paroxysmal%20exercise-induce%20dystonia%20and%20writer's%20cramp%2C%20608105%20(3)%2C%20Autosomal%20recessive%3B%20Myoclonic%20epilepsy%2C%20infantile%2C%20familial%2C%20605021%20(3)%2C%20Autosomal%20recessive%3B%20Deafness%2C%20autosomal%20dominant%2065%2C%20616044%20(3)%2C%20Autosomal%20dominant%3B%20Developmental%20and%20epileptic%20encephalopathy%2016%2C%20615338%20(3)%2C%20Autosomal%20recessive%3B%20DOORS%20syndrome%2C%20220500%20(3)%2C%20Autosomal%20recessive];ClinVar=139396%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%201%2CCaused%20by%20mutation%20in%20the%20TBC1%20domain%20family%2C%20member%2024%2CAutosomal%20dominant%20nonsyndromic%20hearing%20loss%2065%2Cnot%20specified%2CInborn%20genetic%20diseases%2CFamilial%20infantile%20myoclonic%20epilepsy%20GENE%3DTBC1D24]%3B;dbSNP=rs72768728;gnomAD=0.00578;gnomAD_sub=0.00197%2C0.00189%2C0.00000%2C0.01099%2C0.00062;gnomAD_hom_hemi=4%2C;gnomAD_het=872;gnomAD_wt=151490;phyloP=0.7100;CADD=16.46;REVEL=0.074;AlphaMissense=0.66;MaxEntScan=/6.1>5.7/0.0>0.0;SpliceAI=RP11-20I23.1|0.00|0.00|0.00|0.00|1|10|-19|10%2CTBC1D24|0.00|0.00|0.00|0.00|1|10|-19|10;PubMed=25741868%2C24033266%2C29671961%2C33462484%2C35710981%2C10574461;NGSD_hom=5;NGSD_het=801;NGSD_mosaic=0;NGSD_group=0%20/%20127;gene_info=TBC1D24%20(inh%3DAR+AD%20oe_syn%3D1.10%20oe_mis%3D0.89%20oe_lof%3D0.73)	GT	1/0
chr16	3589229	.	G	A	2595	.	quality=DP%3D238%3BQD%3D10.90%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D3%3BABP%3D8%3BSAR%3D53%3BSAF%3D54;gene=SLX4;variant_type=missense;coding_and_splicing=SLX4:ENST00000294008.4:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu:;OMIM=613278_[GENE%3DSLX4_PHENOS%3DFanconi%20anemia%2C%20complementation%20group%20P%2C%20613951%20(3)%2C%20Autosomal%20recessive];ClinVar=885261%20[uncertain%20significance%20DISEASE%3DFanconi%20anemia%2CFanconi%20anemia%20complementation%20group%20P%20GENE%3DSLX4]%3B;HGMD=CM136925%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Breast%20and/or%20ovarian%20cancer"%20GENE%3DSLX4]%3B;dbSNP=rs72778139;gnomAD=0.00009;gnomAD_sub=0.00005%2C0.00007%2C0.00000%2C0.00015%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152274;phyloP=0.6280;CADD=16.52;REVEL=0.112;AlphaMissense=0.12;MaxEntScan=/1.6>2.3/0.0>0.0;COSMIC=COSV53560456;SpliceAI=SLX4|0.00|0.00|0.00|0.00|17|-30|16|10;PubMed=22401137%2C23840564%2C23211700;NGSD_hom=0;NGSD_het=26;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=SLX4%20(inh%3DAR%20oe_syn%3D1.24%20oe_mis%3D1.16%20oe_lof%3D0.68)	GT	1/0
chr16	3662962	.	C	T	2034	.	quality=DP%3D202%3BQD%3D10.07%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D5%3BABP%3D17%3BSAR%3D46%3BSAF%3D37;gene=DNASE1%2CTRAP1;variant_type=3'UTR%2Cmissense%2Cdownstream_gene;coding_and_splicing=DNASE1:ENST00000407479.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*5009C>T::%2CTRAP1:ENST00000246957.10:missense_variant:MODERATE:exon15/18:c.1714G>A:p.Glu572Lys:PF00183%20[Hsp90%20protein]%2CTRAP1:ENST00000575671.5:missense_variant:MODERATE:exon10/13:c.1087G>A:p.Glu363Lys:PF00183%20[Hsp90%20protein]%2CTRAP1:ENST00000538171.5:missense_variant:MODERATE:exon14/17:c.1555G>A:p.Glu519Lys:PF00183%20[Hsp90%20protein]%2CDNASE1:ENST00000246949.10:downstream_gene_variant:MODIFIER::::;OMIM=125505_[GENE%3DDNASE1_PHENOS%3D{Systemic%20lupus%20erythematosus%2C%20susceptibility%20to}%2C%20152700%20(3)%2C%20Autosomal%20dominant];ClinVar=559146%20[uncertain%20significance%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DDNASE1]%3B;dbSNP=rs55766649;gnomAD=0.00005;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00006%2C0.00062;gnomAD_hom_hemi=0%2C;gnomAD_het=8;gnomAD_wt=152302;phyloP=7.0230;CADD=20.50;REVEL=0.127;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=DNASE1|0.00|0.00|0.00|0.00|8|-5|-38|-5%2CTRAP1|0.00|0.00|0.00|0.00|-3|5|-1|3;NGSD_hom=0;NGSD_het=15;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=DNASE1%20(inh%3DAD%20oe_syn%3D1.51%20oe_mis%3D1.55%20oe_lof%3D1.65)%2C%20TRAP1%20(inh%3Dn/a%20oe_syn%3D1.41%20oe_mis%3D1.37%20oe_lof%3D1.09)	GT	1/0
chr16	11254849	.	C	G	1013	.	quality=DP%3D104%3BQD%3D9.74%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D5%3BABP%3D7%3BSAR%3D19%3BSAF%3D26;gene=RMI2%2CSOCS1;variant_type=intron%2Cmissense;coding_and_splicing=RMI2:ENST00000572173.1:intron_variant:MODIFIER:intron1/4:c.-516+5071C>G::%2CSOCS1:ENST00000644787.1:missense_variant:MODERATE:exon1/1:c.630G>C:p.Gln210His:%2CSOCS1:ENST00000332029.4:missense_variant:MODERATE:exon2/2:c.630G>C:p.Gln210His:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=603597_[GENE%3DSOCS1_PHENOS%3DAutoinflammatory%20syndrome%2C%20familial%2C%20with%20or%20without%20immunodeficiency%2C%20619375%20(3)%2C%20Autosomal%20dominant];ClinVar=135275%20[likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%20GENE%3DSOCS1]%3B;dbSNP=rs11549428;gnomAD=0.00534;gnomAD_sub=0.00241%2C0.00242%2C0.00000%2C0.00922%2C0.00041;gnomAD_hom_hemi=4%2C;gnomAD_het=805;gnomAD_wt=151489;phyloP=1.9220;CADD=22.40;REVEL=0.059;AlphaMissense=0.30;MaxEntScan=/0.0>0.0/0.0>0.0%2C/10.8>6.6/0.0>0.0;COSMIC=COSV59659165;SpliceAI=SOCS1|0.00|0.00|0.00|0.00|-14|-1|2|-1;PubMed=24728327%2C30595370%2C37495858;NGSD_hom=3;NGSD_het=460;NGSD_mosaic=0;NGSD_group=0%20/%2051;gene_info=RMI2%20(inh%3Dn/a%20oe_syn%3D1.54%20oe_mis%3D1.30%20oe_lof%3D1.31)%2C%20SOCS1%20(inh%3DAD%20oe_syn%3D1.61%20oe_mis%3D0.75%20oe_lof%3D0.00)	GT	1/0
chr16	15724635	.	CG	C	1681	.	quality=DP%3D161%3BQD%3D10.44%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D6%3BABP%3D7%3BSAR%3D31%3BSAF%3D41;gene=NDE1%2CMYH11;variant_type=3'UTR%2Csplice_region&intron;coding_and_splicing=NDE1:ENST00000396355.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*388del::%2CNDE1:ENST00000396354.6:3_prime_UTR_variant:MODIFIER:exon9/9:c.*388del::%2CMYH11:ENST00000300036.6:splice_region_variant&intron_variant:LOW:intron30/40:c.4116+11del::%2CMYH11:ENST00000452625.7:splice_region_variant&intron_variant:LOW:intron31/42:c.4137+11del::%2CMYH11:ENST00000713757.1:splice_region_variant&intron_variant:LOW:intron30/40:c.4116+11del::%2CMYH11:ENST00000396324.7:splice_region_variant&intron_variant:LOW:intron31/41:c.4137+11del::%2CMYH11:ENST00000576790.7:splice_region_variant&intron_variant:LOW:intron30/41:c.4116+11del::;OMIM=609449_[GENE%3DNDE1_PHENOS%3DMicrohydranencephaly%2C%20605013%20(3)%2C%20Autosomal%20recessive%3B%20Lissencephaly%204%20(with%20microcephaly)%2C%20614019%20(3)%2C%20Autosomal%20recessive]&160745_[GENE%3DMYH11_PHENOS%3DMegacystis-microcolon-intestinal%20hypoperistalsis%20syndrome%202%2C%20619351%20(3)%2C%20Autosomal%20recessive%3B%20Aortic%20aneurysm%2C%20familial%20thoracic%204%2C%20132900%20(3)%2C%20Autosomal%20dominant%3B%20Visceral%20myopathy%202%2C%20619350%20(3)%2C%20Autosomal%20dominant];ClinVar=201034%20[benign(replaced%20by%20megSAP%20based%20on%20classifications:6x1%2C2x2%2C1x3)%20DISEASE%3Dnot%20specified%2CAortic%20aneurysm%2C%20familial%20thoracic%204%2CLissencephaly%204%2Cnot%20provided%2CFamilial%20thoracic%20aortic%20aneurysm%20and%20aortic%20dissection%20GENE%3DMYH11]%3B;dbSNP=rs543763112;gnomAD=0.00060;gnomAD_sub=0.00031%2C0.00000%2C0.00000%2C0.00109%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=92;gnomAD_wt=152158;phyloP=-2.5350;CADD=0.00;MaxEntScan=/0.0>0.0/0.0>0.0%2C/1.8>0.8/0.0>0.0;SpliceAI=MYH11|0.00|0.00|0.00|0.00|11|47|2|10%2CNDE1|0.00|0.00|0.00|0.00|-40|45|44|24;PubMed=25741868;NGSD_hom=0;NGSD_het=122;NGSD_mosaic=0;NGSD_group=0%20/%2020;classification=2;classification_comment="[2]%20ahstaea1%2026.09.2018:%20CliNavr%201-2";gene_info=NDE1%20(inh%3DAR%20oe_syn%3D1.19%20oe_mis%3D1.22%20oe_lof%3D0.37)%2C%20MYH11%20(inh%3DAD%20oe_syn%3D1.17%20oe_mis%3D0.88%20oe_lof%3D0.22)	GT	1/0
chr16	23380765	.	C	T	1070	.	quality=DP%3D88%3BQD%3D12.16%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D34%3BABP%3D5%3BSAR%3D37%3BSAF%3D11;gene=SCNN1B;variant_type=synonymous;coding_and_splicing=SCNN1B:ENST00000343070.7:synonymous_variant:LOW:exon13/13:c.1887C>T:p.Asp629%3D:%2CSCNN1B:ENST00000307331.9:synonymous_variant:LOW:exon14/14:c.2022C>T:p.Asp674%3D:%2CSCNN1B:ENST00000568085.5:synonymous_variant:LOW:exon11/11:c.1779C>T:p.Asp593%3D:%2CSCNN1B:ENST00000568923.5:synonymous_variant:LOW:exon12/12:c.1806C>T:p.Asp602%3D:;OMIM=600760_[GENE%3DSCNN1B_PHENOS%3DBronchiectasis%20with%20or%20without%20elevated%20sweat%20chloride%201%2C%20211400%20(3)%2C%20Autosomal%20dominant%3B%20Pseudohypoaldosteronism%2C%20type%20IB2%2C%20autosomal%20recessive%2C%20620125%20(3)%2C%20Autosomal%20recessive%3B%20Liddle%20syndrome%201%2C%20177200%20(3)%2C%20Autosomal%20dominant];ClinVar=318446%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x1%2C2x2%2C1x3)%20DISEASE%3DAutosomal%20recessive%20pseudohypoaldosteronism%20type%201%2CBronchiectasis%20with%20or%20without%20elevated%20sweat%20chloride%201%2Cnot%20provided%2Cnot%20specified%2CLiddle%20syndrome%201%20GENE%3DSCNN1B]%3B;dbSNP=rs61759917;gnomAD=0.00122;gnomAD_sub=0.00024%2C0.00366%2C0.00000%2C0.00172%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=186;gnomAD_wt=152102;phyloP=-0.8810;CADD=1.83;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SCNN1B|0.00|0.00|0.00|0.00|38|-8|16|1;PubMed=25900089%2C19462466;NGSD_hom=0;NGSD_het=88;NGSD_mosaic=0;NGSD_group=0%20/%205;gene_info=SCNN1B%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.97%20oe_lof%3D0.53)	GT	1/0
chr16	27761500	.	C	T	2397	.	quality=DP%3D196%3BQD%3D12.23%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D10%3BABP%3D4%3BSAR%3D38%3BSAF%3D56;gene=KATNIP;variant_type=missense;coding_and_splicing=KATNIP:ENST00000261588.10:missense_variant:MODERATE:exon19/28:c.3719C>T:p.Ala1240Val:PF14652%20[Domain%20of%20unknown%20function%20(DUF4457)];OMIM=616650_[GENE%3DKATNIP_PHENOS%3DJoubert%20syndrome%2026%2C%20616784%20(3)%2C%20Autosomal%20recessive];ClinVar=783064%20[benign/likely%20benign%20DISEASE%3DJoubert%20syndrome%2026%2Cnot%20provided%20GENE%3DKATNIP]%3B;dbSNP=rs55953014;gnomAD=0.00907;gnomAD_sub=0.00270%2C0.00732%2C0.00000%2C0.01402%2C0.00083;gnomAD_hom_hemi=11%2C;gnomAD_het=1359;gnomAD_wt=150903;phyloP=4.8610;CADD=22.80;REVEL=0.054;AlphaMissense=0.20;MaxEntScan=/0.8>0.7/0.0>4.9;COSMIC=COSV99852260;SpliceAI=KIAA0556|0.00|0.00|0.00|0.00|40|42|-2|-23;NGSD_hom=6;NGSD_het=907;NGSD_mosaic=0;NGSD_group=1%20/%20137;gene_info=KATNIP%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D1.01%20oe_lof%3D0.73)	GT	1/0
chr16	27777669	.	G	A	2543	.	quality=DP%3D208%3BQD%3D12.23%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D55%3BABP%3D3%3BSAR%3D26%3BSAF%3D75;gene=KATNIP;variant_type=synonymous;coding_and_splicing=KATNIP:ENST00000261588.10:synonymous_variant:LOW:exon26/28:c.4611G>A:p.Val1537%3D:;OMIM=616650_[GENE%3DKATNIP_PHENOS%3DJoubert%20syndrome%2026%2C%20616784%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72780133;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152309;phyloP=-5.1040;CADD=0.08;MaxEntScan=/0.1>0.2/3.4>6.4;SpliceAI=KIAA0556|0.00|0.00|0.00|0.00|2|-32|-3|-15;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=KATNIP%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D1.01%20oe_lof%3D0.73)	GT	1/0
chr16	28498069	.	C	G	3314	.	quality=DP%3D259%3BQD%3D12.80%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D6%3BABP%3D3%3BSAR%3D70%3BSAF%3D57;gene=APOBR%2CCLN3%2CIL27;variant_type=splice_region&intron%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=APOBR:ENST00000564831.6:splice_region_variant&intron_variant:LOW:intron2/3:c.2956-12C>G::%2CCLN3:ENST00000569430.7:upstream_gene_variant:MODIFIER::::%2CIL27:ENST00000356897.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=607042_[GENE%3DCLN3_PHENOS%3DCeroid%20lipofuscinosis%2C%20neuronal%2C%203%2C%20204200%20(3)%2C%20Autosomal%20recessive];dbSNP=rs114392557;gnomAD=0.00249;gnomAD_sub=0.00075%2C0.00059%2C0.00000%2C0.00425%2C0.00166;gnomAD_hom_hemi=2%2C;gnomAD_het=375;gnomAD_wt=151843;phyloP=-0.7430;CADD=4.49;MaxEntScan=11.9>11.1/11.9>11.1/0.0>0.0;SpliceAI=APOBR|0.01|0.02|0.00|0.00|37|12|12|-14;NGSD_hom=4;NGSD_het=455;NGSD_mosaic=0;NGSD_group=1%20/%2038;gene_info=CLN3%20(inh%3DAR%20oe_syn%3D1.13%20oe_mis%3D1.03%20oe_lof%3D0.59)%2C%20APOBR%20(inh%3Dn/a%20oe_syn%3D1.12%20oe_mis%3D0.95%20oe_lof%3D0.51)%2C%20IL27%20(inh%3Dn/a%20oe_syn%3D0.79%20oe_mis%3D0.75%20oe_lof%3D0.11)	GT	1/0
chr16	30089080	.	C	T	4635	.	quality=DP%3D386%3BQD%3D12.01%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D6%3BSAR%3D92%3BSAF%3D89;gene=TBX6%2CPPP4C%2CYPEL3;variant_type=missense%2Cdownstream_gene;coding_and_splicing=TBX6:ENST00000395224.7:missense_variant:MODERATE:exon4/9:c.484G>A:p.Gly162Ser:PF00907%20[T-box]%2CTBX6:ENST00000279386.6:missense_variant:MODERATE:exon3/8:c.484G>A:p.Gly162Ser:PF00907%20[T-box]%2CTBX6:ENST00000553607.1:missense_variant:MODERATE:exon3/5:c.484G>A:p.Gly162Ser:PF00907%20[T-box]%2CPPP4C:ENST00000279387.12:downstream_gene_variant:MODIFIER::::%2CPPP4C:ENST00000627746.2:downstream_gene_variant:MODIFIER::::%2CPPP4C:ENST00000561610.1:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000398841.6:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000566134.5:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000398838.8:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000563788.5:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000566595.5:downstream_gene_variant:MODIFIER::::%2CYPEL3:ENST00000562641.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=602427_[GENE%3DTBX6_PHENOS%3DSpondylocostal%20dysostosis%205%2C%20122600%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=786429%20[benign/likely%20benign%20DISEASE%3DTBX6-related%20disorder%2Cnot%20provided%2CSpondylocostal%20dysostosis%205%2CNeurodevelopmental%20abnormality%20GENE%3DTBX6]%3B;HGMD=CM1313171%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Mllerian%20aplasia%20association%20with"%20GENE%3DTBX6]%3B;dbSNP=rs56098093;gnomAD=0.00382;gnomAD_sub=0.00101%2C0.00144%2C0.00000%2C0.00600%2C0.00041;gnomAD_hom_hemi=2%2C;gnomAD_het=578;gnomAD_wt=151710;phyloP=6.0000;CADD=28.70;REVEL=0.669;AlphaMissense=0.68;MaxEntScan=/0.0>0.0/1.9>0.0;SpliceAI=TBX6|0.00|0.00|0.00|0.00|-2|-10|-5|0;PubMed=23954021;NGSD_hom=2;NGSD_het=414;NGSD_mosaic=0;NGSD_group=0%20/%2051;gene_info=PPP4C%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D0.30%20oe_lof%3D0.21)%2C%20TBX6%20(inh%3DAR+AD%20oe_syn%3D0.98%20oe_mis%3D0.91%20oe_lof%3D0.37)%2C%20YPEL3%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D0.57%20oe_lof%3D0.45)	GT	1/0
chr16	55820456	.	G	A	535	.	quality=DP%3D145%3BQD%3D3.69%3BAF%3D0.29%3BMQM%3D37%3BSAP%3D94%3BABP%3D59%3BSAR%3D0%3BSAF%3D42;gene=CES1;variant_type=synonymous;coding_and_splicing=CES1:ENST00000360526.8:synonymous_variant:LOW:exon6/14:c.717C>T:p.Asn239%3D:PF00135%20[Carboxylesterase%20family]%2CCES1:ENST00000422046.6:synonymous_variant:LOW:exon6/14:c.714C>T:p.Asn238%3D:PF00135%20[Carboxylesterase%20family]%2CCES1:ENST00000361503.8:synonymous_variant:LOW:exon6/14:c.714C>T:p.Asn238%3D:PF00135%20[Carboxylesterase%20family];OMIM=114835_[GENE%3DCES1_PHENOS%3DDrug%20metabolism%2C%20altered%2C%20CES1-related%2C%20618057%20(3)%2C%20Autosomal%20dominant];dbSNP=rs17850910;gnomAD=0.00681;gnomAD_sub=0.00189%2C0.01111%2C0.00000%2C0.00851%2C0.00168;gnomAD_hom_hemi=1%2C;gnomAD_het=1030;gnomAD_wt=150612;phyloP=-0.5010;CADD=2.14;MaxEntScan=/0.4>0.3/0.0>0.0;SpliceAI=CES1|0.00|0.00|0.00|0.00|2|23|24|0;NGSD_hom=2;NGSD_het=592;NGSD_mosaic=0;NGSD_group=0%20/%2059;gene_info=CES1%20(inh%3DAD%20oe_syn%3D1.45%20oe_mis%3D1.38%20oe_lof%3D1.02)	GT	1/0
chr16	67654269	.	T	C	1661	.	quality=DP%3D163%3BQD%3D10.19%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D74%3BABP%3D7%3BSAR%3D12%3BSAF%3D61;gene=CARMIL2%2CACD;variant_type=splice_region&intron%2Cdownstream_gene;coding_and_splicing=CARMIL2:ENST00000696175.1:splice_region_variant&intron_variant:LOW:intron31/38:c.3128+20T>C::%2CCARMIL2:ENST00000696176.1:splice_region_variant&intron_variant:LOW:intron31/38:c.3128+20T>C::%2CCARMIL2:ENST00000334583.11:splice_region_variant&intron_variant:LOW:intron30/37:c.3221+20T>C::%2CCARMIL2:ENST00000545661.5:splice_region_variant&intron_variant:LOW:intron31/37:c.3113+20T>C::%2CCARMIL2:ENST00000602924.2:splice_region_variant&intron_variant:LOW:intron2/8:c.203+20T>C::%2CACD:ENST00000620761.6:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695694.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695732.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695733.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695734.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000219251.13:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000602382.6:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695658.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000602320.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695659.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695648.1:downstream_gene_variant:MODIFIER::::%2CACD:ENST00000695697.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=610859_[GENE%3DCARMIL2_PHENOS%3DImmunodeficiency%2058%2C%20618131%20(3)%2C%20Autosomal%20recessive]&609377_[GENE%3DACD_PHENOS%3D?Dyskeratosis%20congenita%2C%20autosomal%20recessive%207%2C%20616553%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20?Dyskeratosis%20congenita%2C%20autosomal%20dominant%206%2C%20616553%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=1164990%20[benign/likely%20benign%20DISEASE%3DSevere%20combined%20immunodeficiency%20due%20to%20CARMIL2%20deficiency%2Cnot%20provided%20GENE%3DCARMIL2]%3B;dbSNP=rs56088143;gnomAD=0.00641;gnomAD_sub=0.00184%2C0.00493%2C0.00000%2C0.01024%2C0.00077;gnomAD_hom_hemi=2%2C;gnomAD_het=918;gnomAD_wt=142924;phyloP=-2.3390;CADD=2.65;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=RLTPR|0.00|0.00|0.00|0.00|-30|38|-16|-20;NGSD_hom=2;NGSD_het=488;NGSD_mosaic=0;NGSD_group=0%20/%2052;gene_info=CARMIL2%20(inh%3DAR%20oe_syn%3D0.95%20oe_mis%3D0.85%20oe_lof%3D0.41)%2C%20ACD%20(inh%3DAR+AD%20oe_syn%3D1.20%20oe_mis%3D1.08%20oe_lof%3D0.82)	GT	1/0
chr16	67830493	.	G	A	1882	.	quality=DP%3D165%3BQD%3D11.41%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D25%3BABP%3D4%3BSAR%3D53%3BSAF%3D25;gene=CENPT%2CTSNAXIP1;variant_type=synonymous%2C3'UTR%2Cdownstream_gene;coding_and_splicing=CENPT:ENST00000562787.6:synonymous_variant:LOW:exon11/16:c.759C>T:p.Asn253%3D:PF16171%20[Centromere%20kinetochore%20component%20CENP-T%20N-terminus]%2CCENPT:ENST00000440851.6:synonymous_variant:LOW:exon9/14:c.759C>T:p.Asn253%3D:PF16171%20[Centromere%20kinetochore%20component%20CENP-T%20N-terminus]%2CCENPT:ENST00000626059.2:3_prime_UTR_variant:MODIFIER:exon7/12:c.*449C>T::%2CCENPT:ENST00000564817.5:synonymous_variant:LOW:exon8/13:c.759C>T:p.Asn253%3D:PF16171%20[Centromere%20kinetochore%20component%20CENP-T%20N-terminus]%2CTSNAXIP1:ENST00000415766.7:downstream_gene_variant:MODIFIER::::%2CTSNAXIP1:ENST00000561639.6:downstream_gene_variant:MODIFIER::::%2CTSNAXIP1:ENST00000388833.7:downstream_gene_variant:MODIFIER::::;OMIM=611510_[GENE%3DCENPT_PHENOS%3D?Short%20stature%20and%20microcephaly%20with%20genital%20anomalies%2C%20618702%20(3)%2C%20Autosomal%20recessive];ClinVar=3042973%20[likely%20benign%20DISEASE%3DCENPT-related%20disorder%20GENE%3DCENPT]%3B;dbSNP=rs56045040;gnomAD=0.00093;gnomAD_sub=0.00024%2C0.00026%2C0.00000%2C0.00148%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=141;gnomAD_wt=152209;phyloP=-0.4720;CADD=1.09;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CENPT|0.00|0.00|0.00|0.00|-44|20|15|-2;NGSD_hom=0;NGSD_het=103;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=TSNAXIP1%20(inh%3Dn/a%20oe_syn%3D1.00%20oe_mis%3D1.07%20oe_lof%3D1.16)%2C%20CENPT%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.98%20oe_lof%3D0.49)	GT	1/0
chr16	68353432	.	C	A	2584	.	quality=DP%3D219%3BQD%3D11.80%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D10%3BABP%3D4%3BSAR%3D43%3BSAF%3D62;gene=PRMT7%2CSMPD3;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=PRMT7:ENST00000565745.6:intron_variant:MODIFIER:intron15/18:c.1576-60C>A::%2CPRMT7:ENST00000692760.1:intron_variant:MODIFIER:intron15/18:c.1576-60C>A::%2CPRMT7:ENST00000441236.3:intron_variant:MODIFIER:intron15/18:c.1576-60C>A::%2CPRMT7:ENST00000692632.1:missense_variant:MODERATE:exon16/19:c.1519C>A:p.Leu507Met:%2CPRMT7:ENST00000691804.1:intron_variant:MODIFIER:intron13/16:c.1438-60C>A::%2CPRMT7:ENST00000691961.1:intron_variant:MODIFIER:intron12/15:c.1354-60C>A::%2CPRMT7:ENST00000692966.1:missense_variant:MODERATE:exon16/17:c.1613C>A:p.Ala538Asp:%2CPRMT7:ENST00000691663.1:intron_variant:MODIFIER:intron12/15:c.1282-60C>A::%2CPRMT7:ENST00000449359.7:intron_variant:MODIFIER:intron13/16:c.1426-60C>A::%2CPRMT7:ENST00000687558.1:intron_variant:MODIFIER:intron14/17:c.1576-60C>A::%2CPRMT7:ENST00000339507.9:intron_variant:MODIFIER:intron15/18:c.1576-60C>A::%2CSMPD3:ENST00000219334.10:downstream_gene_variant:MODIFIER::::;OMIM=610087_[GENE%3DPRMT7_PHENOS%3DShort%20stature%2C%20brachydactyly%2C%20intellectual%20developmental%20disability%2C%20and%20seizures%2C%20617157%20(3)%2C%20Autosomal%20recessive];ClinVar=2646659%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPRMT7]%3B;dbSNP=rs56365255;gnomAD=0.00583;gnomAD_sub=0.00120%2C0.00209%2C0.00000%2C0.00714%2C0.00000;gnomAD_hom_hemi=2%2C;gnomAD_het=884;gnomAD_wt=151478;phyloP=-0.6860;CADD=0.26;MaxEntScan=/2.9>0.1/0.0>0.0;SpliceAI=PRMT7|0.00|0.00|0.00|0.00|27|-29|-17|-38;NGSD_hom=3;NGSD_het=506;NGSD_mosaic=0;NGSD_group=0%20/%2060;gene_info=PRMT7%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.91%20oe_lof%3D0.72)%2C%20SMPD3%20(inh%3Dn/a%20oe_syn%3D1.12%20oe_mis%3D0.85%20oe_lof%3D0.20)	GT	1/0
chr16	69343567	.	A	G	1903	.	quality=DP%3D131%3BQD%3D14.53%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D14%3BABP%3D7%3BSAR%3D46%3BSAF%3D27;gene=TMED6%2CCOG8%2CNIP7;variant_type=missense%2Cupstream_gene%2Cdownstream_gene;coding_and_splicing=TMED6:ENST00000288025.4:missense_variant:MODERATE:exon4/4:c.563T>C:p.Met188Thr:PF01105%20[emp24/gp25L/p24%20family/GOLD]%2CCOG8:ENST00000306875.10:upstream_gene_variant:MODIFIER::::%2CCOG8:ENST00000562081.2:upstream_gene_variant:MODIFIER::::%2CNIP7:ENST00000569637.6:downstream_gene_variant:MODIFIER::::%2CNIP7:ENST00000254940.10:downstream_gene_variant:MODIFIER::::%2CNIP7:ENST00000254941.6:downstream_gene_variant:MODIFIER::::;OMIM=606979_[GENE%3DCOG8_PHENOS%3DCongenital%20disorder%20of%20glycosylation%2C%20type%20IIh%2C%20611182%20(3)];dbSNP=rs72795291;gnomAD=0.00275;gnomAD_sub=0.00094%2C0.00222%2C0.00000%2C0.00463%2C0.00270;gnomAD_hom_hemi=0%2C;gnomAD_het=419;gnomAD_wt=151831;phyloP=-0.0870;CADD=2.67;REVEL=0.024;AlphaMissense=0.06;MaxEntScan=/0.0>0.0/0.2>0.0;SpliceAI=RP11-343C2.7|0.00|0.00|0.00|0.00|5|-19|-45|2%2CRP11-343C2.9|0.00|0.00|0.00|0.00|5|-19|-45|2%2CTMED6|0.00|0.00|0.00|0.00|5|-38|-37|11;NGSD_hom=3;NGSD_het=440;NGSD_mosaic=0;NGSD_group=1%20/%2053;gene_info=COG8%20(inh%3DAR%20oe_syn%3D1.14%20oe_mis%3D1.01%20oe_lof%3D0.75)%2C%20NIP7%20(inh%3Dn/a%20oe_syn%3D1.27%20oe_mis%3D0.95%20oe_lof%3D0.22)%2C%20TMED6%20(inh%3Dn/a%20oe_syn%3D1.15%20oe_mis%3D1.13%20oe_lof%3D0.64)	GT	1/0
chr16	70466972	.	T	C	3110	.	quality=DP%3D255%3BQD%3D12.20%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D15%3BABP%3D4%3BSAR%3D74%3BSAF%3D48;gene=FCSK;variant_type=intron%2Csplice_region&intron;coding_and_splicing=FCSK:ENST00000571514.5:intron_variant:MODIFIER:intron1/15:c.-697-1877T>C::%2CFCSK:ENST00000288078.11:splice_region_variant&intron_variant:LOW:intron6/23:c.484+18T>C::%2CFCSK:ENST00000378912.6:splice_region_variant&intron_variant:LOW:intron6/23:c.580+18T>C::;OMIM=608675_[GENE%3DFCSK_PHENOS%3DCongenital%20disorder%20of%20glycosylation%20with%20defective%20fucosylation%202%2C%20618324%20(3)%2C%20Autosomal%20recessive];ClinVar=1682352%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DFCSK]%3B;dbSNP=rs56366805;gnomAD=0.00549;gnomAD_sub=0.00137%2C0.00307%2C0.00019%2C0.00850%2C0.00145;gnomAD_hom_hemi=5%2C;gnomAD_het=826;gnomAD_wt=151528;phyloP=-1.0180;CADD=0.21;REVEL=0.124;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=FUK|0.00|0.00|0.00|0.00|-12|24|-18|-21;NGSD_hom=0;NGSD_het=539;NGSD_mosaic=0;NGSD_group=0%20/%2072;gene_info=FCSK%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.96%20oe_lof%3D0.89)	GT	1/0
chr16	70664191	.	G	A	1544	.	quality=DP%3D125%3BQD%3D12.35%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D35%3BABP%3D3%3BSAR%3D48%3BSAF%3D17;gene=MTSS2%2CIL34;variant_type=missense%2Cdownstream_gene;coding_and_splicing=MTSS2:ENST00000338779.11:missense_variant:MODERATE:exon15/15:c.1730C>T:p.Ala577Val:%2CIL34:ENST00000429149.6:downstream_gene_variant:MODIFIER::::%2CIL34:ENST00000288098.7:downstream_gene_variant:MODIFIER::::%2CIL34:ENST00000566361.1:downstream_gene_variant:MODIFIER::::;OMIM=616951_[GENE%3DMTSS2_PHENOS%3DIntellectual%20developmental%20disorder%20with%20ocular%20anomalies%20and%20distinctive%20facial%20features%2C%20620086%20(3)%2C%20Autosomal%20dominant];RepeatMasker=(GGACGGT)n%20(Simple_repeat);dbSNP=rs77173170;gnomAD=0.00722;gnomAD_sub=0.00226%2C0.00483%2C0.00019%2C0.01101%2C0.00973;gnomAD_hom_hemi=9%2C;gnomAD_het=1081;gnomAD_wt=151191;phyloP=4.0820;CADD=24.90;REVEL=0.059;AlphaMissense=0.15;MaxEntScan=/6.6>7.1/0.0>0.0;SpliceAI=FLJ00418|0.00|0.00|0.08|0.00|-44|-9|11|-1%2CMTSS1L|0.00|0.00|0.00|0.00|16|8|-46|11;NGSD_hom=9;NGSD_het=834;NGSD_mosaic=0;NGSD_group=0%20/%20112;gene_info=IL34%20(inh%3Dn/a%20oe_syn%3D1.08%20oe_mis%3D1.18%20oe_lof%3D0.18)%2C%20MTSS2%20(inh%3DAD%20oe_syn%3D1.32%20oe_mis%3D0.90%20oe_lof%3D0.15)	GT	1/0
chr16	72120111	.	C	T	1452	.	quality=DP%3D125%3BQD%3D11.62%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D43%3BABP%3D3%3BSAR%3D48%3BSAF%3D14;gene=PMFBP1;variant_type=intron%2Cmissense;coding_and_splicing=PMFBP1:ENST00000537792.5:intron_variant:MODIFIER:intron3/3:c.266+2803G>A::%2CPMFBP1:ENST00000537465.5:intron_variant:MODIFIER:intron19/19:c.2784-22G>A::%2CPMFBP1:ENST00000237353.15:intron_variant:MODIFIER:intron19/20:c.2769-22G>A::%2CPMFBP1:ENST00000355636.10:missense_variant:MODERATE:exon20/21:c.2372G>A:p.Arg791His:;OMIM=618085_[GENE%3DPMFBP1_PHENOS%3DSpermatogenic%20failure%2031%2C%20618112%20(3)%2C%20Autosomal%20recessive];ClinVar=3055584%20[benign%20DISEASE%3DPMFBP1-related%20disorder%20GENE%3DPMFBP1]%3B;dbSNP=rs72787072;gnomAD=0.00735;gnomAD_sub=0.00149%2C0.00640%2C0.00000%2C0.00995%2C0.00580;gnomAD_hom_hemi=3%2C;gnomAD_het=1114;gnomAD_wt=151158;phyloP=-0.2050;CADD=2.35;REVEL=0.009;MaxEntScan=/2.1>1.6/0.0>0.0;SpliceAI=PMFBP1|0.00|0.00|0.00|0.00|-22|38|-34|35;NGSD_hom=7;NGSD_het=782;NGSD_mosaic=0;NGSD_group=0%20/%2082;gene_info=PMFBP1%20(inh%3DAR%20oe_syn%3D1.10%20oe_mis%3D1.06%20oe_lof%3D0.88)	GT	1/0
chr16	72788113	.	TGCTGCTGCTGCTGTAGTTGCC	T	1148	.	quality=DP%3D114%3BQD%3D10.07%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D14%3BABP%3D3%3BSAR%3D21%3BSAF%3D38;gene=ZFHX3-AS1%2CZFHX3;variant_type=intron&non_coding_transcript%2Cnon_coding_transcript_exon%2Cinframe_deletion;coding_and_splicing=ZFHX3-AS1:ENST00000653037.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.444+6308_444+6328del::%2CZFHX3-AS1:ENST00000687589.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/7:n.482+6308_482+6328del::%2CZFHX3-AS1:ENST00000686426.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/3:n.418-32646_418-32626del::%2CZFHX3-AS1:ENST00000563328.4:non_coding_transcript_exon_variant:MODIFIER:exon5/5:n.1345_1365del::%2CZFHX3:ENST00000268489.10:inframe_deletion:MODERATE:exon10/10:c.10142_10162del:p.Arg3381_Gln3387del:%2CZFHX3:ENST00000397992.5:inframe_deletion:MODERATE:exon9/9:c.7400_7420del:p.Arg2467_Gln2473del:%2CZFHX3:ENST00000641206.2:inframe_deletion:MODERATE:exon18/18:c.10142_10162del:p.Arg3381_Gln3387del:;OMIM=104155_[GENE%3DZFHX3_PHENOS%3DProstate%20cancer%2C%20somatic%2C%20176807%20(3)];ClinVar=808084%20[likely%20benign%20DISEASE%3Dnot%20provided%2CZFHX3-related%20disorder%20GENE%3DZFHX3]%3B;HGMD=CG065880%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Prostate%20cancer%20risk%20association%20with"%20GENE%3DZFHX3]%3B;RepeatMasker=(GCT)n%20(Simple_repeat);dbSNP=rs755516522;gnomAD=0.00297;gnomAD_sub=0.00077%2C0.00237%2C0.00019%2C0.00450%2C0.00104;gnomAD_hom_hemi=1%2C;gnomAD_het=449;gnomAD_wt=151377;phyloP=7.1180;CADD=16.91;MaxEntScan=/3.5>0.1/0.0>0.0%2C/0.0>0.0/0.0>0.0;SpliceAI=ZFHX3|0.00|0.00|0.00|0.00|-45|10|44|-7;NGSD_hom=5;NGSD_het=390;NGSD_mosaic=3;NGSD_group=1%20/%2048;gene_info=ZFHX3-AS1%20(inh%3DAD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20ZFHX3%20(inh%3DAD%20oe_syn%3D1.04%20oe_mis%3D0.91%20oe_lof%3D0.18)	GT	1/0
chr16	75635906	.	G	A	1503	.	quality=DP%3D158%3BQD%3D9.51%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D7%3BABP%3D17%3BSAR%3D26%3BSAF%3D37;gene=KARS1;variant_type=splice_region&intron%2Cintron;coding_and_splicing=KARS1:ENST00000319410.9:splice_region_variant&intron_variant:LOW:intron6/14:c.753+6C>T::%2CKARS1:ENST00000302445.8:splice_region_variant&intron_variant:LOW:intron5/13:c.669+6C>T::%2CKARS1:ENST00000568378.5:intron_variant:MODIFIER:intron2/2:c.147-7917C>T::;OMIM=601421_[GENE%3DKARS1_PHENOS%3DDeafness%2C%20autosomal%20recessive%2089%2C%20613916%20(3)%2C%20Autosomal%20recessive%3B%20Leukoencephalopathy%2C%20progressive%2C%20infantile-onset%2C%20with%20or%20without%20deafness%2C%20619147%20(3)%2C%20Autosomal%20recessive%3B%20?Charcot-Marie-Tooth%20disease%2C%20recessive%20intermediate%2C%20B%2C%20613641%20(3)%2C%20Autosomal%20recessive%3B%20Deafness%2C%20congenital%2C%20and%20adult-onset%20progressive%20leukoencephalopathy%2C%20619196%20(3)%2C%20Autosomal%20recessive];ClinVar=320636%20[uncertain%20significance(replaced%20by%20megSAP%20based%20on%20classifications:1x2%2C1x3)%20DISEASE%3Dnot%20provided%20GENE%3DKARS1]%3B;dbSNP=rs72789443;gnomAD=0.00003;gnomAD_sub=0.00000%2C0.00000%2C0.00077%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=5;gnomAD_wt=152235;phyloP=-0.1210;CADD=5.43;MaxEntScan=10.2>11.0/4.0>4.4/10.2>11.0%2C/4.0>4.4/10.2>11.0;SpliceAI=KARS|0.00|0.00|0.00|0.00|10|6|6|3;PubMed=9536098%2C17576681;NGSD_hom=0;NGSD_het=15;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=KARS1%20(inh%3DAR%20oe_syn%3D1.24%20oe_mis%3D1.11%20oe_lof%3D0.61)	GT	1/0
chr16	81908423	.	C	G	2503	.	quality=DP%3D243%3BQD%3D10.30%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D96%3BABP%3D10%3BSAR%3D20%3BSAF%3D88;gene=PLCG2;variant_type=missense;coding_and_splicing=PLCG2:ENST00000564138.6:missense_variant:MODERATE:exon17/33:c.1565C>G:p.Pro522Arg:%2CPLCG2:ENST00000697564.1:missense_variant:MODERATE:exon15/31:c.1448C>G:p.Pro483Arg:%2CPLCG2:ENST00000697583.1:missense_variant:MODERATE:exon17/33:c.1364C>G:p.Pro455Arg:%2CPLCG2:ENST00000697584.1:missense_variant:MODERATE:exon16/32:c.1364C>G:p.Pro455Arg:%2CPLCG2:ENST00000697585.1:missense_variant:MODERATE:exon17/33:c.1364C>G:p.Pro455Arg:%2CPLCG2:ENST00000697586.1:missense_variant:MODERATE:exon16/32:c.1364C>G:p.Pro455Arg:%2CPLCG2:ENST00000697587.1:missense_variant:MODERATE:exon16/32:c.1364C>G:p.Pro455Arg:;OMIM=600220_[GENE%3DPLCG2_PHENOS%3DAutoinflammation%2C%20antibody%20deficiency%2C%20and%20immune%20dysregulation%20syndrome%2C%20614878%20(3)%2C%20Autosomal%20dominant%3B%20Familial%20cold%20autoinflammatory%20syndrome%203%2C%20614468%20(3)%2C%20Autosomal%20dominant];ClinVar=440154%20[benign/likely%20benign%20DISEASE%3DFamilial%20cold%20autoinflammatory%20syndrome%203%2CPLCG2-related%20disorder%2Cnot%20provided%20GENE%3DPLCG2]%3B;HGMD=CM1515704%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Neuronal%20ceroid%20lipofuscinosis"%20GENE%3DPLCG2]%3B;dbSNP=rs72824905;gnomAD=0.00494;gnomAD_sub=0.00128%2C0.00255%2C0.00000%2C0.00882%2C0.00062;gnomAD_hom_hemi=3%2C;gnomAD_het=746;gnomAD_wt=151484;phyloP=2.5570;CADD=15.62;REVEL=0.085;AlphaMissense=0.10;MaxEntScan=/3.6>2.3/0.0>0.0;COSMIC=COSV100842711%2CCOSV63873320;SpliceAI=PLCG2|0.02|0.00|0.00|0.00|-41|9|43|9;PubMed=33815092%2C33926499%2C30705288%2C28714976%2C31131421%2C32166339%2C32917267%2C33523007%2C31080872%2C35180881%2C33117616%2C33797837%2C33823896%2C33578866%2C30258121%2C35693341%2C36058959%2C35429259%2C34749609%2C36147734%2C33092647%2C34615897%2C37081539%2C30326945%2C34381040%2C34992629%2C37008802%2C34935119%2C30337151%2C28666525%2C33152005%2C35000612%2C32657454%2C30344948%2C35379992%2C33589840%2C33239300%2C35813947%2C37626736%2C37569491;NGSD_hom=9;NGSD_het=786;NGSD_mosaic=0;NGSD_group=3%20/%2099;classification=2;classification_comment="[2]%20faust%2021.03.2018";gene_info=PLCG2%20(inh%3DAD%20oe_syn%3D1.36%20oe_mis%3D0.92%20oe_lof%3D0.18)	GT	1/0
chr16	87891824	.	T	C	1488	.	quality=DP%3D132%3BQD%3D11.27%3BAF%3D0.45%3BMQM%3D58%3BSAP%3D5%3BABP%3D5%3BSAR%3D26%3BSAF%3D34;gene=CA5A;variant_type=missense%2Csynonymous;coding_and_splicing=CA5A:ENST00000649158.1:missense_variant:MODERATE:exon6/7:c.749A>G:p.Glu250Gly:PF00194%20[Eukaryotic-type%20carbonic%20anhydrase]%2CCA5A:ENST00000648177.1:synonymous_variant:LOW:exon4/5:c.567A>G:p.Gly189%3D:%2CCA5A:ENST00000649794.3:missense_variant:MODERATE:exon6/7:c.749A>G:p.Glu250Gly:PF00194%20[Eukaryotic-type%20carbonic%20anhydrase];regulatory=regulatory_region_variant:enhancer;OMIM=114761_[GENE%3DCA5A_PHENOS%3DHyperammonemia%20due%20to%20carbonic%20anhydrase%20VA%20deficiency%2C%20615751%20(3)%2C%20Autosomal%20recessive];ClinVar=559305%20[likely%20benign%20DISEASE%3DCA5A-related%20disorder%2Cnot%20provided%2CHyperammonemic%20encephalopathy%20due%20to%20carbonic%20anhydrase%20VA%20deficiency%20GENE%3DCA5A]%3B;dbSNP=rs146136907;gnomAD=0.00414;gnomAD_sub=0.00127%2C0.00137%2C0.00000%2C0.00773%2C0.00000;gnomAD_hom_hemi=3%2C;gnomAD_het=625;gnomAD_wt=151683;phyloP=0.8430;CADD=19.91;REVEL=0.123;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CA5A|0.00|0.00|0.00|0.00|-12|4|27|-25;NGSD_hom=4;NGSD_het=304;NGSD_mosaic=1;NGSD_group=0%20/%2030;gene_info=CA5A%20(inh%3DAR%20oe_syn%3D1.23%20oe_mis%3D1.25%20oe_lof%3D0.56)	GT	1/0
chr16	88734397	.	G	A	2272	.	quality=DP%3D168%3BQD%3D13.52%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D7%3BABP%3D4%3BSAR%3D38%3BSAF%3D50;gene=PIEZO1;variant_type=synonymous;coding_and_splicing=PIEZO1:ENST00000301015.14:synonymous_variant:LOW:exon16/51:c.2139C>T:p.His713%3D:;OMIM=611184_[GENE%3DPIEZO1_PHENOS%3DER%20blood%20group%20system%2C%20620207%20(3)%2C%20Autosomal%20recessive%3B%20Lymphatic%20malformation%206%2C%20616843%20(3)%2C%20Autosomal%20recessive%3B%20Dehydrated%20hereditary%20stomatocytosis%20with%20or%20without%20pseudohyperkalemia%20and/or%20perinatal%20edema%2C%20194380%20(3)%2C%20Autosomal%20dominant];ClinVar=773310%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPIEZO1]%3B;dbSNP=rs36067616;gnomAD=0.00545;gnomAD_sub=0.00149%2C0.00385%2C0.00019%2C0.00750%2C0.00518;gnomAD_hom_hemi=10%2C;gnomAD_het=811;gnomAD_wt=151543;phyloP=2.3070;CADD=1.63;REVEL=0.299;MaxEntScan=/0.9>1.4/0.0>0.0;COSMIC=COSV56334819;SpliceAI=PIEZO1|0.00|0.00|0.00|0.00|31|30|31|-41;NGSD_hom=5;NGSD_het=375;NGSD_mosaic=0;NGSD_group=0%20/%2034;gene_info=PIEZO1%20(inh%3DAR+AD%20oe_syn%3D1.59%20oe_mis%3D1.25%20oe_lof%3D0.46)	GT	1/0
chr16	89697634	.	A	G	3769	.	quality=DP%3D325%3BQD%3D11.60%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D4%3BABP%3D7%3BSAR%3D72%3BSAF%3D79;gene=SPATA2L%2CCDK10;variant_type=synonymous%2Cintron%2Cdownstream_gene;coding_and_splicing=SPATA2L:ENST00000289805.10:synonymous_variant:LOW:exon3/3:c.975T>C:p.Pro325%3D:%2CSPATA2L:ENST00000335360.11:intron_variant:MODIFIER:intron3/3:c.414+561T>C::%2CCDK10:ENST00000331006.12:downstream_gene_variant:MODIFIER::::%2CCDK10:ENST00000505473.5:downstream_gene_variant:MODIFIER::::%2CCDK10:ENST00000353379.12:downstream_gene_variant:MODIFIER::::%2CCDK10:ENST00000617879.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:enhancer;OMIM=603464_[GENE%3DCDK10_PHENOS%3DAl%20Kaissi%20syndrome%2C%20617694%20(3)%2C%20Autosomal%20recessive];dbSNP=rs55645629;gnomAD=0.00436;gnomAD_sub=0.00089%2C0.00281%2C0.00000%2C0.00607%2C0.00207;gnomAD_hom_hemi=4%2C;gnomAD_het=656;gnomAD_wt=151628;phyloP=-0.1190;CADD=0.67;MaxEntScan=/2.2>1.1/0.0>0.0;COSMIC=COSV99232479;SpliceAI=SPATA2L|0.00|0.00|0.00|0.00|21|-14|-28|31;NGSD_hom=2;NGSD_het=400;NGSD_mosaic=0;NGSD_group=1%20/%2049;gene_info=CDK10%20(inh%3DAR%20oe_syn%3D1.34%20oe_mis%3D1.09%20oe_lof%3D1.03)%2C%20SPATA2L%20(inh%3Dn/a%20oe_syn%3D1.38%20oe_mis%3D1.05%20oe_lof%3D0.37)	GT	1/0
chr17	819449	.	G	A	1851	.	quality=DP%3D171%3BQD%3D10.82%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D58%3BABP%3D8%3BSAR%3D16%3BSAF%3D60;gene=NXN;variant_type=synonymous;coding_and_splicing=NXN:ENST00000336868.8:synonymous_variant:LOW:exon5/8:c.810C>T:p.Tyr270%3D:PF13905%20[Thioredoxin-like]%2CNXN:ENST00000575801.5:synonymous_variant:LOW:exon5/8:c.486C>T:p.Tyr162%3D:PF13905%20[Thioredoxin-like]%2CNXN:ENST00000537628.6:synonymous_variant:LOW:exon5/8:c.63C>T:p.Tyr21%3D:;OMIM=612895_[GENE%3DNXN_PHENOS%3DRobinow%20syndrome%2C%20autosomal%20recessive%202%2C%20618529%20(3)%2C%20Autosomal%20recessive];ClinVar=1661787%20[benign/likely%20benign%20DISEASE%3DNXN-related%20disorder%2Cnot%20provided%20GENE%3DNXN]%3B;dbSNP=rs72810286;gnomAD=0.00104;gnomAD_sub=0.00017%2C0.00033%2C0.00000%2C0.00157%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=158;gnomAD_wt=152180;phyloP=-0.3780;CADD=4.73;MaxEntScan=/0.0>0.2/2.0>1.4;COSMIC=COSV61099126;SpliceAI=NXN|0.00|0.00|0.00|0.00|-11|4|-7|4;NGSD_hom=0;NGSD_het=127;NGSD_mosaic=0;NGSD_group=0%20/%2013;gene_info=NXN%20(inh%3DAR%20oe_syn%3D0.89%20oe_mis%3D0.61%20oe_lof%3D0.05)	GT	1/0
chr17	1827927	.	A	G	1412	.	quality=DP%3D116%3BQD%3D12.17%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D27%3BSAF%3D31;gene=SMYD4%2CRPA1;variant_type=missense%2Cupstream_gene;coding_and_splicing=SMYD4:ENST00000305513.12:missense_variant:MODERATE:exon2/11:c.68T>C:p.Val23Ala:%2CRPA1:ENST00000254719.10:upstream_gene_variant:MODIFIER::::;OMIM=179835_[GENE%3DRPA1_PHENOS%3DPulmonary%20fibrosis%20and/or%20bone%20marrow%20failure%20syndrome%2C%20telomere-related%2C%206%2C%20619767%20(3)%2C%20Autosomal%20dominant];dbSNP=rs72822491;gnomAD=0.00330;gnomAD_sub=0.00137%2C0.00255%2C0.00000%2C0.00581%2C0.00021;gnomAD_hom_hemi=3%2C;gnomAD_het=496;gnomAD_wt=151836;phyloP=-0.0720;CADD=0.77;REVEL=0.036;AlphaMissense=0.10;MaxEntScan=/6.1>4.8/0.5>0.0;SpliceAI=SMYD4|0.00|0.00|0.00|0.00|22|-5|-27|-4;NGSD_hom=0;NGSD_het=328;NGSD_mosaic=0;NGSD_group=0%20/%2040;gene_info=SMYD4%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D1.00%20oe_lof%3D0.78)%2C%20RPA1%20(inh%3DAD%20oe_syn%3D1.01%20oe_mis%3D0.82%20oe_lof%3D0.25)	GT	1/0
chr17	6703999	.	C	T	1953	.	quality=DP%3D181%3BQD%3D10.79%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D20%3BABP%3D7%3BSAR%3D53%3BSAF%3D28;gene=SLC13A5;variant_type=synonymous;coding_and_splicing=SLC13A5:ENST00000433363.7:synonymous_variant:LOW:exon4/12:c.426G>A:p.Thr142%3D:PF00939%20[Sodium%20sulfate%20symporter%20transmembrane%20region]%2CSLC13A5:ENST00000293800.10:synonymous_variant:LOW:exon4/12:c.375G>A:p.Thr125%3D:PF00939%20[Sodium%20sulfate%20symporter%20transmembrane%20region]%2CSLC13A5:ENST00000381074.8:synonymous_variant:LOW:exon3/11:c.297G>A:p.Thr99%3D:PF00939%20[Sodium%20sulfate%20symporter%20transmembrane%20region]%2CSLC13A5:ENST00000573648.5:synonymous_variant:LOW:exon4/11:c.426G>A:p.Thr142%3D:PF00939%20[Sodium%20sulfate%20symporter%20transmembrane%20region];OMIM=608305_[GENE%3DSLC13A5_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2025%2C%20with%20amelogenesis%20imperfecta%2C%20615905%20(3)%2C%20Autosomal%20recessive];ClinVar=380898%20[benign/likely%20benign%20DISEASE%3DInborn%20genetic%20diseases%2Cnot%20specified%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2025%2Cnot%20provided%20GENE%3DSLC13A5]%3B;dbSNP=rs72836208;gnomAD=0.00240;gnomAD_sub=0.00060%2C0.00118%2C0.00000%2C0.00443%2C0.00042;gnomAD_hom_hemi=1%2C;gnomAD_het=364;gnomAD_wt=151838;phyloP=-2.3900;CADD=8.11;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SLC13A5|0.01|0.00|0.00|0.00|6|28|-2|-18;NGSD_hom=2;NGSD_het=356;NGSD_mosaic=0;NGSD_group=0%20/%2045;gene_info=SLC13A5%20(inh%3DAR%20oe_syn%3D1.02%20oe_mis%3D0.83%20oe_lof%3D0.39)	GT	1/0
chr17	17796723	.	AAGG	A	2891	.	quality=DP%3D296%3BQD%3D9.77%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D4%3BABP%3D13%3BSAR%3D62%3BSAF%3D68;gene=RAI1;variant_type=inframe_deletion;coding_and_splicing=RAI1:ENST00000353383.6:inframe_deletion:MODERATE:exon3/6:c.3781_3783del:p.Glu1261del:;OMIM=607642_[GENE%3DRAI1_PHENOS%3DSmith-Magenis%20syndrome%2C%20182290%20(3)%2C%20Isolated%20cases%2C%20Autosomal%20dominant];ClinVar=96187%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CSmith-Magenis%20syndrome%2CRAI1-related%20disorder%2CInborn%20genetic%20diseases%20GENE%3DRAI1]%3B;HGMD=CD116392%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Smith-Magenis%20syndrome"%20GENE%3DRAI1]%3B;dbSNP=rs149716029;gnomAD=0.00371;gnomAD_sub=0.00123%2C0.00150%2C0.00000%2C0.00542%2C0.00021;gnomAD_hom_hemi=7%2C;gnomAD_het=550;gnomAD_wt=151660;phyloP=7.5870;CADD=16.35;MaxEntScan=/0.0>0.0/1.7>1.7;SpliceAI=RAI1|0.00|0.00|0.00|0.00|-37|41|-25|-21;PubMed=25741868%2C18414213%2C23757202%2C27082237%2C21857958;NGSD_hom=4;NGSD_het=412;NGSD_mosaic=0;NGSD_group=0%20/%2048;classification=2;classification_comment="[2]%20ahkehrm1%2024.06.2016%3B%20zwar%20als%20DM?%20in%20HGMD%20klassifiziert%2C%20in%20Originalpub%20(Vilboux%20et%20al.%202011)%20jedoch%20paternal%20ererbt%20(Vater%20gesund)%2C%20in%20ExAC%200%2C26%20?bereits%209%20x%20in%20ihdb%2C%20auch%20bei%20mind.%20einem%20anderweitig%20gelsten%20Fall%2C%20in%20ClinVAr%20auch%20als%20benigne%2C%20Experten-Review%20mit%20UG";gene_info=RAI1%20(inh%3DAD%20oe_syn%3D1.17%20oe_mis%3D0.91%20oe_lof%3D0.04)	GT	1/0
chr17	18144511	.	G	A	3608	.	quality=DP%3D266%3BQD%3D13.56%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D67%3BSAF%3D70;gene=MYO15A;variant_type=synonymous;coding_and_splicing=MYO15A:ENST00000647165.2:synonymous_variant:LOW:exon29/66:c.6192G>A:p.Gly2064%3D:;regulatory=regulatory_region_variant:enhancer;OMIM=602666_[GENE%3DMYO15A_PHENOS%3DDeafness%2C%20autosomal%20recessive%203%2C%20600316%20(3)%2C%20Autosomal%20recessive];ClinVar=178446%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C1x2%2C1x3)%20DISEASE%3Dnot%20specified%2CAutosomal%20recessive%20nonsyndromic%20hearing%20loss%203%2Cnot%20provided%2CMYO15A-related%20disorder%20GENE%3DMYO15A]%3B;dbSNP=rs55688805;gnomAD=0.00437;gnomAD_sub=0.00072%2C0.00046%2C0.00000%2C0.00615%2C0.00000;gnomAD_hom_hemi=4%2C;gnomAD_het=657;gnomAD_wt=151617;phyloP=4.7550;CADD=8.43;MaxEntScan=/2.9>3.0/0.0>0.0;COSMIC=COSV52766467;SpliceAI=MYO15A|0.01|0.00|0.00|0.00|11|-48|11|-14;PubMed=24033266;NGSD_hom=1;NGSD_het=509;NGSD_mosaic=0;NGSD_group=0%20/%2046;gene_info=MYO15A%20(inh%3DAR%20oe_syn%3D0.93%20oe_mis%3D0.96%20oe_lof%3D0.69)	GT	1/0
chr17	40750466	.	C	T	1826	.	quality=DP%3D173%3BQD%3D10.55%3BAF%3D0.44%3BMQM%3D56%3BSAP%3D7%3BABP%3D9%3BSAR%3D32%3BSAF%3D44;gene=KRT25;variant_type=synonymous;coding_and_splicing=KRT25:ENST00000312150.5:synonymous_variant:LOW:exon6/8:c.1089G>A:p.Lys363%3D:PF00038%20[Intermediate%20filament%20protein];regulatory=regulatory_region_variant:open_chromatin_region;OMIM=616646_[GENE%3DKRT25_PHENOS%3DWoolly%20hair%2C%20autosomal%20recessive%203%2C%20616760%20(3)%2C%20Autosomal%20recessive];ClinVar=708240%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DKRT25]%3B;dbSNP=rs72821891;gnomAD=0.00850;gnomAD_sub=0.00224%2C0.00562%2C0.00000%2C0.01311%2C0.00601;gnomAD_hom_hemi=7%2C;gnomAD_het=1280;gnomAD_wt=150986;phyloP=-2.3700;CADD=2.36;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV56446434;SpliceAI=KRT25|0.00|0.00|0.01|0.00|27|-1|27|1;NGSD_hom=9;NGSD_het=994;NGSD_mosaic=0;NGSD_group=1%20/%20106;gene_info=KRT25%20(inh%3DAR%20oe_syn%3D0.98%20oe_mis%3D0.97%20oe_lof%3D0.72)	GT	1/0
chr17	63484535	.	G	A	1922	.	quality=DP%3D161%3BQD%3D11.94%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D64%3BABP%3D3%3BSAR%3D63%3BSAF%3D16;gene=ACE;variant_type=missense%2Cupstream_gene;coding_and_splicing=ACE:ENST00000290866.10:missense_variant:MODERATE:exon12/25:c.1915G>A:p.Gly639Ser:%2CACE:ENST00000428043.5:missense_variant:MODERATE:exon12/24:c.1915G>A:p.Gly639Ser:%2CACE:ENST00000290863.10:upstream_gene_variant:MODIFIER::::%2CACE:ENST00000413513.7:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:promoter;OMIM=106180_[GENE%3DACE_PHENOS%3D{Stroke%2C%20hemorrhagic}%2C%20614519%20(3)%3B%20Renal%20tubular%20dysgenesis%2C%20267430%20(3)%2C%20Autosomal%20recessive%3B%20{Myocardial%20infarction%2C%20susceptibility%20to}%20(3)%3B%20{Microvascular%20complications%20of%20diabetes%203}%2C%20612624%20(3)%3B%20Angiotensin%20I-converting%20enzyme%2C%20benign%20serum%20increase%20(3)%3B%20{SARS%2C%20progression%20of}%20(3)];ClinVar=324389%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CRenal%20tubular%20dysgenesis%2CMicrovascular%20complications%20of%20diabetes%2C%20susceptibility%20to%2C%203%2CHemorrhage%2C%20intracerebral%2C%20susceptibility%20to%2CRenal%20tubular%20dysgenesis%20of%20genetic%20origin%20GENE%3DACE]%3B;dbSNP=rs72845024;gnomAD=0.00009;gnomAD_sub=0.00002%2C0.00007%2C0.00019%2C0.00012%2C0.00062;gnomAD_hom_hemi=0%2C;gnomAD_het=14;gnomAD_wt=152234;phyloP=3.4510;CADD=14.78;REVEL=0.038;AlphaMissense=0.10;MaxEntScan=/0.0>0.0/0.0>0.5;SpliceAI=ACE|0.00|0.00|0.00|0.00|2|-41|6|40;NGSD_hom=0;NGSD_het=18;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=ACE%20(inh%3DAR%20oe_syn%3D1.24%20oe_mis%3D1.07%20oe_lof%3D0.87)	GT	1/0
chr17	78466792	.	C	G	2382	.	quality=DP%3D195%3BQD%3D12.22%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D17%3BABP%3D3%3BSAR%3D60%3BSAF%3D35;gene=DNAH17;variant_type=missense;coding_and_splicing=DNAH17:ENST00000389840.7:missense_variant:MODERATE:exon56/81:c.8803G>C:p.Gly2935Arg:PF12780%20[P-loop%20containing%20dynein%20motor%20region%20D4];OMIM=610063_[GENE%3DDNAH17_PHENOS%3DSpermatogenic%20failure%2039%2C%20618643%20(3)%2C%20Autosomal%20recessive];dbSNP=rs72925862;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152354;phyloP=7.4040;CADD=28.10;REVEL=0.527;AlphaMissense=0.98;MaxEntScan=/4.4>1.8/0.0>0.8;SpliceAI=DNAH17|0.08|0.03|0.00|0.00|-26|24|4|25;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=DNAH17%20(inh%3DAR%20oe_syn%3D1.40%20oe_mis%3D1.17%20oe_lof%3D0.65)	GT	1/0
chr17	78475270	.	G	A	584	.	quality=DP%3D105%3BQD%3D5.56%3BAF%3D0.31%3BMQM%3D60%3BSAP%3D22%3BABP%3D34%3BSAR%3D8%3BSAF%3D25;gene=DNAH17;variant_type=splice_region&intron;coding_and_splicing=DNAH17:ENST00000389840.7:splice_region_variant&intron_variant:LOW:intron54/80:c.8511+8C>T::;OMIM=610063_[GENE%3DDNAH17_PHENOS%3DSpermatogenic%20failure%2039%2C%20618643%20(3)%2C%20Autosomal%20recessive];dbSNP=rs116826317;phyloP=0.5450;CADD=0.75;MaxEntScan=/3.3>3.4/0.0>0.0;SpliceAI=DNAH17|0.00|0.00|0.00|0.00|46|8|8|-27;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=DNAH17%20(inh%3DAR%20oe_syn%3D1.40%20oe_mis%3D1.17%20oe_lof%3D0.65)	GT	1/0
chr17	78572799	.	A	G	1725	.	quality=DP%3D157%3BQD%3D10.99%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D3%3BABP%3D7%3BSAR%3D36%3BSAF%3D34;gene=DNAH17;variant_type=synonymous;coding_and_splicing=DNAH17:ENST00000389840.7:synonymous_variant:LOW:exon3/81:c.441T>C:p.Asn147%3D:;OMIM=610063_[GENE%3DDNAH17_PHENOS%3DSpermatogenic%20failure%2039%2C%20618643%20(3)%2C%20Autosomal%20recessive];ClinVar=3055275%20[benign%20DISEASE%3DDNAH17-related%20disorder%20GENE%3DDNAH17]%3B;dbSNP=rs72920975;gnomAD=0.00771;gnomAD_sub=0.00214%2C0.00929%2C0.00039%2C0.01112%2C0.01494;gnomAD_hom_hemi=11%2C;gnomAD_het=1152;gnomAD_wt=151018;phyloP=-0.8500;CADD=0.01;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=DNAH17|0.00|0.00|0.00|0.00|17|44|-5|18;NGSD_hom=7;NGSD_het=712;NGSD_mosaic=0;NGSD_group=1%20/%2080;gene_info=DNAH17%20(inh%3DAR%20oe_syn%3D1.40%20oe_mis%3D1.17%20oe_lof%3D0.65)	GT	1/0
chr17	80317214	.	A	G	2594	.	quality=DP%3D205%3BQD%3D12.65%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D46%3BSAF%3D55;gene=RNF213;variant_type=synonymous;coding_and_splicing=RNF213:ENST00000582970.6:synonymous_variant:LOW:exon16/68:c.2838A>G:p.Gln946%3D:%2CRNF213:ENST00000508628.6:synonymous_variant:LOW:exon17/69:c.2985A>G:p.Gln995%3D:%2CRNF213:ENST00000319921.4:synonymous_variant:LOW:exon16/17:c.2838A>G:p.Gln946%3D:;OMIM=613768_[GENE%3DRNF213_PHENOS%3D{Moyamoya%20disease%202%2C%20susceptibility%20to}%2C%20607151%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=791652%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DRNF213]%3B;dbSNP=rs72849865;gnomAD=0.00462;gnomAD_sub=0.00125%2C0.00222%2C0.00000%2C0.00685%2C0.00083;gnomAD_hom_hemi=2%2C;gnomAD_het=700;gnomAD_wt=151570;phyloP=0.1290;CADD=3.70;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=RNF213|0.00|0.00|0.00|0.00|-26|13|-27|-26;NGSD_hom=2;NGSD_het=402;NGSD_mosaic=1;NGSD_group=0%20/%2054;gene_info=RNF213%20(inh%3DAR+AD%20oe_syn%3D1.07%20oe_mis%3D0.88%20oe_lof%3D0.57)	GT	1/0
chr17	80383800	.	A	G	2336	.	quality=DP%3D174%3BQD%3D13.43%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D50%3BSAF%3D40;gene=RNF213%2CRNF213-AS1;variant_type=missense%2Cintron&non_coding_transcript;coding_and_splicing=RNF213:ENST00000582970.6:missense_variant:MODERATE:exon59/68:c.14194A>G:p.Lys4732Glu:%2CRNF213:ENST00000508628.6:missense_variant:MODERATE:exon60/69:c.14341A>G:p.Lys4781Glu:%2CRNF213-AS1:ENST00000575034.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.191-28512T>C::%2CRNF213-AS1:ENST00000667202.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.190-21592T>C::;OMIM=613768_[GENE%3DRNF213_PHENOS%3D{Moyamoya%20disease%202%2C%20susceptibility%20to}%2C%20607151%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=708562%20[benign%20DISEASE%3DMoyamoya%20disease%202%2Cnot%20provided%2CRNF213-related%20disorder%20GENE%3DRNF213]%3B;HGMD=CM2324009%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Moyamoya%20disease"%20GENE%3DRNF213]%3B;dbSNP=rs12944385;gnomAD=0.00728;gnomAD_sub=0.00183%2C0.00399%2C0.00000%2C0.01073%2C0.00270;gnomAD_hom_hemi=10%2C;gnomAD_het=1088;gnomAD_wt=151172;phyloP=0.0060;CADD=0.93;REVEL=0.050;AlphaMissense=0.07;MaxEntScan=/0.0>0.0/0.0>2.6%2C/9.1>9.0/0.0>0.0;COSMIC=COSV60394997;SpliceAI=RNF213|0.00|0.00|0.00|0.00|38|-26|-36|50;NGSD_hom=2;NGSD_het=647;NGSD_mosaic=0;NGSD_group=0%20/%2077;gene_info=RNF213%20(inh%3DAR+AD%20oe_syn%3D1.07%20oe_mis%3D0.88%20oe_lof%3D0.57)%2C%20RNF213-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr17	81537057	.	G	A	1019	.	quality=DP%3D87%3BQD%3D11.71%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D105%3BABP%3D4%3BSAR%3D47%3BSAF%3D0;gene=FSCN2%2CFAAP100;variant_type=missense%2Cdownstream_gene;coding_and_splicing=FSCN2:ENST00000417245.7:missense_variant:MODERATE:exon5/5:c.1456G>A:p.Gly486Arg:PF06268%20[Fascin%20domain]%2CFSCN2:ENST00000334850.7:missense_variant:MODERATE:exon5/5:c.1528G>A:p.Gly510Arg:PF06268%20[Fascin%20domain]%2CFAAP100:ENST00000425898.2:downstream_gene_variant:MODIFIER::::%2CFAAP100:ENST00000327787.13:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=607643_[GENE%3DFSCN2_PHENOS%3DRetinitis%20pigmentosa%2030%2C%20607921%20(3)];ClinVar=972630%20[uncertain%20significance%20DISEASE%3Dnot%20provided%20GENE%3DFSCN2]%3B;dbSNP=rs1030790374;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152303;phyloP=0.2510;CADD=20.40;REVEL=0.071;AlphaMissense=0.13;MaxEntScan=/0.0>2.6/0.0>0.0;SpliceAI=FSCN2|0.00|0.00|0.00|0.00|2|36|16|0;NGSD_hom=0;NGSD_het=14;NGSD_mosaic=0;NGSD_group=0%20/%201;classification=3;classification_comment="[3]%20ahzulet1%2031.05.2022";gene_info=FSCN2%20(inh%3DAR+AD%20oe_syn%3D1.19%20oe_mis%3D1.02%20oe_lof%3D1.01)%2C%20FAAP100%20(inh%3Dn/a%20oe_syn%3D1.20%20oe_mis%3D0.91%20oe_lof%3D0.46)	GT	1/0
chr17	81701232	.	G	C	2082	.	quality=DP%3D196%3BQD%3D10.62%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D32%3BABP%3D9%3BSAR%3D60%3BSAF%3D26;gene=HGS%2CMRPL12;variant_type=intron%2Csplice_region&intron%2Cupstream_gene;coding_and_splicing=HGS:ENST00000677161.1:intron_variant:MODIFIER:intron20/20:c.1962+101G>C::%2CHGS:ENST00000676462.1:intron_variant:MODIFIER:intron21/21:c.2223+101G>C::%2CHGS:ENST00000678196.1:splice_region_variant&intron_variant:LOW:intron21/21:c.2224-12G>C::%2CHGS:ENST00000679336.1:splice_region_variant&intron_variant:LOW:intron20/20:c.2104-12G>C::%2CHGS:ENST00000677044.1:intron_variant:MODIFIER:intron21/21:c.2223+101G>C::%2CHGS:ENST00000677243.1:intron_variant:MODIFIER:intron21/21:c.2223+101G>C::%2CHGS:ENST00000677109.1:intron_variant:MODIFIER:intron21/21:c.2187+101G>C::%2CHGS:ENST00000677484.1:intron_variant:MODIFIER:intron21/21:c.2241+101G>C::%2CHGS:ENST00000678105.1:intron_variant:MODIFIER:intron22/22:c.2022+101G>C::%2CHGS:ENST00000329138.9:intron_variant:MODIFIER:intron21/21:c.2223+101G>C::%2CHGS:ENST00000677225.1:intron_variant:MODIFIER:intron21/21:c.2175+101G>C::%2CHGS:ENST00000678866.1:intron_variant:MODIFIER:intron21/21:c.2277+101G>C::%2CHGS:ENST00000676729.1:intron_variant:MODIFIER:intron22/22:c.2196+101G>C::%2CMRPL12:ENST00000333676.8:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:open_chromatin_region;OMIM=602375_[GENE%3DMRPL12_PHENOS%3D?Combined%20oxidative%20phosphorylation%20deficiency%2045%2C%20618951%20(3)%2C%20Autosomal%20recessive];dbSNP=rs56210089;gnomAD=0.00003;gnomAD_sub=0.00005%2C0.00000%2C0.00000%2C0.00003%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=4;gnomAD_wt=152360;phyloP=-0.4380;CADD=1.18;MaxEntScan=7.0>7.7/7.0>7.7/7.7>0.9%2C/7.0>7.7/7.7>0.9;SpliceAI=HGS|0.03|0.00|0.00|0.00|12|0|-45|-5;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=HGS%20(inh%3Dn/a%20oe_syn%3D1.23%20oe_mis%3D0.84%20oe_lof%3D0.29)%2C%20MRPL12%20(inh%3DAR%20oe_syn%3D1.09%20oe_mis%3D0.93%20oe_lof%3D0.57)	GT	1/0
chr17	82019339	.	G	A	3872	.	quality=DP%3D316%3BQD%3D12.25%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D8%3BABP%3D4%3BSAR%3D85%3BSAF%3D66;gene=CENPX%2CASPSCR1%2CLRRC45;variant_type=missense%2Cdownstream_gene%2Cupstream_gene;coding_and_splicing=CENPX:ENST00000392359.8:missense_variant:MODERATE:exon4/5:c.185C>T:p.Ala62Val:PF09415%20[CENP-S%20associating%20Centromere%20protein%20X]%2CCENPX:ENST00000580435.5:missense_variant:MODERATE:exon3/4:c.131C>T:p.Ala44Val:%2CCENPX:ENST00000306704.10:missense_variant:MODERATE:exon3/4:c.131C>T:p.Ala44Val:PF09415%20[CENP-S%20associating%20Centromere%20protein%20X]%2CCENPX:ENST00000584347.1:missense_variant:MODERATE:exon4/5:c.316C>T:p.Arg106Cys:%2CASPSCR1:ENST00000306729.11:downstream_gene_variant:MODIFIER::::%2CASPSCR1:ENST00000306739.9:downstream_gene_variant:MODIFIER::::%2CASPSCR1:ENST00000580534.5:downstream_gene_variant:MODIFIER::::%2CLRRC45:ENST00000306688.8:upstream_gene_variant:MODIFIER::::;OMIM=606236_[GENE%3DASPSCR1_PHENOS%3DAlveolar%20soft-part%20sarcoma%2C%20606243%20(3)];dbSNP=rs75826554;gnomAD=0.00426;gnomAD_sub=0.00113%2C0.00163%2C0.00000%2C0.00622%2C0.00000;gnomAD_hom_hemi=1%2C;gnomAD_het=647;gnomAD_wt=151623;phyloP=-0.0290;CADD=3.54;REVEL=0.015;AlphaMissense=0.07;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV100141990;SpliceAI=STRA13|0.01|0.00|0.00|0.00|36|39|-50|-33;NGSD_hom=4;NGSD_het=518;NGSD_mosaic=2;NGSD_group=0%20/%2077;gene_info=ASPSCR1%20(inh%3DAD%20oe_syn%3D1.07%20oe_mis%3D1.00%20oe_lof%3D0.68)%2C%20CENPX%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20LRRC45%20(inh%3Dn/a%20oe_syn%3D0.96%20oe_mis%3D0.85%20oe_lof%3D0.62)	GT	1/0
chr18	2700879	.	A	G	1273	.	quality=DP%3D115%3BQD%3D11.07%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D24%3BABP%3D3%3BSAR%3D39%3BSAF%3D16;gene=SMCHD1;variant_type=synonymous;coding_and_splicing=SMCHD1:ENST00000688342.1:synonymous_variant:LOW:exon12/47:c.1608A>G:p.Lys536%3D:%2CSMCHD1:ENST00000320876.11:synonymous_variant:LOW:exon12/48:c.1608A>G:p.Lys536%3D:;OMIM=614982_[GENE%3DSMCHD1_PHENOS%3DBosma%20arhinia%20microphthalmia%20syndrome%2C%20603457%20(3)%2C%20Autosomal%20dominant%3B%20Fascioscapulohumeral%20muscular%20dystrophy%202%2C%20digenic%2C%20158901%20(3)%2C%20Digenic%20dominant];ClinVar=260630%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:3x2%2C1x3)%20DISEASE%3Dnot%20provided%2CFacioscapulohumeral%20muscular%20dystrophy%202%2Cnot%20specified%20GENE%3DSMCHD1]%3B;dbSNP=rs72862973;gnomAD=0.00022;gnomAD_sub=0.00002%2C0.00000%2C0.00000%2C0.00047%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=34;gnomAD_wt=152302;phyloP=1.8430;CADD=10.03;MaxEntScan=/0.0>0.1/2.4>1.0;SpliceAI=SMCHD1|0.02|0.00|0.00|0.00|-47|24|39|-48;PubMed=25741868;NGSD_hom=0;NGSD_het=21;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=SMCHD1%20(inh%3DAD%20oe_syn%3D0.94%20oe_mis%3D0.67%20oe_lof%3D0.09)	GT	1/0
chr18	10691248	.	G	A	1311	.	quality=DP%3D112%3BQD%3D11.71%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D61%3BABP%3D3%3BSAR%3D9%3BSAF%3D48;gene=PIEZO2;variant_type=synonymous;coding_and_splicing=PIEZO2:ENST00000302079.10:synonymous_variant:LOW:exon44/51:c.6987C>T:p.Tyr2329%3D:%2CPIEZO2:ENST00000674853.1:synonymous_variant:LOW:exon48/56:c.7326C>T:p.Tyr2442%3D:%2CPIEZO2:ENST00000503781.7:synonymous_variant:LOW:exon44/52:c.6987C>T:p.Tyr2329%3D:%2CPIEZO2:ENST00000580640.5:synonymous_variant:LOW:exon46/54:c.7062C>T:p.Tyr2354%3D:;OMIM=613629_[GENE%3DPIEZO2_PHENOS%3DArthrogryposis%2C%20distal%2C%20type%205%2C%20108145%20(3)%2C%20Autosomal%20dominant%3B%20Arthrogryposis%2C%20distal%2C%20with%20impaired%20proprioception%20and%20touch%2C%20617146%20(3)%2C%20Autosomal%20recessive%3B%20Arthrogryposis%2C%20distal%2C%20type%203%2C%20114300%20(3)%2C%20Autosomal%20dominant%3B%20?Marden-Walker%20syndrome%2C%20248700%20(3)%2C%20Autosomal%20dominant];ClinVar=775114%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPIEZO2]%3B;dbSNP=rs72970080;gnomAD=0.00229;gnomAD_sub=0.00084%2C0.00052%2C0.00000%2C0.00401%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=348;gnomAD_wt=151938;phyloP=-0.3360;CADD=0.21;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PIEZO2|0.01|0.00|0.00|0.02|-28|39|-22|-23;NGSD_hom=0;NGSD_het=225;NGSD_mosaic=0;NGSD_group=0%20/%2017;gene_info=PIEZO2%20(inh%3DAR+AD%20oe_syn%3D0.87%20oe_mis%3D0.75%20oe_lof%3D0.28)	GT	1/0
chr18	10705419	.	G	A	4092	.	quality=DP%3D275%3BQD%3D14.88%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D4%3BABP%3D13%3BSAR%3D73%3BSAF%3D82;gene=PIEZO2;variant_type=synonymous;coding_and_splicing=PIEZO2:ENST00000302079.10:synonymous_variant:LOW:exon37/51:c.5577C>T:p.Asp1859%3D:%2CPIEZO2:ENST00000674853.1:synonymous_variant:LOW:exon41/56:c.5916C>T:p.Asp1972%3D:%2CPIEZO2:ENST00000503781.7:synonymous_variant:LOW:exon37/52:c.5577C>T:p.Asp1859%3D:%2CPIEZO2:ENST00000580640.5:synonymous_variant:LOW:exon39/54:c.5652C>T:p.Asp1884%3D:;OMIM=613629_[GENE%3DPIEZO2_PHENOS%3DArthrogryposis%2C%20distal%2C%20type%205%2C%20108145%20(3)%2C%20Autosomal%20dominant%3B%20Arthrogryposis%2C%20distal%2C%20with%20impaired%20proprioception%20and%20touch%2C%20617146%20(3)%2C%20Autosomal%20recessive%3B%20Arthrogryposis%2C%20distal%2C%20type%203%2C%20114300%20(3)%2C%20Autosomal%20dominant%3B%20?Marden-Walker%20syndrome%2C%20248700%20(3)%2C%20Autosomal%20dominant];ClinVar=728895%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPIEZO2]%3B;dbSNP=rs529388684;gnomAD=0.00104;gnomAD_sub=0.00178%2C0.00085%2C0.00000%2C0.00094%2C0.00041;gnomAD_hom_hemi=0%2C;gnomAD_het=159;gnomAD_wt=152139;phyloP=-0.4790;CADD=0.16;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV106389452%2CCOSV53294738;SpliceAI=PIEZO2|0.00|0.00|0.00|0.00|-19|41|29|-23;NGSD_hom=0;NGSD_het=119;NGSD_mosaic=0;NGSD_group=0%20/%2012;gene_info=PIEZO2%20(inh%3DAR+AD%20oe_syn%3D0.87%20oe_mis%3D0.75%20oe_lof%3D0.28)	GT	1/0
chr18	44952958	.	T	C	1893	.	quality=DP%3D133%3BQD%3D14.23%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D5%3BABP%3D5%3BSAR%3D40%3BSAF%3D32;gene=SETBP1;variant_type=synonymous;coding_and_splicing=SETBP1:ENST00000677068.1:synonymous_variant:LOW:exon4/6:c.3618T>C:p.His1206%3D:%2CSETBP1:ENST00000649279.2:synonymous_variant:LOW:exon4/6:c.3618T>C:p.His1206%3D:%2CSETBP1:ENST00000677699.1:synonymous_variant:LOW:exon4/5:c.3618T>C:p.His1206%3D:%2CSETBP1:ENST00000678152.1:synonymous_variant:LOW:exon4/6:c.3618T>C:p.His1206%3D:%2CSETBP1:ENST00000677077.1:synonymous_variant:LOW:exon4/6:c.3618T>C:p.His1206%3D:%2CSETBP1:ENST00000677130.1:synonymous_variant:LOW:exon4/6:c.3618T>C:p.His1206%3D:;OMIM=611060_[GENE%3DSETBP1_PHENOS%3DSchinzel-Giedion%20midface%20retraction%20syndrome%2C%20269150%20(3)%2C%20Autosomal%20dominant%3B%20Intellectual%20developmental%20disorder%2C%20autosomal%20dominant%2029%2C%20616078%20(3)%2C%20Autosomal%20dominant];ClinVar=326753%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CSchinzel-Giedion%20syndrome%2CIntellectual%20disability%2C%20autosomal%20dominant%2029%20GENE%3DSETBP1]%3B;RepeatMasker=(AAGCAC)n%20(Simple_repeat);dbSNP=rs34882016;gnomAD=0.00672;gnomAD_sub=0.00261%2C0.00812%2C0.00000%2C0.00949%2C0.00209;gnomAD_hom_hemi=4%2C;gnomAD_het=1013;gnomAD_wt=150935;phyloP=1.1800;CADD=7.23;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV56323661;SpliceAI=SETBP1|0.00|0.00|0.00|0.00|1|-21|-8|-21;NGSD_hom=7;NGSD_het=769;NGSD_mosaic=0;NGSD_group=0%20/%20114;gene_info=SETBP1%20(inh%3DAD%20oe_syn%3D1.07%20oe_mis%3D0.90%20oe_lof%3D0.02)	GT	1/0
chr18	45916543	.	G	A	1943	.	quality=DP%3D167%3BQD%3D11.63%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D29%3BABP%3D4%3BSAR%3D55%3BSAF%3D24;gene=EPG5;variant_type=synonymous;coding_and_splicing=EPG5:ENST00000696483.1:synonymous_variant:LOW:exon18/44:c.3279C>T:p.Ser1093%3D:%2CEPG5:ENST00000696484.1:synonymous_variant:LOW:exon18/43:c.3279C>T:p.Ser1093%3D:%2CEPG5:ENST00000282041.11:synonymous_variant:LOW:exon18/44:c.3279C>T:p.Ser1093%3D:%2CEPG5:ENST00000696489.1:synonymous_variant:LOW:exon18/44:c.3279C>T:p.Ser1093%3D:%2CEPG5:ENST00000696490.1:synonymous_variant:LOW:exon18/43:c.3279C>T:p.Ser1093%3D:;OMIM=615068_[GENE%3DEPG5_PHENOS%3DVici%20syndrome%2C%20242840%20(3)%2C%20Autosomal%20recessive];ClinVar=466246%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CVici%20syndrome%2CEPG5-related%20disorder%20GENE%3DEPG5]%3B;dbSNP=rs72918350;gnomAD=0.00877;gnomAD_sub=0.00217%2C0.00484%2C0.00019%2C0.01400%2C0.00332;gnomAD_hom_hemi=13%2C;gnomAD_het=1309;gnomAD_wt=150907;phyloP=-0.4240;CADD=7.87;MaxEntScan=/4.2>4.4/0.0>0.0;SpliceAI=EPG5|0.16|0.00|0.00|0.00|0|39|40|-39;NGSD_hom=9;NGSD_het=1140;NGSD_mosaic=1;NGSD_group=0%20/%20136;gene_info=EPG5%20(inh%3DAR%20oe_syn%3D1.05%20oe_mis%3D0.92%20oe_lof%3D0.36)	GT	1/0
chr18	70088101	.	T	G	2096	.	quality=DP%3D158%3BQD%3D13.27%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D16%3BABP%3D4%3BSAR%3D52%3BSAF%3D30;gene=RTTN;variant_type=missense;coding_and_splicing=RTTN:ENST00000640769.2:missense_variant:MODERATE:exon31/49:c.4190A>C:p.Glu1397Ala:%2CRTTN:ENST00000255674.11:missense_variant:MODERATE:exon31/49:c.4190A>C:p.Glu1397Ala:;OMIM=610436_[GENE%3DRTTN_PHENOS%3DMicrocephaly%2C%20short%20stature%2C%20and%20polymicrogyria%20with%20seizures%2C%20614833%20(3)%2C%20Autosomal%20recessive];ClinVar=2172920%20[uncertain%20significance%20DISEASE%3DInborn%20genetic%20diseases%2Cnot%20provided%20GENE%3DRTTN]%3B;dbSNP=rs72959893;gnomAD=0.00005;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00010%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=7;gnomAD_wt=152331;phyloP=4.8220;CADD=21.70;REVEL=0.078;AlphaMissense=0.16;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=RTTN|0.00|0.00|0.00|0.00|46|47|-44|47;NGSD_hom=0;NGSD_het=18;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=RTTN%20(inh%3DAR%20oe_syn%3D1.03%20oe_mis%3D0.99%20oe_lof%3D0.61)	GT	1/0
chr19	617466	.	A	G	1268	.	quality=DP%3D112%3BQD%3D11.32%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D6%3BABP%3D3%3BSAR%3D31%3BSAF%3D23;gene=POLRMT%2CHCN2;variant_type=missense%2Cdownstream_gene;coding_and_splicing=POLRMT:ENST00000588649.7:missense_variant:MODERATE:exon20/21:c.3596T>C:p.Leu1199Ser:PF00940%20[DNA-dependent%20RNA%20polymerase]%2CHCN2:ENST00000251287.3:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:TF_binding_site;OMIM=602781_[GENE%3DHCN2_PHENOS%3DFebrile%20seizures%2C%20familial%2C%202%2C%20602477%20(3)%2C%20Autosomal%20dominant%3B%20{Epilepsy%2C%20idiopathic%20generalized%2C%20susceptibility%20to%2C%2017}%2C%20602477%20(3)%2C%20Autosomal%20dominant%3B%20Generalized%20epilepsy%20with%20febrile%20seizures%20plus%2C%20type%2011%2C%20602477%20(3)%2C%20Autosomal%20dominant]&601778_[GENE%3DPOLRMT_PHENOS%3DCombined%20oxidative%20phosphorylation%20deficiency%2055%2C%20619743%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=718243%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DPOLRMT]%3B;dbSNP=rs151287767;gnomAD=0.00579;gnomAD_sub=0.00142%2C0.00975%2C0.00000%2C0.00853%2C0.00311;gnomAD_hom_hemi=10%2C;gnomAD_het=861;gnomAD_wt=151169;phyloP=0.2190;CADD=1.69;REVEL=0.056;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV99241193;SpliceAI=POLRMT|0.00|0.00|0.00|0.00|7|4|5|-47;NGSD_hom=6;NGSD_het=678;NGSD_mosaic=0;NGSD_group=0%20/%2066;gene_info=HCN2%20(inh%3DAD%20oe_syn%3D1.55%20oe_mis%3D0.53%20oe_lof%3D0.21)%2C%20POLRMT%20(inh%3DAR+AD%20oe_syn%3D1.54%20oe_mis%3D1.19%20oe_lof%3D0.72)	GT	1/0
chr19	1109596	.	G	T	1394	.	quality=DP%3D126%3BQD%3D11.06%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D57%3BABP%3D3%3BSAR%3D52%3BSAF%3D12;gene=SBNO2%2CGPX4;variant_type=splice_region&synonymous%2Cdownstream_gene;coding_and_splicing=SBNO2:ENST00000438103.6:splice_region_variant&synonymous_variant:LOW:exon25/29:c.2955C>A:p.Ile985%3D:%2CSBNO2:ENST00000361757.8:splice_region_variant&synonymous_variant:LOW:exon28/32:c.3126C>A:p.Ile1042%3D:%2CSBNO2:ENST00000587024.5:splice_region_variant&synonymous_variant:LOW:exon28/32:c.3096C>A:p.Ile1032%3D:%2CGPX4:ENST00000706713.1:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000354171.13:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000589115.6:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000611653.4:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000593032.6:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000706714.1:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000588919.5:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000706715.1:downstream_gene_variant:MODIFIER::::%2CGPX4:ENST00000585362.7:downstream_gene_variant:MODIFIER::::;OMIM=138322_[GENE%3DGPX4_PHENOS%3DSpondylometaphyseal%20dysplasia%2C%20Sedaghatian%20type%2C%20250220%20(3)%2C%20Autosomal%20recessive];dbSNP=rs185032569;gnomAD=0.00861;gnomAD_sub=0.00283%2C0.00394%2C0.00000%2C0.01405%2C0.00148;gnomAD_hom_hemi=9%2C;gnomAD_het=1282;gnomAD_wt=149624;phyloP=2.4380;CADD=12.20;MaxEntScan=7.7>7.4/7.7>7.4/0.0>1.7;SpliceAI=SBNO2|0.00|0.00|0.00|0.00|-22|-3|3|-20;NGSD_hom=2;NGSD_het=689;NGSD_mosaic=1;NGSD_group=1%20/%2089;gene_info=GPX4%20(inh%3DAR%20oe_syn%3D1.59%20oe_mis%3D1.27%20oe_lof%3D0.71)%2C%20SBNO2%20(inh%3Dn/a%20oe_syn%3D1.29%20oe_mis%3D0.76%20oe_lof%3D0.27)	GT	1/0
chr19	1461843	.	T	C	1327	.	quality=DP%3D157%3BQD%3D8.45%3BAF%3D0.39%3BMQM%3D60%3BSAP%3D35%3BABP%3D18%3BSAR%3D16%3BSAF%3D46;gene=APC2%2CC19orf25;variant_type=intron%2Csplice_region&intron;coding_and_splicing=APC2:ENST00000590469.6:intron_variant:MODIFIER:intron13/14:c.1639-120T>C::%2CAPC2:ENST00000233607.6:intron_variant:MODIFIER:intron13/14:c.1639-120T>C::%2CAPC2:ENST00000535453.5:intron_variant:MODIFIER:intron12/13:c.1639-120T>C::%2CC19orf25:ENST00000588427.5:splice_region_variant&intron_variant:LOW:intron2/2:c.131-19A>G::;OMIM=612034_[GENE%3DAPC2_PHENOS%3DCortical%20dysplasia%2C%20complex%2C%20with%20other%20brain%20malformations%2010%2C%20618677%20(3)%2C%20Autosomal%20recessive%3B%20Intellectual%20developmental%20disorder%2C%20autosomal%20recessive%2074%2C%20617169%20(3)%2C%20Autosomal%20recessive];RepeatMasker=AluYk2%20(SINE/Alu);dbSNP=rs776196435;gnomAD=0.00030;gnomAD_sub=0.00012%2C0.00020%2C0.00000%2C0.00049%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=44;gnomAD_wt=148878;phyloP=-1.4400;CADD=0.44;MaxEntScan=9.1>8.5/9.1>8.5/0.0>0.0%2C/0.0>0.0/0.0>0.0;SpliceAI=APC2|0.00|0.00|0.00|0.00|-19|-7|15|-50;NGSD_hom=0;NGSD_het=54;NGSD_mosaic=0;NGSD_group=0%20/%207;gene_info=APC2%20(inh%3DAR%20oe_syn%3D1.14%20oe_mis%3D0.94%20oe_lof%3D0.12)%2C%20C19ORF25%20(inh%3Dn/a%20oe_syn%3D1.16%20oe_mis%3D1.07%20oe_lof%3D0.00)	GT	1/0
chr19	4175107	.	C	T	3839	.	quality=DP%3D297%3BQD%3D12.93%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D4%3BABP%3D3%3BSAR%3D70%3BSAF%3D78;gene=SIRT6%2CCREB3L3;variant_type=missense%2Cdownstream_gene;coding_and_splicing=SIRT6:ENST00000601488.5:missense_variant:MODERATE:exon6/7:c.436G>A:p.Gly146Ser:%2CSIRT6:ENST00000305232.10:missense_variant:MODERATE:exon6/7:c.578G>A:p.Arg193Gln:%2CSIRT6:ENST00000337491.7:missense_variant:MODERATE:exon7/8:c.659G>A:p.Arg220Gln:PF02146%20[Sir2%20family]%2CSIRT6:ENST00000594279.5:missense_variant:MODERATE:exon7/8:c.403G>A:p.Gly135Ser:%2CCREB3L3:ENST00000078445.7:downstream_gene_variant:MODIFIER::::%2CCREB3L3:ENST00000595923.5:downstream_gene_variant:MODIFIER::::%2CCREB3L3:ENST00000602257.5:downstream_gene_variant:MODIFIER::::%2CCREB3L3:ENST00000602147.1:downstream_gene_variant:MODIFIER::::;OMIM=611998_[GENE%3DCREB3L3_PHENOS%3DHypertriglyceridemia%202%2C%20619324%20(3)%2C%20Autosomal%20dominant];ClinVar=2372006%20[uncertain%20significance%20DISEASE%3Dnot%20specified%20GENE%3DSIRT6]%3B;dbSNP=rs75244031;gnomAD=0.00006;gnomAD_sub=0.00000%2C0.00000%2C0.00019%2C0.00010%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=9;gnomAD_wt=152185;phyloP=3.4450;CADD=23.00;REVEL=0.069;AlphaMissense=0.14;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SIRT6|0.05|0.00|0.00|0.00|4|-7|4|19;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CREB3L3%20(inh%3DAD%20oe_syn%3D1.21%20oe_mis%3D0.96%20oe_lof%3D1.01)%2C%20SIRT6%20(inh%3Dn/a%20oe_syn%3D0.95%20oe_mis%3D0.88%20oe_lof%3D0.33)	GT	1/0
chr19	7528162	.	C	T	3010	.	quality=DP%3D278%3BQD%3D10.83%3BAF%3D0.45%3BMQM%3D60%3BSAP%3D28%3BABP%3D10%3BSAR%3D43%3BSAF%3D81;gene=MCOLN1;variant_type=missense;coding_and_splicing=MCOLN1:ENST00000264079.11:missense_variant:MODERATE:exon7/14:c.782C>T:p.Thr261Met:PF21381%20[];OMIM=605248_[GENE%3DMCOLN1_PHENOS%3DMucolipidosis%20IV%2C%20252650%20(3)%2C%20Autosomal%20recessive];ClinVar=283177%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:1x1%2C2x2%2C3x3)%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CMucolipidosis%20type%20IV%20GENE%3DMCOLN1]%3B;dbSNP=rs73003348;gnomAD=0.00315;gnomAD_sub=0.00075%2C0.00947%2C0.00000%2C0.00385%2C0.00269;gnomAD_hom_hemi=2%2C;gnomAD_het=476;gnomAD_wt=151790;phyloP=0.4590;CADD=13.11;REVEL=0.133;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV105070481;SpliceAI=MCOLN1|0.01|0.00|0.00|0.00|15|-4|15|0;PubMed=25933391%2C31578829;NGSD_hom=0;NGSD_het=326;NGSD_mosaic=1;NGSD_group=0%20/%2040;gene_info=MCOLN1%20(inh%3DAR%20oe_syn%3D1.15%20oe_mis%3D0.76%20oe_lof%3D0.37)	GT	1/0
chr19	11208956	.	C	T	3065	.	quality=DP%3D245%3BQD%3D12.51%3BAF%3D0.51%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D62%3BSAF%3D63;gene=DOCK6%2CDOCK6-AS1;variant_type=synonymous%2Cintron&non_coding_transcript%2Cdownstream_gene;coding_and_splicing=DOCK6:ENST00000294618.12:synonymous_variant:LOW:exon38/48:c.4899G>A:p.Leu1633%3D:PF06920%20[Dock%20homology%20region%202]%2CDOCK6:ENST00000587656.6:synonymous_variant:LOW:exon39/49:c.5004G>A:p.Leu1668%3D:PF06920%20[Dock%20homology%20region%202]%2CDOCK6-AS1:ENST00000588634.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/3:n.537+2848C>T::%2CDOCK6-AS1:ENST00000715252.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=614194_[GENE%3DDOCK6_PHENOS%3DAdams-Oliver%20syndrome%202%2C%20614219%20(3)%2C%20Autosomal%20recessive];ClinVar=774953%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DDOCK6]%3B;dbSNP=rs72985308;gnomAD=0.00242;gnomAD_sub=0.00058%2C0.00144%2C0.00000%2C0.00384%2C0.00041;gnomAD_hom_hemi=3%2C;gnomAD_het=363;gnomAD_wt=151831;phyloP=6.0560;CADD=3.24;MaxEntScan=/0.0>0.8/0.0>0.0%2C/2.8>1.7/0.0>1.5;SpliceAI=DOCK6|0.00|0.00|0.00|0.00|-46|11|-24|-49;NGSD_hom=0;NGSD_het=318;NGSD_mosaic=0;NGSD_group=0%20/%2041;gene_info=DOCK6-AS1%20(inh%3DAR+AD%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)%2C%20DOCK6%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D0.89%20oe_lof%3D0.58)	GT	1/0
chr19	13144774	.	C	T	3198	.	quality=DP%3D234%3BQD%3D13.67%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D9%3BABP%3D6%3BSAR%3D54%3BSAF%3D72;gene=STX10%2CNACC1;variant_type=missense%2Cdownstream_gene;coding_and_splicing=STX10:ENST00000343587.9:missense_variant:MODERATE:exon5/7:c.421G>A:p.Glu141Lys:%2CSTX10:ENST00000587230.6:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:%2CSTX10:ENST00000242770.9:missense_variant:MODERATE:exon6/8:c.568G>A:p.Glu190Lys:%2CSTX10:ENST00000589083.5:missense_variant:MODERATE:exon6/7:c.568G>A:p.Glu190Lys:%2CNACC1:ENST00000292431.5:downstream_gene_variant:MODIFIER::::%2CNACC1:ENST00000700232.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:enhancer;OMIM=610672_[GENE%3DNACC1_PHENOS%3DNeurodevelopmental%20disorder%20with%20epilepsy%2C%20cataracts%2C%20feeding%20difficulties%2C%20and%20delayed%20brain%20myelination%2C%20617393%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73006877;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=2;gnomAD_wt=152352;phyloP=3.7410;CADD=25.80;REVEL=0.278;AlphaMissense=0.20;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=STX10|0.00|0.00|0.02|0.00|43|-6|43|-15;NGSD_hom=0;NGSD_het=12;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=NACC1%20(inh%3DAD%20oe_syn%3D0.97%20oe_mis%3D0.39%20oe_lof%3D0.00)%2C%20STX10%20(inh%3Dn/a%20oe_syn%3D0.98%20oe_mis%3D1.00%20oe_lof%3D0.96)	GT	1/0
chr19	14107827	.	G	A	3461	.	quality=DP%3D252%3BQD%3D13.73%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D4%3BABP%3D5%3BSAR%3D70%3BSAF%3D63;gene=PRKACA%2CSMIM46;variant_type=intron%2Cmissense%2Cdownstream_gene;coding_and_splicing=PRKACA:ENST00000677951.1:intron_variant:MODIFIER:intron1/9:c.-128-418C>T::%2CPRKACA:ENST00000308677.9:intron_variant:MODIFIER:intron1/9:c.47-418C>T::%2CPRKACA:ENST00000350356.7:missense_variant:MODERATE:exon1/10:c.158C>T:p.Pro53Leu:%2CPRKACA:ENST00000590853.5:intron_variant:MODIFIER:intron1/2:c.47-418C>T::%2CPRKACA:ENST00000589994.6:intron_variant:MODIFIER:intron1/9:c.23-418C>T::%2CPRKACA:ENST00000536649.5:intron_variant:MODIFIER:intron1/7:c.-128-418C>T::%2CSMIM46:ENST00000699221.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter;OMIM=601639_[GENE%3DPRKACA_PHENOS%3DCushing%20syndrome%2C%20ACTH-independent%20adrenal%2C%20somatic%2C%20615830%20(3)%3B%20Cardioacrofacial%20dysplasia%201%2C%20619142%20(3)%2C%20Autosomal%20dominant];ClinVar=3038933%20[likely%20benign%20DISEASE%3DPRKACA-related%20disorder%20GENE%3DPRKACA]%3B;dbSNP=rs41296252;gnomAD=0.00199;gnomAD_sub=0.00077%2C0.00059%2C0.00000%2C0.00342%2C0.00083;gnomAD_hom_hemi=1%2C;gnomAD_het=301;gnomAD_wt=152033;phyloP=-0.0600;CADD=14.83;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PRKACA|0.00|0.00|0.00|0.00|-25|-45|-25|35;NGSD_hom=3;NGSD_het=167;NGSD_mosaic=0;NGSD_group=1%20/%2019;gene_info=PRKACA%20(inh%3DAD%20oe_syn%3D1.03%20oe_mis%3D0.43%20oe_lof%3D0.10)%2C%20SMIM46%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr19	17365336	.	T	A	1464	.	quality=DP%3D165%3BQD%3D8.87%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D28%3BABP%3D14%3BSAR%3D20%3BSAF%3D48;gene=PLVAP;variant_type=missense;coding_and_splicing=PLVAP:ENST00000252590.9:missense_variant:MODERATE:exon3/6:c.1129A>T:p.Met377Leu:PF06637%20[PV-1%20protein%20(PLVAP)];OMIM=607647_[GENE%3DPLVAP_PHENOS%3DDiarrhea%2010%2C%20protein-losing%20enteropathy%20type%2C%20618183%20(3)%2C%20Autosomal%20recessive];dbSNP=rs73016435;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152271;phyloP=-0.3980;CADD=0.19;REVEL=0.022;AlphaMissense=0.10;MaxEntScan=/0.0>0.0/0.0>5.6;SpliceAI=PLVAP|0.00|0.00|0.07|0.01|-50|-25|2|-50;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=PLVAP%20(inh%3DAR%20oe_syn%3D1.11%20oe_mis%3D0.91%20oe_lof%3D0.60)	GT	1/0
chr19	32676869	.	C	CG	2010	.	quality=DP%3D160%3BQD%3D12.56%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D32%3BABP%3D3%3BSAR%3D58%3BSAF%3D25;gene=RGS9BP%2CANKRD27;variant_type=frameshift%2Cupstream_gene;coding_and_splicing=RGS9BP:ENST00000334176.4:frameshift_variant:HIGH:exon1/1:c.614dup:p.Cys206LeufsTer94:%2CANKRD27:ENST00000306065.9:upstream_gene_variant:MODIFIER::::%2CANKRD27:ENST00000587352.5:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:CTCF_binding_site%2Cregulatory_region_variant:promoter;OMIM=607814_[GENE%3DRGS9BP_PHENOS%3DBradyopsia%202%2C%20620344%20(3)];ClinVar=964535%20[uncertain%20significance%20DISEASE%3DProlonged%20electroretinal%20response%20suppression%202%2Cnot%20provided%20GENE%3DRGS9BP]%3B;HGMD=CI100092%20[CLASS%3DDM%20MUT%3DALT%20PHEN%3D"Retinal%20dysfunction"%20GENE%3DRGS9BP]%3B;dbSNP=rs757764760;gnomAD=0.00021;gnomAD_sub=0.00010%2C0.00013%2C0.00039%2C0.00034%2C0.00021;gnomAD_hom_hemi=0%2C;gnomAD_het=32;gnomAD_wt=151640;CADD=22.40;MaxEntScan=/0.0>0.0/0.9>0.9;SpliceAI=RGS9BP|0.00|0.00|0.00|0.00|-42|-5|-42|-21;PubMed=19818506%2C31144483;NGSD_hom=0;NGSD_het=26;NGSD_mosaic=79;NGSD_group=0%20/%204;classification=4;classification_comment="[4]%20ahzulet1%2010.11.2020";gene_info=ANKRD27%20(inh%3Dn/a%20oe_syn%3D1.05%20oe_mis%3D1.03%20oe_lof%3D0.87)%2C%20RGS9BP%20(inh%3DAR%20oe_syn%3D0.81%20oe_mis%3D0.83%20oe_lof%3D0.87)	GT	1/0
chr19	35716200	.	G	A	2262	.	quality=DP%3D209%3BQD%3D10.82%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D4%3BABP%3D4%3BSAR%3D53%3BSAF%3D47;gene=ZBTB32%2CKMT2B;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=ZBTB32:ENST00000392197.7:synonymous_variant:LOW:exon6/7:c.1092G>A:p.Pro364%3D:%2CZBTB32:ENST00000262630.7:synonymous_variant:LOW:exon5/6:c.1092G>A:p.Pro364%3D:%2CKMT2B:ENST00000673918.2:upstream_gene_variant:MODIFIER::::%2CKMT2B:ENST00000420124.4:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=606834_[GENE%3DKMT2B_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%2068%2C%20619934%20(3)%2C%20Autosomal%20dominant%3B%20Dystonia%2028%2C%20childhood-onset%2C%20617284%20(3)%2C%20Autosomal%20dominant];RepeatMasker=(CCCCCT)n%20(Simple_repeat);dbSNP=rs2234374;gnomAD=0.00321;gnomAD_sub=0.00089%2C0.00209%2C0.00000%2C0.00572%2C0.00208;gnomAD_hom_hemi=1%2C;gnomAD_het=487;gnomAD_wt=151693;phyloP=-0.7790;CADD=1.94;MaxEntScan=/3.1>5.9/0.0>0.0;SpliceAI=ZBTB32|0.01|0.00|0.00|0.00|2|50|-33|14;NGSD_hom=3;NGSD_het=309;NGSD_mosaic=0;NGSD_group=0%20/%2046;gene_info=ZBTB32%20(inh%3Dn/a%20oe_syn%3D1.06%20oe_mis%3D0.84%20oe_lof%3D0.47)%2C%20KMT2B%20(inh%3DAD%20oe_syn%3D1.22%20oe_mis%3D0.76%20oe_lof%3D0.03)	GT	1/0
chr19	41414125	.	C	T	1257	.	quality=DP%3D110%3BQD%3D11.43%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D17%3BABP%3D3%3BSAR%3D37%3BSAF%3D18;gene=BCKDHA;variant_type=missense;coding_and_splicing=BCKDHA:ENST00000269980.7:missense_variant:MODERATE:exon4/9:c.452C>T:p.Thr151Met:PF00676%20[Dehydrogenase%20E1%20component]%2CBCKDHA:ENST00000457836.6:missense_variant:MODERATE:exon4/9:c.386C>T:p.Thr129Met:PF00676%20[Dehydrogenase%20E1%20component];OMIM=608348_[GENE%3DBCKDHA_PHENOS%3DMaple%20syrup%20urine%20disease%2C%20type%20Ia%2C%20248600%20(3)%2C%20Autosomal%20recessive];ClinVar=93361%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CMaple%20syrup%20urine%20disease%20type%201A%2CMaple%20syrup%20urine%20disease%2Cnot%20specified%20GENE%3DBCKDHA]%3B;HGMD=CM021497%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Maple%20syrup%20urine%20disease"%20GENE%3DBCKDHA]%3B;dbSNP=rs34442879;gnomAD=0.00786;gnomAD_sub=0.00149%2C0.00510%2C0.00039%2C0.01030%2C0.00414;gnomAD_hom_hemi=14%2C;gnomAD_het=1170;gnomAD_wt=151130;phyloP=1.3090;CADD=22.40;REVEL=0.434;AlphaMissense=0.09;MaxEntScan=/2.2>2.2/0.0>0.0;COSMIC=COSV54197148;SpliceAI=BCKDHA|0.00|0.00|0.00|0.00|20|-46|-46|36%2CCTC-435M10.3|0.00|0.00|0.00|0.00|20|-46|-46|36;PubMed=25741868%2C23757202%2C12118532;NGSD_hom=10;NGSD_het=1003;NGSD_mosaic=0;NGSD_group=0%20/%20115;classification=1;classification_comment="[1]%20Stefanie%20Beck-Woedl%2007.07.2014";gene_info=BCKDHA%20(inh%3DAR%20oe_syn%3D0.99%20oe_mis%3D0.89%20oe_lof%3D0.68)	GT	1/0
chr19	42287842	.	T	C	1954	.	quality=DP%3D143%3BQD%3D13.66%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D18%3BABP%3D6%3BSAR%3D51%3BSAF%3D28;gene=CIC;variant_type=synonymous;coding_and_splicing=CIC:ENST00000572681.6:synonymous_variant:LOW:exon7/21:c.3525T>C:p.Asp1175%3D:PF00505%20[HMG%20(high%20mobility%20group)%20box]%2CCIC:ENST00000681038.1:synonymous_variant:LOW:exon7/21:c.3525T>C:p.Asp1175%3D:PF00505%20[HMG%20(high%20mobility%20group)%20box]%2CCIC:ENST00000160740.7:synonymous_variant:LOW:exon6/20:c.798T>C:p.Asp266%3D:PF00505%20[HMG%20(high%20mobility%20group)%20box]%2CCIC:ENST00000575354.6:synonymous_variant:LOW:exon6/20:c.798T>C:p.Asp266%3D:PF00505%20[HMG%20(high%20mobility%20group)%20box];OMIM=612082_[GENE%3DCIC_PHENOS%3DIntellectual%20developmental%20disorder%2C%20autosomal%20dominant%2045%2C%20617600%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73033426;gnomAD=0.00999;gnomAD_sub=0.00219%2C0.00706%2C0.00000%2C0.01421%2C0.00415;gnomAD_hom_hemi=14%2C;gnomAD_het=1493;gnomAD_wt=150735;phyloP=0.7320;CADD=6.91;MaxEntScan=/0.0>0.0/0.9>0.9;COSMIC=COSV50652130;SpliceAI=CIC|0.01|0.00|0.00|0.00|-26|-11|42|5;NGSD_hom=5;NGSD_het=1161;NGSD_mosaic=1;NGSD_group=2%20/%20152;gene_info=CIC%20(inh%3DAD%20oe_syn%3D1.28%20oe_mis%3D0.93%20oe_lof%3D0.08)	GT	1/0
chr19	43553432	.	G	C	3095	.	quality=DP%3D239%3BQD%3D12.95%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D3%3BABP%3D3%3BSAR%3D58%3BSAF%3D61;gene=XRCC1;variant_type=synonymous;coding_and_splicing=XRCC1:ENST00000262887.10:synonymous_variant:LOW:exon6/17:c.570C>G:p.Leu190%3D:%2CXRCC1:ENST00000543982.5:synonymous_variant:LOW:exon5/16:c.477C>G:p.Leu159%3D:;OMIM=194360_[GENE%3DXRCC1_PHENOS%3D?Spinocerebellar%20ataxia%2C%20autosomal%20recessive%2026%2C%20617633%20(3)%2C%20Autosomal%20recessive];ClinVar=777496%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DXRCC1]%3B;dbSNP=rs2307170;gnomAD=0.00441;gnomAD_sub=0.00142%2C0.00216%2C0.00000%2C0.00744%2C0.00041;gnomAD_hom_hemi=2%2C;gnomAD_het=667;gnomAD_wt=151605;phyloP=0.6550;CADD=6.37;MaxEntScan=/6.2>4.6/0.0>0.0;SpliceAI=XRCC1|0.00|0.00|0.00|0.00|41|-9|-30|-31;NGSD_hom=3;NGSD_het=415;NGSD_mosaic=1;NGSD_group=1%20/%2055;gene_info=XRCC1%20(inh%3DAR%20oe_syn%3D0.91%20oe_mis%3D0.90%20oe_lof%3D0.51)	GT	1/0
chr19	44900864	.	G	A	1782	.	quality=DP%3D118%3BQD%3D15.10%3BAF%3D0.58%3BMQM%3D60%3BSAP%3D5%3BABP%3D10%3BSAR%3D38%3BSAF%3D31;gene=TOMM40%2CAPOE;variant_type=splice_region&intron%2Cupstream_gene;coding_and_splicing=TOMM40:ENST00000405636.6:splice_region_variant&intron_variant:LOW:intron7/9:c.766+12G>A::%2CTOMM40:ENST00000252487.9:splice_region_variant&intron_variant:LOW:intron7/9:c.766+12G>A::%2CTOMM40:ENST00000592434.5:splice_region_variant&intron_variant:LOW:intron7/8:c.766+12G>A::%2CTOMM40:ENST00000426677.7:splice_region_variant&intron_variant:LOW:intron6/8:c.766+12G>A::%2CAPOE:ENST00000252486.9:upstream_gene_variant:MODIFIER::::;OMIM=107741_[GENE%3DAPOE_PHENOS%3DAlzheimer%20disease%202%2C%20104310%20(3)%2C%20Autosomal%20dominant%3B%20Sea-blue%20histiocyte%20disease%2C%20269600%20(3)%2C%20Autosomal%20recessive%3B%20{?Alzheimer%20disease%2C%20protection%20against%2C%20due%20to%20APOE3-Christchurch}%2C%20607822%20(3)%2C%20Autosomal%20dominant%3B%20{Coronary%20artery%20disease%2C%20severe%2C%20susceptibility%20to}%2C%20617347%20(3)%3B%20Lipoprotein%20glomerulopathy%2C%20611771%20(3)%3B%20{?Macular%20degeneration%2C%20age-related}%2C%20603075%20(3)%2C%20Autosomal%20dominant%3B%20Hyperlipoproteinemia%2C%20type%20III%2C%20617347%20(3)];RepeatMasker=MSR1%20(Satellite);dbSNP=rs73052321;gnomAD=0.00575;gnomAD_sub=0.00135%2C0.00601%2C0.00000%2C0.00889%2C0.00290;gnomAD_hom_hemi=7%2C;gnomAD_het=862;gnomAD_wt=151474;phyloP=-0.3350;CADD=7.27;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV99376113;SpliceAI=TOMM40|0.00|0.00|0.00|0.00|5|-26|-20|-12;PubMed=30443289;NGSD_hom=7;NGSD_het=578;NGSD_mosaic=0;NGSD_group=1%20/%2069;gene_info=TOMM40%20(inh%3Dn/a%20oe_syn%3D0.85%20oe_mis%3D0.55%20oe_lof%3D0.00)%2C%20APOE%20(inh%3DAR+AD%20oe_syn%3D0.87%20oe_mis%3D0.86%20oe_lof%3D0.52)	GT	1/0
chr19	48966729	.	C	T	1412	.	quality=DP%3D130%3BQD%3D10.86%3BAF%3D0.44%3BMQM%3D60%3BSAP%3D3%3BABP%3D7%3BSAR%3D28%3BSAF%3D29;gene=FTL%2CBAX%2CGYS1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=FTL:ENST00000331825.11:synonymous_variant:LOW:exon4/4:c.522C>T:p.His174%3D:%2CBAX:ENST00000345358.12:downstream_gene_variant:MODIFIER::::%2CBAX:ENST00000293288.12:downstream_gene_variant:MODIFIER::::%2CGYS1:ENST00000323798.8:downstream_gene_variant:MODIFIER::::%2CGYS1:ENST00000263276.6:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=600040_[GENE%3DBAX_PHENOS%3DColorectal%20cancer%2C%20somatic%2C%20114500%20(3)%3B%20T-cell%20acute%20lymphoblastic%20leukemia%2C%20somatic%2C%20613065%20(3)]&134790_[GENE%3DFTL_PHENOS%3DHyperferritinemia-cataract%20syndrome%2C%20600886%20(3)%2C%20Autosomal%20dominant%3B%20L-ferritin%20deficiency%2C%20dominant%20and%20recessive%2C%20615604%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive%3B%20Neurodegeneration%20with%20brain%20iron%20accumulation%203%2C%20606159%20(3)%2C%20Autosomal%20dominant]&138570_[GENE%3DGYS1_PHENOS%3DGlycogen%20storage%20disease%200%2C%20muscle%2C%20611556%20(3)%2C%20Autosomal%20recessive];ClinVar=329787%20[benign/likely%20benign%20DISEASE%3DHereditary%20hyperferritinemia%20with%20congenital%20cataracts%2CNeuroferritinopathy%2Cnot%20provided%2Cnot%20specified%20GENE%3DFTL]%3B;dbSNP=rs73046709;gnomAD=0.00178;gnomAD_sub=0.00036%2C0.00013%2C0.00000%2C0.00334%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=271;gnomAD_wt=151993;phyloP=-2.9160;CADD=8.59;REVEL=0.089;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=FTL|0.00|0.00|0.00|0.00|-35|48|-35|48;NGSD_hom=1;NGSD_het=226;NGSD_mosaic=0;NGSD_group=0%20/%2028;gene_info=BAX%20(inh%3DAD%20oe_syn%3D1.05%20oe_mis%3D0.93%20oe_lof%3D0.24)%2C%20FTL%20(inh%3DAR+AD%20oe_syn%3D0.99%20oe_mis%3D1.13%20oe_lof%3D1.62)%2C%20GYS1%20(inh%3DAR%20oe_syn%3D0.92%20oe_mis%3D0.76%20oe_lof%3D0.34)	GT	1/0
chr19	55137083	.	G	C	29	.	quality=DP%3D107%3BQD%3D0.27%3BAF%3D0.38%3BMQM%3D58%3BSAP%3D92%3BABP%3D16%3BSAR%3D0%3BSAF%3D41;gene=TNNT1;variant_type=splice_region&intron;coding_and_splicing=TNNT1:ENST00000588981.6:splice_region_variant&intron_variant:LOW:intron11/13:c.611+20C>G::%2CTNNT1:ENST00000587758.5:splice_region_variant&intron_variant:LOW:intron11/13:c.578+20C>G::%2CTNNT1:ENST00000291901.12:splice_region_variant&intron_variant:LOW:intron11/13:c.611+20C>G::%2CTNNT1:ENST00000356783.9:splice_region_variant&intron_variant:LOW:intron10/12:c.578+20C>G::%2CTNNT1:ENST00000588426.5:splice_region_variant&intron_variant:LOW:intron7/9:c.302+20C>G::%2CTNNT1:ENST00000587465.6:splice_region_variant&intron_variant:LOW:intron8/10:c.401+20C>G::%2CTNNT1:ENST00000585321.6:splice_region_variant&intron_variant:LOW:intron7/9:c.401+20C>G::;OMIM=191041_[GENE%3DTNNT1_PHENOS%3DNemaline%20myopathy%205C%2C%20autosomal%20dominant%2C%20620389%20(3)%2C%20Autosomal%20dominant%3B%20Nemaline%20myopathy%205A%2C%20autosomal%20recessive%2C%20severe%20infantile%2C%20605355%20(3)%2C%20Autosomal%20recessive%3B%20Nemaline%20myopathy%205B%2C%20autosomal%20recessive%2C%20childhood-onset%2C%20620386%20(3)%2C%20Autosomal%20recessive];ClinVar=2166245%20[likely%20benign%20DISEASE%3DNemaline%20myopathy%205%20GENE%3DTNNT1]%3B;dbSNP=rs771532842;gnomAD=0.00168;gnomAD_sub=0.00197%2C0.00224%2C0.00443%2C0.00087%2C0.00853;gnomAD_hom_hemi=0%2C;gnomAD_het=149;gnomAD_wt=88547;phyloP=0.4000;CADD=1.00;MaxEntScan=/1.0>0.0/0.0>0.0;COSMIC=COSV106056564;SpliceAI=TNNT1|0.00|0.00|0.00|0.00|35|24|36|20;NGSD_hom=0;NGSD_het=1418;NGSD_mosaic=2;NGSD_group=0%20/%20137;gene_info=TNNT1%20(inh%3DAR%20oe_syn%3D1.05%20oe_mis%3D0.79%20oe_lof%3D1.02)	GT	1/0
chr20	487542	.	G	A	1081	.	quality=DP%3D108%3BQD%3D10.01%3BAF%3D0.47%3BMQM%3D50%3BSAP%3D3%3BABP%3D4%3BSAR%3D26%3BSAF%3D25;gene=CSNK2A1;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=CSNK2A1:ENST00000217244.9:synonymous_variant:LOW:exon12/14:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000646561.1:synonymous_variant:LOW:exon11/13:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000643660.1:synonymous_variant:LOW:exon11/14:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000645623.1:synonymous_variant:LOW:exon12/15:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000400227.8:synonymous_variant:LOW:exon11/13:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000349736.10:synonymous_variant:LOW:exon10/12:c.450C>T:p.His150%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000646305.1:synonymous_variant:LOW:exon13/15:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000645260.1:synonymous_variant:LOW:exon9/11:c.747C>T:p.His249%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000642689.1:synonymous_variant:LOW:exon10/12:c.807C>T:p.His269%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000645234.1:synonymous_variant:LOW:exon11/13:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000646814.1:synonymous_variant:LOW:exon12/14:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000644885.1:synonymous_variant:LOW:exon10/12:c.774C>T:p.His258%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000646477.1:synonymous_variant:LOW:exon13/15:c.450C>T:p.His150%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000644710.1:synonymous_variant:LOW:exon11/13:c.807C>T:p.His269%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000644003.1:synonymous_variant:LOW:exon11/13:c.450C>T:p.His150%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000647026.1:synonymous_variant:LOW:exon10/12:c.747C>T:p.His249%3D:%2CCSNK2A1:ENST00000400217.7:synonymous_variant:LOW:exon11/13:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000647348.1:synonymous_variant:LOW:exon12/14:c.858C>T:p.His286%3D:PF00069%20[Protein%20kinase%20domain]%2CCSNK2A1:ENST00000643600.1:downstream_gene_variant:MODIFIER::::;OMIM=115440_[GENE%3DCSNK2A1_PHENOS%3DOkur-Chung%20neurodevelopmental%20syndrome%2C%20617062%20(3)%2C%20Autosomal%20dominant];ClinVar=708253%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DCSNK2A1]%3B;dbSNP=rs41306790;gnomAD=0.00586;gnomAD_sub=0.00154%2C0.00555%2C0.00000%2C0.00826%2C0.00083;gnomAD_hom_hemi=3%2C;gnomAD_het=886;gnomAD_wt=151424;phyloP=3.0510;CADD=8.24;MaxEntScan=/5.7>4.8/0.0>0.0;SpliceAI=CSNK2A1|0.00|0.00|0.00|0.00|-24|-3|33|-3;NGSD_hom=1;NGSD_het=556;NGSD_mosaic=0;NGSD_group=0%20/%2077;gene_info=CSNK2A1%20(inh%3DAD%20oe_syn%3D0.95%20oe_mis%3D0.30%20oe_lof%3D0.13)	GT	1/0
chr20	44428408	.	C	T	1314	.	quality=DP%3D149%3BQD%3D8.82%3BAF%3D0.42%3BMQM%3D60%3BSAP%3D4%3BABP%3D12%3BSAR%3D28%3BSAF%3D34;gene=HNF4A;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=HNF4A:ENST00000316673.9:synonymous_variant:LOW:exon9/10:c.1137C>T:p.Asn379%3D:%2CHNF4A:ENST00000457232.5:synonymous_variant:LOW:exon9/10:c.1137C>T:p.Asn379%3D:%2CHNF4A:ENST00000316099.10:synonymous_variant:LOW:exon9/10:c.1203C>T:p.Asn401%3D:%2CHNF4A:ENST00000415691.2:synonymous_variant:LOW:exon9/10:c.1203C>T:p.Asn401%3D:%2CHNF4A:ENST00000609795.5:downstream_gene_variant:MODIFIER::::%2CHNF4A:ENST00000443598.6:downstream_gene_variant:MODIFIER::::;OMIM=600281_[GENE%3DHNF4A_PHENOS%3DFanconi%20renotubular%20syndrome%204%2C%20with%20maturity-onset%20diabetes%20of%20the%20young%2C%20616026%20(3)%2C%20Autosomal%20dominant%3B%20{Diabetes%20mellitus%2C%20noninsulin-dependent}%2C%20125853%20(3)%2C%20Autosomal%20dominant%3B%20MODY%2C%20type%20I%2C%20125850%20(3)%2C%20Autosomal%20dominant];ClinVar=36343%20[benign/likely%20benign%20DISEASE%3DType%202%20diabetes%20mellitus%2CFanconi%20renotubular%20syndrome%204%20with%20maturity-onset%20diabetes%20of%20the%20young%2CMaturity-onset%20diabetes%20of%20the%20young%20type%201%2CMaturity%20onset%20diabetes%20mellitus%20in%20young%2Cnot%20specified%2Cnot%20provided%2CFamilial%20hyperinsulinism%20GENE%3DHNF4A]%3B;HGMD=CM2137475%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"MODY1"%20GENE%3DHNF4A]%3B;dbSNP=rs61737145;gnomAD=0.00384;gnomAD_sub=0.00260%2C0.00333%2C0.00019%2C0.00572%2C0.00249;gnomAD_hom_hemi=4%2C;gnomAD_het=577;gnomAD_wt=151723;phyloP=-1.6020;CADD=5.80;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=HNF4A|0.00|0.00|0.00|0.00|36|-17|0|47;PubMed=25741868%2C18268044%2C17563455%2C35052457%2C35118593%2C32583173;NGSD_hom=0;NGSD_het=331;NGSD_mosaic=0;NGSD_group=0%20/%2040;gene_info=HNF4A%20(inh%3DAD%20oe_syn%3D1.09%20oe_mis%3D0.70%20oe_lof%3D0.26)	GT	1/0
chr20	48941880	.	C	T	2226	.	quality=DP%3D185%3BQD%3D12.03%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D25%3BABP%3D4%3BSAR%3D29%3BSAF%3D59;gene=ARFGEF2;variant_type=missense;coding_and_splicing=ARFGEF2:ENST00000371917.5:missense_variant:MODERATE:exon3/39:c.169C>T:p.Pro57Ser:PF16213%20[Dimerisation%20and%20cyclophilin-binding%20domain%20of%20Mon2]%2CARFGEF2:ENST00000681021.1:missense_variant:MODERATE:exon3/38:c.169C>T:p.Pro57Ser:PF16213%20[Dimerisation%20and%20cyclophilin-binding%20domain%20of%20Mon2]%2CARFGEF2:ENST00000679436.1:missense_variant:MODERATE:exon3/39:c.169C>T:p.Pro57Ser:PF16213%20[Dimerisation%20and%20cyclophilin-binding%20domain%20of%20Mon2];OMIM=605371_[GENE%3DARFGEF2_PHENOS%3DPeriventricular%20heterotopia%20with%20microcephaly%2C%20608097%20(3)%2C%20Autosomal%20recessive];ClinVar=128433%20[likely%20benign(replaced%20by%20megSAP%20based%20on%20classifications:4x1%2C3x2%2C1x3)%20DISEASE%3Dnot%20specified%2CPeriventricular%20heterotopia%20with%20microcephaly%2C%20autosomal%20recessive%2Cnot%20provided%20GENE%3DARFGEF2]%3B;dbSNP=rs73113975;gnomAD=0.00536;gnomAD_sub=0.00123%2C0.00425%2C0.00019%2C0.00954%2C0.00186;gnomAD_hom_hemi=4%2C;gnomAD_het=809;gnomAD_wt=151543;phyloP=3.7760;CADD=24.80;REVEL=0.087;AlphaMissense=0.10;MaxEntScan=/1.3>2.6/0.0>0.0;SpliceAI=ARFGEF2|0.00|0.00|0.00|0.00|-16|1|31|-16;PubMed=25741868;NGSD_hom=5;NGSD_het=788;NGSD_mosaic=0;NGSD_group=0%20/%2094;gene_info=ARFGEF2%20(inh%3DAR%20oe_syn%3D0.94%20oe_mis%3D0.76%20oe_lof%3D0.16)	GT	1/0
chr20	50960127	.	T	G	2598	.	quality=DP%3D232%3BQD%3D11.20%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D8%3BABP%3D7%3BSAR%3D61%3BSAF%3D45;gene=MOCS3%2CDPM1;variant_type=missense%2Cupstream_gene;coding_and_splicing=MOCS3:ENST00000244051.3:missense_variant:MODERATE:exon1/1:c.1285T>G:p.Ser429Ala:PF00581%20[Rhodanese-like%20domain]%2CDPM1:ENST00000371582.8:upstream_gene_variant:MODIFIER::::%2CDPM1:ENST00000371588.10:upstream_gene_variant:MODIFIER::::%2CDPM1:ENST00000371584.9:upstream_gene_variant:MODIFIER::::%2CDPM1:ENST00000683466.1:upstream_gene_variant:MODIFIER::::;OMIM=603503_[GENE%3DDPM1_PHENOS%3DCongenital%20disorder%20of%20glycosylation%2C%20type%20Ie%2C%20608799%20(3)%2C%20Autosomal%20recessive];ClinVar=1166025%20[benign%20DISEASE%3Dnot%20provided%20GENE%3DMOCS3]%3B;HGMD=CM1620413%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Chronic%20obstructive%20pulmonary%20disease"%20GENE%3DMOCS3]%3B;dbSNP=rs7269297;gnomAD=0.00654;gnomAD_sub=0.00197%2C0.00216%2C0.00000%2C0.01173%2C0.00393;gnomAD_hom_hemi=4%2C;gnomAD_het=988;gnomAD_wt=151344;phyloP=-0.0030;CADD=0.50;REVEL=0.022;AlphaMissense=0.06;MaxEntScan=/3.5>0.0/0.0>0.0;COSMIC=COSV99056501;SpliceAI=MOCS3|0.00|0.00|0.00|0.00|1|7|1|13;PubMed=28526295%2C26917578;NGSD_hom=6;NGSD_het=724;NGSD_mosaic=0;NGSD_group=0%20/%2093;gene_info=DPM1%20(inh%3DAR%20oe_syn%3D1.32%20oe_mis%3D0.91%20oe_lof%3D0.50)%2C%20MOCS3%20(inh%3Dn/a%20oe_syn%3D1.00%20oe_mis%3D0.89%20oe_lof%3D0.80)	GT	1/0
chr20	54157275	.	G	A	2617	.	quality=DP%3D190%3BQD%3D13.77%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D51%3BSAF%3D49;gene=CYP24A1;variant_type=synonymous;coding_and_splicing=CYP24A1:ENST00000216862.8:synonymous_variant:LOW:exon11/12:c.1449C>T:p.Tyr483%3D:PF00067%20[Cytochrome%20P450]%2CCYP24A1:ENST00000395955.7:synonymous_variant:LOW:exon10/11:c.1251C>T:p.Tyr417%3D:%2CCYP24A1:ENST00000395954.3:synonymous_variant:LOW:exon9/10:c.1023C>T:p.Tyr341%3D:PF00067%20[Cytochrome%20P450];regulatory=regulatory_region_variant:TF_binding_site;OMIM=126065_[GENE%3DCYP24A1_PHENOS%3DHypercalcemia%2C%20infantile%2C%201%2C%20143880%20(3)%2C%20Autosomal%20recessive];ClinVar=338812%20[uncertain%20significance%20DISEASE%3DHypercalcemia%2C%20infantile%2C%201%20GENE%3DCYP24A1]%3B;dbSNP=rs73135773;gnomAD=0.00004;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00009%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=6;gnomAD_wt=152318;phyloP=-1.3680;CADD=0.40;MaxEntScan=/0.0>1.5/0.0>0.0;COSMIC=COSV99397963;SpliceAI=CYP24A1|0.00|0.00|0.00|0.00|-10|14|48|4;NGSD_hom=0;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CYP24A1%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D1.19%20oe_lof%3D1.15)	GT	1/0
chr21	32726890	.	C	T	1041	.	quality=DP%3D82%3BQD%3D12.70%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D14%3BABP%3D3%3BSAR%3D29%3BSAF%3D14;gene=SYNJ1%2CPAXBP1-AS1;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=SYNJ1:ENST00000357345.7:synonymous_variant:LOW:exon2/32:c.6G>A:p.Ala2%3D:%2CSYNJ1:ENST00000382491.7:synonymous_variant:LOW:exon2/29:c.6G>A:p.Ala2%3D:%2CSYNJ1:ENST00000382499.7:synonymous_variant:LOW:exon2/33:c.123G>A:p.Ala41%3D:%2CSYNJ1:ENST00000433931.7:synonymous_variant:LOW:exon2/32:c.123G>A:p.Ala41%3D:%2CSYNJ1:ENST00000630077.3:synonymous_variant:LOW:exon2/28:c.6G>A:p.Ala2%3D:%2CSYNJ1:ENST00000674204.1:synonymous_variant:LOW:exon2/33:c.6G>A:p.Ala2%3D:%2CSYNJ1:ENST00000674308.1:synonymous_variant:LOW:exon2/32:c.6G>A:p.Ala2%3D:%2CSYNJ1:ENST00000674351.1:synonymous_variant:LOW:exon2/33:c.6G>A:p.Ala2%3D:%2CPAXBP1-AS1:ENST00000655758.1:upstream_gene_variant:MODIFIER::::%2CPAXBP1-AS1:ENST00000660366.1:upstream_gene_variant:MODIFIER::::%2CPAXBP1-AS1:ENST00000653345.1:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604297_[GENE%3DSYNJ1_PHENOS%3DParkinson%20disease%2020%2C%20early-onset%2C%20615530%20(3)%2C%20Autosomal%20recessive%3B%20Developmental%20and%20epileptic%20encephalopathy%2053%2C%20617389%20(3)%2C%20Autosomal%20recessive];ClinVar=478326%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CEarly-onset%20Parkinson%20disease%2020%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2053%2CSYNJ1-related%20disorder%20GENE%3DSYNJ1]%3B;dbSNP=rs61750221;gnomAD=0.00600;gnomAD_sub=0.00205%2C0.00582%2C0.00019%2C0.00954%2C0.00186;gnomAD_hom_hemi=8%2C;gnomAD_het=897;gnomAD_wt=151335;phyloP=1.5300;CADD=15.02;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SYNJ1|0.00|0.00|0.00|0.00|-6|27|-4|1;NGSD_hom=5;NGSD_het=544;NGSD_mosaic=0;NGSD_group=1%20/%2070;gene_info=SYNJ1%20(inh%3DAR%20oe_syn%3D0.97%20oe_mis%3D0.78%20oe_lof%3D0.22)%2C%20PAXBP1-AS1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr21	39277242	.	G	A	744	.	quality=DP%3D59%3BQD%3D12.61%3BAF%3D0.54%3BMQM%3D60%3BSAP%3D30%3BABP%3D4%3BSAR%3D6%3BSAF%3D26;gene=BRWD1;variant_type=splice_region&intron;coding_and_splicing=BRWD1:ENST00000333229.6:splice_region_variant&intron_variant:LOW:intron11/41:c.1104+9C>T::%2CBRWD1:ENST00000342449.8:splice_region_variant&intron_variant:LOW:intron11/40:c.1104+9C>T::%2CBRWD1:ENST00000380800.7:splice_region_variant&intron_variant:LOW:intron11/41:c.1104+9C>T::;OMIM=617824_[GENE%3DBRWD1_PHENOS%3DCiliary%20dyskinesia%2C%20primary%2C%2051%2C%20620438%20(3)%2C%20Autosomal%20recessive];ClinVar=3033837%20[likely%20benign%20DISEASE%3DBRWD1-related%20disorder%20GENE%3DBRWD1]%3B;dbSNP=rs73209844;gnomAD=0.00171;gnomAD_sub=0.00063%2C0.00039%2C0.00116%2C0.00303%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=260;gnomAD_wt=151994;phyloP=0.5460;CADD=10.69;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=BRWD1|0.00|0.00|0.00|0.00|43|9|9|5;NGSD_hom=1;NGSD_het=222;NGSD_mosaic=0;NGSD_group=0%20/%2026;gene_info=BRWD1%20(inh%3DAR%20oe_syn%3D1.06%20oe_mis%3D0.77%20oe_lof%3D0.15)	GT	1/0
chr21	43060506	.	G	A	3258	.	quality=DP%3D258%3BQD%3D12.63%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D13%3BABP%3D3%3BSAR%3D76%3BSAF%3D52;gene=CBS;variant_type=synonymous;coding_and_splicing=CBS:ENST00000398158.5:synonymous_variant:LOW:exon12/17:c.1080C>T:p.Ala360%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000398165.8:synonymous_variant:LOW:exon12/17:c.1080C>T:p.Ala360%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000359624.7:synonymous_variant:LOW:exon12/18:c.1080C>T:p.Ala360%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000352178.9:synonymous_variant:LOW:exon12/17:c.1080C>T:p.Ala360%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme];OMIM=613381_[GENE%3DCBS_PHENOS%3DThrombosis%2C%20hyperhomocysteinemic%2C%20236200%20(3)%2C%20Autosomal%20recessive%3B%20Homocystinuria%2C%20B6-responsive%20and%20nonresponsive%20types%2C%20236200%20(3)%2C%20Autosomal%20recessive];ClinVar=92424%20[benign%20DISEASE%3Dnot%20provided%2CFamilial%20thoracic%20aortic%20aneurysm%20and%20aortic%20dissection%2CClassic%20homocystinuria%2CHYPERHOMOCYSTEINEMIA%2C%20THROMBOTIC%2C%20CBS-RELATED%2Cnot%20specified%20GENE%3DCBS]%3B;dbSNP=rs1801181;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=11;phyloP=-2.3850;CADD=0.12;REVEL=0.009;MaxEntScan=/0.3>0.1/0.0>0.0;COSMIC=COSV61441401;SpliceAI=CBSL|0.00|0.00|0.00|0.00|33|40|41|-36%2CCBS|0.00|0.00|0.00|0.00|33|40|41|-36;PubMed=25741868%2C21533139%2C24033266%2C30168256%2C19493349%2C23757202%2C21254359%2C19064578%2C17035141%2C17119116%2C18098291%2C18708408%2C18830263%2C19112534%2C19336559%2C23913011%2C21957013%2C25939784%2C33278453%2C26108676%2C31323740%2C36479483%2C15922487;NGSD_hom=3509;NGSD_het=11904;NGSD_mosaic=10;NGSD_group=345%20/%201172;gene_info=CBS%20(inh%3DAR%20oe_syn%3D1.11%20oe_mis%3D0.87%20oe_lof%3D0.45)	GT	1/0
chr21	43065240	.	G	A	4842	.	quality=DP%3D362%3BQD%3D13.38%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D3%3BABP%3D5%3BSAR%3D92%3BSAF%3D97;gene=CBS;variant_type=synonymous;coding_and_splicing=CBS:ENST00000398158.5:synonymous_variant:LOW:exon8/17:c.699C>T:p.Tyr233%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000398165.8:synonymous_variant:LOW:exon8/17:c.699C>T:p.Tyr233%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000359624.7:synonymous_variant:LOW:exon8/18:c.699C>T:p.Tyr233%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme]%2CCBS:ENST00000352178.9:synonymous_variant:LOW:exon8/17:c.699C>T:p.Tyr233%3D:PF00291%20[Pyridoxal-phosphate%20dependent%20enzyme];OMIM=613381_[GENE%3DCBS_PHENOS%3DThrombosis%2C%20hyperhomocysteinemic%2C%20236200%20(3)%2C%20Autosomal%20recessive%3B%20Homocystinuria%2C%20B6-responsive%20and%20nonresponsive%20types%2C%20236200%20(3)%2C%20Autosomal%20recessive];ClinVar=92426%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CFamilial%20thoracic%20aortic%20aneurysm%20and%20aortic%20dissection%2CConnective%20tissue%20disorder%2CClassic%20homocystinuria%2CHYPERHOMOCYSTEINEMIA%2C%20THROMBOTIC%2C%20CBS-RELATED%20GENE%3DCBS]%3B;HGMD=CM074081%20[CLASS%3DDFP%20MUT%3DALT%20PHEN%3D"Altered%20one-carbon%20metabolism"%20GENE%3DCBS]%3B;dbSNP=rs234706;phyloP=-0.9070;CADD=2.61;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV61441798;SpliceAI=CBSL|0.00|0.00|0.00|0.00|18|32|-31|-37%2CCBS|0.00|0.00|0.00|0.00|18|32|-31|-37;PubMed=25741868%2C21467728%2C21533139%2C34308116%2C24033266%2C21992066%2C17601350%2C33195260%2C23757202%2C19379518%2C20565774%2C22024213%2C19048631%2C22496743%2C21204206%2C29694444%2C19064578%2C20718043%2C22792358%2C24130171%2C17119116%2C17697348%2C18098291%2C18203168%2C18708408%2C18830263%2C19336559%2C20670920%2C20813848%2C34065323%2C23913011%2C32996248%2C21957013%2C12529702%2C17436311%2C23882023%2C25939784%2C28777022%2C31187898%2C35054087%2C33278453%2C28544455%2C35736408%2C26955774%2C34503214%2C26177343%2C26105871%2C35315575%2C25891169%2C26306664%2C17553479%2C15922487;NGSD_hom=2773;NGSD_het=11551;NGSD_mosaic=8;NGSD_group=289%20/%201113;gene_info=CBS%20(inh%3DAR%20oe_syn%3D1.11%20oe_mis%3D0.87%20oe_lof%3D0.45)	GT	1/0
chr21	43169105	.	C	T	12930	.	quality=DP%3D407%3BQD%3D31.77%3BAF%3D1.00%3BMQM%3D60%3BSAP%3D77%3BABP%3D0%3BSAR%3D144%3BSAF%3D262;gene=CRYAA;variant_type=synonymous%2Cupstream_gene;coding_and_splicing=CRYAA:ENST00000291554.6:synonymous_variant:LOW:exon1/3:c.6C>T:p.Asp2%3D:PF00525%20[Alpha%20crystallin%20A%20chain%20N%20terminal]%2CCRYAA:ENST00000398133.5:upstream_gene_variant:MODIFIER::::%2CCRYAA:ENST00000398132.1:upstream_gene_variant:MODIFIER::::;OMIM=123580_[GENE%3DCRYAA_PHENOS%3DCataract%209%2C%20multiple%20types%2C%20604219%20(3)%2C%20Autosomal%20dominant%2C%20Autosomal%20recessive];ClinVar=256010%20[benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CCataract%209%20multiple%20types%20GENE%3DCRYAA]%3B;HGMD=CM104786%20[CLASS%3DDP%20MUT%3DALT%20PHEN%3D"Cataract%20type%20association%20with"%20GENE%3DCRYAA]%3B;dbSNP=rs872331;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=85928;phyloP=0.9360;CADD=13.90;MaxEntScan=/2.0>2.8/0.1>0.9;COSMIC=COSV52352216;SpliceAI=CH507-152C13.3|0.00|0.00|0.00|0.00|13|-29|0|-21%2CCRYAA|0.00|0.00|0.00|0.00|13|-29|0|20;PubMed=25741868%2C26996484%2C21031021%2C19390652%2C2671581%2C20606865%2C28690483%2C26867756;NGSD_hom=9121;NGSD_het=12564;NGSD_mosaic=7;NGSD_group=927%20/%201187;gene_info=CRYAA%20(inh%3DAR+AD%20oe_syn%3D1.11%20oe_mis%3D0.91%20oe_lof%3D0.31)	GT	1/1
chr21	43417671	.	G	A	18208	.	quality=DP%3D577%3BQD%3D31.56%3BAF%3D0.98%3BMQM%3D60%3BSAP%3D76%3BABP%3D0%3BSAR%3D215%3BSAF%3D353;gene=SIK1;variant_type=synonymous;coding_and_splicing=SIK1:ENST00000270162.8:synonymous_variant:LOW:exon13/14:c.1848C>T:p.Pro616%3D:;OMIM=605705_[GENE%3DSIK1_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2030%2C%20616341%20(3)%2C%20Autosomal%20dominant];ClinVar=586586%20[benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CInborn%20genetic%20diseases%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2030%20GENE%3DSIK1]%3B;dbSNP=rs430552;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=42124;phyloP=-0.2980;CADD=1.92;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV54258613;SpliceAI=CH507-42P11.8|0.00|0.00|0.00|0.00|-18|14|15|12%2CSIK1|0.00|0.00|0.00|0.00|-18|14|15|12;NGSD_hom=16426;NGSD_het=8875;NGSD_mosaic=95;NGSD_group=1595%20/%20827;gene_info=SIK1%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.80%20oe_lof%3D0.16)	GT	1/1
chr21	43426136	.	C	T	9791	.	quality=DP%3D312%3BQD%3D31.38%3BAF%3D1.00%3BMQM%3D60%3BSAP%3D139%3BABP%3D0%3BSAR%3D226%3BSAF%3D86;gene=SIK1;variant_type=missense;coding_and_splicing=SIK1:ENST00000270162.8:missense_variant:MODERATE:exon2/14:c.43G>A:p.Gly15Ser:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=605705_[GENE%3DSIK1_PHENOS%3DDevelopmental%20and%20epileptic%20encephalopathy%2030%2C%20616341%20(3)%2C%20Autosomal%20dominant];ClinVar=586588%20[benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CInborn%20genetic%20diseases%2CDevelopmental%20and%20epileptic%20encephalopathy%2C%2030%20GENE%3DSIK1]%3B;dbSNP=rs3746951;phyloP=1.0320;CADD=12.17;REVEL=0.059;AlphaMissense=0.08;MaxEntScan=/0.0>0.0/2.6>0.0;COSMIC=COSV54259059;SpliceAI=CH507-42P11.8|0.00|0.00|0.00|0.00|-2|0|-26|0%2CSIK1|0.00|0.00|0.00|0.00|-2|0|-26|0;PubMed=31142279%2C27837419%2C31165925%2C33579883%2C22045124%2C24698975%2C36565421;NGSD_hom=1669;NGSD_het=9460;NGSD_mosaic=6;NGSD_group=184%20/%20942;gene_info=SIK1%20(inh%3DAD%20oe_syn%3D0.99%20oe_mis%3D0.80%20oe_lof%3D0.16)	GT	1/1
chr21	43565321	.	G	A	260	.	quality=DP%3D175%3BQD%3D1.49%3BAF%3D0.22%3BMQM%3D32%3BSAP%3D6%3BABP%3D120%3BSAR%3D16%3BSAF%3D23;gene=HSF2BP%2CH2BC12L;variant_type=intron%2Cmissense;coding_and_splicing=HSF2BP:ENST00000291560.7:intron_variant:MODIFIER:intron8/8:c.796+26904C>T::%2CH2BC12L:ENST00000599962.2:missense_variant:MODERATE:exon1/1:c.83G>A:p.Arg28Lys:PF00125%20[Core%20histone%20H2A/H2B/H3/H4];regulatory=regulatory_region_variant:open_chromatin_region%2CTF_binding_site_variant;OMIM=604554_[GENE%3DHSF2BP_PHENOS%3DPremature%20ovarian%20failure%2019%2C%20619245%20(3)%2C%20Autosomal%20recessive];dbSNP=rs9637217;phyloP=4.7460;CADD=6.29;AlphaMissense=0.05;MaxEntScan=/1.7>1.0/0.0>0.0%2C/0.0>0.0/0.8>2.9;COSMIC=COSV52355225;SpliceAI=H2BFS|0.00|0.00|0.00|0.00|50|1|49|0%2CHSF2BP|0.00|0.00|0.00|0.00|-25|27|41|-23;NGSD_hom=8431;NGSD_het=12635;NGSD_mosaic=5;NGSD_group=806%20/%201208;gene_info=HSF2BP%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D1.03%20oe_lof%3D1.31)%2C%20H2BC12L%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr21	43565355	.	C	T	1031	.	quality=DP%3D235%3BQD%3D4.39%3BAF%3D0.30%3BMQM%3D34%3BSAP%3D35%3BABP%3D86%3BSAR%3D19%3BSAF%3D51;gene=HSF2BP%2CH2BC12L;variant_type=intron%2Csynonymous;coding_and_splicing=HSF2BP:ENST00000291560.7:intron_variant:MODIFIER:intron8/8:c.796+26870G>A::%2CH2BC12L:ENST00000599962.2:synonymous_variant:LOW:exon1/1:c.117C>T:p.Ser39%3D:PF00125%20[Core%20histone%20H2A/H2B/H3/H4];regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604554_[GENE%3DHSF2BP_PHENOS%3DPremature%20ovarian%20failure%2019%2C%20619245%20(3)%2C%20Autosomal%20recessive];dbSNP=rs570129454;phyloP=1.4660;CADD=8.21;MaxEntScan=/0.0>3.6/0.0>0.0%2C/1.6>1.6/0.0>0.0;SpliceAI=H2BFS|0.00|0.00|0.00|0.00|16|-33|2|15%2CHSF2BP|0.00|0.00|0.00|0.00|-2|-1|-2|5;NGSD_hom=0;NGSD_het=39;NGSD_mosaic=1;NGSD_group=0%20/%202;gene_info=HSF2BP%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D1.03%20oe_lof%3D1.31)%2C%20H2BC12L%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr21	43565391	.	C	T	1745	.	quality=DP%3D270%3BQD%3D6.46%3BAF%3D0.36%3BMQM%3D38%3BSAP%3D43%3BABP%3D52%3BSAR%3D27%3BSAF%3D69;gene=HSF2BP%2CH2BC12L;variant_type=intron%2Csynonymous;coding_and_splicing=HSF2BP:ENST00000291560.7:intron_variant:MODIFIER:intron8/8:c.796+26834G>A::%2CH2BC12L:ENST00000599962.2:synonymous_variant:LOW:exon1/1:c.153C>T:p.Pro51%3D:PF00125%20[Core%20histone%20H2A/H2B/H3/H4];regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604554_[GENE%3DHSF2BP_PHENOS%3DPremature%20ovarian%20failure%2019%2C%20619245%20(3)%2C%20Autosomal%20recessive];dbSNP=rs9637218;phyloP=0.1830;CADD=8.84;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV52355237;SpliceAI=H2BFS|0.08|0.00|0.01|0.00|22|-20|-21|-9%2CHSF2BP|0.00|0.00|0.00|0.00|-2|16|-2|10;NGSD_hom=7437;NGSD_het=13008;NGSD_mosaic=1;NGSD_group=702%20/%201259;gene_info=HSF2BP%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D1.03%20oe_lof%3D1.31)%2C%20H2BC12L%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr21	43565592	.	C	T	3446	.	quality=DP%3D294%3BQD%3D11.72%3BAF%3D0.49%3BMQM%3D51%3BSAP%3D18%3BABP%3D3%3BSAR%3D87%3BSAF%3D56;gene=HSF2BP%2CH2BC12L;variant_type=intron%2Csynonymous;coding_and_splicing=HSF2BP:ENST00000291560.7:intron_variant:MODIFIER:intron8/8:c.796+26633G>A::%2CH2BC12L:ENST00000599962.2:synonymous_variant:LOW:exon1/1:c.354C>T:p.Ala118%3D:;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604554_[GENE%3DHSF2BP_PHENOS%3DPremature%20ovarian%20failure%2019%2C%20619245%20(3)%2C%20Autosomal%20recessive];dbSNP=rs2838315;phyloP=-0.2440;CADD=7.83;MaxEntScan=/0.2>1.9/0.5>0.0%2C/0.0>0.0/0.0>0.0;SpliceAI=H2BFS|0.00|0.00|0.00|0.00|-26|23|-37|8%2CHSF2BP|0.00|0.00|0.00|0.00|-2|44|-2|34;NGSD_hom=6671;NGSD_het=13089;NGSD_mosaic=5;NGSD_group=653%20/%201255;gene_info=HSF2BP%20(inh%3DAR%20oe_syn%3D0.96%20oe_mis%3D1.03%20oe_lof%3D1.31)%2C%20H2BC12L%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr21	44109038	.	G	A	12754	.	quality=DP%3D406%3BQD%3D31.41%3BAF%3D1.00%3BMQM%3D60%3BSAP%3D74%3BABP%3D0%3BSAR%3D145%3BSAF%3D260;gene=PWP2%2CTRAPPC10;variant_type=missense%2Cdownstream_gene;coding_and_splicing=PWP2:ENST00000291576.12:missense_variant:MODERATE:exon2/21:c.73G>A:p.Asp25Asn:%2CTRAPPC10:ENST00000291574.9:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=602103_[GENE%3DTRAPPC10_PHENOS%3DNeurodevelopmental%20disorder%20with%20microcephaly%2C%20short%20stature%2C%20and%20speech%20delay%2C%20620027%20(3)%2C%20Autosomal%20recessive];dbSNP=rs2020945;phyloP=7.4970;CADD=25.00;REVEL=0.226;AlphaMissense=0.12;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV52378282;SpliceAI=CH507-9B2.5|0.00|0.00|0.00|0.00|13|-25|-39|11%2CPWP2|0.00|0.00|0.00|0.00|13|-25|-39|11;PubMed=25358694;NGSD_hom=11989;NGSD_het=6688;NGSD_mosaic=4;NGSD_group=1091%20/%20595;classification_comment="[3]%20ahbadei1%2023.11.2022%20[n/a]%20ahzulet1%2014.03.2024%2C%20a.e.%20Artefakt";gene_info=TRAPPC10%20(inh%3DAR%20oe_syn%3D1.01%20oe_mis%3D0.84%20oe_lof%3D0.11)%2C%20PWP2%20(inh%3Dn/a%20oe_syn%3D1.11%20oe_mis%3D0.96%20oe_lof%3D0.32)	GT	1/1
chr22	18913237	.	G	A	2075	.	quality=DP%3D155%3BQD%3D13.39%3BAF%3D0.52%3BMQM%3D60%3BSAP%3D20%3BABP%3D4%3BSAR%3D28%3BSAF%3D53;gene=PRODH%2CDGCR6;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=PRODH:ENST00000610940.4:synonymous_variant:LOW:exon15/15:c.1741C>T:p.Leu581%3D:%2CPRODH:ENST00000357068.11:synonymous_variant:LOW:exon14/14:c.1741C>T:p.Leu581%3D:%2CPRODH:ENST00000420436.5:synonymous_variant:LOW:exon14/14:c.1417C>T:p.Leu473%3D:%2CPRODH:ENST00000334029.6:synonymous_variant:LOW:exon14/14:c.1417C>T:p.Leu473%3D:%2CDGCR6:ENST00000413981.5:downstream_gene_variant:MODIFIER::::%2CDGCR6:ENST00000331444.12:downstream_gene_variant:MODIFIER::::%2CDGCR6:ENST00000608842.1:downstream_gene_variant:MODIFIER::::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=127267%20[benign%20DISEASE%3Dnot%20provided%2CProline%20dehydrogenase%20deficiency%20GENE%3DPRODH]%3B;dbSNP=rs372055;gnomAD=0.00003;gnomAD_sub=0.00007%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=31715;phyloP=6.1710;CADD=7.30;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV58230985;SpliceAI=PRODH|0.00|0.00|0.00|0.00|10|34|-4|-32;PubMed=27895608%2C29047144%2C17604122%2C18408230%2C16860541%2C18989458%2C26068888%2C24498354%2C19729054%2C34285201%2C18325483%2C19232576;NGSD_hom=12203;NGSD_het=6721;NGSD_mosaic=4;NGSD_group=1084%20/%20589;gene_info=DGCR6%20(inh%3DAD%20oe_syn%3D1.13%20oe_mis%3D1.03%20oe_lof%3D1.28)%2C%20PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/0
chr22	18913491	.	C	T	2505	.	quality=DP%3D84%3BQD%3D29.82%3BAF%3D0.98%3BMQM%3D60%3BSAP%3D69%3BABP%3D0%3BSAR%3D66%3BSAF%3D16;gene=PRODH%2CDGCR6;variant_type=missense%2Cdownstream_gene;coding_and_splicing=PRODH:ENST00000610940.4:missense_variant:MODERATE:exon14/15:c.1562G>A:p.Arg521Gln:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000357068.11:missense_variant:MODERATE:exon13/14:c.1562G>A:p.Arg521Gln:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000420436.5:missense_variant:MODERATE:exon13/14:c.1238G>A:p.Arg413Gln:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000334029.6:missense_variant:MODERATE:exon13/14:c.1238G>A:p.Arg413Gln:PF01619%20[Proline%20dehydrogenase]%2CDGCR6:ENST00000413981.5:downstream_gene_variant:MODIFIER::::%2CDGCR6:ENST00000331444.12:downstream_gene_variant:MODIFIER::::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1168803%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%2CSchizophrenia%204%20GENE%3DPRODH]%3B;dbSNP=rs450046;gnomAD=0.00268;gnomAD_sub=0.00572%2C0.00000%2C0.00250%2C0.00000%2C0.00148;gnomAD_hom_hemi=0%2C;gnomAD_het=63;gnomAD_wt=23483;phyloP=3.7870;CADD=19.70;REVEL=0.055;MaxEntScan=/4.8>6.8/0.0>2.6;COSMIC=COSV58230786;SpliceAI=PRODH|0.01|0.02|0.01|0.00|-2|35|-1|-23;PubMed=29334895%2C17708757%2C19693005%2C29047144%2C18408230%2C22763378%2C18989458%2C26068888%2C12217952%2C15662599%2C24498354%2C30659259%2C19729054%2C34285201%2C29047040%2C25981510%2C19232576%2C20060941%2C18832372;NGSD_hom=17786;NGSD_het=2676;NGSD_mosaic=0;NGSD_group=1659%20/%20221;gene_info=DGCR6%20(inh%3DAD%20oe_syn%3D1.13%20oe_mis%3D1.03%20oe_lof%3D1.28)%2C%20PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/1
chr22	18916901	.	A	G	3655	.	quality=DP%3D137%3BQD%3D26.68%3BAF%3D0.99%3BMQM%3D39%3BSAP%3D154%3BABP%3D0%3BSAR%3D19%3BSAF%3D116;gene=PRODH%2CDGCR6;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=PRODH:ENST00000610940.4:synonymous_variant:LOW:exon13/15:c.1515T>C:p.Phe505%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000357068.11:synonymous_variant:LOW:exon12/14:c.1515T>C:p.Phe505%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000420436.5:synonymous_variant:LOW:exon12/14:c.1191T>C:p.Phe397%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000334029.6:synonymous_variant:LOW:exon12/14:c.1191T>C:p.Phe397%3D:PF01619%20[Proline%20dehydrogenase]%2CDGCR6:ENST00000413981.5:downstream_gene_variant:MODIFIER::::%2CDGCR6:ENST00000331444.12:downstream_gene_variant:MODIFIER::::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1169511%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%2Cnot%20provided%20GENE%3DPRODH]%3B;dbSNP=rs455072;gnomAD=0.00003;gnomAD_sub=0.00005%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=36579;phyloP=1.9180;CADD=5.21;MaxEntScan=/6.7>6.6/0.0>0.0;COSMIC=COSV58230709;SpliceAI=PRODH|0.00|0.00|0.00|0.00|-3|39|-11|39;PubMed=34285201;NGSD_hom=22190;NGSD_het=3926;NGSD_mosaic=0;NGSD_group=2189%20/%20349;gene_info=DGCR6%20(inh%3DAD%20oe_syn%3D1.13%20oe_mis%3D1.03%20oe_lof%3D1.28)%2C%20PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/1
chr22	18921362	.	A	G	2231	.	quality=DP%3D71%3BQD%3D31.42%3BAF%3D1.00%3BMQM%3D55%3BSAP%3D5%3BABP%3D0%3BSAR%3D32%3BSAF%3D39;gene=PRODH;variant_type=synonymous;coding_and_splicing=PRODH:ENST00000610940.4:synonymous_variant:LOW:exon9/15:c.991T>C:p.Leu331%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000357068.11:synonymous_variant:LOW:exon8/14:c.991T>C:p.Leu331%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000420436.5:synonymous_variant:LOW:exon8/14:c.667T>C:p.Leu223%3D:PF01619%20[Proline%20dehydrogenase]%2CPRODH:ENST00000334029.6:synonymous_variant:LOW:exon8/14:c.667T>C:p.Leu223%3D:PF01619%20[Proline%20dehydrogenase];OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1169513%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%2Cnot%20provided%20GENE%3DPRODH]%3B;dbSNP=rs1808320;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=0;phyloP=1.9430;CADD=8.81;MaxEntScan=/0.0>0.0/0.0>0.1;SpliceAI=PRODH|0.00|0.00|0.00|0.00|34|-41|-20|-2;PubMed=29658973%2C34285201;NGSD_hom=10304;NGSD_het=12109;NGSD_mosaic=7;NGSD_group=937%20/%201210;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/1
chr22	18922937	.	CA	C	5724	.	quality=DP%3D194%3BQD%3D29.51%3BAF%3D0.99%3BMQM%3D60%3BSAP%3D30%3BABP%3D0%3BSAR%3D121%3BSAF%3D72;gene=PRODH;variant_type=splice_region&intron;coding_and_splicing=PRODH:ENST00000610940.4:splice_region_variant&intron_variant:LOW:intron6/14:c.733-5del::%2CPRODH:ENST00000357068.11:splice_region_variant&intron_variant:LOW:intron5/13:c.733-5del::%2CPRODH:ENST00000420436.5:splice_region_variant&intron_variant:LOW:intron5/13:c.409-5del::%2CPRODH:ENST00000334029.6:splice_region_variant&intron_variant:LOW:intron5/13:c.409-5del::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1164746%20[benign%20DISEASE%3Dnot%20provided%2CProline%20dehydrogenase%20deficiency%20GENE%3DPRODH]%3B;dbSNP=rs3216765;phyloP=0.5170;MaxEntScan=/4.5>0.0/0.0>0.0;SpliceAI=PRODH|0.10|0.11|0.00|0.00|10|-4|-18|-35;NGSD_hom=1715;NGSD_het=9674;NGSD_mosaic=4;NGSD_group=164%20/%20965;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/1
chr22	18925165	.	A	G	8943	.	quality=DP%3D285%3BQD%3D31.38%3BAF%3D0.99%3BMQM%3D60%3BSAP%3D69%3BABP%3D0%3BSAR%3D188%3BSAF%3D95;gene=PRODH;variant_type=missense;coding_and_splicing=PRODH:ENST00000610940.4:missense_variant:MODERATE:exon5/15:c.553T>C:p.Trp185Arg:%2CPRODH:ENST00000357068.11:missense_variant:MODERATE:exon4/14:c.553T>C:p.Trp185Arg:%2CPRODH:ENST00000420436.5:missense_variant:MODERATE:exon4/14:c.229T>C:p.Trp77Arg:%2CPRODH:ENST00000334029.6:missense_variant:MODERATE:exon4/14:c.229T>C:p.Trp77Arg:;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1168806%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%20GENE%3DPRODH]%3B;dbSNP=rs4819756;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=550;phyloP=3.8250;CADD=5.31;REVEL=0.124;MaxEntScan=/3.0>3.4/0.0>0.0;SpliceAI=PRODH|0.00|0.00|0.00|0.00|6|-20|6|36;PubMed=19693005%2C23910792%2C24853458%2C25325218%2C18989458%2C24498354%2C29658973%2C34285201%2C30710087%2C18832372;NGSD_hom=10496;NGSD_het=12082;NGSD_mosaic=4;NGSD_group=958%20/%201197;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/1
chr22	18936011	.	G	A	2914	.	quality=DP%3D190%3BQD%3D15.34%3BAF%3D0.59%3BMQM%3D60%3BSAP%3D13%3BABP%3D18%3BSAR%3D68%3BSAF%3D45;gene=PRODH;variant_type=splice_region&intron%2Cintron;coding_and_splicing=PRODH:ENST00000610940.4:splice_region_variant&intron_variant:LOW:intron2/14:c.273+4C>T::%2CPRODH:ENST00000357068.11:splice_region_variant&intron_variant:LOW:intron1/13:c.273+4C>T::%2CPRODH:ENST00000420436.5:intron_variant:MODIFIER:intron1/13:c.-35+159C>T::%2CPRODH:ENST00000334029.6:intron_variant:MODIFIER:intron1/13:c.-52+379C>T::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1164747%20[benign%20DISEASE%3Dnot%20provided%2CProline%20dehydrogenase%20deficiency%20GENE%3DPRODH]%3B;dbSNP=rs3815653;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=0;phyloP=-0.2140;CADD=12.01;MaxEntScan=9.1>6.5/0.0>0.1/9.1>6.5%2C/0.0>0.1/9.1>6.5;SpliceAI=PRODH|0.00|0.00|0.01|0.07|4|22|2|4;NGSD_hom=332;NGSD_het=4352;NGSD_mosaic=3;NGSD_group=27%20/%20480;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/0
chr22	18936072	.	C	G	2089	.	quality=DP%3D143%3BQD%3D14.61%3BAF%3D0.57%3BMQM%3D59%3BSAP%3D27%3BABP%3D10%3BSAR%3D56%3BSAF%3D26;gene=PRODH;variant_type=synonymous%2Cintron;coding_and_splicing=PRODH:ENST00000610940.4:synonymous_variant:LOW:exon2/15:c.216G>C:p.Arg72%3D:%2CPRODH:ENST00000357068.11:synonymous_variant:LOW:exon1/14:c.216G>C:p.Arg72%3D:%2CPRODH:ENST00000420436.5:intron_variant:MODIFIER:intron1/13:c.-35+98G>C::%2CPRODH:ENST00000334029.6:intron_variant:MODIFIER:intron1/13:c.-52+318G>C::;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1164748%20[benign%20DISEASE%3Dnot%20provided%2CProline%20dehydrogenase%20deficiency%20GENE%3DPRODH]%3B;dbSNP=rs1808323;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=0;phyloP=0.3130;CADD=13.79;REVEL=0.014;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=PRODH|0.00|0.00|0.00|0.00|-3|38|-9|-20;NGSD_hom=321;NGSD_het=4556;NGSD_mosaic=2;NGSD_group=26%20/%20483;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/0
chr22	18936200	.	G	A	963	.	quality=DP%3D80%3BQD%3D12.04%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D23%3BSAF%3D17;gene=PRODH;variant_type=missense%2C5'UTR%2Cintron;coding_and_splicing=PRODH:ENST00000610940.4:missense_variant:MODERATE:exon2/15:c.88C>T:p.Pro30Ser:%2CPRODH:ENST00000357068.11:missense_variant:MODERATE:exon1/14:c.88C>T:p.Pro30Ser:%2CPRODH:ENST00000420436.5:5_prime_UTR_variant:MODIFIER:exon1/14:c.-65C>T::%2CPRODH:ENST00000334029.6:intron_variant:MODIFIER:intron1/13:c.-52+190C>T::;regulatory=regulatory_region_variant:promoter;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=281129%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%2Cnot%20specified%2Cnot%20provided%20GENE%3DPRODH]%3B;HGMD=CM106032%20[CLASS%3DDFP%20MUT%3DALT%20PHEN%3D"Hyperprolinaemia"%20GENE%3DPRODH]%3B;dbSNP=rs3815655;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=0;phyloP=1.9120;CADD=7.65;REVEL=0.014;MaxEntScan=/4.9>4.9/0.0>0.0;SpliceAI=PRODH|0.00|0.00|0.00|0.00|3|0|-30|0;NGSD_hom=329;NGSD_het=4556;NGSD_mosaic=8;NGSD_group=27%20/%20482;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/0
chr22	18936232	.	G	T	687	.	quality=DP%3D62%3BQD%3D11.08%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D20%3BABP%3D4%3BSAR%3D22%3BSAF%3D7;gene=PRODH;variant_type=missense%2C5'UTR%2Cintron;coding_and_splicing=PRODH:ENST00000610940.4:missense_variant:MODERATE:exon2/15:c.56C>A:p.Pro19Gln:%2CPRODH:ENST00000357068.11:missense_variant:MODERATE:exon1/14:c.56C>A:p.Pro19Gln:%2CPRODH:ENST00000420436.5:5_prime_UTR_variant:MODIFIER:exon1/14:c.-97C>A::%2CPRODH:ENST00000334029.6:intron_variant:MODIFIER:intron1/13:c.-52+158C>A::;regulatory=regulatory_region_variant:promoter%2CTF_binding_site_variant;OMIM=606810_[GENE%3DPRODH_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to%2C%204}%2C%20600850%20(3)%2C%20Autosomal%20dominant%3B%20Hyperprolinemia%2C%20type%20I%2C%20239500%20(3)%2C%20Autosomal%20recessive];ClinVar=1168807%20[benign%20DISEASE%3DProline%20dehydrogenase%20deficiency%2Cnot%20provided%20GENE%3DPRODH]%3B;dbSNP=rs2008720;gnomAD=0.00000;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=0;gnomAD_wt=0;phyloP=-0.2930;CADD=2.84;REVEL=0.005;MaxEntScan=/3.0>5.0/0.0>0.0;COSMIC=COSV61838822;SpliceAI=PRODH|0.06|0.00|0.00|0.00|-2|-32|-2|-32;PubMed=25569235%2C18408230%2C23910792%2C24498354%2C19729054%2C34285201%2C36292575%2C30710087;NGSD_hom=6097;NGSD_het=12255;NGSD_mosaic=10;NGSD_group=559%20/%201244;gene_info=PRODH%20(inh%3DAR+AD%20oe_syn%3D1.09%20oe_mis%3D0.99%20oe_lof%3D0.76)	GT	1/0
chr22	19941619	.	GGCCACCGCCGCGCGGACACCCTCACGAGGACACCCCGGCCGCGCGGACACCTACCGCGGGGACGCCCCGACCCCATCCTACCTGCTGCGCCCCGCGCCGCGCCCCGCACCCCGCCCGCCACGGCCTGCGTCCGCCACCGGAAGCGCCCTCCTAATCCCCGCAGC	G	19	.	quality=DP%3D4%3BQD%3D4.75%3BAF%3D1.00%3BMQM%3D60%3BSAP%3D3%3BABP%3D0%3BSAR%3D2%3BSAF%3D2;gene=TXNRD2%2CCOMT;variant_type=splice_donor&inframe_deletion%2Cintron%2Cupstream_gene;coding_and_splicing=TXNRD2:ENST00000400519.6:splice_donor_variant&inframe_deletion:HIGH:exon1/17intron1/16:c.21_103+81del:p.?:%2CTXNRD2:ENST00000400521.7:splice_donor_variant&inframe_deletion:HIGH:exon1/18intron1/17:c.21_103+81del:p.?:%2CTXNRD2:ENST00000400525.6:splice_donor_variant&inframe_deletion:HIGH:exon1/17intron1/16:c.21_103+81del:p.?:%2CTXNRD2:ENST00000334363.14:splice_donor_variant&inframe_deletion:HIGH:exon1/12intron1/11:c.21_103+81del:p.?:%2CCOMT:ENST00000676678.1:intron_variant:MODIFIER:intron1/5:c.-92+54_-92+217del::%2CTXNRD2:ENST00000542719.6:upstream_gene_variant:MODIFIER::::%2CCOMT:ENST00000403184.5:upstream_gene_variant:MODIFIER:exon1/5:::%2CCOMT:ENST00000361682.11:upstream_gene_variant:MODIFIER:exon1/6:::%2CCOMT:ENST00000403710.5:upstream_gene_variant:MODIFIER:exon1/6:::%2CCOMT:ENST00000407537.5:upstream_gene_variant:MODIFIER:exon1/7:::%2CCOMT:ENST00000678868.1:upstream_gene_variant:MODIFIER::::%2CCOMT:ENST00000678769.1:upstream_gene_variant:MODIFIER::::%2CCOMT:ENST00000428707.2:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:promoter%2CTFBS_ablation&TF_binding_site_variant%2CTF_binding_site_variant;OMIM=606448_[GENE%3DTXNRD2_PHENOS%3D?Glucocorticoid%20deficiency%205%2C%20617825%20(3)%2C%20Autosomal%20recessive]&116790_[GENE%3DCOMT_PHENOS%3D{Schizophrenia%2C%20susceptibility%20to}%2C%20181500%20(3)%2C%20Autosomal%20dominant%3B%20{Panic%20disorder%2C%20susceptibility%20to}%2C%20167870%20(3)%2C%20?Autosomal%20dominant];RepeatMasker=(GCGCCGC)n%20(Simple_repeat);phyloP=2.6920;MaxEntScan=/5.1>5.1/9.8>9.8%2C/9.7>0.0/0.7>0.0;NGSD_hom=1;NGSD_het=0;NGSD_mosaic=0;NGSD_group=1%20/%200;gene_info=TXNRD2%20(inh%3DAR%20oe_syn%3D1.07%20oe_mis%3D0.90%20oe_lof%3D0.69)%2C%20COMT%20(inh%3DAD%20oe_syn%3D0.94%20oe_mis%3D0.91%20oe_lof%3D1.02)	GT	1/1
chr22	20429375	.	C	G	7	.	quality=DP%3D103%3BQD%3D0.07%3BAF%3D0.33%3BMQM%3D58%3BSAP%3D77%3BABP%3D29%3BSAR%3D34%3BSAF%3D0;gene=SCARF2;variant_type=intron%2Csplice_region&intron;coding_and_splicing=SCARF2:ENST00000622235.5:intron_variant:MODIFIER:intron8/10:c.1425-35G>C::%2CSCARF2:ENST00000623402.1:splice_region_variant&intron_variant:LOW:intron8/10:c.1425-20G>C::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=613619_[GENE%3DSCARF2_PHENOS%3DVan%20den%20Ende-Gupta%20syndrome%2C%20600920%20(3)%2C%20Autosomal%20recessive];RepeatMasker=G-rich%20(Low_complexity);dbSNP=rs755163625;gnomAD=0.00001;gnomAD_sub=0.00004%2C0.00000%2C0.00000%2C0.00000%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=88189;phyloP=0.6220;CADD=6.21;MaxEntScan=6.2>7.6/6.2>7.6/0.0>0.0%2C/6.2>7.6/0.0>0.0;SpliceAI=SCARF2|0.00|0.00|0.00|0.00|-20|-35|46|-39%2CXXbac-B562F10.12|0.00|0.00|0.00|0.00|-20|-35|46|-1;NGSD_hom=0;NGSD_het=9480;NGSD_mosaic=4;NGSD_group=0%20/%201065;gene_info=SCARF2%20(inh%3DAR%20oe_syn%3D0.79%20oe_mis%3D0.62%20oe_lof%3D0.06)	GT	1/0
chr22	23311788	.	T	TCCGG	38	.	quality=DP%3D89%3BQD%3D0.43%3BAF%3D0.21%3BMQM%3D35%3BSAP%3D44%3BABP%3D66%3BSAR%3D19%3BSAF%3D0;gene=BCR;variant_type=frameshift;coding_and_splicing=BCR:ENST00000359540.7:frameshift_variant:HIGH:exon18/22:c.3143_3146dup:p.Val1050ArgfsTer17:PF00620%20[RhoGAP%20domain]%2CBCR:ENST00000305877.13:frameshift_variant:HIGH:exon19/23:c.3275_3278dup:p.Val1094ArgfsTer17:PF00620%20[RhoGAP%20domain];regulatory=regulatory_region_variant:enhancer;OMIM=151410_[GENE%3DBCR_PHENOS%3DLeukemia%2C%20chronic%20myeloid%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20608232%20(4)%3B%20Leukemia%2C%20acute%20lymphocytic%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20613065%20(4)];ClinVar=1206149%20[uncertain%20significance%20DISEASE%3Dnot%20provided%2CChronic%20myelogenous%20leukemia%2C%20BCR-ABL1%20positive%20GENE%3DBCR]%3B;HGMD=CI2312613%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Lynch%20syndrome"%20GENE%3DBCR]%3B;dbSNP=rs372013175;MaxEntScan=/0.0>0.5/0.0>0.0;SpliceAI=BCR|0.00|0.00|0.03|0.02|50|24|-19|48;PubMed=36979105%2C37692064;NGSD_hom=3;NGSD_het=1494;NGSD_mosaic=25;NGSD_group=0%20/%20107;gene_info=BCR%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D0.91%20oe_lof%3D0.17)	GT	1/0
chr22	23315417	.	T	C	2079	.	quality=DP%3D168%3BQD%3D12.38%3BAF%3D0.49%3BMQM%3D60%3BSAP%3D22%3BABP%3D3%3BSAR%3D28%3BSAF%3D55;gene=BCR;variant_type=splice_region&intron;coding_and_splicing=BCR:ENST00000359540.7:splice_region_variant&intron_variant:LOW:intron21/21:c.3595-16T>C::%2CBCR:ENST00000305877.13:splice_region_variant&intron_variant:LOW:intron22/22:c.3727-16T>C::;regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=151410_[GENE%3DBCR_PHENOS%3DLeukemia%2C%20chronic%20myeloid%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20608232%20(4)%3B%20Leukemia%2C%20acute%20lymphocytic%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20613065%20(4)];dbSNP=rs116411381;gnomAD=0.00360;gnomAD_sub=0.00140%2C0.00666%2C0.00000%2C0.00545%2C0.00145;gnomAD_hom_hemi=5%2C;gnomAD_het=539;gnomAD_wt=151759;phyloP=-0.5940;CADD=0.74;MaxEntScan=9.2>9.6/9.2>9.6/0.0>0.0;SpliceAI=BCR|0.01|0.00|0.00|0.00|22|43|22|21;NGSD_hom=3;NGSD_het=586;NGSD_mosaic=0;NGSD_group=0%20/%2076;gene_info=BCR%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D0.91%20oe_lof%3D0.17)	GT	1/0
chr22	23315477	.	C	T	2210	.	quality=DP%3D168%3BQD%3D13.15%3BAF%3D0.52%3BMQM%3D59%3BSAP%3D13%3BABP%3D4%3BSAR%3D54%3BSAF%3D34;gene=BCR;variant_type=synonymous;coding_and_splicing=BCR:ENST00000359540.7:synonymous_variant:LOW:exon22/22:c.3639C>T:p.Ala1213%3D:%2CBCR:ENST00000305877.13:synonymous_variant:LOW:exon23/23:c.3771C>T:p.Ala1257%3D:;regulatory=regulatory_region_variant:CTCF_binding_site;OMIM=151410_[GENE%3DBCR_PHENOS%3DLeukemia%2C%20chronic%20myeloid%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20608232%20(4)%3B%20Leukemia%2C%20acute%20lymphocytic%2C%20Philadelphia%20chromosome%20positive%2C%20somatic%2C%20613065%20(4)];ClinVar=784726%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DBCR]%3B;dbSNP=rs73152683;gnomAD=0.00324;gnomAD_sub=0.00103%2C0.00660%2C0.00000%2C0.00497%2C0.00000;gnomAD_hom_hemi=5%2C;gnomAD_het=483;gnomAD_wt=151831;phyloP=0.0330;CADD=7.70;MaxEntScan=/5.3>5.3/0.0>0.0;SpliceAI=BCR|0.01|0.00|0.00|0.00|-17|41|9|47;NGSD_hom=1;NGSD_het=453;NGSD_mosaic=0;NGSD_group=0%20/%2059;gene_info=BCR%20(inh%3Dn/a%20oe_syn%3D1.13%20oe_mis%3D0.91%20oe_lof%3D0.17)	GT	1/0
chr22	30967827	.	T	C	1820	.	quality=DP%3D135%3BQD%3D13.48%3BAF%3D0.53%3BMQM%3D60%3BSAP%3D11%3BABP%3D4%3BSAR%3D28%3BSAF%3D44;gene=MORC2%2CTUG1;variant_type=synonymous%2C5'UTR%2Cupstream_gene;coding_and_splicing=MORC2:ENST00000397641.8:synonymous_variant:LOW:exon1/26:c.63A>G:p.Thr21%3D:%2CMORC2:ENST00000215862.8:5_prime_UTR_variant:MODIFIER:exon1/27:c.-990A>G::%2CTUG1:ENST00000644773.3:upstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=616661_[GENE%3DMORC2_PHENOS%3DCharcot-Marie-Tooth%20disease%2C%20axonal%2C%20type%202Z%2C%20616688%20(3)%2C%20Autosomal%20dominant%3B%20Developmental%20delay%2C%20impaired%20growth%2C%20dysmorphic%20facies%2C%20and%20axonal%20neuropathy%2C%20619090%20(3)%2C%20Autosomal%20dominant];ClinVar=766527%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CCharcot-Marie-Tooth%20disease%20axonal%20type%202Z%2Cnot%20specified%2CDevelopmental%20delay%2C%20impaired%20growth%2C%20dysmorphic%20facies%2C%20and%20axonal%20neuropathy%20GENE%3DMORC2]%3B;dbSNP=rs73156742;gnomAD=0.00219;gnomAD_sub=0.00058%2C0.00320%2C0.00000%2C0.00304%2C0.00041;gnomAD_hom_hemi=1%2C;gnomAD_het=332;gnomAD_wt=151982;phyloP=-0.1170;CADD=11.21;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=MORC2|0.00|0.00|0.00|0.00|42|-21|-5|1;NGSD_hom=1;NGSD_het=188;NGSD_mosaic=0;NGSD_group=1%20/%2014;gene_info=MORC2%20(inh%3DAD%20oe_syn%3D0.92%20oe_mis%3D0.63%20oe_lof%3D0.10)%2C%20TUG1%20(inh%3Dn/a%20oe_syn%3Dn/a%20oe_mis%3Dn/a%20oe_lof%3Dn/a)	GT	1/0
chr22	33277139	.	C	T	3740	.	quality=DP%3D331%3BQD%3D11.30%3BAF%3D0.46%3BMQM%3D60%3BSAP%3D17%3BABP%3D9%3BSAR%3D60%3BSAF%3D91;gene=LARGE1;variant_type=intron%2Cmissense;coding_and_splicing=LARGE1:ENST00000608642.6:intron_variant:MODIFIER:intron11/11:c.1730+27090G>A::%2CLARGE1:ENST00000609799.6:intron_variant:MODIFIER:intron10/10:c.1451+38946G>A::%2CLARGE1:ENST00000610186.6:intron_variant:MODIFIER:intron12/12:c.1877+6063G>A::%2CLARGE1:ENST00000397394.8:missense_variant:MODERATE:exon14/15:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000674780.1:missense_variant:MODERATE:exon10/11:c.1391G>A:p.Arg464His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000674999.1:missense_variant:MODERATE:exon13/14:c.1790G>A:p.Arg597His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000674668.1:missense_variant:MODERATE:exon12/13:c.1868G>A:p.Arg623His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000676126.1:missense_variant:MODERATE:exon12/13:c.1715G>A:p.Arg572His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000676132.1:missense_variant:MODERATE:exon15/16:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000675416.1:missense_variant:MODERATE:exon14/15:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000402320.6:missense_variant:MODERATE:exon13/14:c.1838G>A:p.Arg613His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000354992.7:missense_variant:MODERATE:exon15/16:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000676370.1:missense_variant:MODERATE:exon14/15:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000676070.1:missense_variant:MODERATE:exon14/15:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000413114.6:missense_variant:MODERATE:exon15/16:c.1994G>A:p.Arg665His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000674789.1:missense_variant:MODERATE:exon13/14:c.1847G>A:p.Arg616His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan]%2CLARGE1:ENST00000675277.1:missense_variant:MODERATE:exon14/15:c.1790G>A:p.Arg597His:PF13896%20[Glycosyl-transferase%20for%20dystroglycan];OMIM=603590_[GENE%3DLARGE1_PHENOS%3DMuscular%20dystrophy-dystroglycanopathy%20(congenital%20with%20impaired%20intellectual%20development)%2C%20type%20B%2C%206%2C%20608840%20(3)%2C%20Autosomal%20recessive%3B%20Muscular%20dystrophy-dystroglycanopathy%20(congenital%20with%20brain%20and%20eye%20anomalies)%2C%20type%20A%2C%206%2C%20613154%20(3)%2C%20Autosomal%20recessive];ClinVar=95171%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2CMuscular%20dystrophy-dystroglycanopathy%20(congenital%20with%20brain%20and%20eye%20anomalies)%2C%20type%20A6%2Cnot%20provided%2CMuscular%20dystrophy-dystroglycanopathy%20type%20B6%20GENE%3DLARGE1]%3B;dbSNP=rs1046166;gnomAD=0.00597;gnomAD_sub=0.00228%2C0.00215%2C0.00019%2C0.00992%2C0.00290;gnomAD_hom_hemi=5%2C;gnomAD_het=900;gnomAD_wt=151466;phyloP=2.9110;CADD=25.70;REVEL=0.149;AlphaMissense=0.11;MaxEntScan=/0.0>0.0/3.0>0.0;SpliceAI=LARGE|0.00|0.00|0.00|0.00|44|-33|18|-24;PubMed=18414213%2C23757202%2C17878207;NGSD_hom=1;NGSD_het=546;NGSD_mosaic=2;NGSD_group=1%20/%2070;gene_info=LARGE1%20(inh%3DAR%20oe_syn%3D1.12%20oe_mis%3D0.74%20oe_lof%3D0.15)	GT	1/0
chr22	36292132	.	G	A	2398	.	quality=DP%3D200%3BQD%3D11.99%3BAF%3D0.48%3BMQM%3D60%3BSAP%3D21%3BABP%3D4%3BSAR%3D62%3BSAF%3D34;gene=MYH9;variant_type=missense;coding_and_splicing=MYH9:ENST00000216181.11:missense_variant:MODERATE:exon31/41:c.4198C>T:p.Arg1400Trp:PF01576%20[Myosin%20tail]%2CMYH9:ENST00000685801.1:missense_variant:MODERATE:exon32/42:c.4261C>T:p.Arg1421Trp:PF01576%20[Myosin%20tail];regulatory=regulatory_region_variant:enhancer;OMIM=160775_[GENE%3DMYH9_PHENOS%3DMacrothrombocytopenia%20and%20granulocyte%20inclusions%20with%20or%20without%20nephritis%20or%20sensorineural%20hearing%20loss%2C%20155100%20(3)%2C%20Autosomal%20dominant%3B%20Deafness%2C%20autosomal%20dominant%2017%2C%20603622%20(3)%2C%20Autosomal%20dominant];ClinVar=44562%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2Cnot%20specified%2CMYH9-related%20disorder%2CAutosomal%20dominant%20nonsyndromic%20hearing%20loss%2017%2CMacrothrombocytopenia%20and%20granulocyte%20inclusions%20with%20or%20without%20nephritis%20or%20sensorineural%20hearing%20loss%2CMeniere%20disease%20GENE%3DMYH9]%3B;HGMD=CM024613%20[CLASS%3DDM?%20MUT%3DALT%20PHEN%3D"Epstein%20syndrome"%20GENE%3DMYH9]%3B;dbSNP=rs76368635;gnomAD=0.00117;gnomAD_sub=0.00058%2C0.00111%2C0.00000%2C0.00196%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=178;gnomAD_wt=152136;phyloP=3.2630;CADD=27.90;REVEL=0.670;AlphaMissense=0.13;MaxEntScan=/0.0>0.0/0.2>0.0;COSMIC=COSV106339336;SpliceAI=MYH9|0.00|0.00|0.00|0.00|12|-9|43|-14;PubMed=25741868%2C24033266%2C22995991%2C11752022%2C22123909%2C22477015%2C24643058%2C28059092%2C29090586%2C30720677%2C18676005;NGSD_hom=0;NGSD_het=99;NGSD_mosaic=0;NGSD_group=0%20/%2012;gene_info=MYH9%20(inh%3DAD%20oe_syn%3D1.18%20oe_mis%3D0.71%20oe_lof%3D0.04)	GT	1/0
chr22	37765831	.	G	GT	858	.	quality=DP%3D96%3BQD%3D8.94%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D4%3BABP%3D10%3BSAR%3D21%3BSAF%3D18;gene=TRIOBP;variant_type=splice_region&intron;coding_and_splicing=TRIOBP:ENST00000644935.1:splice_region_variant&intron_variant:LOW:intron18/23:c.6472+14_6472+15insT::%2CTRIOBP:ENST00000403663.6:splice_region_variant&intron_variant:LOW:intron8/13:c.1333+14_1333+15insT::;OMIM=609761_[GENE%3DTRIOBP_PHENOS%3DDeafness%2C%20autosomal%20recessive%2028%2C%20609823%20(3)%2C%20Autosomal%20recessive];ClinVar=1548069%20[benign/likely%20benign%20DISEASE%3DTRIOBP-related%20disorder%2Cnot%20provided%20GENE%3DTRIOBP]%3B;dbSNP=rs546389039;gnomAD=0.00027;gnomAD_sub=0.00019%2C0.00020%2C0.00039%2C0.00024%2C0.00250;gnomAD_hom_hemi=0%2C;gnomAD_het=41;gnomAD_wt=151403;CADD=2.89;MaxEntScan=/0.0>0.0/0.0>0.8;NGSD_hom=2;NGSD_het=38;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TRIOBP%20(inh%3DAR%20oe_syn%3D0.94%20oe_mis%3D1.01%20oe_lof%3D0.58)	GT	1/0
chr22	39670112	.	C	T	3761	.	quality=DP%3D316%3BQD%3D11.90%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D5%3BABP%3D5%3BSAR%3D81%3BSAF%3D69;gene=CACNA1I;variant_type=synonymous;coding_and_splicing=CACNA1I:ENST00000407673.5:synonymous_variant:LOW:exon24/35:c.4164C>T:p.Leu1388%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1I:ENST00000401624.5:synonymous_variant:LOW:exon25/36:c.4269C>T:p.Leu1423%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1I:ENST00000404898.5:synonymous_variant:LOW:exon24/36:c.4164C>T:p.Leu1388%3D:PF00520%20[Ion%20transport%20protein]%2CCACNA1I:ENST00000402142.4:synonymous_variant:LOW:exon25/37:c.4269C>T:p.Leu1423%3D:PF00520%20[Ion%20transport%20protein];OMIM=608230_[GENE%3DCACNA1I_PHENOS%3DNeurodevelopmental%20disorder%20with%20speech%20impairment%20and%20with%20or%20without%20seizures%2C%20620114%20(3)%2C%20Autosomal%20dominant];ClinVar=710286%20[benign%20DISEASE%3Dnot%20provided%2CCACNA1I-related%20disorder%20GENE%3DCACNA1I]%3B;dbSNP=rs55968092;gnomAD=0.00427;gnomAD_sub=0.00106%2C0.00431%2C0.00000%2C0.00706%2C0.00062;gnomAD_hom_hemi=4%2C;gnomAD_het=642;gnomAD_wt=151710;phyloP=1.8770;CADD=12.82;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CACNA1I|0.05|0.00|0.00|0.00|28|-12|-18|9;NGSD_hom=0;NGSD_het=491;NGSD_mosaic=0;NGSD_group=0%20/%2072;gene_info=CACNA1I%20(inh%3DAD%20oe_syn%3D1.08%20oe_mis%3D0.59%20oe_lof%3D0.12)	GT	1/0
chr22	46377227	.	T	C	1378	.	quality=DP%3D106%3BQD%3D13.00%3BAF%3D0.55%3BMQM%3D60%3BSAP%3D97%3BABP%3D5%3BSAR%3D54%3BSAF%3D4;gene=CELSR1;variant_type=missense;coding_and_splicing=CELSR1:ENST00000262738.9:missense_variant:MODERATE:exon24/35:c.7418A>G:p.Tyr2473Cys:PF00002%20[7%20transmembrane%20receptor%20(Secretin%20family)]%2CCELSR1:ENST00000674500.2:missense_variant:MODERATE:exon24/35:c.7418A>G:p.Tyr2473Cys:PF00002%20[7%20transmembrane%20receptor%20(Secretin%20family)];regulatory=regulatory_region_variant:open_chromatin_region;OMIM=604523_[GENE%3DCELSR1_PHENOS%3DLymphatic%20malformation%209%2C%20619319%20(3)%2C%20Autosomal%20dominant];dbSNP=rs73177077;gnomAD=0.00012;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00025%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=19;gnomAD_wt=152211;phyloP=3.5990;CADD=22.40;REVEL=0.364;AlphaMissense=0.18;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=CELSR1|0.00|0.00|0.00|0.00|10|-27|34|-27;NGSD_hom=0;NGSD_het=24;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=CELSR1%20(inh%3DAD%20oe_syn%3D1.15%20oe_mis%3D0.92%20oe_lof%3D0.17)	GT	1/0
chr22	50244017	.	T	C	3393	.	quality=DP%3D266%3BQD%3D12.76%3BAF%3D0.50%3BMQM%3D60%3BSAP%3D5%3BABP%3D3%3BSAR%3D71%3BSAF%3D61;gene=TUBGCP6%2CHDAC10;variant_type=missense%2Cdownstream_gene;coding_and_splicing=TUBGCP6:ENST00000248846.10:missense_variant:MODERATE:exon1/25:c.443A>G:p.Tyr148Cys:PF19340%20[Gamma-tubulin%20complex%20component%206%20N-terminus]%2CHDAC10:ENST00000216271.10:downstream_gene_variant:MODIFIER::::%2CHDAC10:ENST00000448072.5:downstream_gene_variant:MODIFIER::::%2CHDAC10:ENST00000349505.4:downstream_gene_variant:MODIFIER::::;OMIM=610053_[GENE%3DTUBGCP6_PHENOS%3DMicrocephaly%20and%20chorioretinopathy%2C%20autosomal%20recessive%2C%201%2C%20251270%20(3)%2C%20Autosomal%20recessive];ClinVar=972631%20[uncertain%20significance%20DISEASE%3Dnot%20provided%20GENE%3DTUBGCP6]%3B;dbSNP=rs73187278;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00001%2C0.00000;gnomAD_hom_hemi=0%2C;gnomAD_het=1;gnomAD_wt=152373;phyloP=7.6060;CADD=24.80;REVEL=0.430;AlphaMissense=0.31;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=TUBGCP6|0.00|0.00|0.00|0.00|5|-41|-17|12;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=TUBGCP6%20(inh%3DAR%20oe_syn%3D1.24%20oe_mis%3D1.08%20oe_lof%3D0.74)%2C%20HDAC10%20(inh%3Dn/a%20oe_syn%3D1.15%20oe_mis%3D1.06%20oe_lof%3D1.17)	GT	1/0
chr22	50457029	.	G	C	1057	.	quality=DP%3D94%3BQD%3D11.24%3BAF%3D0.47%3BMQM%3D60%3BSAP%3D3%3BABP%3D4%3BSAR%3D21%3BSAF%3D23;gene=SBF1;variant_type=intron%2Csplice_region&intron;coding_and_splicing=SBF1:ENST00000689129.1:intron_variant:MODIFIER:intron28/39:c.3830-356C>G::%2CSBF1:ENST00000380817.8:splice_region_variant&intron_variant:LOW:intron29/40:c.3904+5C>G::%2CSBF1:ENST00000693052.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3922+5C>G::%2CSBF1:ENST00000693440.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3901+5C>G::%2CSBF1:ENST00000690990.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3898+5C>G::%2CSBF1:ENST00000348911.11:intron_variant:MODIFIER:intron28/39:c.3827-356C>G::%2CSBF1:ENST00000691233.1:intron_variant:MODIFIER:intron28/39:c.3824-356C>G::%2CSBF1:ENST00000689981.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3904+5C>G::%2CSBF1:ENST00000685809.1:intron_variant:MODIFIER:intron28/39:c.3818-356C>G::%2CSBF1:ENST00000687016.1:intron_variant:MODIFIER:intron28/39:c.3806-356C>G::%2CSBF1:ENST00000684986.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3907+5C>G::%2CSBF1:ENST00000691792.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3904+5C>G::%2CSBF1:ENST00000688066.1:splice_region_variant&intron_variant:LOW:intron29/40:c.3904+5C>G::;regulatory=regulatory_region_variant:TF_binding_site%2Cregulatory_region_variant:CTCF_binding_site;OMIM=603560_[GENE%3DSBF1_PHENOS%3DCharcot-Marie-Tooth%20disease%2C%20type%204B3%2C%20615284%20(3)%2C%20Autosomal%20recessive];ClinVar=440250%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2CCharcot-Marie-Tooth%20disease%20type%204B3%2Cnot%20provided%20GENE%3DSBF1]%3B;dbSNP=rs115032856;gnomAD=0.00250;gnomAD_sub=0.00063%2C0.00065%2C0.00000%2C0.00441%2C0.00021;gnomAD_hom_hemi=1%2C;gnomAD_het=379;gnomAD_wt=151861;phyloP=-0.2160;CADD=11.91;MaxEntScan=8.5>9.4/0.7>0.0/8.5>9.4%2C/0.7>0.0/8.5>9.4;SpliceAI=SBF1|0.00|0.00|0.00|0.00|21|5|5|-36;NGSD_hom=1;NGSD_het=298;NGSD_mosaic=0;NGSD_group=0%20/%2040;gene_info=SBF1%20(inh%3DAR%20oe_syn%3D1.39%20oe_mis%3D0.96%20oe_lof%3D0.17)	GT	1/0
chrX	2935105	.	C	T	2078	.	quality=DP%3D201%3BQD%3D10.34%3BAF%3D0.43%3BMQM%3D59%3BSAP%3D9%3BABP%3D11%3BSAR%3D51%3BSAF%3D36;gene=ARSL;variant_type=synonymous%2Cdownstream_gene;coding_and_splicing=ARSL:ENST00000681963.1:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000682184.1:synonymous_variant:LOW:exon10/10:c.1374G>A:p.Pro458%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000683290.1:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000683677.1:synonymous_variant:LOW:exon11/11:c.1485G>A:p.Pro495%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000684364.1:synonymous_variant:LOW:exon11/11:c.1485G>A:p.Pro495%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000684117.1:synonymous_variant:LOW:exon10/10:c.1335G>A:p.Pro445%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000540563.6:synonymous_variant:LOW:exon11/11:c.1497G>A:p.Pro499%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000381134.9:synonymous_variant:LOW:exon11/11:c.1497G>A:p.Pro499%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000673032.1:synonymous_variant:LOW:exon11/11:c.1335G>A:p.Pro445%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000672097.1:synonymous_variant:LOW:exon11/11:c.1494G>A:p.Pro498%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000672761.1:synonymous_variant:LOW:exon10/10:c.1335G>A:p.Pro445%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000545496.6:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000684077.1:synonymous_variant:LOW:exon7/7:c.1050G>A:p.Pro350%3D:%2CARSL:ENST00000684738.1:synonymous_variant:LOW:exon9/9:c.936G>A:p.Pro312%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000682364.1:synonymous_variant:LOW:exon9/9:c.936G>A:p.Pro312%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000672027.1:synonymous_variant:LOW:exon12/12:c.1572G>A:p.Pro524%3D:PF14707%20[C-terminal%20region%20of%20aryl-sulfatase]%2CARSL:ENST00000683958.1:downstream_gene_variant:MODIFIER::::;regulatory=regulatory_region_variant:open_chromatin_region;OMIM=300180_[GENE%3DARSL_PHENOS%3DChondrodysplasia%20punctata%2C%20X-linked%20recessive%2C%20302950%20(3)%2C%20X-linked%20recessive];ClinVar=2729141%20[likely%20benign%20DISEASE%3DChondrodysplasia%20punctata%2C%20brachytelephalangic%2C%20autosomal%20GENE%3DARSL]%3B;dbSNP=rs75821383;gnomAD=0.00035;gnomAD_sub=0.00107%2C0.00029%2C0.00000%2C0.00002%2C0.00000;gnomAD_hom_hemi=0%2C10;gnomAD_het=39;gnomAD_wt=111655;phyloP=-3.6470;CADD=0.03;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=ARSE|0.00|0.00|0.00|0.00|-35|41|9|-15;NGSD_hom=1;NGSD_het=14;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=ARSL%20(inh%3DXLR%20oe_syn%3D0.93%20oe_mis%3D0.66%20oe_lof%3D0.19)	GT	1/0
chrX	21882577	.	G	T	1043	.	quality=DP%3D80%3BQD%3D13.04%3BAF%3D0.56%3BMQM%3D60%3BSAP%3D29%3BABP%3D6%3BSAR%3D34%3BSAF%3D11;gene=MBTPS2;variant_type=synonymous;coding_and_splicing=MBTPS2:ENST00000379484.10:synonymous_variant:LOW:exon11/11:c.1482G>T:p.Gly494%3D:PF02163%20[Peptidase%20family%20M50];regulatory=regulatory_region_variant:enhancer;OMIM=300294_[GENE%3DMBTPS2_PHENOS%3DKeratosis%20follicularis%20spinulosa%20decalvans%2C%20X-linked%2C%20308800%20(3)%2C%20X-linked%20recessive%3B%20Osteogenesis%20imperfecta%2C%20type%20XIX%2C%20301014%20(3)%2C%20X-linked%20recessive%3B%20IFAP%20syndrome%20with%20or%20without%20BRESHECK%20syndrome%2C%20308205%20(3)%2C%20X-linked%20recessive%3B%20?Olmsted%20syndrome%2C%20X-linked%2C%20300918%20(3)%2C%20X-linked%20recessive];ClinVar=2895445%20[likely%20benign%20DISEASE%3Dnot%20provided%20GENE%3DMBTPS2]%3B;dbSNP=rs73195148;gnomAD=0.00001;gnomAD_sub=0.00000%2C0.00000%2C0.00000%2C0.00002%2C0.00000;gnomAD_hom_hemi=0%2C0;gnomAD_het=1;gnomAD_wt=112022;phyloP=1.6670;CADD=6.34;MaxEntScan=/0.1>0.6/0.0>0.0;SpliceAI=MBTPS2|0.00|0.00|0.00|0.00|24|-34|-2|-36;NGSD_hom=0;NGSD_het=11;NGSD_mosaic=0;NGSD_group=0%20/%201;gene_info=MBTPS2%20(inh%3DXLR%20oe_syn%3D0.98%20oe_mis%3D0.58%20oe_lof%3D0.00)	GT	1/0
chrX	36205127	.	G	A	369	.	quality=DP%3D22%3BQD%3D16.77%3BAF%3D0.73%3BMQM%3D60%3BSAP%3D23%3BABP%3D13%3BSAR%3D14%3BSAF%3D2;gene=CFAP47;variant_type=splice_region&intron;coding_and_splicing=CFAP47:ENST00000378653.8:splice_region_variant&intron_variant:LOW:intron45/63:c.6817+17G>A::;OMIM=301057_[GENE%3DCFAP47_PHENOS%3DSpermatogenic%20failure%2C%20X-linked%203%2C%20301059%20(3)%2C%20X-linked%20recessive];dbSNP=rs73197180;gnomAD=0.00052;gnomAD_sub=0.00023%2C0.00019%2C0.00000%2C0.00087%2C0.00000;gnomAD_hom_hemi=0%2C15;gnomAD_het=58;gnomAD_wt=111314;phyloP=-0.7910;CADD=0.70;MaxEntScan=/0.2>0.0/0.8>0.0;NGSD_hom=8;NGSD_het=13;NGSD_mosaic=0;NGSD_group=0%20/%202;gene_info=CFAP47%20(inh%3DXLR%20oe_syn%3D1.20%20oe_mis%3D0.87%20oe_lof%3D0.35)	GT	1/0
chrX	45062751	.	G	A	268	.	quality=DP%3D30%3BQD%3D8.93%3BAF%3D0.43%3BMQM%3D60%3BSAP%3D7%3BABP%3D4%3BSAR%3D9%3BSAF%3D4;gene=KDM6A;variant_type=splice_region&intron%2Cintron;coding_and_splicing=KDM6A:ENST00000674586.1:splice_region_variant&intron_variant:LOW:intron16/29:c.1605+3G>A::%2CKDM6A:ENST00000674867.1:splice_region_variant&intron_variant:LOW:intron13/26:c.1389+3G>A::%2CKDM6A:ENST00000382899.9:splice_region_variant&intron_variant:LOW:intron15/28:c.1548+3G>A::%2CKDM6A:ENST00000536777.6:splice_region_variant&intron_variant:LOW:intron14/27:c.1392+3G>A::%2CKDM6A:ENST00000543216.6:intron_variant:MODIFIER:intron13/26:c.1291-671G>A::%2CKDM6A:ENST00000377967.9:splice_region_variant&intron_variant:LOW:intron15/28:c.1527+3G>A::%2CKDM6A:ENST00000611820.5:splice_region_variant&intron_variant:LOW:intron16/29:c.1683+3G>A::%2CKDM6A:ENST00000683021.1:intron_variant:MODIFIER:intron14/27:c.1447-671G>A::;OMIM=300128_[GENE%3DKDM6A_PHENOS%3DKabuki%20syndrome%202%2C%20300867%20(3)%2C%20X-linked%20dominant];ClinVar=261406%20[benign/likely%20benign%20DISEASE%3Dnot%20specified%2Cnot%20provided%2CKabuki%20syndrome%202%20GENE%3DKDM6A]%3B;dbSNP=rs61751429;gnomAD=0.00274;gnomAD_sub=0.00039%2C0.00047%2C0.00000%2C0.00473%2C0.00000;gnomAD_hom_hemi=1%2C78;gnomAD_het=305;gnomAD_wt=111908;phyloP=0.9650;CADD=14.69;MaxEntScan=3.8>7.4/0.0>0.0/3.8>7.4%2C/0.0>0.0/3.8>7.4;SpliceAI=KDM6A|0.00|0.00|0.00|0.00|47|-1|-3|-1;PubMed=25741868;NGSD_hom=94;NGSD_het=186;NGSD_mosaic=0;NGSD_group=5%20/%2032;classification=1;classification_comment="[1]%20ahbuchr1%2025.08.2016%20MAF>0%2C5?75%20Hemizygote%20in%20ExAC";gene_info=KDM6A%20(inh%3DXLD%20oe_syn%3D0.99%20oe_mis%3D0.63%20oe_lof%3D0.07)	GT	1/0
chrX	48806443	.	C	T	1789	.	quality=DP%3D132%3BQD%3D13.55%3BAF%3D0.54%3BMQM%3D59%3BSAP%3D3%3BABP%3D5%3BSAR%3D36%3BSAF%3D35;gene=HDAC6;variant_type=synonymous%2C3'UTR%2Cintron%2Cdownstream_gene;coding_and_splicing=HDAC6:ENST00000423941.6:synonymous_variant:LOW:exon8/30:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000438518.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*768C>T::%2CHDAC6:ENST00000376643.7:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000469223.6:synonymous_variant:LOW:exon6/28:c.348C>T:p.Tyr116%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000376610.7:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000462730.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*768C>T::%2CHDAC6:ENST00000376619.7:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000697348.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*768C>T::%2CHDAC6:ENST00000697349.1:synonymous_variant:LOW:exon7/29:c.501C>T:p.Tyr167%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000697320.1:synonymous_variant:LOW:exon6/28:c.348C>T:p.Tyr116%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000334136.11:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000697368.1:synonymous_variant:LOW:exon7/28:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000646703.2:intron_variant:MODIFIER:intron3/18:c.160+3506C>T::%2CHDAC6:ENST00000461608.2:synonymous_variant:LOW:exon7/8:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000477561.6:synonymous_variant:LOW:exon7/29:c.348C>T:p.Tyr116%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000443563.6:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000643374.2:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000644068.1:synonymous_variant:LOW:exon7/29:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000697328.1:intron_variant:MODIFIER:intron4/24:c.312-1590C>T::%2CHDAC6:ENST00000643934.1:synonymous_variant:LOW:exon6/28:c.348C>T:p.Tyr116%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000440653.2:synonymous_variant:LOW:exon6/28:c.513C>T:p.Tyr171%3D:PF00850%20[Histone%20deacetylase%20domain]%2CHDAC6:ENST00000642405.2:synonymous_variant:LOW:exon6/27:c.513C>T:p.Tyr171%3D:%2CHDAC6:ENST00000465269.6:downstream_gene_variant:MODIFIER::::%2CHDAC6:ENST00000476625.5:downstream_gene_variant:MODIFIER::::%2CHDAC6:ENST00000441703.6:downstream_gene_variant:MODIFIER::::%2CHDAC6:ENST00000489352.5:downstream_gene_variant:MODIFIER::::;OMIM=300272_[GENE%3DHDAC6_PHENOS%3D?Chondrodysplasia%20with%20platyspondyly%2C%20distinctive%20brachydactyly%2C%20hydrocephaly%2C%20and%20microphthalmia%2C%20300863%20(3)%2C%20X-linked%20dominant];ClinVar=717434%20[benign/likely%20benign%20DISEASE%3Dnot%20provided%2CX-linked%20dominant%20chondrodysplasia%2C%20Chassaing-Lacombe%20type%20GENE%3DHDAC6]%3B;dbSNP=rs73209760;gnomAD=0.00205;gnomAD_sub=0.00116%2C0.00028%2C0.00000%2C0.00351%2C0.00073;gnomAD_hom_hemi=1%2C58;gnomAD_het=229;gnomAD_wt=112304;phyloP=0.8420;CADD=5.51;MaxEntScan=/0.0>0.0/0.0>0.0;COSMIC=COSV100491390;SpliceAI=HDAC6|0.00|0.00|0.00|0.02|21|-10|6|21;NGSD_hom=64;NGSD_het=157;NGSD_mosaic=0;NGSD_group=2%20/%2030;gene_info=HDAC6%20(inh%3DXLD%20oe_syn%3D0.97%20oe_mis%3D0.58%20oe_lof%3D0.00)	GT	1/0
chrX	71127480	.	G	A	516	.	quality=DP%3D63%3BQD%3D8.19%3BAF%3D0.40%3BMQM%3D60%3BSAP%3D49%3BABP%3D9%3BSAR%3D24%3BSAF%3D1;gene=MED12;variant_type=splice_region&intron;coding_and_splicing=MED12:ENST00000690242.1:splice_region_variant&intron_variant:LOW:intron21/45:c.2981+13G>A::%2CMED12:ENST00000692304.1:splice_region_variant&intron_variant:LOW:intron21/44:c.2981+13G>A::%2CMED12:ENST00000687382.1:splice_region_variant&intron_variant:LOW:intron21/45:c.2981+13G>A::%2CMED12:ENST00000333646.11:splice_region_variant&intron_variant:LOW:intron21/44:c.2861+13G>A::%2CMED12:ENST00000374080.8:splice_region_variant&intron_variant:LOW:intron21/44:c.2981+13G>A::%2CMED12:ENST00000374102.6:splice_region_variant&intron_variant:LOW:intron21/44:c.2981+13G>A::%2CMED12:ENST00000690145.1:splice_region_variant&intron_variant:LOW:intron21/44:c.2981+13G>A::;OMIM=300188_[GENE%3DMED12_PHENOS%3DLujan-Fryns%20syndrome%2C%20309520%20(3)%2C%20X-linked%20recessive%3B%20Ohdo%20syndrome%2C%20X-linked%2C%20300895%20(3)%2C%20X-linked%20recessive%3B%20Hardikar%20syndrome%2C%20301068%20(3)%2C%20X-linked%20dominant%3B%20Opitz-Kaveggia%20syndrome%2C%20305450%20(3)%2C%20X-linked%20recessive];ClinVar=213622%20[benign%20DISEASE%3DFG%20syndrome%2Cnot%20specified%20GENE%3DMED12]%3B;dbSNP=rs73214870;gnomAD=0.00106;gnomAD_sub=0.00020%2C0.00341%2C0.00000%2C0.00138%2C0.00000;gnomAD_hom_hemi=0%2C36;gnomAD_het=118;gnomAD_wt=111470;phyloP=1.5300;CADD=18.38;MaxEntScan=/0.0>0.0/0.0>2.9;SpliceAI=MED12|0.00|0.00|0.12|0.01|-45|-3|3|-13;NGSD_hom=19;NGSD_het=47;NGSD_mosaic=0;NGSD_group=0%20/%206;gene_info=MED12%20(inh%3DXLR%20oe_syn%3D0.91%20oe_mis%3D0.38%20oe_lof%3D0.02)	GT	1/0
chrX	124061774	.	T	A	113	.	quality=DP%3D35%3BQD%3D3.23%3BAF%3D0.11%3BMQM%3D60%3BSAP%3D12%3BABP%3D48%3BSAR%3D0%3BSAF%3D4;gene=STAG2;variant_type=missense;coding_and_splicing=STAG2:ENST00000455404.6:missense_variant:MODERATE:exon16/33:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000218089.13:missense_variant:MODERATE:exon17/35:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000371160.5:missense_variant:MODERATE:exon17/34:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000687852.1:missense_variant:MODERATE:exon20/38:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000371145.8:missense_variant:MODERATE:exon17/35:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000692982.1:missense_variant:MODERATE:exon16/32:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000371157.7:missense_variant:MODERATE:exon16/33:c.1538T>A:p.Leu513Gln:%2CSTAG2:ENST00000371144.7:missense_variant:MODERATE:exon17/34:c.1538T>A:p.Leu513Gln:;OMIM=300826_[GENE%3DSTAG2_PHENOS%3DHoloprosencephaly%2013%2C%20X-linked%2C%20301043%20(3)%2C%20X-linked%20recessive%2C%20X-linked%20dominant%3B%20Mullegama-Klein-Martinez%20syndrome%2C%20301022%20(3)%2C%20X-linked];dbSNP=rs1304128992;gnomAD=0.00007;gnomAD_sub=0.00000%2C0.00000%2C0.00044%2C0.00009%2C0.00080;gnomAD_hom_hemi=0%2C0;gnomAD_het=6;gnomAD_wt=82519;phyloP=7.9480;CADD=26.40;REVEL=0.560;AlphaMissense=0.98;MaxEntScan=/1.9>0.8/0.0>0.0;COSMIC=COSV54370702;SpliceAI=STAG2|0.09|0.00|0.00|0.00|6|-3|9|-9;NGSD_hom=73;NGSD_het=85;NGSD_mosaic=0;NGSD_group=5%20/%208;gene_info=STAG2%20(inh%3DXLR%20oe_syn%3D1.04%20oe_mis%3D0.34%20oe_lof%3D0.02)	GT	1/0
chrX	135985516	.	G	C	519	.	quality=DP%3D72%3BQD%3D7.21%3BAF%3D0.36%3BMQM%3D60%3BSAP%3D30%3BABP%3D15%3BSAR%3D4%3BSAF%3D22;gene=SLC9A6;variant_type=intron%2Cmissense;coding_and_splicing=SLC9A6:ENST00000636347.1:intron_variant:MODIFIER:intron2/17:c.-35-108G>C::%2CSLC9A6:ENST00000636092.1:intron_variant:MODIFIER:intron1/16:c.-56-87G>C::%2CSLC9A6:ENST00000637195.1:intron_variant:MODIFIER:intron1/16:c.-35-108G>C::%2CSLC9A6:ENST00000637234.1:intron_variant:MODIFIER:intron3/18:c.-56-87G>C::%2CSLC9A6:ENST00000637581.1:intron_variant:MODIFIER:intron1/16:c.-56-87G>C::%2CSLC9A6:ENST00000370701.6:intron_variant:MODIFIER:intron1/16:c.-57+39G>C::%2CSLC9A6:ENST00000370698.7:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:%2CSLC9A6:ENST00000370695.8:missense_variant:MODERATE:exon1/16:c.14G>C:p.Gly5Ala:%2CSLC9A6:ENST00000630721.3:intron_variant:MODIFIER:intron1/17:c.-57+39G>C::%2CSLC9A6:ENST00000678163.1:missense_variant:MODERATE:exon1/17:c.14G>C:p.Gly5Ala:;regulatory=regulatory_region_variant:promoter;OMIM=300231_[GENE%3DSLC9A6_PHENOS%3DIntellectual%20developmental%20disorder%2C%20X-linked%20syndromic%2C%20Christianson%20type%2C%20300243%20(3)%2C%20X-linked];ClinVar=2895446%20[uncertain%20significance%20DISEASE%3DChristianson%20syndrome%20GENE%3DSLC9A6]%3B;RepeatMasker=G-rich%20(Low_complexity);dbSNP=rs2089318307;phyloP=1.3440;CADD=17.77;REVEL=0.131;AlphaMissense=0.09;MaxEntScan=/0.0>0.0/0.0>0.0;SpliceAI=SLC9A6|0.00|0.00|0.00|0.00|-39|40|-6|-39;NGSD_hom=0;NGSD_het=4;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=SLC9A6%20(inh%3DXLR%20oe_syn%3D0.96%20oe_mis%3D0.50%20oe_lof%3D0.04)	GT	1/0
chrX	150638926	.	T	G	810	.	quality=DP%3D93%3BQD%3D8.71%3BAF%3D0.41%3BMQM%3D60%3BSAP%3D36%3BABP%3D10%3BSAR%3D7%3BSAF%3D31;gene=MTM1;variant_type=splice_region&intron;coding_and_splicing=MTM1:ENST00000685944.1:splice_region_variant&intron_variant:LOW:intron6/14:c.445-17T>G::%2CMTM1:ENST00000691232.1:splice_region_variant&intron_variant:LOW:intron2/10:c.100-17T>G::%2CMTM1:ENST00000691851.1:splice_region_variant&intron_variant:LOW:intron6/10:c.445-17T>G::%2CMTM1:ENST00000691686.1:splice_region_variant&intron_variant:LOW:intron6/13:c.445-17T>G::%2CMTM1:ENST00000370396.7:splice_region_variant&intron_variant:LOW:intron6/14:c.445-17T>G::%2CMTM1:ENST00000692015.1:splice_region_variant&intron_variant:LOW:intron4/12:c.232-17T>G::%2CMTM1:ENST00000692852.1:splice_region_variant&intron_variant:LOW:intron6/13:c.445-17T>G::%2CMTM1:ENST00000689694.1:splice_region_variant&intron_variant:LOW:intron6/14:c.445-17T>G::%2CMTM1:ENST00000690282.1:splice_region_variant&intron_variant:LOW:intron1/9:c.-300-17T>G::%2CMTM1:ENST00000688403.1:splice_region_variant&intron_variant:LOW:intron1/9:c.-300-17T>G::%2CMTM1:ENST00000689314.1:splice_region_variant&intron_variant:LOW:intron7/15:c.490-17T>G::%2CMTM1:ENST00000685439.1:splice_region_variant&intron_variant:LOW:intron2/10:c.100-17T>G::;OMIM=300415_[GENE%3DMTM1_PHENOS%3DMyopathy%2C%20centronuclear%2C%20X-linked%2C%20310400%20(3)%2C%20X-linked%20recessive];ClinVar=1592201%20[likely%20benign%20DISEASE%3DSevere%20X-linked%20myotubular%20myopathy%20GENE%3DMTM1]%3B;dbSNP=rs73250563;gnomAD=0.00004;gnomAD_sub=0.00010%2C0.00000%2C0.00000%2C0.00002%2C0.00000;gnomAD_hom_hemi=0%2C2;gnomAD_het=4;gnomAD_wt=112105;phyloP=-0.5100;CADD=14.84;MaxEntScan=9.3>7.2/9.3>7.2/0.0>0.0%2C/9.3>7.2/0.0>0.0;SpliceAI=MTM1|0.37|0.12|0.00|0.00|1|17|17|35;NGSD_hom=4;NGSD_het=7;NGSD_mosaic=1;NGSD_group=0%20/%201;gene_info=MTM1%20(inh%3DXLR%20oe_syn%3D0.77%20oe_mis%3D0.57%20oe_lof%3D0.04)	GT	1/0